entity,frequency
CLL,14983
Acalabrutinib-Venetoclax,1
AV,2
MCL,53
AstraZeneca,642
AstraZeneca’s Calquence,43
FCR / BR,1
Optimal Management of High-Risk CLL,1
Acalabrutinib,252
2 - Group Captain,1
"Pune

Chair",1
@SWBH_RandD,1
The National Institute for Health and Care Excellence,1
FCR,153
NHS,34
https://t.co/nLoyYbepRA,1
PharmiwebNews,1
@IPPOSI,5
Nilemdo and Nustendi #,1
Sky News,1
@MDAndersonNews,133
KTE-X19,2
Ublituximab,49
Solidarity,12
Astra-Zeneca,1
ICYMI,22
Janssen Vaccines &,1
Prevention B.V.,1
Pharma B.V.,1
AstraZeneca AB,1
Amgen Inc.,4
FDA,1485
Brexucarbatagene Autoleucel FDA,1
BTK,750
TGTherapeutics,3
el objetivo,1
"LLC @AstraZenecaES       
 ",1
AZN,103
CLL Research,2
Comparing,32
Mantle Cell Lymphoma Survival Likely Affected,1
#rarecancer #,1
CLL Therapy,1
Mantle Cell Lymphoma Treatment Market By Product Type,1
Forecast Data,1
In-Depth Analysis,1
Detailed Overview,1
Forecast,14
HTA,1
National Centre for Pharmacoeconomics,1
Dr Danilov,1
SLL,442
MedEd,28
MedTwitter #,1
Healthcare,19
Dr Graff,1
Calquence Meets Primary Efficacy Endpoint,1
Imbruvica https://t.co/AAQF9Btz5,1
#cardiology,1
Less Atrial Fibrillation Versus Ibrutinib,1
@Merck @statnews,1
Calquence,97
Johnson &,15
AbbVie,108
CALQUENCE,119
AZ,126
The European Medicines Agency Review,2
CALQUENCE Met,2
#Refractory,7
CardioOnc,8
Quick Takes,1
Albireo and Iterum,1
BioPharma Dive,4
Relapsed/Refractory CLL #,4
https://t.co/3KLyHko5DQ,1
CALQUENCE Met Primary Efficacy Endpoint,4
Eli Lilly,2
#pharmaceutical #,3
BRIEF-AstraZeneca,4
ELEVATE-RR Phase III,1
Imbruvica,29
Goldman,4
Astrazeneca auf ',3
dpa-AFX Analyser,5
US-Investmentbank Goldman Sachs,4
MET,1
LEUKAEMIA,1
SUPERIOR SAFETY ON KEY SECONDARY ENDPOINT,1
LiveSquawk,1
AstraZeneca Plc - Calquence Met Primary Endpoint,2
Calquence Met Primary Endpoint,1
ASTRAZENECA PLC,1
IBRUTINIB,7
CALQUENCE MET,1
New CALQUENCE® Data,1
Mantle Cell Lymphoma,137
CADTH,4
Chronic,1
@AnnaSchuh3,10
https://t.co/fdzRB6KRVD - https://t.co/5tIxXQsJ3c,1
Bruton,10
Der Neuling,1
das,3
Global Manufacturers Analysis,1
Tx,18
CTsm,8
PCNSL,1
Health Technology Assessments,1
MRD,362
Francesca Romana Mauro,1
Tagrisso,6
"Lynparza, Calquence, Enhertu",1
COVID-19,264
WHO Solidarity Trials,1
Los datos de #,2
"crónica @AstraZenecaES 

",2
Kinumpirma ng Department of Health,1
World Health Organization,5
WHO,12
"Calquence
https://t.co/8JwlIjSHTd",1
COVID-19 sa,1
Acalabrutinib sa,1
Solidarity Trial,2
DOH,4
solidarity,1
sa paghanap ng,1
https://t.co/7q8vWzSwbS #,1
Learn,93
https://t.co/bcU1EB38YM #,1
ND #,1
AVO,7
NHS England,2
https://t.co/8GvCMTXMRB,1
Management of Waldenström Macroglobulinemia,1
Prescient,3
LOXO305,1
Refractory Autoimmune Hemolytic Anemia,1
Aprobación de,3
contra,4
https://t.co/dmm83g8Osj,1
Cardiovascular,1
ASH,165
CARAMEL,1
AwesomeCapital,1
Refractory Mantle Cell Lymphoma - Neuro Central,2
FiercePharma #,1
https://t.co/gBB1X0TTK1,1
MPH,13
Refractory Mantle Cell ,1
Refractory Mantle Cell Lymphoma,25
CV,1
BGNE ASH,1
ACE-LY-004 Phase II,2
VIΛ,3
MCL https://t.co/4DdzNkc7tO,1
TNF,7
AstraZeneca’s Calquence and,1
Efficacy,17
Johnson - ASH,1
ICO,1
Refractory Mantle Cell Lymphoma https://t.co/lyPJvlt8Pj,1
AZN Reveals,2
Refractory Mantle C,1
Btk,16
EMA,38
un,98
https://t.co/b3IjDBRMXt,1
https://t.co/LAJJr1sdOP #,1
https://t.co/17s9RWLeha,1
Solidarity Therapeutics Trial,2
Interferon,10
https://t.co/q96D7TjXSI #,1
Behandlungsoption,1
LLC,31
https://t.co/AK5C2fLTfh,1
https://t.co/LhC0IinxYC #,1
Calquence Fails Pair of Phase II COVID-19 Trials,1
Danilov &,1
EU,243
Platinum-Resistant Metastatic #,1
https://t.co/ai5FkMGUan #,1
Die Europäische Kommission,1
https://t.co/r0X9hV6lu8,1
Calquence Fails Pair of Phase II,7
https://t.co/kRN5kp5QkI #,1
Pooled Safety Data,1
CURE &,1
CALQUENCE Connections,2
https://t.co/avT0IQnVP7 #,1
CLL Treatment Research,1
ASCEND,62
https://t.co/fdHqNuMcQa.,1
https://t.co/adJBSj8xr4 #,1
Oncology News Update,1
Oncology News,3
https://t.co/LFwoRUAzFn,1
アストラゼネカのアカラブルチニブ（Calquence®,1
https://t.co/Vh1Mjj2zBR,1
https://t.co/FqxIkGA9LG,1
https://t.co/3cwA10K84Q,1
BioSpace https://t.co/Q75SU9gNOC,1
https://t.co/eNkelaGsec,1
Calquence Fails Pair of Phase II COVID-19 Trials https://t.co/VQxSOTahdA,1
https://t.co/TNjSHnR92l,1
NOVITA,1
NEL,1
Join CURE &,1
Learn more &,2
MedLancr,1
Reduce Mortality,1
AstraZeneca press,1
Costco - AstraZeneca's,1
la leucemia,1
OncoReporte,1
AstraZenaca,1
First Line Therapy,1
olan ilacı koronavirüs tedavisinde,2
kan,5
kanseri,3
Calquence'in,2
La adición del inhibidor BTK,1
AGNPF,1
ARD,1
NP,2
MedNews,4
@Yahoo,2
The European Union,1
AstraZenca,3
Meet its Primary Endpoint,2
P-II Studies,2
BioSpace,10
FiercePharma,12
https://t.co/8JwlIjSHTd,1
the White House,1
Otro,2
el posicionamiento de,1
эффективен в качестве потенциального метода,1
İngiltere-İsveç,1
olan,1
Covid-19 https://t.co/WNl3oitzvL via,1
COVID,21
BioSpace https://t.co/q38xyvY6wD,1
RHHBY,37
NVS,7
Calquence'ın koronavirüs,1
Medicago,1
GSK,3
Kanser,5
Calquence'ın koronavirüs tedavisinde etkisiz,1
https://t.co/vLlIRsRpEn,1
#pharmaceuticals news,1
FPRX,1
эффективен в качестве потенциального метода лечения,1
COVID-19 - https://t.co/QALAuDCaMK https://t.co/2V4uqnPUe7,1
Phase II,1
BSC,4
qui échoue sur les,1
Calavi Phase Ii Trials for Calquence in Patients Hospitalised With Respiratory Symptoms,1
AstraZeneca Announced Calavi Phase Ii Trials for Calquence in Patients Hospitalised With Respiratory Symptoms,1
El fármaco contra,1
AstraZeneca Plc,4
FinancialPersonal,1
The European Commission,8
@AstraZeneca,3
https://t.co/tPMvNlXCJJ,1
como el linfoma linfocítico pequeño,1
El medicamento,4
la sección,1
pembrolizumab &,3
UroToday &gt,3
Venetoclax,690
https://t.co/wpIvzeffdG,1
@ASTRAZENECAUK,1
dans la leucémie lymphoïde chronique,1
Terapia,4
nella malattia,1
Approval for Chronic Lymphocytic Leukaemia https://t.co/uyQyvyJ0Iv,1
Approval for Chronic Lymphocytic Leukaemia @Pharmashot @AstraZeneca,1
the European Union,5
Calquence https://t.co/gGhPz9jTzu,1
Nasdaq News - https://t.co/fWUdbvKdVL,1
AstraZeneca Announced,2
the Treatment of Chronic Lymphocytic Leukaemia,1
European Union,1
CCL,5
Platinum-Resistant Metastatic Urothelial Carcinoma,2
@OncologyTimes with,1
@EngIPM,2
American Society of Hematology,88
ASH2020,6
Acalabrutinib Clear PAFSC Review OrphanPacific,1
HAE,1
REMoDL-A,1
CNS,23
ICMR,21
https://t.co/N4grQkEfrH,1
Kombination,3
WHO Covid Solidarity,1
AstraZeneca #,1
NARI,2
PAFSC Review,1
OrphanPacific,1
the World Health Organization (WHO,3
@LLSusa &amp,1
@LLSusa &,3
COVID19nCancer,1
AstraZeneca Pharma India,9
SOLIDARITY,2
ACCORD,1
https://t.co/EHVDRqZsyS,1
"Calquence @AstraZeneca,@AstraZenecaIn",1
PERSISTENT SYSTEMS,1
AstraZeneca Pharma,6
Update,11
Drugs Controller General,1
AstraZeneca Pharma | Company,1
CAPIOT Software,2
KPMG,1
UPL,2
Mauritius - UPL Corporation,1
MANTLE CELL LYMPHOMA,1
#Pharmaceutical #,2
CoronaVirus,1
चाहता है,1
"coronavirusindia
https://t.co/RKoQzwYv3j",1
the ⁦⁦@WHOSEARO⁩ ‘Solidarity,1
body-Indian Council of Medical Research,1
the World Heath Organization’s,1
BTK阻害薬acalabrutinibは日本人の再発・難治性CLL/SLL、MCLでも忍容性があり有効性示す【日本血液学会2020】：がんナビ,1
ETHealthworld,3
https://t.co/DT86C7w1sq,1
ThePrint,2
Panel,1
Medscape Hematology-Oncology,3
III,1
RESONATE-2 &amp,1
Proton Pump Inhibitor,3
NCT04488016,1
BTK阻害薬acalabrutinibがCLL/SLLを対象に申請 　BTK阻害薬acalabrutinibを、アストラゼネカが再発または難治性の慢性リンパ性白血病/小リンパ球性リンパ腫（CLL,1
"BTK阻害薬acalabrutinibがCLL/SLLを対象に申請：がんナビ
",1
BTK阻害薬acalabrutinibがCLL/SLLを対象に申請,1
El Instituto Nacional del Cáncer,1
para ayudar,2
el estudio,1
@Notimex,1
COVID-19 - Healio,1
COVID-19 - Healio https://t.co/1oHiaow5BJ,1
BTK阻害薬acalabrutinibがCLL/SLLを対象に申請 https://t.co/XCgZedw9bP,1
SLLを対象に申請,1
CALQUENCE Drug Profile,2
#ClinicalTherapeutics #Physicians,1
@FLOTUS,1
@OncNursingNews,2
Caluquence,1
#Lymphoma AwarenessMonth,1
ClinicalTrial,179
Previously Untreated Mantle Cell Lymphoma,2
Acalabrutinib Tablet,1
Protonpump Inhibitor Effect,1
@KingsCollegeNHS &amp,1
@UHSFT,2
@AnnaSchuh3 @tobyeyre82 @CRCTU,1
Its Therapeutic Potential,3
@michaelwangmd @MDAndersonNews Durable,1
Dr Rafferty,1
@CRCTU @AnnaSchuh3,1
UPLC-MS/MS,2
Relapsed/Refractory Primary,2
SOHO2020 - Calquence Prescribing Information,1
Relapsed/Refractory CLL,12
CONGRESS,46
WCC,1
P Ghia,9
Deauville 1,1
FISH,15
SCI,6
TX,9
PI,20
"M.D., Ph.D. of @MDAndersonNews #Leukemia",1
NCT04505254,1
Acalabrutinib Improves Progression-Free Survival,1
Refractory CLL,8
PBS,7
the Pharmaceutical Benefits Scheme,1
CLL &,18
BTKinhibitors,22
https://t.co/R1LDo3H4xe,1
Refractory Chronic Lymphocytic Leukemia,112
Subjects With Previously Untreated Non-GCB Subtype,1
UrothelialCancer,2
US FDA,23
@WileyNews,1
https://t.co/RZPyIWgYyH,1
VEnetoclax,3
Acalabrutinib After Venetoclax Limited Duration,3
Suivi,2
the Clinical Journal of #Oncology Nursing,1
the Clinical Journal of Oncology Nursing,1
Improve Outcomes,1
@MoffittNews,19
FACP,6
el medicamento,8
OpenAccess,1
The European Medicines Agency,2
Lymphoma #LymphomaMatters https://t.co/3fcyHwPR2s,1
ACA,4
VEN,11
@wwierda of @MDAndersonNews #Leukemia,4
BTK inhibitors &amp,1
EUA,2
EMA Recommends Marketing Authorisation,1
CLL-Arznei,1
Ein,1
Bruton-Tyrosinkinase,1
https://t.co/aIcSF7pvHl,1
Healthy Participants,1
Die Europäische,1
Zulassung von #,1
EMA Green Light,1
AstraZeneca: Imfinzi,2
AstraZeneca Calquence,3
#Stocks,1
AZN - AstraZeneca PLC Calquence,1
https://t.co/3uiVwlALY8,1
AstraZeneca's,3
EndCancer,9
NEOPLASIE,1
DI BTK,1
symptoms &amp,3
Lymphoma BTK,1
monocytes &amp,2
distress &amp,2
https://t.co/RJ6m59jbJZ,1
الجيل,1
لعلاج,4
@ASCO,72
Virtual Congress - CALQUENCE® Trial Results for Chronic Lymphocytic Leukemia,1
https://t.co/vTUN73Iibi,1
BID,3
QD,1
El Medicamento Acalabrutinib,1
de la respuesta inmune hiperactiva que causa,1
https://t.co/edRIrfc4ow,1
https://t.co/zfs8VEb1Tm,1
ASCEND Data Confirm Safety,1
की,2
https://t.co/CQcIWHiHR1,1
💥#AZN #вакцина #,1
SEC,3
Calquence for CLL/SLL,1
CLL Enhertu,1
LUNGO,2
Cancer Research,5
CLL/SLL,62
https://t.co/hwcaV1qx92,1
https://t.co/50HX3pDMUn,1
Prof Paolo Ghia,3
https://t.co/zKPivWw07e,1
OncoAlert Clinical,2
IndustriaFarmacéutica,2
RINVOQ Phase 3,1
SKYRIZI Phase 3,1
BI,1
HUMIRA,2
Calquence/IMBRUVICA,1
Jak/Stat,1
ACE,2
crónica refractaria - ecancer,1
AscentagePharma,1
Science Immunology,8
アストラゼネカ株式会社、アストラゼネカのアカラブルチニブ（Calquence）、慢性リンパ性白血病患者さんに対する長期有効性と忍容性を2つの臨床試験で示す,1
El,14
el tratamiento,6
la proteína BTK,8
Especialistas,3
aplique para los casos,3
https://t.co/KATk86qNZW,1
@TheLancet,12
EHA Library,1
"Naive CLL 
Comparisons",1
idelalisib+rituximab,1
Idr/BR overall &amp,1
mutations.#lymsm,1
La #OIT,2
la propagación de,2
Lancet,10
l'inhibiteur de BTK,1
chez,1
el ritonavir,1
la ivermectina son,1
graves de #COVID19,2
Medical News Bulletin,1
Acerta Pharma B.V.,1
https://t.co/mImMIrwJW0,1
La OIT,1
COVIDー19 infection &amp,1
ARDS),1
US Oncology Research,3
https://t.co/a6MkBjv4PQ,1
https://t.co,42
Estados Unidos,3
utilizado en,1
Response,7
Idelalisib/Rituximab,1
Bendamustine/Rituximab for Relapsed or,1
Novo Nordisk’s Rybelsus,3
DDW #,1
muy,1
https://t.co/Mwo4Heh0s4,1
La compañía que,2
QuédateEnRadio https://t.co/5rbrSTzWGa,2
Blood Cancer Drug,7
De,1
Truxima®,1
Nieuwe,1
verdragen,1
Neue Phase-II-Daten,1
Wirksamkeit des Therapieschemas,1
calmada,1
vakalarında potansiyel,4
stratejisi,2
Buena,18
prueban,17
European Hematology Association,9
https://t.co/5icYzjSfzZ,1
air &amp,1
Refractory CLL https://t.co/QnYqKPSQpZ  BTK,1
PI3K,35
SYK,12
https://t.co/s85O4KrPx9 and https://t.co/0feXholQVk,1
LGBTQA,1
शकतं ',1
ScienceMagazine,3
SPM,2
EAMS,3
graves de la #COVID19,2
El hallazgo,2
al descubrimiento de la proteína,2
la reacción hiperinflamatoria,3
la enfermedad,2
Acalabrutinib https://t.co/bHhxWSHxl5,1
para frenar la respuesta inmune,1
https://t.co/iV55cdheri,1
COVI,1
https://t.co/YR07QfR6m4,1
como,9
para tratar,2
necesitan las vacunas,2
UCI,3
https://t.co/U31nNmV3fs,1
PruebanFármaco,1
contra el,2
Cohort 1,1
STELLAR,2
Jess,1
Coronavirus,2
the Phase II ACE-CL-001,1
Acalabrutinib -  ,1
BTK Inhibitor,14
Un,13
bajos,1
Resultat,1
https://t.co/BWXloUcjrC,1
Nello,1
ACE-CL-001,1
della #,1
https://t.co/Wq94Okd2Rl,1
https://t.co/LiLN9rBM5,1
la consecución de un,1
https://t.co/QWnimFnZ3i,1
Coca Cola,18
TRADUC,1
@csiriict @MoHFW_India @DrHarshVardhan,1
NUEVO ESTUDIO EN,1
para los,3
🇲,2
Investigadores observaron,5
el uso del medicamento #,2
el tratamiento de varios,5
el tratamiento de casos,1
estudio de mejoría,1
Leyendo,1
la inflamacion provocada,1
OMS,1
Rocky Mountain Cancer Centers,7
casos de Covid-19,1
graves de la #,1
Coke,2
u! &amp;gt,1
⁦@IrmaRaste⁩,2
Prueban,5
Acalabrutinib https://t.co/5Ur1YkhgHJ,1
del coronavirus https://t.co/6JecdoEZGV,1
AUN,1
HOY,38
BELIEVE,2
graves de la,1
El Acalabrutinib,4
https://t.co/dSQhvUfLjg,1
El estudio fue desarrollado,1
para probar,1
el bloqueo de la proteína BTK,1
un medicamento que se usa actualmente para tratar,1
formas,2
agudas de la enfermedad,1
el nuevo medicamento,1
el producto,1
la BTK,2
la tormenta de citoquinas,1
contra el cáncer,2
EEUU,3
el uso del medicamento “,3
Hola @PabloFuente,1
SmartNews,1
El fármaco,2
PhillyVoice,1
toda la tormenta de citoquinas,1
quinasa de Bruton,3
capacidad de oxigenación,1
"contra la tormenta de citoquinas
https://t.co/3mvbf38q4y",1
nota de @vanesalop,1
u! &gt,1
https://t.co/99Xbeo7TNE,1
CRP &,1
Trump,6
https://t.co/8KXpdEK7r3,1
https://t.co/npyznddWey,1
disminuyó los,1
el linfoma,2
de BTK,2
the National Cancer Institute,4
https://t.co/Sp1UnLsQ1p,1
The US Oncology Network,2
https://t.co/ayZNgVCG5Y,1
Hospitalized COVID-19 Patients,1
Bruton’s,3
Elle,1
qui fait des,1
qu'il,1
"Lynparza, Fasenra,Faxiga ,Calquence ROXADUSTAT",1
https://t.co/bZ8qL4JvrO,1
para el,1
https://t.co/AxxZnIbqR4,1
una mejora,1
del estudio,1
Science Immunology Referencia,1
Acalabrutinib - Wikipedia https://t.co/3tQah5qwyj,1
fue,1
SLE,4
RA,8
Treating COVID-19,1
the National Cancer Institute.https://t.co/UVSRcpBTEe,1
del BTK,1
COVID-19 https://t.co/pGFMF6WpFh #pharmanews #,1
провела исследование,1
где,1
@Forbes #GlobalConnections,1
CancerResearch,53
Image CC,1
https://t.co/Tve7YR7yZb,1
CORONAVIRUS,1
Forbes &,1
COVID-19 https://t.co/rTJCzqPJLh,1
#Cancer,1
https://t.co/hOR8fadbCy,1
AZN #,2
Complex Event Analysis,2
Top News Focus,2
cv19,1
ForbesTech,1
BTK-Inhibitor,3
1/n),1
に新たな有力候補。英アストラゼネカ社のCalquence(一般名acalabrutinib、#アカラブルチニブ)がフェーズ2に進む予定,1
https://t.co/wXLrZu72VW,1
https://t.co/0I7IkwbLp4,1
शकतं,1
CLL治療薬,1
https://t.co/xxNObzC1JJ,1
@Clinical Trials Arena,1
El estudio,1
Covid-19,2
اجمالي,2
Calquence - BTK,1
https://t.co/sbUCm1y1cV,1
@AUThackeray,1
Covid-19with Respiratory Distress,1
pri vnetju,1
Forbes - https://t.co/lbG4j53FeP https://t.co/Bl6MG8FRmo,1
Health Tips,1
Chemotherapy,10
"Lactobacillus rhamnosus,,,https://t.co/GJDd8FvFPh",1
FDA Approved Drug,1
Nat'l Cancer Institute,1
COVID-19 https://t.co/CBUVNBGubj,1
Reuters,73
peor de la enfermedad,4
Para,1
de la BTK,1
disminuir el,1
Dampen #Cytokinestorm,1
Infection,1
@nathanvardi @Forbes,1
Health News,5
ET HealthWorld,1
REUTERS,2
https://t.co/C8PCrdcGXD,1
TendenciasTech,1
-Business Journal https://t.co/INe3FcEEi8,1
https://t.co/jSjG8WsYyl,1
IL-6,2
covid-19 https://t.co/xNHVRFq2UD,1
BTKのシグナルを勉強せな,1
https://t.co/lPaLzyalgh,1
el respaldo de Institutos Nacionales de Salud de Estados Unidos,1
Cytokine,1
@Clotmaster,1
peor de la,1
https://t.co/PINNZDtK3q,1
"https://t.co/jon8C09wfm
https://t.co/8JwlIjSHTd",1
Astra,18
för,2
https://t.co/nkGk7Bs8p7,1
https://t.co/kPovNedv44,1
ASTRAZENECA'S CANCER DRUG CALQUENCE SHOWS INITIAL SIGNS OF HELPING HOSPITALISED COVID-19,2
ASTRAZENECA'S CANCER DRUG CALQUENCE,5
SPY,1
estudio de observación no indicado en la etiqueta sugiere,1
VR-EPOCH,1
@tobyeyre82,22
al,7
El aca,2
Randomized Trial,1
co19,1
"Azithromycin,Convalescent",1
@ASCO Abstract,1
Sun,3
PhII,2
@wwierda @LeukemiaMDA,3
CLL Update,3
Refractory Chronic Lymphocytic,11
FL,88
the Expert Review of Clinical Pharmacology,1
https://t.co/A8CjQ6qwhJ,1
https://t.co/kezL2IJy5Q #,1
⚡,1
Oncologie France,1
dans la lutte,1
PO,4
OS &amp;safety,1
ABG,1
Skills Challenge and Clinical Pearls,16
Drug-Drug Interactions,1
Bruton-Kinase-Inhibitor,1
Anteil,1
Galaxy,1
🚀Acalabrutinib,1
EPS,3
Guide,1
Farxiga HF,1
でも価格の高いのにびっくり,1
Baricitinib &,1
Favipiravir,1
AstraZeneca Announces,4
#Power Belongs,1
MS,12
Coronavirus #Health,1
CLLファーストラインに第二世代BTK阻害薬Acalabrutinib：ELEVATE,1
https://t.co/Vqdop6jbFU,1
NIH,19
@FiercePharma,1
TKI,8
？,2
acalabrutinib)をサイトカインストーム治療に使う無作為化比較試験を開始とのこと,1
コロナ治療薬】アストラゼネカのアカラブルチニブ（Calquence）、新型コロナウイルス感染症を対象としたCALAVI試験を開始　https://t.co/SpBHYegp1P,1
アストラゼネカのアカラブルチニブ（Calquence）、新型コロナウイルス感染症を対象としたCALAVI試験を開始 - PR TIMES https://t.co/bqn0wJXzHi,1
https://t.co/d8l9NbuSyi,1
Astrazeneca,4
Nurse Times,1
Nurse Times Coronavirus,1
NurseTimes,1
PNN,1
PNN JournalWatch,1
AstraZeneca’s Calquence (,1
pan-BTK,3
DOR,7
EFS,4
the TAP STELLAR #ClinicalTrial,1
RichtersSyndrome,1
ELEVATE,4
Acalabrutinib BTK,1
https://t.co/rLWUh8wZnu,1
ThisWeek,1
AstraZeneca Initiates CALAVI Clinical Trial With Calquence Against COVID-19,1
@nathanvardi @AstraZeneca @Karyopharm,1
de IC,1
AstraZeneca Begins Clinical Trial of Calquence as COVID-19 Treatment,1
@TheLancet      ,1
fda,6
AstraZeneca Initiates Calquence Clinical Trial,1
Calquence against COVID-19 https://t.co/SQX6I1qLdu,1
AstraZeneca Begins Global Clinical Trial of Calquence to Treat COVID-19 Infection,1
https://t.co/qQrr3dtLpy,1
https://t.co/fj8Ptad1pS,1
AstraZeneca Initiates CALAVI Study Evaluating Calquence,2
Forbes,6
no tto da hipercitocinemia associada à,1
tto da,1
Acalabrutinib https://t.co/N8ykIl0i2w,1
Bruton TKI,1
⁦@LeedJulia⁩ #haem #,1
https://t.co/IfuzZkjWcA,1
https://t.co/s5mSfymhrB #NewsInTweets #WorldNewsInTweets,1
PharmaScrip,6
AstraZeneca’s COVID-19 Taskforce Starts With Calquence Trial https://t.co/6CmE3lZ6TF  #,1
Trial Launching https://t.co/pP1vFJWJH0,1
AstraZeneca Launches Drug,1
@Reuters,2
AstraZeneca Initiates Clinical Trial,1
COVID-19 - https://t.co/5wisz8Os9r https://t.co/VOwD4h4Msm,1
https://t.co/NoVSWjgXUV,1
Ohio State,5
cllsm @astrazeneca,1
AstraZeneca’s,1
COVID-19 Taskforce Starts With,1
https://t.co/ZEFg2FtIKq,1
https://t.co/mvrJoYaY7K,4
@ThisIsMoney #,1
AstraZeneca To Test Blood Cancer Drug Calquence,1
kliničko TESTIRANJE,1
tipova,1
NCI,8
C.E. ELABOREAZA,1
DE RELANSARE EC,1
CRITICAT DUR,1
BarringtonJames #DrugTrial #,1
Astrazeneca soars +6%,1
🖊️Dan Grote,1
https://t.co/gbEp8ZqJhc,1
https://t.co/ZNltaCYH2Y,1
https://t.co/5oIsiwH3BW,1
HeartNews,1
Calquence drug’s,1
FTSE,6
Calquence for COVID-19 https://t.co/VQmJmFGZEP #biotechnews #,1
Calquence for COVID-19 https://t.co/vOG53jfbBy,1
ICU,12
CoronavirusUpdates,1
https://t.co/5skDbyIM0E,1
SOMEONE,1
GSK #,1
NYT,2
BRIEF-AstraZeneca Initiates Trial With Calquence Against COVID-19,1
https://t.co/dvbEQo3dr7,1
MEDICIN,1
https://t.co/FeV2SUvhYQ,1
Acalabrutinib &,2
Coca-Cola,1
Calquence &,1
https://t.co/kyV9361Vsi,1
COVID-19 Patients https://t.co/6OjROPrHoW &gt;&gt;&gt,1
Kinase Inhibitors,1
Acalabrutinib - mantle,2
Nilotinib - CML,2
COVID-19 Patients,1
OncoAlert,69
AGN,1
IMBRUVICA,56
"Calquence, Gazyva",1
Venclexta,78
ImmunoOnc,24
a Phase 2 Study https://t.co/th0YX0bu2L,1
"https://t.co/0N5FoElaIU 

",1
Relapsed/Refractory Chronic Lymphocytic Leukemia,73
@SeattleCCA University of Washington,1
Fred Hutchinson Cancer Research Center,1
Front-Line Treatment,3
Calquence-Acalabrutinib,1
AstraZeneca Pharma India Ltd,2
DCGI - Equity Bulls https://t.co/37bLpiVSKh &gt;&gt;&gt,1
Relapsed/Refractory Mantle Cell Lymphoma,8
https://t.co/iMp54XyHDW Project Orbis,1
SIV,1
@michael_overman &amp,1
Pembro,3
PancreaticCancer,1
Real-World Analysis Explores Current Role,1
RWE,15
the STELLAR Site Initiation for @Derriford_Hosp,1
CLTAP,1
Value-Based Cancer Care,1
Acalabrutinib Monotherapy Active,1
Waldenström Macroglobulinemia,1
Oncology Learning Network,3
Calquence) Indicación,1
BTK Inhibitors,23
@Bannermdandersn,8
OhioState,3
AF,2
SAVR &gt,1
CardioOnc @datsunian @avirupguha @CardioOncology,1
Bcell,12
Therapy for the Treatment of B-cell,3
HemeOnc,18
@WVCancer,16
Macroglobulinemia with &gt;80%,1
LymSM,13
Southampton &,1
Oxford,13
Real-World Study Defines Acalabrutinib Users,1
PhramaTimes,1
Relapsed/Refractory CLL Are Durable,1
the American Society of Hematology,9
the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic Lymphocytic Leukemia,4
Journal,4
Ib/II,2
PFS,19
@DrJamKothari,1
neutropenia &amp,1
The UK CLL Forum Paper,1
https://t.co/noiA1GrfUJ,1
AstraZeneca Canada,1
Small Lymphocytic Lymphoma https://t.co/UjOFSwmUfE,1
https://t.co/f3zyare1Ia,1
Antitumor Potency,1
the @Pelotonia Institute of Immuno-Oncology,1
OLN,2
Calquence Sets Sights,6
Twitter,14
the Lymphoma Calquence,1
https://t.co/jvF4dIWERO,1
AstraZenica,2
#lymsm https://t.co/uVY0Y3XawM,1
de la macroglobulinémie de Waldenström,1
the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic Lymphocytic,1
"AstraZeneca Co., Ltd.",2
allontana la progressione.#ASH19 @PharmaStar,2
ECM https://t.co/RfwcuJufQG,1
CancerNews,66
Avec un suivi plus,1
Chlorambucil https://t.co/n9z9W093ix,1
DI BTK DI,1
LA PROGRESSIONE SIA DA,1
I. Someone,1
Nuevas,2
"Calquence, Vascepa",1
https://t.co/Kt4cha4sHu,1
@WeillCornell @WCMCLymphoma https://t.co/H1rWTLVClK,1
First-Line,15
del ensayo Fase III ELEVATE-TN,1
Merck,3
ArQule,3
Merck Lilly,1
EliLilly,1
el tiempo,1
inhibiteur de la kinase,1
associé à l',1
"de la
 https://t.co/vvt1T2I1Lw",1
#News,3
#Haematology,2
RandD,1
the US Oncology Network,1
Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia,1
Project Orbis,7
ProjectOrbis,3
https://t.co/eunAaf1mdN,1
ELEVATE TN,1
https://t.co/nDmId0TMJk,1
Hems/Oncs,1
Breaking Data,1
CLL Rapid Impact Report,1
https://t.co/QGhMomgeis,1
Pada 2017 Food and Drug Administration U.S. Government,2
https://t.co/d1Vsi7bknx,1
"LDH, &amp",1
BTK C481S,4
C481,7
Healio,1
AstraZenecaのBTK阻害剤CalquenceのCLL初治療Ph3の2年間無増悪生存率約90％,1
@ASH Clinical News,2
Location,1
"@CalquenceHCP, @AstraZeneca",1
Frontline CLL,1
KnowNow,2
Amgen,3
CLL&gt;,1
IMHO,2
Fly,2
C4,1
TLS,25
BM uMRD &amp,1
CR,28
BM,6
C8,1
C16,1
the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic Lymphocy,1
VS,18
G-Acala,1
G-Chl,2
K,2
TN CLL,3
GChl,1
Canadiens,1
ProjetOrbis,1
BGNE,4
Refractory Lymphoma https://t.co/2AjzFQDFk1 #DLBCL,1
Refractory Lymphoma https://t.co/3feHSvLTPa,1
SCL,5
IYCMI,1
Jeezus,1
The Food and Drug Administration’s,1
del ensayo Fase III ELEVATE-TN de Calquence,1
Preliminary Safety,2
a Phase 2 Study of Acalabrutinib,2
Treatment-Naive Chronic Lymphocytic Leukemia,2
los primeros datos de ',1
Industria,1
linfocítica crónica,2
SaludDigital,1
US Food and Drug Administration,3
ANDA #210945,2
NDA,17
Weekly Drug News,1
Xcopri,2
Treat CLL,12
SLLCategory,1
CLL/SLLが来年あたりから慌ただしくなりそうな予感,1
SLL https://t.co/xkmz4wkK0o,1
Binet Staging System,1
Fda,5
SLL https://t.co/sRlWTndsWY,1
SLL Category: Health News Created,1
Pharmafile,1
TGA,8
@WeillCornell @nyphospital,1
AstraZeneca scores,6
Interactions &,2
Project Orbis Collaboration (Calquence,1
Another Humira Biosimilar,1
BIIB,2
Treat CLL/,1
The US Food and Drug Administration,3
"PS: https://t.co/GPAsuikRFF 
",1
#Hematology,6
SLL https://t.co/zu2MUWcGE3 https://t.co/5WpysKqH7s,1
https://t.co/yEMb8Vfknn,1
"Neon, Horizon",1
WuXi Vaccines,1
CLL Indication,2
Adult Patients with,1
Previously Treated Mantle Cell Lymphoma,1
Fleming,1
The U.S. FDA,1
SLL - https://t.co/bSJJiAOPoX,1
AstraZeneca Gets,1
FDA Nod,1
Orbis,2
https://t.co/5ZfLZnmWcU &gt;&gt;&gt,1
https://t.co/dy5ApexyNR,1
w/ @TGAgovau &,1
@GovCanHealth,1
#Singapore #HealthSciencesAuthority &amp,1
#Switzerland @FDAOncology,1
Pharma Industry News,1
USFDA,3
BUY,1
NEUTRAL,2
CLL Calquence,1
the US FDA’s,1
Approval for Chronic Lymphocytic Leukemia Under,1
https://t.co/VnTitz1CDI,1
GLYC,4
Calquence Prescribing Information,1
US Food &amp,1
Drug Administration,2
Biotech,3
Pipeline,3
ENTX,1
TNXP,1
Canada Approve New Drug,1
Project Orbis FDA,1
the U.S. Food and Drug Administration,4
https://t.co/oKS8plr9Zh,1
el tratamiento de la LLC,1
ScienceLink,1
FYI,2
CLL/SLL https://t.co/32pTdmkWeF,1
Copy/Paste,1
https://t.co/1xaSOxXvpM #,1
Brukinsa @AstraZeneca #,1
BeiGene FDA,1
n=69,1
n=13,1
IBR intol,1
Nice wk @Maryam_Yazdy,1
C481S,5
PLCG2,20
MDACC,2
CALQUENCE® #Data To Show Improved Progression-Free Survival In Phase III Front-Line Chronic Lymphocytic Leukemia,1
Bendamustine/Rituximab,9
SABCS,1
Health Canada,24
https://t.co/9ynV6AY3RF &gt;&gt;&gt,1
HOPE,1
NCCN,10
McGill University,1
https://t.co/WafzkAMdV0,1
@SWOG,2
MRK - Schering Plough,1
GILD - $,1
SNY - Genzyme,1
Ibrutinib-Treated Relapsed/Refractory CLL,4
OncoAlert Durable,1
@MDAndersonNews Lymphoma &,1
mantle cell #lymphoma,24
AstraZeneca Canada’s,1
Health Canada Approval for Patients Previously Treated,1
CALQUENCE®,2
EA4181,1
A Randomized 3-Arm Phase II Study Comparing,1
Bruton’s Tyrosine Kinase,3
Wang,5
ACE-LY-004,15
PET,4
Therapie,3
#iwCLL2019,1
NHL,220
Non-Hodgkin Lymphoma,43
Breakthrough Therapy Designation for Calquence - https://t.co/Y2Le4M38mq,1
JP,2
lymsm @lymphomahub,1
TN,13
Roxa,1
"DS8201
Busy 2H",1
"Lynparza, Roxa and Calquence",1
Epanova,1
DS8201,1
Breakthrough Therapy Designation,20
BTD,4
Non-Hodgkin,15
Calquence for Export,1
EU Regulatory Roundup,4
https://t.co/lWcxlhirz2,1
阿斯利康（AstraZeneca）近日宣布，美国食品和药物管理局（FDA）已授予靶向抗癌药Calquence（acalabrutinib）突破性药物资格（BTD），作为一种单药疗法治疗慢性淋巴细胞白血病（CLL）成人患者。CLL是成人最常见的白血病类型之一,1
Ibrutinib-Treated Relapsed/Refractory CLL https://t.co/mdTAmKRms6,1
Calquence https://t.co/6rgadjKZya,1
@Trial Site News,10
Fasenra and Symbicort,1
CVRM,1
Bruton-TKI,1
世代もあってか、どうしても、この薬剤名を見ると、とんねるずがCMしてたワインの、「赤レゼルブ、白レゼルブ,1
」を思い出してしまいます,1
Breakthrough Therapy Designation for Calquence,1
PARP,1
Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia,1
BTK inhibitor.@PallawiTorkaMD,1
@kotharishalin,1
AstraZeneca onco,1
BloodCancer,12
Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia,2
the US Food and Drug Administration FDA,1
Calquence https://t.co/eLC0pDHj5A &gt;&gt;&gt,1
https://t.co/rn49u1dQVe,1
the US,1
Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia,1
Lynparza and Calquence https://t.co/8gyBUXYxuq,1
AstraZeneca plc Calquence,1
the Potential Future of Acalabrutinib,1
Infection Rate &,6
pre-NDA,1
Catalyst,2
NSCLC,8
the safety &,2
@UniCologne,6
Abedin,1
RSP,24
ACP-319,2
lymphomas,5
BJH Single,1
Dans @BloodJournal,1
SpringerLink,5
EHA,68
https://t.co/qHTV0IzHgE,1
I. Mechanistic,1
Acalabrutinib/Obinutuzumab Combo,1
DAEPOCHR,2
nonHodgkin,4
AstraZeneca/Acerta):,1
Global Drug Overview,1
AstraZenecaAcerta Overview,1
DUBLIN&amp;8211;BUSINESS WIRE&amp;8211;The &amp;8220;Calquence&amp;8221,1
https://t.co/rN9nXnTM9v&amp;8217;s,1
AstraZeneca/Acerta) Overview,1
https://t.co/tB0O4iG470,1
ACE-LY-004 https://t.co/sBDbVMxJf3,1
https://t.co/ABFqj9DDG6 #,1
@aecc_es,1
@medivizor,19
AMSTERDAM,1
https://t.co/r59LTw315,1
refractaria https://t.co/k2CqiDA3ED,1
AstraZeneca Calquence CLL Data Sets It Up For Regulatory Submissions,2
Calquence CLL,1
Hematology,3
PIP,1
the Mantle Cell Lymphoma Program of Excellence,1
IL TEMPO LIBERO DA PROGRESSIONE NEI PAZIENTI,2
anticancéreux,3
The ASCO Post,2
Investigator’s Choice,2
che non prevede l’uso della,1
@Maryam_Yazdy,1
IL TEMPO LIBERO DA PROGRESSIONE NEI,4
Acalabrutinib/Pembrolizumab Combo,1
https://t.co/J4NakbmAYN,1
New Post,8
Acerta Collaborate,1
SoC,3
RR-CLL #,1
https://t.co/BAoZEXD3gm &gt;&gt;&gt,1
Relapsed/Refractory CLL https://t.co/msD4isTbTn,1
EHA Congress,2
ScienceLink https://t.co/TdFCmbSLck,1
AstraZeneca PLC,3
#Business #,1
AbbVie/Johnson &,1
AstraZeneca Presented Detailed Data,1
AbbVie/J&amp;J’s,1
EHA24,5
AstraZeneca PLC Calquence,1
Università Vita-Salute San Raffaele,2
Keytruda,2
LymphocyticLeukemia Meets,1
#Primary #Endpoint,1
CC,14
nuova,1
@albertomussetti,2
LB2601,1
Ibrutinib / Calquence,1
pharmacovigilance congrès #,1
https://t.co/wvTv18fq72,1
Phase 2,6
PS,1
BJH,6
Acalabrutinib/Obinutuzumab Combo Improves PFS,3
Calquence Meets Endpoint,1
https://t.co/fVoUrvbPAF @PharmaTimes @AstraZeneca #,1
"CLL
 #",1
https://t.co/6rvROCXqn8 @AstraZeneca #,1
Calquence Hits Endpoint,1
https://t.co/Cwk5emfO3g,1
jargon,1
#Business,1
AstraZeneca Ends CLL Study Early After Endpoints,1
AbbVie https://t.co/KeZQTnXLo1 https://t.co/K1Mit1pmUu,1
Trial Met Primary Endpoint,3
https://t.co/WU5YYxRPLR,1
RHHBY - AstraZeneca's,2
chemo+obi,1
Bartlett &,6
Davids - 7500,6
Ibrutinib-Intolerant R/R Chronic Lymphocytic,1
LYMsm #Lymphoma,1
Oncology and Hematology,1
Investigate the Influence of Severe Hepatic Impairment,1
RS,5
ANC,1
https://t.co/5IUJlkb7uF #ClinicalTrials #Observations,1
Imbruvic,1
Blood Advances,12
nonHodgkins,1
@Blood Advances https://t.co/fK8xqP6RTE,1
AstraZeneca Announced Positive Results From Phase III ASCEND Trial of Calquence in Previously Treated,1
dans la #,3
https://t.co/pSoD7fEiEO,1
Scrutiny,1
Rare Disease Drug,1
RareDisease,4
Relapsed/Refractory CLL https://t.co/WYRoIuyEmQ,1
Interim Analysis,1
Refractory Chronic Lymphocytic Leukaemia,1
https://t.co/U8sASQreLH #pharma #,1
UBS,2
Daten,4
DPA,2
Calquence https://t.co/20srqnaqOC,1
Phase 3,10
Chinese Adult Subjects With Relapsed,3
M.D. #Lymphoma @michaelwangmd,1
Hematologist/Oncologist,2
https://t.co/6iPXKw66Cc,1
https://t.co/cXq2Ol5dwR,1
the Oncology Nursing Society Congress 2019,1
ONS Congress 2019,1
Oncology Nursing Society Congress 2019,1
Anaheim,1
CHOPR,1
&lt;60y,1
tox+discontinuations &gt;60yr:,1
CS,1
EndCancer #,21
MDAnderson,6
@LLSusa @knowyournodes,2
Novità,1
Xagena,1
Xagena - #EmatologiaOncologica,1
https://t.co/qVz7YcgjMr &,1
https://t.co/SzpkCOFleZ &amp,1
Ematologia &,1
OncoEmatologia,1
Xagena - WEB,1
https://t.co/SzpkCOFleZ,1
"Previously Untreated CLL

",1
OSU,2
ASH2018,2
@michaelwangmd @MDAndersonNews,1
P2,1
Tregs,4
SHINE,1
ECHO,1
SYMPATICO,1
Zuma-2,2
Juno/Celgene Car,1
Bendamustine-Rituximab-Acalabrutinib,1
Bendamustine-Rituximab-Placebo,1
Bioavailability,1
Journal of @OfTreatment,1
Confira &gt,1
https://t.co/kzRhZWZGgw,1
NCT02477696,1
Acalabrutinib Monotherapy Produces Durable Response,2
Mantle Cell Lymphoma @MDAndersonNews,1
lymsm,23
MCL Data,1
the Safety of Acalabrutinib Plus Bendamustine/Rituximab,1
https://t.co/JNocIkq8pV @michaelwangmd @ASH_hematology @MDAndersonNews,1
Untreated CLL/SLL Patients in Phase 1/2 Trial https://t.co/XqLFQzewwW,1
Untreated CLL/SLL Patients in,1
https://t.co/kqSIjDcHbN,1
Headaches https://t.co/j31N9klSVZ @MDAndersonNews,1
Acalabrutinib Versus Ibrutinib,2
para tipo,3
tenham recebido,3
prévio de linfoma,3
un inibitore BTK,1
https://t.co/34NjYPrK5k,1
Anvisa,1
non-Hodgkin,26
the BTK Inhibitor Acalabrutinib,1
Active Metabolite,1
Healthy Volunteers and Patients,1
https://t.co/V1lZmWCV3z See,1
Regimen Highly Active,1
Acalabrutinib Regimen Highly Active,2
ASH 2018,8
Cosentyx,1
Keytruda 1L NSCLC,1
https://t.co/VLj59jhpKm,1
Calquence at ASH 2018,1
Acalabrutinib Plus Bendamustine,2
Relapsed/Refractory Mantle Cell Lymphoma https://t.co/cuEczbzlgt,1
KEY,2
New Long-Term Data,1
Society of Hematology Annual Meeting,1
MCL &,1
LC-MS/MS,5
DMD,1
An Application to Pharmacokinetic Study,1
La monoterapia,1
Mantle Cell,6
Another BTK Inhibitor    Active,6
Waldenstrom Macroglobulinemia,12
VelosBio,1
el primer,1
Bijal D. Shah,1
Shah Compares Toxicity Profiles,2
NonHodgkin,2
HCsm,1
Combination for Follicular Lymphoma,1
https://t.co/aBujkZyx0,1
Dr Bijal Shah of,1
Mantle,9
👞👢,1
Dr Pip Nicolson,1
Btk-Specific Concentrations Of Ibrutinib And Acalabrutinib Delays But Does Not Block Platelet Aggregation,1
https://t.co/45zYUDv9Ck,1
https://t.co/quzZGdGH3d,1
@PipNicolson,1
GPVI,1
AstraZeneca Outlook,10
Patients With MCL,1
DBL3001,2
de la FDA,3
LOL,1
LOXO,7
WM https://t.co/mnfYrw6cJ8,1
🎥,6
@rule_simon,1
Ibrutinib.#EHA23,1
КАЛКВЕНС,523
NTRC,1
https://t.co/YBv3XligOg https://t.co/bWzUeE3s54,1
EU Pharma,1
Another BTK Inhibitor Active,1
https://t.co/bLusNoiUZd,1
Waldenstrom,6
Communicated,1
a Mantle Cell Lymphoma,1
Waldenstroms,1
Oral Abstracts Hematologic Malignancies Lymphoma,1
CR #,2
lymSM Btk,1
ref,3
GCB,1
ABC,2
https://t.co/kDAvG2aI8G,1
Relapsed Chronic Lymphocytic Leukemia,69
NEJM,73
Small Lymphocytic Lymphoma,35
CCND1 Negative,1
Standard,3
Lymphoma https://t.co/Yzn5U5d3AV,1
https://t.co/cEYqSBueS4,1
https://t.co/xYXXQW7q9k,1
VA Heme,1
https://t.co/eTVhPN5srf,1
https://t.co/DK7PMDQ0Pj,1
https://t.co/pGxhb58Zzk,1
https://t.co/utbVuJ6JUT,1
https://t.co/ZiUvGqdQ2M,1
https://t.co/w1g7uxUNom,1
BGB3111,1
https://t.co/otz8ClQJvz,1
https://t.co/oaNTY4gB68,1
https://t.co/zrUxw5JvcQ,1
https://t.co/zmJOzLORql,1
https://t.co/HAliaRouZj,1
https://t.co/0F0kheEQya,1
BMO,2
Humira,1
Rova,1
Colorectal Cancer Charity,1
Goy Lends #Insight,1
Acalabrutinib Launch,1
Insight,1
hypertension &amp,1
https://t.co/VE4fsJfxDF,1
4)Acalabrutinib併用は未治療／再発白血病に安全かつ有効,1
Efficacy &,1
Safety of (Acalabrutinib,1
Relapsed/Refractory CLL &,1
Intolerant of Ibrutinib Therapy,1
@NEJM,53
Mantle Cell Lymphoma Patients Benefit,9
@MSDNederland,1
Life Sciences Industry Oss,1
@Medivizor,9
Ibrutinib &,3
FDA Grants Accelerated,20
Aprenda,1
Accelerated Approval for Aliqopa,1
@theLancet,1
"https://t.co/sTqzuJdhl3
#",1
https://t.co/XXi3AkHvPK,1
Acalabrutinib &amp,2
the Overall Response Rate,1
The Food and Drug Administration,11
BGB-3111,7
CRR,3
AE,3
Mantle Cell Lymphoma https://t.co/RmTQ1mMvMk,2
healthcare,4
Next Steps With the Ag,1
IRB,1
@UCSF,2
#ASH17 Oral Abstract,1
Previously Treated Mantle Cell Lymphoma https://t.co/ThXHihQXZ1,1
"@EFPIA 
 https://t.co/CcSWAT1eUy",1
https://t.co/nm2s1j5whX,1
non Hodgkin #,1
Times &,1
The Sunday Times,1
https://t.co/dCZCUgkjHR,1
Bioimpact News,1
First Global Approval,1
essai de phase,1
https://t.co/nw2q5lTb6I,1
Refractory Mantle Cell Lymphoma Trial,15
Acalabrutinib Highly Effective for Refractory MCL #,1
Acalabrutinib Highly Effective for Refractory,1
Acalabrutinib Highly Effective for Refractory MCL,2
AstraZeneca :&amp;rsquo;s Calquence,2
ibrutinib+R,1
IR,7
Refractory Mantle Cell Lymphoma Trial - Business Wire,1
TCSC,1
Drugs &,4
Pharma Cos News AstraZeneca’s,1
Refractory Mantle Cell Lymphoma Trial - 81,6
AstraZenecas Calquence,1
Refractory Mantle Cell Lymphoma Tri,1
https://t.co/9o0DQiFSEs,1
AstraZenecas,1
MCL #ASH2017,1
#ASH2017,1
CR 40%,2
RR MCL,1
btk inhibitor,2
Obat Baru Untuk Terapi Lymphoma,1
Highlight Its Commitment,3
CALQUENCEÂ,3
Chronic Lymphocytic,73
Relapsed/Refractory,27
Lymphoma RX,1
Angelica Welch @OncLive https://t.co/jJwHLaMvja,1
NB,3
The Delaney Clause – You Were What You Ate,1
https://t.co/KlQXkQ3l6k,8
Calquence for Adult Patients w/ Previously-Treated Mantle Cell,1
BTK Inhibitor Calquence for Mantle Cell Lymphoma,2
mantle cell #lymphoma https://t.co/ApTbjWtLEH,1
the U.S. FDA,4
FDA Clears CBC Test for Office Use,1
G-CSF Priming,1
ClinicalEdg,1
Calquence Treatment for Treatment of Mantle Cell Lymphoma,1
https://t.co/Y5Re9L1tkF,1
RxWiki,18
Calquence https://t.co/qlAR44ELCv,1
https://t.co/99krVFacAa,1
Nieuws,1
PW FDA,1
PW #,1
lymphoma &,7
Biologics,4
RxWiki https://t.co/pSWAV5XGBX,1
RxWiki https://t.co/L2ycdiwsGU,1
RxWiki https://t.co/AXw5LkdePx,1
approvalsWatch News,1
Nov 3,1
Immunology Team,1
GeneNominator,1
Calquence - BN - https://t.co/nPHjyLOES5,1
PDUFA,2
#Cytokine Research: Pharmacodynamics,1
Therapy Designationin Mantle Cell Lymphoma - https://t.co/Rq74uDeG3L,1
Calquence https://t.co/oTAkRmoPCW,1
Calquence https://t.co/G5QLcIoUbf,1
Calquence https://t.co/9Oj5WCUXvD $,1
https://t.co/xAXM5uolUg @wstranscript #,1
Calquence - Drug Store News https://t.co/cEDzxWXKXx,1
RT https://t.co/fApUyhII65,1
Mantle Cell Lymphoma https://t.co/F4Xx3C46aG,1
Calquence - David,2
Calquence*)new,1
Previously-Treated,1
AstraZeneca #Oncológico #Linfoma,2
https://t.co/wI9QM54PqM https://t.co/MuP9EAOURx,1
Avella,4
mantle cell #Lymphoma,1
AstraZeneca Snags Quick FDA,9
Potential Lymphoma Blockbuster Calquence  https://t.co/rAt6OV6fYm,1
Previously-Treated Mantle Cell Lymphoma https://t.co/kjG0CBVpPP,1
"MCL
https://t.co/vCezzejFKF",1
Previously-Treated Mantle Cell Lymphoma,1
新着記事]FDA Approves BTK Inhibitor Calquence for Mantle Cel,1
https://t.co/bU22GYVdHA,1
Feedback,1
PreviouslyTreated Mantle Cell Lymphoma Available,6
Potential Lymphoma Blockbuster Calquence,5
"Biologics, Inc.",4
HealthDay,1
Related MedlinePlus Pages: Lymphoma,1
https://t.co/971Nz1i5cP https://t.co/dkzoJuegXd,1
Mantle Cell Lymphoma #,1
Potential Lymphoma Blockbuster Calquence https://t.co/QGLTGatOX0,1
Potential Lymphoma Blockbuster,1
Potential Lymphoma Blockbuster Calquence https://t.co/ugb6YCcsli https://t.co/Jk0El8Y8L5 https://t.co/0PdqtGeeyO,1
https://t.co/fJd3a3BxEq https://t.co/GnqpYM5uXD #Cancer,1
https://t.co/5lUHtYHU6g,1
"MCL
https://t.co/QDqH2Kw3bE",1
profite d'une approbation de,1
https://t.co/CpNaTqcp2S,1
BTK inhibitor &amp,1
Potential Lymphoma Blockbuster Calquence https://t.co/qxwkDBC0R2,1
FDAが成人マントル細胞リンパ腫にacalabrutinibを承認,1
Calquence - AstraZeneca’s Calquence,1
profite d'une approbation,2
Calquence https://t.co/QLCNHzeu9M #,2
Mantle Cell Lymphoma - Medscape,2
NewsAssistant,1
ORR,3
@Starpharma_ASX,1
HealthDay News,1
Acal RR,1
MRNS,1
AstraZeneca Wins,1
ASTRAZENECA,3
AstraZeneca plc,1
#spx #,1
Mantle Cell Lymphoma https://t.co/i3m9qM0pvy,1
https://t.co/m1wxAl4hZZ,1
mantle cell #,1
RT Reuters,1
BTK FDA,1
Mantle Cell #Lymphoma,6
Calquence - FiercePharma,1
https://t.co/z2hISU57PR,1
mantle cell #lymphoma https://t.co/8HKzP78DD9,1
https://t.co/nyX6UdCbhM,1
Second BTK,1
US Food &,1
Drug Administration - Interactive Investor,1
Calquence https://t.co/QKSCVWEc0Q https://t.co/Jk0El8Y8L5,1
The U.S. Food and Drug Administration,6
mantelcellslymfom https://t.co/u2ZAdBCjtA,1
AZN BTK,1
Calquence: https://t.co/uStNXbJjyJ #,1
Calquence - https://t.co/eUQqMlStSi,1
The U.S. Food,1
FDA Granted Accelerated Approval of Calquence to AstraZeneca Pharmaceuticals,1
New Treatment for Adults With Mantle Cell Lymphoma,1
"https://t.co/kiOImqVILu 
",1
AstraZeneca Retracts Preclinical Paper,5
Falsified Data,5
https://t.co/a0IRyqiml8,1
BTK &,4
ACP-319 Improves Survival &,1
Tumor Control,2
Ascerta &,1
PI3K{delta} Inhibition,1
Acalabrutinib Breakthrough Designation,1
FDA News,1
New Combo Treatment,7
Vistusertib,3
Review AstraZeneca NDA,9
Treat Mantle Cell Lymphoma,7
Breakthrough Therapy Designation e Priority Review,8
FDA Breakthrough Therapy Designation,7
https://t.co/fHFhrc2qc7,1
mantle cell #lymphoma #Cancer,1
https://t.co/YIJJDq28Z3,1
Potential Mantle Cell Lymphoma,1
FDA Accepts Regulatory Submission for Acalabrutinib,5
Grants Priority Review,6
Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma,1
Priority Review,17
the Treatment of Patients,10
https://t.co/5efptl8WOQ @AstraZeneca,1
Grants Priority Review -  https://t.co/LliVW9guuZ,1
#Priority #Review,1
ACE-LY110,1
NDA Priority Review,1
FDA Accepts Regulatory Submission,1
Grants #PriorityReview https://t.co/cMnRqgUlri,1
Priority Review https://t.co/z7Y8yUXJzq,1
アストラゼネカのACALABRUTINIB、マントル細胞リンパ腫治療薬として米国食品医薬品局（FDA）より画期的治療薬に指定,3
アストラゼネカのACALABRUTINIB、マントル細胞リンパ腫治療薬として米国食品医薬品局（FDA）より画期的治療薬に指定 - PR TIMES,1
w. mantle,1
https://t.co/oEpq5QQ1HD,1
Acalabrutinib Granted Priority Review,4
FDA Awards Acalabrutinib Priority Review,5
AstraZeneca FDA,1
FDA Priority Review,4
https://t.co/BB5ywaxmGt RT https://t.co/GdpJCdkXDf,1
@MDLinx,3
https://t.co/XY5uTOevGH,1
Breakthrough Therapy Designation e Priority,2
https://t.co/wPp9Soc0Tl,1
US FDA Priority Review,1
mantle cell #lymphoma https://t.co/X4G9mdWQ9u,1
https://t.co/n7X2rHNEmF,1
AcertaPharma Priority,1
ACP-196,2
Journal of Hematology &,1
FDA Breakthrough Designation,3
Clock,4
EmergencyMed,1
AZN Receives Priority Review,1
https://t.co/ypaeQ9rxLO,1
AstraZeneca AZ,1
MYSTIC,2
ACP196) https://t.co/0lOQy12Ywb https://t.co/rtmWkYJJA5,1
https://t.co/9gP2g2Of1l,1
mantle cell #lymphoma #MCL,1
https://t.co/BB5ywaxmGt https://t.co/idBlthAQI2,1
Pharma Giant AstraZeneca PLC,4
LOXO &,1
the Acerta BTK,1
2.7B,1
jobsearch,3
GEMP HoFH,1
AstraZeneca Pharmaceuticals LP: Global Brand,1
The Bruton Tyrosine Kinase,1
AstraZeneca Pharmaceuticals LP: Global Medical Aff,1
https://t.co/zK31mAXOJY,1
transformation &amp,3
P Hillmen,1
Ibrutinib,16
BGNE BGB-3111,1
Lymphoma - Leukemia,1
SRC,1
Comparison,4
https://t.co/PUYWPRTuA5,1
Ibrutinib-Intolerant CLL/,7
https://t.co/KP1fuSI20Y,1
Acalabrutinib Produces,4
SLL https://t.co/LADNZwYmeV,1
"Safe, Effective",1
BTKinhibitor,1
AstraZeneca Early Data,4
DifficulttoTreat C,1
DifficulttoTreat Chronic Lymphocytic L,1
Ibrutinib-Intolerant CLL/SLL https://t.co/xR4IFFfkBZ,1
DifficulttoTreat Chronic Lymphocytic Leukemia,1
WI,1
Astrazeneca plc,1
#ASH16 $,1
ABBV,6
#ASH16 Words,1
Acalabrutinib Monotherapy Effective for Richter Transformation,1
Acalabrutinib Monotherapy Effective for Richter Transformation https://t.co/UVLDqy6TE9 #,1
CLL https://t.co/yXy4Eog5UH https://t.co/oRWVtYNI72,1
https://t.co/MkvubnfL9e,1
Upcoming Trials,1
BGNE Bgb-3111,1
AstraZaneca,1
naar,2
Checkpoint Inhibitor,1
MedicBoard,11
GS-4059,1
Hematology News,2
PI3K) &,1
4B,2
simi... https://t.co/i2kV2cfPjY,1
AgingData,30
simi... https://t.co/yXFjHBcQva,1
#USAN #,4
CLL https://t.co/xOsufNP1y1,1
Intolerant of Ibrutinib https://t.co/UG68Rt2QOU,1
La EMA,19
recomendó,4
NewsCancer,3
La @EMA_News,1
https://t.co/kNd4CpGN2m #lymphoma #,1
Europa https://t.co/YElowaayeL,1
designación como,1
ClashofClans News La EMA,1
DI FARMACO,1
BTK de,1
EMA - Bidness Etc,1
https://t.co/FHu1LvCXEJ,1
The European Medicines Ag,1
https://t.co/f2eL6qoAKZ,1
Pharma News,2
International Business Times,1
@ibtimes_india,1
Orphan Drug,4
Article &gt,1
ACP196,2
EU Orphan Designation,1
NASDAQ OMX GlobeNewswire,1
New Leukemia,1
ブルトン型チロシンキナーゼ阻害剤acalabrutinibは慢性リンパ性白血病治療において安全かつ有効  ,1
https://t.co/6s6isN4hy3,1
Bruton @NEJM New,1
Selective BTK,2
Chronic #Lymphocytic,3
Acalabrutinib Active,4
Safety in Adult CLL,3
mkt,1
@clarkhumphrey #CLL #,1
ASH15,3
Acerta Pharma Phase III BTK,1
@scoopit,3
https://t.co/EHE6QK9JpY,1
Acalabrutinib ACP196 Shows Efficacy Safety,1
StemCells News,2
Research News,4
Acerta Pharma Announces Study Published,7
New England Journal of Medicine Demonstrates Acalabrutinib,6
https://t.co/XP9TVMgwWj,1
MPTMeetings New BTK Inhibitor Active,1
CME/CE,2
MedPage Today,2
https://t.co/KoFTin4LRz,1
GMOfree,1
https://t.co/bZ1prKYSjk,1
New England Journal of Medicine Demonstrates Acalabrutinib ACP,1
the Management of #CLL:,5
CME,133
STAT3,15
GLI1,2
Lymphocytosis,4
AML,130
"Refractory High-Risk #CLL

Comment by Isabel Cunningham",1
https://t.co/sOGl82JHHn,2
Submit,5
@AACR,7
GetVaccinated,2
CDC,47
Interim Recommendations for Fully Vaccinated People,1
MSN,4
APRN,4
NP-C,1
@LurieCancer &amp,1
Leukemia/Small Lymphocytic Lymphoma,85
THE GIMEMA WORKING GROUP https://t.co/m6CT7Qgs9Z,1
MHQ,1
Telemedicine Challenges and Opportunities,3
@CLLSupport @LeukaemiaCareUK &amp,1
"https://t.co/8c9rbRpETx
#CLL #",1
Ibrunat,2
Combination With Ublituximab,2
Pirtobrutinib,3
MARCKS,1
New mRNA Cancer Drivers Revealed,5
GenomeWeb,1
medicare,2
the Global Bridges Core Lecture Series Heme Malignancies Block,1
EOMES,3
🧬 Trisomy 12,1
@BhatiaProgram,1
Join/Share,6
https://t.co/oqwWIBuh8q,1
Leukemia https://t.co/kZQoNkVCT6,1
https://t.co/8wGAV7G0ix #CLL #,1
Cancers,1
"@LurieCancer, @huntsmancancer &",1
"@MDAndersonNews @LeukemiaMDA 
",6
https://t.co/KaZcoGeywH,1
TFR,3
Myeloma #Leukemia,2
PROFILES,5
@aamdsif Patient Education Council,1
EHACampus,1
EHA Unplugged,1
HSCT,5
HeidiYates,1
@JanRynne @gmcrotty @RuthClifford5,1
New BTK Inhibitor,2
Memorial Sloan Kettering Cancer Center,6
NOX E36,1
NOX,3
https://t.co/6LN7Ws1RaC https://t.co/1CJPX4VaiY,1
HappyEmployees,1
https://t.co/srUdV1cTAx,1
Chromosome,2
https://t.co/Lg2GJLx5Hw,1
the ‘watch &amp,1
c.dunnion.1@nuigalway.ie,1
Imbruvica Plus Novel,1
https://t.co/z7Q98TGOml,1
Tanja Stankovic's,1
GNM,1
@kathybrodie,1
PSED,1
CME/CE/CPE,2
Healthline,1
Bispecific Single-Domain Antibody,5
the Functional Assessment of Chronic Illness Therapy-Fatigue,3
Challenges and Solutions for Collecting and Analyzing Real World Data,1
The Leukemia Research Foundation,1
World-Renowned Experts,1
https://t.co/HovY8JCGOm,1
https://t.co/pNdcjApiw8 #hvhebron #hemat,1
SuppOnc #,3
First Approval,1
MAPK,4
Blood Journal 2014,2
Navigating Life,1
@huntsmancancer &amp,1
HematoRules,1
SB,2
"https://t.co/Ks6QGXnkJs
",1
the Stanford University School of Medicine,1
ga,1
Zooooo,1
chemo(immune)therapy https://t.co/tshYbapvh8,1
https://t.co/16p9MXXjzf,1
Bruton's Tyrosine Kinase,5
IKZF3,1
🙏 https://t.co/3v5swJTdQi,1
CLL Join,1
vaccines &amp,1
the MD Anderson Cancer Center,5
The Leukemia &,16
Lymphoma Society,25
BIRC3,6
Regimens https://t.co/zMVW23UosV #CLL #,1
Congratulation,1
UK CLL,3
AP,6
https://t.co/OcFgzeqjcd,1
Listen &,4
the Management of #CLL,3
New CLL Drug,1
GMT,3
FLAIR,2
STATIC,1
@DKFZ,3
aryl,1
BI 836826,2
CXCL12,5
"Bladder Cancer
Colorectal Cancer",1
AbbVie Pharmaceuticals,5
MURANO,54
Vivo Metabolic Profiling of,1
LEF1,1
BRUIN,4
AYA,1
Webinar 'Zeldzame non,1
@chuanzhenzhao,1
HSV,1
GREEN,4
RGDS-Modified Superporous,1
Acute Myeloid Leukemia,22
BH3 Profiling,1
Ibrutinib + Venetoclax,3
@LVV2016 &amp,2
🤗,3
Wildgroei,1
naar de 👍 presentaties,1
Bruton Tyrosine Kinase,3
https://t.co/yq0uxikcE3,1
Program,1
📊 Access,1
the Virtual Exhibition Area,1
New Research Paper,2
the Sussex Cancer Fund,2
Digital Advocacy and Health Equity for,2
Universität zu Köln,5
CLL Research: Ublituximab plus Ibrutinib,1
CXCR7,2
https://t.co/28pTvRmTx5,1
Vittoriale,1
Info,4
Oncology &,4
Hematology Review,5
Phase 1/2 BRUIN,2
@anthonymatomd &amp,7
myeloid,57
https://t.co/qRZpk3Z7g2,1
@anthonymatomd @sloan_kettering #,1
LRF,4
MS of @MDAndersonNews,1
https://t.co/gAW4eNMxrc,5
@clonoSEQ @AdaptiveBiotech @Labcorp  ,1
Meta-Analysis of Randomized Controlled Trials,1
Ocular Toxoplasmosis Mimicking Lymphoma,1
the National Alliance for Caregiving,1
https://t.co/PgcEO8p15M,1
SNU - #,1
Leukaemia Care,1
HemaSphere,6
NGS,34
MyeloidMaligancies,1
GeneTherapy,2
VWF,1
SCD,1
@LymphomaAction,6
BET,6
BCPS,2
TwitteRx,2
Dr Amjad Hayat,1
University Hospital Galway,1
@Haematologica,2
※サブメンバー,1
Montana Cannabis Legalization &,1
Leukemia &,14
Genetics,4
IgG-Aggregation and Chronic Activation,1
Digital Health Coaching Program,2
Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia,2
@ZuckerSoM,1
https://t.co/1AWluGGVBT,1
TrialUpdate,9
Novel Approaches,1
The University of Iowa/Mayo Clinic #Lymphoma SPORE,3
la distance et l’humiliation,1
CMO,5
Dr Brown ⁦@anthonymatomd⁩ @asherchanankhan cochair ⁦@GCC_Cortes⁩ @gotoper,1
⁦@sloan_kettering⁩ ⁦@GACancerCenter⁩ https://t.co/BeXnWR49Ya,1
@Radiorgbe,1
Getuigenis chronische,1
grâce,1
GI,4
https://t.co/7E6BBAvAm0 #CardioOnc #ACCED,1
ATTN,1
@LymphomaAction @MPNVoice @CLLSupport,1
the Tumor Microenvironment,7
Immune #Dysfunction in Patients with Chronic Lymphocytic,1
Medifocus com Inc.,1
Immune Dysfunction,2
USA-NY-,1
Advanced Practice Provider,1
Coevolution of Leukemia and Host Immune Cells,4
https://t.co/L6UlhO3cF8,1
Lymphoreticular,1
Recurrent CLL,1
MSCE,11
Adenoid,1
TG Therapeutics,16
UKONIQ,1
BCR,72
IKAROS,3
EKG,1
RNA,46
NOTCH1,35
Blood Cancer Discovery #,1
Rural Settings,1
CMS,3
Florida Cancer Specialists &amp,3
Research Institute &,1
Smudge Cells,2
"Pathophysiology, Laboratory Considerations",2
IL-23,1
NRWHIP,1
COVIDVaccine,2
Lymphoma Australia Ambassadors,1
Immunoglobulin,19
ERIC,24
DCLL9718S,1
CLL-1,2
@MicheleNadeemB &,1
Research Institute,2
Jingyu,1
ESH,3
GOLDMAN INTERNATIONAL RESEARCH AWARD,1
https://t.co/8KH2KetAXH,1
The Lancet Haematology,2
TG Therapeutics Announces Publication of Final Results,2
"TG Therapeutics, Inc",1
nuevas guías #ESMO,1
Burger JA,2
https://t.co/UsnDozPIZz,1
healthcare professionals &amp,2
@LLS_TriState Surviving &,1
Thriving w/Blood Cancer,1
King's,1
ForeverKings,1
the EHA Endorsement,2
the Management of #CLL: Bringing the Data to Life,3
PAX5,3
NKX2,2
BRAF,3
t(14;18)(q32;q21,1
NVG-111,1
@drjdelaserna,1
@sehh_es,1
⁦@ScrippsHealth,1
Integration of variant characteristics,1
Laplace,1
Therapeutic Options for Patients,1
Syngeneic,1
Heme Malignancies Virtual Meeting,1
@OracleHealthSci,2
Eli Muchtar,1
The Nordic #CLL,1
Richard Rosenquist Brandell,1
Chronic Lymphocytic Leukemia,52
specialized care &amp,4
Great Debates &,1
Patient Power,14
@Pharmacyclics Pharmacyclics,1
Bendamustine,3
Haematologica https://t.co/oPJzbN27aw,1
ALL,15
CML,82
Chemotherapy &,2
Journal of Clinical Oncology,23
Four-Factor Score for Outcome of Ibrutinib Treatment,4
Ehefrau,1
the CLL Society,9
LLS,4
MedTwitter,3
Cardiotoxicity Claims Furthered by Recent Chronic Lymphocytic Leukemia Study,1
@StanfordMed &,1
"@MicheleNadeemB  
Register",1
@FondazioneTLS,1
Siena,2
OMICS,1
Expanded Access Program for Participants Who Completed Study,1
Mini-HCVD,1
Refractory Acute Myeloid Leukemia,2
Acute Lymphoblastic Leukemia,13
FREE,8
BigData,3
myeloma https://t.co/YaDV2WZZNQ,1
Illinois #UAE,1
Register now &gt,1
Nurse Like Cells From Chronic Lymphocytic Leukemia Patients,2
ADRO,1
CDK9,1
Envy,1
The Spike Protein,1
Endoplasmic Reticulum,1
MIMIC,1
Therapeutic Targets,2
"FC, Chlorambucil, Rituximab",1
"Private Healthcare
Ibrutinib",1
the US Veterans Health Administration System,4
#SpotlightOnHematology,1
Haematologica https://t.co/iSHl5EuOtT,1
@columbiacancer &,3
https://t.co/f9EJ4uSKA6,1
@laura_pezzella,1
SMZL,1
Cerebral Invasive Aspergillosis,2
Bruton Tyrosine Kinase Inhibitor,3
"@cancertrials_ie
@EibhlinMulroe",1
https://t.co/fhmREaaNZ1,1
myeloma,2
non-Hodgkin's,19
Patient Involvement,1
Research/ Delphi Projects,1
ChildhoodCancer,2
WhatsApp,5
@UniPadova,1
https://t.co/p0s9QCBa9V,1
Winter Hematology Update,1
DYK,38
https://t.co/qMT3UD6agN,1
Lymphocyte,2
Immunogenicity and Safety of Commercially Available Vaccines Against,1
https://t.co/CyW6AFJ1kg,1
ESMO Guidelines,1
the guidelines &amp,1
First Past the Post,1
https://t.co/r7BaSyqzP4,1
the Lymphoma Research Foundation,2
Update on Oral Therapies for Lymphoma,2
Emory University,2
IG,2
Allogeneic Haematopoietic Stem Cell Transplantation Successfully Treated,1
Oral Venetoclax,1
AKT,3
TRANSCEND,13
@ASTCT @CIBMTR,1
lymsm https://t.co/fB0NUCcrUK,1
Prof Gunnar Larfors,1
Crohn,3
CAR,33
LungCancer,3
CNN,1
Ujjani &,1
NFAT5 Regulated,2
"STUB1,",2
BCL6,2
ZHX2,1
Chelsea,8
Infections,5
CVS,1
OBR Peer-Spectives,1
Aditi Choudhry,1
Pleasant Hill,1
CA,4
Sierra Vista,1
@CNN,1
https://t.co/V4ttzdrYUF,1
Recurrent Uveitis Related,1
https://t.co/jt62QKlK3,1
SWATH-MS,1
Arzerra,63
Effects,1
@unibirmingham,3
HARMONY,15
Core Outcome Sets,1
CAPTIVATE,4
@paulreiddublin,3
Receptor Stereotypy to Design Tailored Immunotherapy,3
Roundup®,1
Untreated Older Patients (&gt;/= 70yo,7
IL-10,3
Journal of Experimental Medicine,1
Rockefeller University,1
PDQ Cancer Information Summaries,8
"https://t.co/kQnfuQhSh5

",1
MBL,25
@AcuteLeuk @knowyournodes @LymphomaAction,1
EYP,3
Dana-Farber Cancer Institute,5
Call Office of Patient Recruitment 1-800-411-1222,3
https://t.co/xCNEMTdenJ,1
Oncologist and Patient Preferences for Novel Agents,1
Lymphoma Society Universität zu,3
Dose Reduction on Clinical Outcomes,1
Evidence Supports BTK Inhibition,1
Leukemia - Targeted Oncology,3
Refractory Lymphoid Malignancies,1
Nouvelle,1
oui je vient,1
moche,1
xenograft,1
CarePartner Nelia,3
Pacheco,1
@CancerCare,3
@PPHchemo Haematology,1
🎙,1
PNH,1
Young Adults With Recurrent or Treatment,1
Cancer,2
the APRIL Oncogene,1
RNAseq,6
DrugSensitivity 👉  ,1
Prof Eichhorst &amp,1
"ESMO Clinical Practice Guidelines for Diagnosis, Treatment, &amp",1
Serum Monoclonal Component,1
Order,1
Rhapsody Music Notes,1
MD Anderson Cancer Center,5
@MDAndersonNews @UTMDA_CPRTP https://t.co/C98wlbIC7I,1
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells,1
Proteomics-Based Regression Model for Assessing the Development of Chronic Lymphocytic Leukemia,1
GETVaccinated,1
Squirrels,1
EAD,12
NF-κB,6
CART2,1
@Swedish,3
@LeukemiaMDA  &amp,1
Attn YA Chronic Lymphocytic,1
CLL Coach,1
Small Lymphocytic Leukemia,2
The Role of Notch,1
Strength,1
NMA,1
s/p 5 lines,1
CIT,8
SLL Indicate Potential Benefit for,1
@MDAndersonNews @LeukemiaMDA,11
既治療高リスクCLLへのアカラブルチニブはイブルチニブにPFSで非劣性を証明、心房細動発現率は有意に減少：がんナビ,1
Sloan Kettering Cancer Center,9
The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways,2
Resource-Limited Center https://t.co/EqkkErOZ4V #,1
KMT2D,1
Ex Vivo Mitochondrial Respiration Parallels Biochemical Response,1
CLL Cells,1
@wwierda @MDAndersonNews,8
https://t.co/uZkauyTEwv,1
@wwierda of @MDAndersonNews @LeukemiaMDA,1
BTEC CPLD,3
OXPLORED,2
Molecular Diagnostics,1
@danafarber &amp,1
MedImmune,1
Novartis - Jumbo News,1
https://t.co/yoyvhha70V @DRGInsights #NHL #,1
⁦@wwierda⁩ ⁦@MDAndersonNews,1
UNITY,13
CTSM,8
Cause of Death in Patients with Chronic Lymphocytic Leukemia,2
IgG K Cryoglobulinemia,1
@BloodAdvances,2
@anthonymatomd,12
PerMed,1
Comparison of Outcomes of Transplant,1
Die Chronisch Lymphatische #Leukämie,1
Impfstoff,2
CAMROON,1
https://t.co/yoyvhha70V @DRGinsights  ,1
new &,3
@DonRalphDMG,2
@DONJAZZY,2
https://t.co/yoyvhha70V #NHL,1
BPK,1
Develop CLL Treatment,1
Freddie Fantastic,1
#MultipleMyeloma &,7
MyelodysplasticSyndrome,1
join &amp,1
AnimationCommerciale #Fidélisation,1
https://t.co/JXaeb9MctF https://t.co/WGxrRGp4Ju,1
https://t.co/72E15cCPbJ,1
MAB,1
post-ASH,2
Bax/Bak,1
Multi Cytogenetic Changes,1
CLL Progresses,1
Enhanced Expression,1
B Cells of CLL Improves,1
Blood Advances |,9
Practical Advice,1
GEP,1
the @MedicalCollege of Wisconsin,1
https://t.co/dQpJ3E9HzO,1
Clinical Cancer Research,2
@BloodJournal on,1
Effect of Bruton,1
https://t.co/vnmIakzflp,1
PEITC,1
정기검진,1
@OSUCCC_James &,1
CT,11
News| Health Canada,1
FDA &,2
Receptor Stereotypy to Design Tailored,1
the Japanese,1
Epstein-Barr,2
EMT,1
#Mutation,2
https://t.co/Zuu57qJLkR,1
TLR9 &,1
Health Canada Approves,10
CLL Sessions,1
FAQ,4
Resource-Limited Center,1
APR246,1
Hematological Malignancies,5
Mutant P53-Dependent Affair,1
ConceptualModel,1
Newly Diagnosed CLL,1
OncoAlert Overcoming,1
https://t.co/aJ1XR4XN5J,1
stratification &,1
Cytoscan HD &,1
BionanoSymposium,1
ESMO Clinical Practice Guidelines,2
the Scientific Working Group,1
CLL/European Research Initiative,1
Join @MDAndersonNews @LeukemiaMDA,2
@wwierda,17
@MSSO,1
VEGF,5
MD &,8
MD &gt;&gt,4
"@MDAndersonNews @LeukemiaMDA 
#",1
First-Line Ibrutinib Effective,1
"Lymphoma Society 
AbbVie",3
Intracranial,1
Results &,1
EYFS,10
ImmunoOnc #CTSM #TrialUpdate,1
Cancer Stat Facts,1
Amphiphilic Block Copolymer/Additive Complexes,1
https://t.co/Hd5Yskv3Fd,5
https://t.co/wH3YRnxFpz,1
CLL Advocates Network COVID,1
Myeloid Disease,1
BIRC5,1
@Xavier_Bettel @R_Bachelot,1
GC,25
Control of Choroidal and Orbital Metastasis,1
TLR,5
DARA,1
The American Journal of Forensic Medicine,1
Medicare,18
EHA Endorsement,1
"ESMO Clinical Practice Guidelines for Diagnosis, Treatment",1
BK,1
Leukemia https://t.co/0MJbUnzx2V,2
@IrishCancerSoc,6
@DrHealeyBird,2
Annals of Hematology,2
IgHV,19
@SEHH @VHIO,1
@VHIO,4
https://t.co/paX70V3bBI,1
help &,1
A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma,1
AUTOLOGOUS POLYMORPHONUCLEAR,1
the Leukemia Microenviroment,1
ImmunoOnc #,5
CLL Society’s,2
Global Chronic Lymphocytic Leukemia Treatment Market Production,1
Patienten,3
Studiendaten,2
https://t.co/iMbCMRYERx,1
@NovantHealth Novant Health Cancer Institute,1
PET/CT Role,2
PsoriasisPhase,1
LGL,3
Central Nervous System Involvement,2
ASH Annual Meeting &,3
"Exposition
Focus",1
Adolescents &,5
Experts Share Advice,1
@columbiacancer &amp,1
#EHA2021,1
Minimal Toxicities for Poor Prognosis IGHV-,1
Previously Untreated Chronic Lymphocytic Leukemia Patients,1
@PracticalNeurol &amp,1
Non-Hodgkin’s Lymphoma,7
Granulomatosis with Polyangiitis,1
Microscopic Polyangiitis,1
the STAT3 Inhibitor Pyrimethamine,1
Augmentation,1
ROS,3
ADCC,2
NOX2,3
Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells,2
HDAC7,2
InnoCare Announces,8
Relapsed/Refractory Mantle Cell Lymphoma - BioSpace,1
la chance,1
l’être,1
https://t.co/axRqYa4Lmq,1
Drugs and Competitive Analysis,7
DelveInsight,7
AbbVie Presents,7
Relapsed/Refractory Mantle Cell Lymphoma - Business Wire,1
Relapsed/Refractory Mantle Cell ,1
"Relapsed/Refractory Mantle Cell Lymphoma - Business Wire

InnoCare Announces",1
Relapsed/Refractory Chronic Lymphocytic,11
First Duration Venetoclax-Obinutuzumab Therapy:,2
Leukemia/Small Lymphocytic Lymphoma https://t.co/cIyyqNTPpR,1
NHL/CLL Patients,2
Non-hodgkin,1
non-Hodgkin’s Lymphoma,10
Wegener,2
MCL1,3
the BRUIN Clinical Trial,1
CLL/SLL https://t.co/69p9hfW1eo #,1
Minimal #Toxicities for Poor #Prognosis IGHV-,1
Maharaj,1
Patients With CLL/,1
https://t.co/W7oAavcnyf,1
@QMUL,7
WonderWoman,2
Combination With Chemotherapy,1
Our CLL Stories,3
Accurate Assessment of Minimal Residual Disease,1
COVID-19 &,1
AOCN,5
Moffitt Cancer Center,3
❓,4
MPN,39
@OncLiveSOSS,2
the Small Things,1
https://t.co/aSQEg9ASqC,1
https://t.co/D0jTtht3b6,1
CFR,2
Spillover Compensation,1
CyTOF Data,1
Previously Untreated Patients With Chronic Lymphocytic Leukemia,1
DFCR,1
the U.S. National Institutes of Health,1
⁦@sloan_kettering⁩,5
LYLE,1
Network @knowyournodes Lymphoma Coalition,1
@waynemedicine,4
"AE

Interrupt for AE",1
the #HCCWebinar,1
PGIMER Chandigarh,1
Antonella Santoro &,1
CovidVaccine,1
CLL Doc @DrMDavids - #CLL https://t.co/952uMdNNyA,1
CLLsm https://t.co/7WPPopZKEr,1
@Amgen,1
Mabtas,5
the Complement System Status,1
https://t.co/VCDiwdLeKI,1
"Nick,",1
CD200,14
https://t.co/9jRDz7C9tA,1
OncoAlert Changes,1
American Society of #Hematology,1
Dr,1
w/ CLL(chronic,1
@MassEyeAndEar &,1
ATM,31
https://t.co/tlyXQKLeQj,1
@anthonymatomd @sloan_kettering,1
https://t.co/fl316mLXVw,1
Rituxan,14
Meghan Thompson &,2
ClinicalTrials,1
concerns &amp,1
The EVOLVE CLL/SLL Study: Testing Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
CTSU,1
Lymphoid,2
Al-Abdull,1
https://t.co/rchW8lNuqk,1
@MDAndersonNews https://t.co/AXdp4R8tZh,1
Immune Dysfunctions,2
Immune-Based Therapeutic Interventions,2
ASH Highlights,1
ASH Annual,1
Nebenwirkungsprofil,1
Dr Love,2
Ublituximab Doublet Bests Chemoimmunotherapy,1
YouTube,8
@MDAndersonNews https://t.co/pJ3CyRtYxw,1
@MDAndersonNews @LeukemiaMDA |,5
CLL Clinical Trials Explained,1
ECG,1
https://t.co/LzlH30bgUY,1
@QMBCI,20
Join Lymphoma Canada’s,1
Versus Investigator's Choice,1
Dec'20,1
https://t.co/sSgqO4EA9Q,1
the Latest Research,1
@NitinJainMD &amp,1
SOC,7
Novel Agents Could Chemoimmunotherapy,3
Download] Kindle Medifocus Guidebook,1
#Business #HealthMedicine #,1
MarketingSales #,1
PharmaceuticalsBiotech,1
https://t.co/rDMa8sm1bF,1
SureSeq #,1
Multiple Chronic Conditions,1
https://t.co/NPoxu4Nq2H,1
Exposition,2
@HallekMichael lab @BloodAdvances,1
Viktoria‘s,1
NEW BLOG - BTK Therapies and Binding Site Implications in Chronic Lymphocytic Leukemia,1
"https://t.co/ESFdJ4tJv3
",1
Hematología,7
BNTX,1
@GOVUK,2
https://t.co/1Qer4f1BQJ,1
C-MYC Amplification,1
Real-World Prognostic Biomarker Testing,1
CLL Society's Test Before Treat,1
the Clinical Development of APG-2575,2
CME credits &gt;&gt,4
COVID Vaccine &,1
Latest Cancer News,1
https://t.co/A6UEmvQLnD,1
luego de 6,1
"@IrishCancerSoc
Episode 2",1
Feinstein Institutes for Medical Research,1
@Roche,12
Rituximab and Hyaluronidase Human for the Treatment of Relapsed,1
BeatingCancerTogether #Hematology,1
Parexel Informatics',1
https://t.co/FthcH3i9iU,1
HamburgEppendorf,1
MultiplesMyelom,3
Tracks #AML,1
Aggressive Progression,3
TRANSCEND CLL 004,2
"Real-World Data Indicating Low Biomarker Testing Rates for These Patients 
https://t.co/YpglZlWVMX",1
HCW,1
Roche,218
MBBS,10
FRACP,2
FRCPA,2
JLB,3
Heitmann,1
Muller,1
Protecting &,1
Subcutaneous Masses,3
Unusual Manifestation of Relapse,3
Disease-Free Survival Data,8
CAPTIVATE Study Demonstrate Benefit of IMBRUVICA®,8
@Pharmdca @pawcio2009 #,1
Loxo Oncology,4
Lilly Announces Updated Data,5
https://t.co/BXz4QgAnGP,1
IgG,7
Participants With Non-Hodgkin Lymphoma,5
@anthonymatoMD,1
Caveats,1
Humoral #Immunodeficiency,1
The Scottish Medicines Consortium,1
SMC,4
NHSScotland,1
#Cornishlithium,1
VENCLEXTA/#VENCLYXTO,3
Combined Data,1
👁,2
MALT1,1
A Phase 1/2 Study,1
Umbralisib Ublituximab,1
https://t.co/hxvTvuJrIA,1
Loxo,1
https://t.co/KFjsgoiKAq,1
"TG Therapeutics, Inc.",5
First-Line Treatment for High-Risk Chronic,1
@Bknisbacher,1
CLL-1100,1
U-CLL,1
@genentech,16
https://t.co/mgUIyq06h5,1
Venclexta &,2
bendamustine &amp,1
UNITY CLL,1
@UBCIMP,1
CLL)/Small Lymphocytic Lymphoma,6
BC,4
Canada American Society of Hematology,1
MZL,20
IGVH,1
Phase 1,7
Stefano Molica,3
@TGTherapeutics,1
CR/CRi,1
LLY Lilly,1
SLL Data,1
RT (all PD,1
NE,1
JustAnnounced,1
UNITY-CLL,1
TN &,1
UNITY-NHL,1
"O-Chl RCT
n=421
&lt;15",1
G3,2
NA,4
CK1ε,2
PI3Ki,6
https://t.co/t7Wr7HfuwF https://t.co/K24UIPr0aG,1
LLY Loxo Oncology,2
Lilly,1
IBR,6
LLY Announces Updated Data,1
@JenCrombieMD,1
Leukemia/Small Lymphocytic #Lymphoma,3
Das,2
Meet &,1
Expertendiskussion,1
Auf 👉 https://t.co/8qmKv4RS5z!,1
https://t.co/mb2c1yvqVr,1
AbbVie's,7
RHHBY - AbbVie's,1
https://t.co/ryWn8VV3lH,1
International Prognostic Score for,1
https://t.co/uQssEcqHmS,1
Venetoclax-Obinutuzumab Significantly Improves Chronic Lymphocytic,1
"Real-World Data Indicating Low Biomarker Testing Rates for These Patients https://t.co/28nExNTsym  

#",1
VEN-R,2
DOI https://t.co/5WsXd8BzUO,1
Real-World Data Indicating Low Biomarker Testing Rates for These Patients,1
reduction &lt;50%,1
CLARITY,17
MURANO &amp,1
presentation &,1
Regimen as Fixed Duration,7
First-Line Treatment for Patients with Chronic Lymphocytic Leukemia #Clinical #Trials/Medical #Discoveries https://t.co/dlaKtjZXRx,1
AbbVie Announced Combined Data,1
BeiGene Announces Data on BRUKINSA,3
Phase 2 Trial,10
MM,24
sample types &amp,9
BGNE BeiGene Announces Data,4
First-Line Treatment for High-Risk Chronic Lymphocytic Leukemia,4
https://t.co/It475tOkRK,1
First-Line Treatment for High-Risk Chronic Lymphocytic,1
METTL3,2
Real-World Data Indicating Low https://t.co/QYHGFaWmlM,1
Real-World Data Indicating Low Biomarker Testing Rates for These Patients,2
ASHTogether #leukemia #,1
Coexisting mut &amp,1
BeiGene Announces Data,1
Real-World Data Indicating Low Biomarker Testing Rates for These Pat,1
@landau_lab,10
WT #CLL,1
BGNE Announces Data,1
m6A,1
@wwierda of,1
Worldwide Examination of Patients,1
videos &amp,1
@dbrandnerMD,1
First-Line Treatment for Patients with Chronic Lymphocytic Leukemia,6
Data For Fixed Duration Treatment Venclextavenclyxto,1
@chaligneRonan @AnnaEnim,1
ITT,2
https://t.co/YVKbiiAVmf,1
CLL https://t.co/o5cMoaFySV,1
Genentech Announces New Data Reinforcing the Long-Term Benefit of Venclexta-Based Combination for People With Relapsed or,7
First-Line Treatment for Patients with Chronic Lymphocytic,4
ASHTogether,1
BAX-mutated,1
Piers Blombery,5
Time,3
CK,5
Obin-Ven CLL14,1
ABBV Reveals New Findings,1
Genentech Announces New Data Reinforcing the Long-Term Benefit of Venclexta-Based Combination for People With Relaps https://t.co/f5eKGYsoQx,1
RHHBY Genentech Announces,2
ROG,18
RocheInnovation,2
Captivate,1
https://t.co/3sJ4022Lno,1
AbbVie Presents Extended Follow-Up Data for Fixed Duration,1
https://t.co/EGUxRFcav2,1
@Rfonsi1,1
al - HELIOS,1
BR - 14.3,1
Moreno &,1
identification &amp,1
register &amp,1
SEQUOIA,4
Student Activities and Leadership sub-committee,1
Center for Language Learning,1
Inter-University,1
BeiGene,6
U.S. Food and Drug Administration,7
PER,2
PB,7
The American Journal of Surgical Pathology,2
@wwierda of @MDAndersonNews @CancerMedMDA @LeukemiaMDA,1
CLL https://t.co/8fgvJ6iCAI,1
MEI,2
Relapsed/Refractory Small Lymphocytic Lymphoma,1
https://t.co/v7wUKkkN4R,1
https://t.co/gtO8OFq2BG,1
@andrewschorr,42
"Dr 
@AnnaSchuh3",1
the Genomics England 100000 Genomes Project,1
WGS,10
SMDH,1
Anderson CLL,1
the New Era,1
"MB, MS",1
Application of Individualized Treatment,1
"Novel Agents, Combinations",1
⁦@CllSociety⁩ https://t.co/pEh1Vtifbn,1
Publication of Phase 2 Data Evaluating,1
MB,10
MS of @MDAndersonNews @LeukemiaMDA,1
PeerView,4
TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib,8
PI3K Inhibitor,1
PI3K Inhibitor Therapy,9
PI3Kδ Inhibitor Therapy,1
TG Therapeutics Initiates Rolling Submission of Biologics License Application,3
Announces Publication of Phase 2 Data Evaluating Umbralisib,1
PI3K Inhibi,1
Lymphom-News,3
Infos &,2
⁦@sloan_kettering⁩ ⁦@Penn⁩ ⁦@dbranderMD⁩ ⁦@LRoekerMD⁩  https://t.co/sNcW3svTFM,1
Cleveland Clinic,2
https://t.co/zuc7ZiyfvR,1
the Food &amp,1
@anthonymatomd &,9
"AE
Important",1
Ix,2
BLA,2
HSCT Webinar,1
Meta-Analysis,1
Linking Immunoevasion,1
Covid Vaccines &,1
@Columbia University,1
Herbst Irving Comprehensive Cancer Center,1
https://t.co/IgWPbYdYNY #CLLsm #,1
Incorporating Shared Decision-Making,1
CLL Care,1
@anthonymatomd @jeff_sharman @dbranderMD &,1
CC @tobyeyre82,1
Venetoclax-R. During,1
COVID-19 PNM,1
@hospitalclinic,7
@UKKoeln,4
@UniklinikUlm,1
Daten des #,1
BOTH mantle,1
https://t.co/WWlmsyjxwo,3
New Research: Method for the Analysis of the Tumor Microenvironment,1
Mass Cytometry: Application to Chronic Lymphocytic Leukemia,4
"Share, Emerging Technologies",1
the stress &amp,1
#charity,2
PNP,1
SAMHD1,1
https://t.co/LK4aUzf6hV,1
Global Chronic Lymphocytic Leukemia Treatment Market,2
the Swedish Cancer Institute,1
Nurse-Like Cells Are the Caretakers of Leukemic Cells,1
F/U,2
Oliguric Acute Kidney Injury,1
Nurse-Like Cells Are the Caretakers of Leukemic Cells,2
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma &gt;&gt;RFP@ bd@mellalta.com,1
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,4
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic ,1
Fannie Mae,1
Freddie Mac,1
https://t.co/gjz6C5HdSj,1
Thompson,7
NEGATIVE,1
Global Chronic Lymphocytic Leukemia Treatment Market Research Report,1
CKD,3
@UniversityofWA &amp,1
@wwierda @MDAndersonNews #,1
#Antioxidants,1
BreakingData,1
IGLV3,4
R110,1
@CIBERONC,3
Focus on,3
⁦@NitinJainMD⁩ &,2
⁦@wwierda⁩ #,1
⁦@tobyeyre82⁩ ⁦@AnnaSchuh3⁩ ⁦@OxfordHaem⁩,1
EndCancer #Leukemia,1
MRI,1
Augmented Human Intelligence,1
https://t.co/rpII9B7L9u,1
clonal evolution &amp,1
Access,3
Elaine Willmore @UniofNewcastle &amp,1
@iiiglasgow,1
CHOP-Ofat #Richters,1
@DVVavoulis @AnnaSchuh3,1
Jenny K &,1
safety &,4
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death,2
SpeakingandListening,1
cellular &amp,2
Relapsed Disease https://t.co/GSZaTH39ki,1
Register➡ https://t.co/kckOK3tEIv,1
ESHCONFERENCES,7
@WCMCLymphoma &,1
lockdown &amp,1
🖥 CLL Management,1
KSA,1
Comparison Between Venetoclax,1
Therapy as Upfront Treatment of Chronic Lymphocytic Leukemia,1
Systematic Review,1
Clinic,1
The ESH Translational Research E-Conference,1
lymsm https://t.co/pWSX2Ssgaa,1
the Immune Microenvironment,1
Evolution of Advanced Chronic,1
Cancer Risk/Mortality,1
Biobank,2
TCGA Datasets With the Genetic Risk Score,1
Mendelian Randomization Approaches,1
Rush - PGY-1 Resident @PharmDKG,1
#Toronto,1
the U.S. Watch,2
Alexey Danilov &,1
Real-World Data Show Temporal Trends,1
Risk of Serious Bacterial Infections,1
https://t.co/lcCz962Gm0,1
MD Anderson Cancer Center Untreated,1
#MophMolMon Lymphocytosis,1
CCND1,2
DigitalHealth,1
Dimitar Efremov &,1
Lunch &,1
GenQA,4
Hellenic Group of Patients,1
the CLL Advocates Network,1
Dominic Pivonka @abbvieuk &amp,1
J. Brown P. Ghia,1
Applying Data,2
Watch and Wait,4
Leukaemia Care and @CLLSupport,2
📰 NEWS,2
Intermittent Fasting,1
Mumbai Hematology Group,1
webinar,2
Chr,1
Manitoba Primary Care Providers,1
Cancer - Chronic Lymphocytic Leukemia,1
Leukemia/Lymphoma IPC,1
530pm ET,1
Empowerment Resource Center,1
el algoritmo de tratamiento de,1
LLC @sehh_es @SCLHH1,1
Untreated CLL https://t.co/HeTsGtrLvb,1
Nitib Capsule,1
@OHSUSOM,5
PSE #,1
https://t.co/f8w7mREzxk,1
the Experts → Register,1
Blood,9
Restricted,1
https://t.co/6X8FBYk9Oc,1
LOXO/Lilly Announces Details,1
BTKin,1
the @ClevelandClinic Taussig #Cancer Center,1
Ibrutinib-Induced Cardiac Tamponade,1
Non-Genetic Mechanisms of Resistance,1
Great News for,1
GMAB $,1
DuoBody-CD3xCD20 #,1
SARSCOV2,1
PCR,6
Genetic and Epigenetic disruption,1
Cancer Epigenetics Group,1
Functional Cytomics Group,1
@andrewschorr &amp,7
groups &amp,1
CLLawareness,1
@utswcancer &amp,1
@michelenadeemb &amp,1
Chronischen Lymphatischen #Leukämie,1
Webinar,3
DIA,5
SVP,4
Follicular Lymphoma,32
https://t.co/4uyKTHMwWb,1
@3meds1,1
https://t.co/rvf76wcpri,1
الذي,1
العمر ٧٧,1
#Epigenetics #,1
Leukemia-Induced Humoral Immunosuppression: A Systematic Review,1
GeneReviews,2
@EPCALM,1
CE,5
The European Society for Medical Oncology,1
LymphomaMatters https://t.co/ceZgP4inqy,1
Pharmacokinetics of Venetoclax,4
https://t.co/IZP0myDLnZ,4
https://t.co/AjhiJH2rHs,1
ELISA,1
PIA,1
Binet,10
BMTsm,1
Worldwide Chronic Lymphocytic Leukemia Treatment Market Witness A Remarkable Growth Projected,1
Blood #Cancer Video Chat Virtual,1
Ublituximab-Umbralisib Combo,1
Pallasch,1
University hospital,1
"Notch1"" @Bloodjournal https://t.co/HPlSv48omO
",1
Curso Chronic Lymphocytic Leukemia,1
HHV-6,1
https://t.co/ueJbGB0Ri4,1
the German CLL Study Group,3
GCLLSG,9
Resistance Mechanisms to Targeted Agents,3
SACT,1
https://t.co/buLZDcRmWI,1
New Targeted Agents,2
a Targeted Oncology Case Based Peer Perspectives,1
https://t.co/IgWPbYdYNY #CLLsm,1
https://t.co/sJsATbEIbu https://t.co/WOA002bxbO,1
ANCC,1
Therapeutic Potential of Extracellular,1
P53,1
Abnormal,1
WWP1,1
https://t.co/XWDj69JFEp,1
Vitamin C,1
JECCR,1
https://t.co/3H4AILtY55,1
Begüm Alankus,2
#Leukemia #Lymphoma,2
#Research,3
Oncogenesis,1
NonHodgkins #,1
Reliance,1
BioXpress #Intas #COVID19,1
1st PR,1
@NormaFoleyTD1,3
VietnamVets,1
https://t.co/iCni1gycWw,1
https://t.co/J9WGTQ0ReI,1
CME/MOC,1
https://t.co/f9hQ6YzHOV,1
HOVON,8
ERK1/2,2
ROR1/DOCK2,2
Worldwide Chronic Lymphocytic Leukemia Treatment Market Ready To Set Outstanding Growth,1
MDS,16
TG Therapeutics Announces,15
CSK,1
cll,72
sll,6
https://t.co/gmoFYsp55S,1
JCWO,1
Acute Lymphocytic Leukemia,14
https://t.co/d29MqIsDu6,1
R-,1
https://t.co/B0EimDBus0,1
ITP,4
@WilmotCancer,1
Outcomes of COVID-19,2
the Lymphoma Program,1
https://t.co/t0CBeeKZi3,1
parthenolide &amp,1
@unibirmingham #OpenAccess,1
JGW Patterson Foundation,1
@NU_Cancer @NCL_medresearch @UoSResearch,1
the ESH Translational Research E-Conference on Chronic Lymphocytic Leukemia,1
PIM/PI3K Inhibitor,1
@lgranichRDN,1
@DianeEnosRDN,1
https://t.co/5HbB55AZzG,1
Relapsed and Refractory Indolent B-cell,1
Malignancies,2
Fc-Engineered Antibodies,1
C19,1
Dublin Deb,1
Patient Power https://t.co/Ik87mCkKtC,1
@peixun_zhou &amp,1
OncoAlert Prognostic,2
"U/L.
",1
Congratulations,1
Inhibit BTK,1
Fast Track Designation,2
ANP-C,3
FightCancer,1
WeChat &,3
Pharmacists Coordinated Care Oncology Model,1
Medications https://t.co/27Hfrgcw87,1
@genentech/@Roche,1
FDA Grants Ublituximab/Umbralisib Combo Fast Track Status,1
TGTX,1
Canada &,1
First-Line Chronic Lymphocytic Leukemia,3
Belfast City Hospital,1
@USFDA,2
NASDAQ,1
PBS &,1
UK &,1
Leukemia - Treatment Breakthroughs For Chronic Lymphocytic Leukemia - https://t.co/DlnpSjSmzD,1
Haematologica Journal Ferrata-Storti Foundation,1
chr,8
watch &amp,23
Host &,2
🙏,25
🌻☀️💫,1
@dinamoMD @AdfitzthumMD,1
"MEET OUR SPEAKERS
View",1
"https://t.co/jCt9jYwcFL
#",1
The Anti-Apoptotic Role of EBV-LMP1,1
Lymphoma Cells,1
@FacebookWatch  @PatientPower,1
CC @PatientPower,1
kun,2
@QMUL &,2
Haemo-Oncologist,1
CLL w/ Lydia Scarfo,1
Nathan’s,1
Nathan,1
Questions &,1
BP,1
Novel Agents Could #Chemoimmunotherapy,1
Lymphoma #Chronic #Lymphocytic,1
European Research Initiative,6
ERIC),2
ER,4
https://t.co/uypl9Zt5AJ,2
Developing Novel Agents,1
https://t.co/Z2pDqO0rJt,1
Real-World Evidence for Chronic Lymphocytic Leukemia,3
WorldSeries,1
the Night Walk Fund Raising Page,1
Place Ninth Circuit En,1
Peer Exchange,3
Patienten-Webinar,1
CNE,1
Millionaire,1
Ruland @TU_Muenchen &amp,1
RANKL,4
Swedish Cancer Institute,1
W #,1
PFS &,6
https://t.co/xU5gu5zG9x  #,1
the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre,1
The Mighty,1
Health Care Resource Utilization,3
VEN-IBR,1
SureSeq,3
https://t.co/WF2Xjcdppf Planning,1
@MSMEDU,1
@DebbieMStephens &amp,1
Association of Common Variants of TNFSF13,1
CLL Risk and Clinical Picture,1
TACI Molecules,1
Awesome,4
Global Virtual Patient &,2
Caregiver Educational Forum,3
New Research: Genetic Loss,1
LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia,2
200MA,1
Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia,1
Clinical Advances in Hematology &,1
CLL Society,9
Hospice,1
Improved Patient Classification,1
Leukemia - News - CMM,1
Troll,1
Hematología #,2
Berberine,1
New Chronic Lymphocytic Leukemia,2
CARTcell,29
non-Hodgkin #,24
Rheumatoid,7
https://t.co/iiNuv6SrdP,1
Hoy queremos,1
acaba de,1
el equipo,1
Betty,3
the National Patient Conference,1
EMEA,2
σπληνικού λεμφώματος οριακής ζώνης,1
NCT01889186,2
https://t.co/3o1YDrZ89u,1
Vitamin,3
CLL Treatments,2
@VJHemOnc,2
Register Now,2
@wwierda &amp,1
Global Chronic Lymphocytic Leukemia Treatment Market Recent Trends,1
Growth Opportunities,2
EBMT,11
@ClevelandClinic &,2
@chrispleyer @ClevelandClinic,1
EOT,4
#ClinicalTrials #,2
#lymphoma,1
EXCEPT,1
PI @MattCheungMD,1
https://t.co/ag3OxI2as0,1
"https://t.co/qWxzisXsUx

",1
Prognosis,5
Monoclonal B lymphocytosis,1
Report Covering Products,1
Financial Information,1
the California Teachers Study,1
Cowan,1
Liebowitz &,1
CI,15
Chornobyl,5
Panagiotis Baliakas,1
RichterTransformation,3
the Canadian Lacrosse League,1
Paolo Ghia,1
"👉https://t.co/O9p0vDBrzw👈

",1
Soniya,1
Virtual Support Group,4
@LLSusa @LeukaemiaAus,1
the Determination of Idelalisib,1
Mucosal,1
MEET OUR SPEAKERS,1
Latest CLL Research,1
@FacebookWatch,1
Fashion Law Institute,1
BTK Inhibition Impairs the Innate Response Against Fungal Infection,1
https://t.co/cuyRFQBHqN,1
@UKNEQAS,2
improvements &,1
high &amp,1
Belimumab Reinforces Small Molecule Inhibitor Treatment,1
"Head, Institute of Blood Disorders and Bone Marrow Transplant",1
Fortis Hospital,1
⚽️🏒🥍🏹🎾,1
🚴🏻‍,1
https://t.co/Fz0HubRcUM,1
the First Epidemiological Investigation of Canine Adenovirus Type 2,1
Extracellular,1
Juravinski Cancer Centre,1
Non-Hodgkin's,10
@MoffittNews https://t.co/l6zKR3ZOlT,1
The Hawaii Society of Clinical Oncology,1
"The Experts Weigh In""",1
Quality of Life,5
QLQ‐CLL17 Questionnaire,1
GIMEMA,7
monocyte,3
https://t.co/SmTNpn5f3A,1
BC Cancer,1
BCCancer,1
@hampel_p,5
UCI Health's,2
Atrial Fibrillation and Bleeding in Patients With Chronic Lymphocytic Leukemia Treated with Ibrutinib,2
the Veterans Health Administration,2
COVID-19:,1
Venetoclax-Obinutuzumab +/-,1
@Healthgrades,1
MarketsandMarkets,2
Diverticulitis,1
the Hawaii Society of Clinical Oncology,1
@UNMC,1
#Bless R.B.G.,2
Safety of Lenalidomide,1
Janssen Research &,1
Development,1
IL-21,1
@MrsKellyWood,1
lymsm https://t.co/f81jzbwGJL,1
Initial Therapy,1
Monoclonal Antibodies for Chronic Lymphocytic Leukemia,1
advocates &amp,2
Learn More &amp,1
Register,19
الجمعية السعودية,1
Isurus Oxyrhincus,1
@VPrasadMDMPH &amp,1
Non-Coding,1
Exosomes in Tumor Progression,1
#Lymphoma #Leukemia #Hematology #Oncology,1
https://t.co/D7D5YB8Odg,1
Drs Carolina &,1
non-Hodgkin’s,31
Mr Zatta &,1
TeleMedicine,1
Community Medical Center’s,1
https://t.co/hehx5oOrEr https://t.co/c8Azh2d7N4,1
https://t.co/TfIfNlIp8R,1
CNE Registration,1
@DanaFarberNews,1
@pbachi,3
https://t.co/RdyxEMMSmF,1
ImmunoOnc #CARTcells #,1
Party,1
Northwestern,1
LCSW &amp,1
LesliePowell,1
MLS,1
T-Cell Dynamics,3
CLL Ireland,1
Rheumatoid Arthritis,9
HEMATOLOGÍA - Scarfo,1
the European Research Initiative,10
CLL Campus  ,1
Patients With,1
Myeloma #Lymphoma,2
https://t.co/dpOz3hfOyb,1
This World Lymphoma Awareness Day #,1
World Lymphoma Awareness Day,3
https://t.co/M2HtigP3nu,1
NPPS,1
Sat,2
SSBMT Webinar,1
University of Amsterdam &,1
Barts Cancer Institute,1
NeoGenomics,2
@IMBRUVICAUSHCP,1
Virtual Patient Educational Forum,1
Clinical Trials,1
Venetoclax &,6
chlorambucil &amp,1
"al
#venetoclax &amp",1
CK &,1
https://t.co/QNrKe9md4,1
The American Cancer Society Cancer Action Network,1
Bismarck ND,1
kidney &amp,1
LightsofHope,1
Daily News,1
Hillmen P,2
HuR Affects Proliferation and Apoptosis of Chronic Lymphocytic Leukemia Cells,1
NF-κB Pathway,1
Mixed Invasive Mold Infections,1
@clonoSEQ,2
MD CLL Society Inc.,2
Adaptive Biotechnologies,16
MD Swedish Cancer Institute,1
Steering Committee,5
Achieving Innovation,1
"BTK Inhibitors: Selection, Safety",1
Sequencing Across,2
"Measuring Residual Disease, Clinical Implications",1
Refractory Non-Hodgkin Lymphoma,1
WeChat,1
未治療CLLに対するイブルチニブとリツキシマブの併用療法が欧州で承認：がんナビ,1
AntiCancer,1
Cll,10
Acute myeloid,5
Prognostic,6
Review,4
@AMPath,1
Norton Medical Group,1
Norton Cancer Institute,1
hospitalization &amp,1
Improving Outcomes,2
the Latest Clinical Advances,2
"🤔

",1
觀看首播：https://t.co/nqq9bSaapJ,1
@biovitenskap,1
the European Commission's,1
Society of Clinical Oncology Annual Meeting,8
the B Cell Lymphoma Micro-Environment,1
https://t.co/9kZg8jth29,1
SOHO2020,1
@LLSusa @CureLeukaemia @LeukaemiaAus https://t.co/9jBtNcOjG6,1
https://t.co/blXVseXYLo,1
Summary Judgement against,1
Costco for Trademark Infringement Vacated,1
"2nd September,@Leic_hospital",1
@CRCTU,6
Glucocorticoid,1
CCR5,1
Venetoclax-Obinutuzumab For Untreated Patients,1
#Ascentage,3
BS,1
HPV,1
EC,17
CDT,6
FDA Grants Orphan Drug Designation,1
ZYBT1,1
Bcl-2 Inhibitor APG-2575,11
Support Group,2
https://t.co/WkfxknTzMI,1
@ancan501c3,1
https://t.co/lqVeNpHcTN clonoSEQ,1
Kenny &,1
Eastern,3
Acute Lymphoblastic,1
Acute Myelocytic,1
Chronic Myelocytic,1
European Commission,10
MabThera,22
Phonics &,1
The Virtual Congress on Hematology,1
Alloa,1
Molecular Tumor Board,1
https://t.co/oKaENlZ3Dl,1
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen,7
https://t.co/5CZdzlmWOV,1
Meet Our Faculty,1
https://t.co/Z4MMAVIjNs,1
CLL.Thanks,1
Giacomo Corleone,1
Effie Kostareli,1
Multiple Myeloma,4
Long-Term Outcomes From a Randomized Dose Optimization Study,1
COVID-19 https://t.co/Lzzw7RjyWt,1
DM me,1
The Ohio State University,1
Acute,13
the Ed Durham Team,1
awareness &amp,1
GP,4
"Haematologica #CLL 
 ",1
Scientific Working,1
translational &amp,1
Deb Sims,4
HEMATOLOGÍA,1
OncoAlert Outcomes,1
Case Report,1
@SidYadavMD &amp,1
"@carisls, &amp",1
the Recurrent Gly101Val Mutation,8
Assess Minimal Residual Disease,12
CLL - Brian K...,1
SMURF1,1
Kappa and Lambda Immunohistochemistry,1
neuroendocrine tumours &amp,1
the Patient Resource Chronic Lymphocytic Leukemia,1
Patient Access Novartis Oncology,1
Blood Cancer Awareness Month,4
Le Creativity,1
MedscapeElevate,1
MRD Testing and Limited Duration Therapies,1
DNA for prognostic &,1
MY SOCIAL SECURITY &,3
MEDICARE,3
Green Tea Extract,1
Extract of Green Tea,1
working &amp,3
Outcomes of Reduced Frequency Dosing of Ibrutinib,1
RNA BM742401,5
International Ultman Chicago Lymphoma Symposium ⁦@NitinJainMD⁩,1
https://t.co/QP98hksMVt,1
"Founder, &amp",1
Leukemia #COVID,1
https://t.co/TOEdim9aap,1
recount &,1
Fc,4
https://t.co/DfIroLlvyC,1
HCV,1
Tumor Lysis Syndrome,3
Treatment-Naive,2
BSI,17
CLL Highlights,1
https://t.co/4Mwvsb7ENC,1
American Society of Hematology https://t.co/hjItjfkNIE,1
Anderson Cancer Center (@LeukemiaMDA,1
@MDAndersonNews #Leukemia,1
Reviews BTK Inhibitors,1
Chronic Lymphocytic #Leukemia,3
caregivers &amp,3
NRM,1
al @BloodAdvances,1
RR #CLL,3
@DrMiguelPerales +,1
CLL Answers Now Program,1
Initial Therapy #CLLsm #,1
CLL - Chronic Lymphocytic Leukemia,2
"food, &amp",1
RWD,4
University of California Irvine,2
Wenserski L,1
Schultheiß C,1
Simnica D,1
Wolters-Eisfeld G,1
Idelalisib for Treatment of Relapsed Follicular Lymphoma,6
A Comparison of Treatment Outcomes in Clinical Trial Participants,2
F(ab')2,1
the Precision Oncology Alliance,1
a Medical Oncologist,1
#EducatedPatient Webinar,1
https://t.co/kvXkI8p5Yj,1
a Metabolic Immune Checkpoint,1
AHR,1
Promotes Tumor Progression,1
Siteman Cancer Center,1
Oncology Access Program for Chronic Lymphocytic Leukemia Patients,10
Die Deutsche Gesellschaft,1
Onkopedia Leitlinie,1
Untersuchungen,1
FDA Clears First MRD Assay,1
Oncology Access Program for Chronic Lymphocytic,1
Novartis,10
McRaven,4
energy &amp,1
Unity,3
@NEJM LTE,1
@TheBehtesdaLabs,1
IVO,2
Chao Family Comprehensive Cancer Center,1
Virtual National Blood Cancer Conference,1
the Royal Oldham Hospital,1
@SummitCancerCen,1
Outcomes of COVID-19 in Patients With Chronic Lymphocytic Leukemia,1
CDA,1
Postdoctoral Fellowship Grantees,1
https://t.co/jggvQw2mFl,1
Previously Untreated Patients with Chronic Lymphocytic Leukemia,2
Better Understand the Patient,2
StatPearls,1
Bezeichnungen,1
https://t.co/yaExsCnFBl #GemeinsamGrenzenVerschieben #Onkologie,1
NEJM Resident 360 &,1
LLNI #Cll #,1
WEBINAR,1
https://t.co/ezH3jn58cQ,1
CST,2
Brighton &,1
Sussex Medical School,1
BioFlux,1
https://t.co/SvkzIO8k3n,1
Quality of Life Significantly Lower With Chronic Lymphocytic Leukemia,1
@ASTCT,1
Southlake Regional Health Centre,1
Bone Marrow Transplantation,1
RandD #,1
Das Vorliegen,1
Lymphoma Australia Virtual Conference,2
Society 1/19/2020,1
al 2do,1
dia,2
Miniaturized Drug Sensitivity,1
MCL Taking,1
EYFSSquad https://t.co/HaFjkdBt6M,1
TOSO,1
Treatment Naive,1
Please Complete,1
Combination With Venetoclax,2
https://t.co/0Q6DXA3OK1,1
@SeattleCCA &,1
Alterations,5
the Badder Than Ever,1
Lymphoma Society of Canada,1
SARS-CoV-2,1
Quality Management,1
T&amp;C,4
https://t.co/Whm8q0kNRw,1
Chinese Technology Huawei,2
ZTE,2
Primary Immune Deficiency Disease,1
Kroger Specialty Pharmacy,1
Ferran &,1
CTLA-4 Immune Checkpoint Molecules,1
CARD9,1
RNS,92
AIM,100
Cello Health PLC,93
PTCMA Virtual CPD - 12,3
FUNDSWIFT - https://t.co/zzZha7petd,1
the Department of Hematology/Oncology,1
Kenny,1
"@nanditadas 
@helpinghandngos",1
Society Adaptive Biotechnologies,1
RT MassiveBio,1
Relevant Securities,1
LCL,1
Virtual #MolecularTumorBoard,1
Simultaneously Inhibiting BCL2,1
Utilities Based,1
https://t.co/qpiKCP0B9,1
DABFM,1
ASCO &amp,6
@DrMDavids &,9
Dose-Escalation,2
Dose-Expansion Study,2
Small Lymphocytic,4
COVID-19 Severity and Mortality,1
SPA,1
him &,1
Burger @NEJM,2
Court Sanction of Scheme,1
https://t.co/tbpXiDRAAL,1
Media Snippet,1
el primer dia,1
the Chronic Lymphocytic Leukemia Patient Management Simulator,1
TIFS,1
Adaptive,6
https://t.co/QtpY0POIwW  #,1
4PM,1
ClonoSeq,1
First-Line Treatment,14
https://t.co/XLLmXXig4o,1
05/12 &amp,1
03/26,1
Safety of Panzyga,1
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL,1
ABO,1
Psychological Distress in Outpatients With Lymphoma During,1
Lombardy Hematology Network,1
Tumor B Cells,1
VIRTUAL,2
Lymphoma Research Foundation,3
Recommendations About Management of Patients,1
RCN,3
The Clarke/Duke Project,1
Duke,2
IMO,2
the EORTC QLQ-C30,1
QLQ-CLL17 Questionnaire,1
https://t.co/6VDE2smnKi #CLL #,1
https://t.co/qyVLyJTzA6,1
Aspergillus,2
NGS CNV,1
Radio 4 Today’s Programme,1
Expectations,3
Oncological Associations,1
Immunopathologic Insights of Paraneoplastic Kelch,1
Encephalitis,2
https://t.co/DyjDVOQnAw,1
@binayshah,1
https://t.co/2Sp79DGUGm,1
https://t.co/Mg0CkE6VPk,3
Primer día de #,1
@JohnPLeonardMD &,1
Goodbye Boston,1
https://t.co/MeoqEBj2VV,1
The New England Journal of Medicine: Search Results,2
2020 Picks,1
PGR,1
OncPharm @MayoPharmRes,1
Real-World Outcomes,1
Cochrane,1
https://t.co/A9GJuxrd0M,1
OncoAlert Chronic,2
TatPremiers,14
FoxMemorial,9
Glenora Rugby League Football Club - EST,1
THREAD - Chronic Lymphocytic Leukemia,1
Technological Innovation,4
Hoffmann-La Roche Ltd.,4
AbbVie Inc.,9
Teva Pharmaceutical Industries Ltd.,4
Johnson Services,4
Clinical Pearls &,1
@BLLPHD @carlhjune @ASTCT @ISCTglobal,1
https://t.co/QRnY4cBYFy Chronic,1
Boomer Buy Setup,1
ALS,3
CCT,2
Online Focus Group,1
lymsm https://t.co/JmIPja5Tuo,1
Clinicopathological Role,1
Waipareira Sponsored #,1
TatProud,6
⁦@IrsyadEnrique⁩,1
#idelalisib #,3
Cohort-Expansion Study,1
CLL Management Webinar,2
IDonc,18
TY,7
SSBD,2
CLL Management,2
Notification of Major Holdings,1
Determination of Venetoclax Using AQbD Principles,1
PD-1,2
Pesticides and Chronic Lymphocytic Leukaemia,1
Chemokine Receptors CCR1,1
miR-15a/16-1,1
miR-497/195,1
Genentech,74
ACE-CL-001試験の全奏効率97％、ASCEND試験では病勢進行のない生存率が82％,1
MedscapeEdu,15
@WVCancer &amp,5
Patient Influencer &,1
Leukemia - Treatment Breakthroughs For Chronic Lymphocytic Leukemia - https://t.co/dGpbllFkpo,1
Educated Patient,1
JackColvinPark,1
@Haematologica  ,1
Strati &,1
Shanafelt @BloodJournal https://t.co/dl6ACbCckN,1
Meta-Analysis Reveals Significant Sex Differences,1
😔,4
TatReserves,4
New Research: Increased Expression of Autophagy Protein LC3,1
Leukemia ⁦@sloan_kettering⁩  https://t.co/kGoOmO987e,1
https://t.co/0RuSzOtoHM,1
Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia,2
curso de capacitación,1
ISO,2
https://t.co/Q3pQhIqaHU,1
Comparison of Access,1
Founder CLL Society USA,1
HOMEGAME,1
CancerCarer,1
Expert Review of Hematology,1
https://t.co/YFYsoeXdgp,1
CLL Patients,1
Ibrutinib-Ublituximab Combo Leads,1
Better Outcomes for Patients,1
https://t.co/5CAvkXRSKM,1
MILLENNIUM,3
Block Listing Update &,1
"@BloodJournal 
Largest",1
CRF,1
Educated Patient Chronic Lymphocytic Leukemia,1
RadicalRemission,1
Kenneth Research Global Leukemia Treatment Market-By Disease Type,1
MNDA,1
MCL-1,3
the future &amp,1
The Howick Hornets,2
lymphocyte count &gt;15×109/L,1
https://t.co/MRhpghrluD #,1
Atrial,3
AMG-176,3
@UWMedicine,2
Top 12 Picks,6
NewJersey,6
https://t.co/hzfUsiqXLT,1
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients:,2
The U.S. Supreme Court,1
https://t.co/dwpynNjIOu https://t.co/EiLHF6lyS7,1
PI3K g/d,1
@ekwaller @FDAOncology @NIH,1
@myESMO @CDCgov,1
Community Oncology,1
@MoffittNews @USouthFlorida,1
PI3Kδ/CK1ε,3
lyle_dk,4
the US Veterans Health Administration,1
BARCLAYS PLC,2
Publication of Scheme Document,1
Mantle Cell #Lymphoma Patients on Ibrutinib,1
https://t.co/doxJ4fltQN,4
@TapKadia @doctorpemm,1
⁦@TapKadia⁩,1
CLL Campus,3
https://t.co/W3FsIsCYWk,1
nosh &amp,1
MRL #,1
ADME,1
IIT,3
#GreyLynnPark Round 4,1
the CancerNetwork® Tumor Board Series,4
Numbers,1
🙏🙏🙏🙏🙏🙏,1
Facebook,1
Sand Grove Capital Management,5
Blood Advances Describing Unique #Immunomodulatory Effects,1
CDK,2
🏆,4
🏆🏆 #MTGLegacy #MTGO,1
TF,2
CTCF,1
@RWJUH,1
#idelalisib &amp,2
Research Opportunity,1
non-Hodgkin's Lymphoma,1
BRB,1
Rutger's CINJ,1
RWJBarnabas Health,1
NJ CLL Patients,1
BTK Inhibitor Zanubrutinib,1
Combination With Rituximab for Previously Untreated Patient,1
https://t.co/E2qFUk7WFn,1
Real-World Data,2
AnCan/Throwing Bones Blood Cancers,1
EQA,2
AcquiredArray,1
NTRK,1
Leukemia Study Group Observational Study,1
PDF,5
the Walter and Eliza Hall Institute,1
https://t.co/3xEk2ncj50,1
Predictive Molecular Biomarkers,2
Tumor Board Series,2
New Jersey,1
Limited,1
https://t.co/rb1NJxe4mJ,1
Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors,1
WEGO Health Awards,1
"@wegohealth
 ",1
WEGO Health,1
⁦@LLSusa⁩,1
the @CllSociety Tribune,1
Non-Hodgkin Lymphoma Incidence,1
SF3B1,27
@BloodJournal,2
Oncology Institute of Southern Switzerland,1
GMR,2
JOG,2
Bullish Signal Line Cross,8
TPT,1
HGM,2
PGIT,5
SSTY,2
BKS,1
ATT,3
GHE,1
NXR,1
HFD,1
DOW #,1
MAIN #,1
BAC,2
EPR,2
https://t.co/iuHLzfdYIa,1
@FionaElseyCRI - Mucosal,1
https://t.co/7wSxrH0tDD,1
"🤔

Investegate |Arsenal Capital Mgmt Announcements",1
Arsenal Capital Mgmt,1
Bronchopulmonary Leukemic Infiltrates,2
"Nasty Pig, Inc.",1
Crain’s NY Business,1
Oncternal Therapeutics,1
https://t.co/J3eW9z9pya,1
Oncternal Therapeutics Announces Orphan Drug Designations of Cirmtuzumab ROR1 Antibody for Treatment of Mantle Cell Lymphoma,3
ONCT Oncternal Therapeutics Announces Orphan Drug Designations of Cirmtuzumab ROR1 Antibody for Treatment of https://t.co/gd8BuxXJAL,1
Oncternal Therapeutics Announces Orphan Drug Designations of Cirmtuzumab ROR1 Antibody for Treatment of Mantle Cell,1
"Share, Size",1
Status,7
"Growth Rate, Services",1
Details:-,1
https://t.co/E7Uz7x0mAY https://t.co/PWqRkutcqp,1
CURE,3
@JanRynne @NYLCandCLL,5
CLL Society ASH 2019,1
Pevonedistat,1
New Clinical Trial,1
Coronavirus Risks for People With Chronic Lymphocytic Leukemia,1
Time-Limited Triplet Therapy Induces Rapid Undetectable MRD Responses,1
EHA-ASH symp/#EHA25Virtual,1
integration &amp,1
augmentedintelligence https://t.co/tBQaxglao9,1
BMY,1
Retroperitoneal Fibrosis,2
The Combination of Venetoclax,1
https://t.co/QBtvoNk39R,1
SLAMF1,1
PDQ Cancer Information Summaries https://t.co/AjIwWK20MA,1
https://t.co/jjgTwFWqcE,1
Self-Improvement,1
Healthy Korean Individuals With Lymphocytosis,2
Korean Society for Laboratory Medicine,1
https://t.co/Yp3rVNVcSV,1
@ASCO Virtual Scientific Program,1
CLLD,1
"Share, Growth Factor and Analysis",1
ONCT Oncternal Therapeutics,1
FDA Orphan Drug Designation,1
The Royal Marsden,1
@jmolldrem,1
Virtual Annual Meeting,1
MF,1
LPD,1
Immunoglobulin Gene Analysis,4
ALC,3
ADP,1
BALL,2
Leukemia https://t.co/wUyM9RCWph,1
Hairy McClary,1
Institute of Oncology Research,1
IOR,1
Brno University Hospital,1
trisomy12 &,1
PLCG2 Mutations,1
@Rigshospitalet,12
the University of Eastern Piedmont,1
VENICE,2
Impressive,12
https://t.co/Kkh5vsG13V @EHA_hematology @CLLAdvocates @Ericllorg #lymsm,1
Tumor Lysis Syndrome Caused,2
Unrecognized Richter's,2
Transformation of Chronic Lymphocytic Leukemia:,1
Secondary School Research,1
BCOP,1
https://t.co/W6yaIG5IHK,1
@BloodJournal for #CLL,1
Richters,2
CLL-PD,1
COVID-19 Meets CLL:,1
Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression,1
https://t.co/Vb7npszewa,1
OncoAlert BTK,2
Shadman,1
IQE,2
BHGG,2
BSD,1
UTLE,2
the UVM Medical Center,1
Prof @AnnaSchuh3,1
mentally &,1
Abdomen/Bowels/Colon/Rectum: Cancer,1
FMC7%,1
https://t.co/JiOK6VCqD2,1
@cityofhope,1
MRD remissions &amp,1
@LeukemiaMDA,31
CLL Answers,2
MERVENDALPS,1
New Therapeutic Advances,1
https://t.co/ilbMD7k65F,1
Entospletinib in Previously Treated Chronic Lymphocytic Leukemia,6
Hetero Healthcare Launches Anti Cancer Drug,1
Chronic Lymphocytic Leukaemia / Small Lymphocytic Leukaemia,1
#EHA2020 @Aptitude_Health Congress Coverage,1
B Eichhorst 🇩🇪,1
PL Zinzani,1
@LoriLeslieMD,1
Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,14
COVID-19 - GlobeNewswire,1
https://t.co/mVaNSf5NZY,1
the European Hematology Association,1
Congress,9
Novel,7
BTK/PLCG2,3
https://t.co/vfcrFOgWhc,1
Flag Day Greetings,1
"al
#",1
"n=39
mFup 11",1
https://t.co/TsZIxGadBS,1
University of Eastern Piedmont,2
https://t.co/ufOgtZsjZ8 #,1
https://t.co/anXPobc05L,1
@andrewschorr @MicheleNadeemB @DanaFarber @DanaFarberNews,1
log &gt;2,1
time &amp,3
Hear Lydia Scarfo,1
"al
BTK &",1
"9-&gt;16m
MRD+ve",1
FC-obinx4,1
FC,3
B-non Hodgkin,1
KML-Videoberichte,3
Weitere Infos &,1
Bachireddy P,1
Global Oncology Trial Management Due,1
Acute Lymphoblastic Leukemia Cells Residing,1
the Central Nervous System,1
Prognosis Factors,1
the Spanish Chronic Lymphocytic Leukemia Study Group,3
https://t.co/NA0mwmzJwa,1
PF-Fund -0.6%,1
Unser,1
Ihnen,1
@Sidnavigare,7
Leeds Teaching Hospitals NHS Trust,1
LLC #CLL:,1
4.-La,1
VRS,3
GHT,1
SYM,1
OncoAlert Novel,1
Mougiakakos,1
the Presenting Complication of Hyperviscosity Syndrome,1
Resveratrol Enhances mRNA,1
examination &amp,1
https://t.co/HWv6BQf8Jf,1
AnCan/Throwing Bones Blood Cancers Virtual Support Group,2
Eastern - https://t.co/vDsHrQ7ZMD,1
Non-Profits,1
Small Lymphocytic Lymphoma Mimicking Primary,1
Colonization of Germinal Center Follicles,1
SureSeq CLL,1
CNV,2
Virtual Community,1
the Batman Ears,1
Chart,2
Comparable AE,1
Pinehurst,1
The Evolution of Targeted Therapies,1
Long-Chain Polyunsaturated Fatty Acids and Genetic Variation,1
"@BloodJournal
 ",1
@HallekMichael https://t.co/yJbqSGTkvA,1
SLL Who Have Been Treated With Venetoclax,1
👉 https://t.co/mQCBQZiSNt #,1
ROR1/non-canonical,1
@CEITEC_Brno,2
https://t.co/W2Q8wNAAKC,1
SLL Who Have Been Treated With Venetoclax https://t.co/CLqwpuFRiF,1
🤯,1
HTCF,1
UAI,2
SGI,2
@AndrewSchorr,4
@LeukemiaMDA @MDAndersonNews @WCMCLymphoma,1
BeiGene Announces,3
Richter Transformation,7
Fine-Needle Aspiration,1
https://t.co/Tg4IwV7YDq,1
eBook,10
https://t.co/YPyeeEu1D1,1
@LeukemiaMDA @MDAndersonNews,7
Nationwide Epidemiological Study: Leukemia &,1
RT.,3
BeiGene Announces Approval Of BRUKINSA,1
BGNE BeiGene Announces,1
Autoimmune Hemolytic Anemia,3
https://t.co/uIXvDo3YBF,1
Radar,1
https://t.co/Co5gR3s39P,1
AI,3
mantle cell #lymphoma and,1
Heme,2
MRD-neg,1
@ASCO 2020 Virtual Annual Meeting,1
https://t.co/aCDZfljOpB,1
GHH,4
the Protective Bone Marrow Microenvironment,2
#COVID-19 Financial Assistance Grant,1
https://t.co/n9PE0zLSjk,1
@cryptocom @Bitcoin https://t.co/NGEe8vs0hl,1
Society of Clinical Oncology,3
@ZuckerSoM @MonashHealth @UCalgary @NUFeinbergMed,1
Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease,1
Nationwide,1
Therapy for Chronic Lymphocytic Leukemia,4
American Society of Clinical Oncology Educational Book,2
#Clinical Progression,1
Waldenstrom Disease Infected With COVID-19: Condition,1
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage,1
Non-Aspergillus,1
"@HallekMichael, @UKKoeln",1
Clinical Kidney Journal,4
Oxford Academic,4
ImmunoOnc #HemOnc,2
Pharmacyclics,1
NuRD,1
Dankbaar &,1
Corona,1
CAR T-19,3
TGP,1
MANO,1
OSI #,1
CSN #,2
https://t.co/lXrSblY0SD,1
ASCO,9
Pancreatic Involvement,2
NIAID Trial Published,1
Breg-like,1
Mitochondrial Genome-Derived,2
Sytuacja,1
@_KLRwP,1
⁦@BloodJournal⁩,3
the Care of Patients with Chronic Lymphocytic Leukemia,1
Research To Practice,1
OncoAlert International,1
RUNX1,1
Azure #IoT Central,1
charities &amp,1
https://t.co/6fLnU2rqsw,1
Register &gt;&gt,1
AGM,3
via,1
Cello,2
115p,1
Cello Health,12
Cello Signal,4
Waldenstrom Disease Infected With COVID-19,2
New Research: Evaluation of Somatic Hypermutation Status,1
@YucaiWangMD &amp,1
Spanish CLL Study Group,1
@ab_pau &amp,1
@mikewdennis,1
OpenBiology,2
The EQA Summary Report,1
ILR,1
ACP,1
chronische lymfatische,1
https://t.co/d3LyebXEjp,1
#Share,1
"https://t.co/4ORpORcPAU

Oncology &",1
Management of Ibrutinib Toxicities,1
https://t.co/dFjFVw4rbF,1
https://t.co/H9jVjxDtDE,1
Self-Management for Patients With Lymphoma,1
https://t.co/q5kwXeuds1,1
Watch &,17
#haematology consultants &amp,2
"https://t.co/eTflDUqQ9e
",1
9 Supporting Emergent Literacy #EYtwittertagteam,1
9 Supporting Emergent Literacy,3
Earn,2
--&gt,2
TeachingPoint,1
https://t.co/NkwVEn1228,2
Marina Lukas,2
SAMHD1 Limits,1
Protecting Cells,1
Real-World Treatment Patterns,1
HIF-1α,7
BAG3 Expression,2
GENIUNE Phase 3,1
n=58,1
Signal Line Cross,2
New Treatments to Stop Chronic Lymphocytic Leukemia From Progressing,1
Imbruvica Plus Rituxan for Chronic Lymphocytic Leukemia,3
the GRACE Blood Cancer Video Library,1
Real-World #Treatment Patterns,1
the Biosimilar Rituximab,1
@SPONDYLITISCA @CRASCRRheum,1
UW2020,2
Tait Shanafelt,3
@AACR Annual Virtual Meeting,1
RN,2
BSN,2
CN-BN,1
@SeattleCCA &amp,3
@UWMedicine #MedscapeEdu,2
NutriSci,1
Metabolic,1
https://t.co/R6PLZjV6Ac https://t.co/0qMc54GzKy,1
New Prognostic Tool,1
HemeOnc #,4
https://t.co/WMGsuhDrxa,1
Manouchehri-Doulabi,1
Improve Care,1
IGHV Mutation Analysis,1
https://t.co/ah8vzk8Cm0 #hematology,1
PDQ®)–Health,2
Professional Version - National Cancer Institute,2
los que podrás,2
The Challenge of Developing #ClinicalPathways,1
@ADVIhealth,1
@TheCenterTX @newcenturyhlth,1
article &gt;&gt,1
@LymphomaCanada,2
Patients with Chronic #LymphocyticLeukemia,1
US National Institutes of Health Study Links,1
https://t.co/oBdxPYrVnN,1
Comenzamos,2
FormaciónOnline,2
06/2020,1
EXTENDED,1
Translational Research Conference,1
Collectively Answering The Venetoclax BTK Inhibitor Sequencing Question,2
OncoAlert Feasibility,1
Across Canada,1
Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival,1
https://t.co/USJSFDwXnB,1
https://t.co/9x0GSUs89p #CLL #,1
https://t.co/Huj173Omn8,2
Thks,1
Dicamba - Researchers,1
U.S. National Institutes of Health,1
Ublituximab Improves Progression-free Survival,1
Dr Piers Patten,2
Kings College London &,2
UNITY-CLL Phase 3,4
@EPA,1
acute &amp,2
https://t.co/oURwbDzbyG,1
untreated &amp,1
First-Line Ibrutinib,1
Cationic,2
Amino Acid,4
12:36:21pm,1
AbbVie Receives Health Canada Approval,4
TG Therapeutics Announces Positive,3
TXT,1
AudioBook,1
umbralisib &amp,1
TG,3
CancerSucks https://t.co/GkPV8pFMmb,1
Related Tickers,2
https://t.co/WpfWqY9IfG,1
Hematologic Malignancies- Data Summaries,1
Ash Research Collaborative,1
Tennessee Oncology,2
@danwpaterson @NCIResearchCtr,1
#epigenetics #,3
Fungal Infections,2
BTK Inhibitors Are Included in Preferred Regimens,1
NCCN® Guidelines,1
para asegurar la,1
CAP,1
RDT,2
NTEA,2
CLL https://t.co/WT0TSVprbd,1
https://t.co/XWIoYmVOs3,1
NCICTEP,1
@eaonc @FDAOncology @Pharmacyclics,1
https://t.co/bs98L0geQL #FormaciónOnline #CLL #100%Digital,1
SIRT1/HIF-1α,1
the Intracellular Signaling Machinery,1
https://t.co/94GGHLRotX,1
KML-Experten,2
https://t.co/OKjNVklfaa,1
CHO Anuba Lohe's,1
CLL/Lymphoma Tweeps,1
American Society of Hematology Annual Meeting,2
https://t.co/cgjEJW5ipr,1
mAbs,4
the Additional Funding Package,1
Pemazyre #,1
LRR,1
Multiple… https://t.co/dGA6JCB3UQ #MF #,1
E1912,2
@DavinaConner &amp,1
Insightful &,1
the European Medicines Agency,1
HealtheDinner,1
Lymphoid Malignancies,2
Single Institution,2
@MDAndersonNews &,9
https://t.co/PdbpIVwKVk https://t.co/2griUox1pM,1
LIVE-Webinar @kml_lymphome am,1
Ärzte,1
Interessierte u.a.,1
Regulation of Humoral Immune Responses,1
Fc Receptor,1
FcμR,1
SpotLeukaemia,19
https://t.co/giatCFd0Pc,1
Imbruvica-Rituximab Combo Approved,2
CombinationTherapy,5
Nagaja Capitani,1
@Pharmacyclics Imbruvica,1
FDAApproved,1
https://t.co/iTuOmaKUsC,1
HCPLive https://t.co/MXnANJfMAg,1
Live-Webinar,1
CoVid-19,1
ImmunoOnc #HemeOnc #,1
The Delaware County Daily Times https://t.co/Tvd3GzA2fd,1
the Food and Drug Administration,1
New Drug Application,14
Leukemia Survivor &,1
CMV-Specific CD8+,1
@HallekMichael,4
https://t.co/wMUpDYJqWJ,1
Notice of AGM,2
Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,4
Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management,1
lymsm https://t.co/B9nxA98580,1
The Connect CLL Registry,4
https://t.co/hsEmIFHU7T,1
Ibrutinib-Based Regimen,1
@UNC &,1
Participate &,2
VAI,2
PCAT,2
August/2019,2
CytokineStorm,1
ERC Consolidator,1
https://t.co/7y7Z6ZE8d3,1
BSI Connected Leaning Live,1
Kymriah https://t.co/0gksLqnKHV https://t.co/F8HZw9MvdN,1
RUXIENCE,2
polyangiitis &amp,1
BCL-2 Proteins,1
Novel Targeted Therapies for Chronic Lymphocytic Leukemia,2
PCP,1
"WEBINAR] Epigenetic Tools for Blood Cancer Research

",1
PJP,1
CD49d,6
AdvancedPractitioners,2
@JADPRO,3
NCA,1
Non-corona,1
NCT01328626,2
Non-Hodgkins Lymphoma,5
Cello Health Group,5
journey &amp,1
https://t.co/wY6ZtCzyCK,1
https://t.co/wNAeP1YrlL,1
HSE &,1
International Prognostic Score for Asymptomatic Early-stage,8
https://t.co/ODjGaQOAJp,1
@RoswellPark,2
Mucho,1
@kotharishalin @SSundaramMD,1
Pfizer Inc.,1
https://t.co/PcoPJx3BMP,1
Telehealth,2
#Cancer Patients,1
Predictive Biomarkers,2
the Context of Chemoimmunotherapy,2
p66SHC,1
An Updated Perspective on Current Prognostic,1
https://t.co/VhN8Nvso3v,1
N95,1
https://t.co/9iND9Ywg85,1
International #Prognostic Score for Asymptomatic Early-stage,1
IPSS,1
https://t.co/Q4szuhJcuv @MayoClinic,1
Allogeneic Hematopoietic Cell Transplants,1
GROUP,2
The #ILLINOISsocialwork Community Learning Lab,2
IL-15,1
NIH CC Office of Patient Recruitment,1
specialist &amp,2
CARTcells,18
Leukemic Arthritis,1
Drop-in,1
Health PLC,2
Patent &,1
Pharma Announces,1
the Treatment of Patients With R/R Chronic Lymphocytic Leukemia,1
Hepatitis B Virus Reactivation,1
https://t.co/nPwo7ZSHeg #FL,1
COVID-19 Update,1
#Lymphoma #AML,1
MPD,1
#Covid-19 &amp,1
care &amp,1
First Person Treated,2
BTK Inhibition Effective Following Venetoclax Discontinuation,1
Binet A,2
the “watch &amp,1
Haematologica #,2
info @ https://t.co/zFQZE6IeJb &amp,1
@Fundaleu,1
FT596,2
Pfizer,6
RA #,1
GPA,1
PV #,1
https://t.co/sno8bqc5y4,1
Automotive,1
the Disruptions Created,1
Divergent Richter's Transformation,2
Plasmablastic Lymphoma,2
Dr Rich Bakst,1
https://t.co/IKHkahPjne,1
Refractory Disease https://t.co/yxdI1848Bm,1
@Bloodjournal,1
NPP,1
COVIDー19,1
CLL - https://t.co/UfncyhKLOa,1
⁦@sloan_kettering⁩ ⁦@CllSociety⁩,1
https://t.co/8cxehQQlBP,1
Chase,3
Tumor-Microenvironment Cell Interactions,1
https://t.co/xClz9Xx57M,1
COVID-19 Virtual Community Meeting,2
CT/,1
American Cancer Society,1
ICYMI—Clinical Picture,1
https://t.co/jTiXnjwV4s,1
Grant of Options,1
NFL,4
HSE,2
RTE News Now,1
Main,1
https://t.co/Pq6UkuyOdL,1
@Orlaodo,1
PCYC-1102 Study,1
https://t.co/XhEsKFroeQ,1
Serum Expression,1
Chronic Lymphocytic Leukemia Patients,1
VLA-4 Expression,1
#PAGC19,1
#Lymphoma,3
The Globe - https://t.co/ed1cLS3PBs,1
Discovery,8
the American Cancer Society,1
https://t.co/HNfPmqNfVB,1
EPAR,15
"Leukemia, Lymphocytic",4
@RuthClifford5 @DrHealeyBird,1
@JanRynne https://t.co/bRoZze1N7z,1
Sat 3/28,1
@tnonc,1
#Health #Professional Version - PubMed - NCBI,1
https://t.co/R7ro04ou6M #,1
Society Virtual Community Meeting,1
Global Chronic Lymphocytic Leukemia Therapeutics Market - Premium Insight,2
Market Sizing &,2
Epidemiology,8
Times,2
@SimonHarrisTD @paulreiddublin,1
Attend,2
CNP,1
CLL)-a,2
German CLL Study Group,2
NEDD8,2
BTK Inhibitors Transform Treatment,1
RA &,1
BSI Connected Learning Live,3
AbbVie Receives European Commission,15
AbbVie News Center https://t.co/6cWkzgg2Zg,1
"https://t.co/XgnDiO75ft

",1
Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes,2
CLL Reveals BTK,1
Refractory Chronic Lymphocytic Leukemia Market Review Epidemiology,1
First View Insight Prices,1
Refractory Chronic Lymphocytic Leukemia Market Review,3
FCR #,1
https://t.co/c49ebKFmw8,1
https://t.co/wXqrcJk0zT,1
the CLL Treatment Spectrum,1
Latest Advice,1
Benign Hematology,1
BioTechniques,2
EMBL,2
Heidelberg,1
Seattle Cancer Care Alliance,2
NEAT1 Long Isoform Is Highly Expressed,2
Juglans RegiaAqueous Extract on Human Chronic Lymphocytic Leukemia,1
Tumor Suppressors,1
Nature Communications,3
Eviti CMO Dr.,1
@ucsc &amp,1
@MIT &,1
@LLSusa @MayoClinic @mayocliniclabs,1
https://t.co/ne85FjGGYq,1
Alliance,12
First View Insight] Prices,1
RT PhysRelations,29
OncLive,2
MD Medical Oncologist,1
Regional Cancer Care Associates,3
https://t.co/lyWnUKGcSj,1
@morningireland,1
https://t.co/D1xpdjFGc2,1
@USATODAY,1
bloodcancer &amp,2
Mitochondrial Respiration Correlates with Prognostic Markers,2
INDV &,1
Jan &,2
III Alliance,2
Precision Medicine Management of Chronic Lymphocytic Leukemia,3
UKCLL Forum,1
info &amp,5
immune systems &amp,1
AbbVie News Center,3
the Unstimulated Cell Culture,1
your computer &amp,1
@harvardmed,3
New UK CLL Forum,1
@JanRynne @gmcrotty,1
the European Commission,6
New UK CLL,1
CancerNetwork,1
https://t.co/TgXMHLVwgr,1
Dual Regimen Receives EC’s,1
Venclyxto,12
ABBV Receives European Commission,1
the Coronary Arteries Leading,2
Acute Myocardial Infarction,2
Cd11c,1
Fmc7 Negativity,1
NovelTherapy,10
TNBC,1
• #,1
Eugen Tausch,2
Department of Internal Medicine III,2
Ulm University,2
El #,1
CNAGCRG,1
PanCancer,1
Alexey Danilov,2
POCUS,1
Clinics,1
HCP,1
Entospletinib in Previously Treated Chronic Lymphocytic,1
OskarStrong,1
Patient Power #CLL Experts,1
https://t.co/8W55gXKJZb,1
@TheBethesdaLabs,4
ResearchMatters,4
Seattle #Cancer Care Alliance,1
Tcell,5
EpsteinBarr,1
home &amp,1
the 2020 Majors Dodgers,1
Claremont American Little League,1
Krazyhorse Farmhouse,1
Classic,2
Ace Cafe,2
Krazy Horse Farmhouse,1
CO,1
PF-Fund,2
PF-Share -0.1%,1
YTD,3
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer,1
Explores,1
Hematology Congress,1
OncoAlert Multiple #,2
@WorldBookDayUk,1
https://t.co/5KjZKWM3F3,1
Lamana &amp,1
DC Metro Blood Cancer Conference,1
pan-neurofascin,1
Elmer,1
Download,2
https://t.co/zlH2m6sDeZ,1
CLL Blood Test Result,1
Lincoln,4
the Illinois Legislature,1
SIU Press,1
SIU #Illinois #AbrahamLincoln #,1
The University of Texas @MDAndersonNews,1
WBC,6
https://t.co/HBXo8zu6HK,1
Copenhagen,4
IL-27,3
Hemati M,1
BCR Signaling Contributes to,1
@NCCN,2
ACPE,2
Page 2 Update on New Chronic Lymphocytic Leukemia Drugs,8
Independent Pathways of Natural Antibody Selection,1
Gastrointestinal Involvement,3
CLLSpecialist,1
Peripheral Blood,2
Patients Treated With Venetoclax,1
Determination of Blood Tumor Cells,1
Supply Chain Analysis,1
Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome,3
Patients Treated With Venetoclax - Cancer Therapy Advisor,1
DOCK10,1
JustGiving,1
CAR NK,8
Claremont American Little League https://t.co/XWA7DzrhCp,1
SWOG,1
HDAC3,1
⚡️The @lymphomahub,1
RT EuropeanCancer,1
Lymphoma Coalition Global Patient Survey,3
BTK-,1
Global Chronic Lymphocytic Leukemia Market: Growth,1
Clinico-Biological Implications of Modified Levels of Cytokines,1
"https://t.co/WMAaG5pKER 

",1
Voices of Faith,1
SHOUTOUT,2
SEX + CANCER,1
@PATIENT POWER SEGMENT,1
"https://t.co/4ORpORcPAU
#",1
the Development of Targeted Therapy,2
ISHBT,1
"Chandigarh
@IJMPOofficial #leusm #",1
VigiBase,3
BCL-2 Inhibitors Reach New Milestones,1
https://t.co/zsS1wXq6i2,1
https://t.co/2D5pGGqOU1,1
ENCLEXTA,1
1st Translational Research Conference,5
"https://t.co/lcf3gjNn3F
#CLL #Hematology",1
Unilateral Blurred Vision,2
https://t.co/dbwzZwC9aN #CLL #,1
Hematologic Malignancies #,1
Diop,1
New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia,1
(New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia – Pharmacy Times,1
The Globe - https://t.co/G3TO5Gt796,1
Refractory Chronic Lymphocytic Leukemia Venetoclax,1
Regimens Outside Clinical Trials,1
https://t.co/Fzt3tyvaj4,1
Lipid Bicelle Micropatterning Using Chemical Lift-Off Lithography,1
UTW,1
CLL Support,4
DISCO Application for the Improvement of Financial Outcomes,1
BCR-ABL1 Positive,1
@tobyeyre82 @anthonymatomd &amp,1
"@Haematologica 
https://t.co/J7FgOGnEFP",1
BGB-10188,1
HLA-Compatible Patients With Hematologic Malignancies,1
SMYD3,3
"BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells",1
CLL14 Trial Outcomes,3
Hematologist-Oncologist,3
Lymphoma Department,3
Hackensack Meridian Health,3
Wilmot Cancer Institute,7
The Treatment Landscape of Chronic Lymphocytic Leukemia https://t.co/voysKKftaN,1
Diagnostic,1
Interessierte,1
Informationen,4
#haematology clinics,1
Hemato Oncology Key Points,2
puntadiamante#pisoton#likeforlikes,2
Globe,1
Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia,3
| &amp,1
Hematologic Malignancies,4
https://t.co/cWxuR1EcRz,1
SMUDGE CELLS,2
"CLL - Chronic Lymphocytic Leukemia

♥Smudge",1
Smudge,15
Potential Milestone,1
ABNORMAL,1
Peripheral,1
Man w Chronic Lymphocytic Leukemia,1
Obinutuzuma/Ibrutinib,1
CNVs,1
Lymphoma Hub,2
Data and Health-Related Quality of Life,1
HemeBench Tweetorial,1
the new site &amp,1
#Raman,1
UCLouvain,1
https://t.co/VIzkxsuVKc #FightBloodCancer,1
@muni_cz,1
OncoAlert Early,1
https://t.co/2eeie7Nkgs,1
https://t.co/iI8fjU863,1
Machine Learning Identifies Newly,2
Obinutuzumab May Benefit CLL Patients With,2
the Effects of Early Treatment With Venetoclax,1
Small Lymphocytic Lymphoma Who Do Not Have Sympto,1
Non-Hodgkin Lymphona,1
IL-17 Signaling,1
Time-Limited Treatments,1
MCN,1
FTR,1
Ibrutinib-Treated Patient,1
https://t.co/0nAyUzBoky,1
NCRI CLL210,2
Good News - https://t.co/t4b4dYoENl,1
The Globe - https://t.co/FAnzvna3Fc,1
Cerebral Metastases,2
First-Line Treatment for Chronic Lymphocytic,6
MACF,2
OncoAlert Achieving,1
https://t.co/mRNtHFB2Qi,1
Marrow Transplantation,5
Post-Transplantation Cyclophosphamide,1
Mi,1
Bajos,1
el índice de,1
the Polish Lymphoma Research Group,3
AAF,1
IPO,1
TMKS #ZIN ...,1
Ibr,1
PTEC,1
non-Hodgkin #Lymphoma,2
Stage IV Small Lymphocytic Lymphoma Presenting,1
Unilateral Vision Loss,1
#CutaneousLymphoma,1
Geriatric Clinic,3
FlappyCrypto,1
EOS,1
BSV #Stellar #Cardano #Tron,1
#Iota #Dash #Dogecoin,1
IBM,2
#Medicare Supplement,1
Access Pulse,1
"@BloodJournal 
@tobyeyre82",1
Salute #SocialNetwork,4
Paramount Spectrum Market,1
Crossings Republik,1
MDAnderson Novel Cell,1
#Immunotherapy Produces,1
@gmcrotty,1
Sr Medical,1
"Pharmacyclics, Inc.",1
AbbVie Company,1
"https://t.co/S3cHlIGx9X 
@EMA_News",1
GAIA,1
V+R,2
I+V+O.,1
The Genetic and Molecular Basis for Canine Models of Human Leukemia,1
pbs,1
https://t.co/ZQPOKyhh7K #,1
Francesco Paolo Tambaro &amp,1
el segundo para el #Rojo,1
VamosRojo ⭐⭐,1
G-SPOT,1
G-SPOT CABLE,1
al #Rojo,1
VamosRojo ⭐⭐ https://t.co/fIknVP56Ez,1
Registry,4
"tenemos el 1 de la fase regular, resultado de",1
Urdinarrain https://t.co/DfP1buCgze,1
Mayo Clinic,6
Leukemia Lymphoma,1
Nationwide Epidemiological Study,1
The @knowyournodes Lymphoma Coalition Global Patient Survey 2020,1
Obinutuzumab Offers Previously Untreated CLL Patients,1
Chemotherapy-Free Treatment,1
PTCE,1
Lymphomas &,1
https://t.co/6WLgXHNFRh,1
Leukemia Patients https://t.co/iIhVv8SJ0u,1
ACCC,7
QI,2
Expression,4
the Chemo-Free Treatment Paradigm,1
CGH,1
NKcells,2
ACCC Quality Improvement Workshops Address,1
BlueCarpet,1
BCMA CAR-NK,1
https://t.co/X5h03LDVYn https://t.co/HBtkfWGxZO,1
HME,2
EPIC,5
@mjsanchezperez  ,1
NCCN Clinical Practice Guidelines in Oncology,1
Pulsar,1
CAR-NK #,1
non-Hodgkin lymphoma &,3
@MDAndersonNews https://t.co/bJvemzJOZC,1
GRI,3
a K-RAS,1
@acmedsci #AMSSpringboard,1
@MHLSQUB,1
SFOR,1
Autoimmune Cytopenias,2
Focus on Molecular Aspects,2
Roundup Options Legal Center of Alabama Encourages Users of Roundup Diagnosed,1
Call for Access,2
the Steinberg Law Group,1
Follicullar Lymphoma,7
Roundup,30
https://t.co/9PWMdl0ZVP,1
Stuart Blakemore,1
CancerSpecialist,1
Novel Agents,2
Scripps Research,1
https://t.co/UJzcukitIs @MDAndersonNews #,1
CD147,1
OnkoLogisch:,1
Teil,1
Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia,5
IPI,4
HSP70/HSF1,1
The European Medicines Agency’s,2
Committee for Medicinal Products for Human Use,2
Snyggt,1
Chemotherapy-Free Combination Regimen for Patients,3
Venetoclax-Rituximab,14
Chemotherapy-Free Combination Regimen for Patients with P,1
Chemotherapy-Free Combination Regimen for Patients with Previously Untreated,1
the Japan Snodgrass Bequest,1
NF-κB-p62-NRF2,2
Lymphoma Coalition,3
NK Cells,6
@andrewschorr #,1
the Chronic Lymphocytic Leukemia,5
LDT,1
Finale Ergebnisse,1
Bulgarian Lymphoma Association,1
Elena,1
https://t.co/jcYXmAUiCX,1
Lilly Presents Interim Clinical Data,2
the American Society Hematology Annual Meeting:,2
https://t.co/5qUvDvHpik,1
Contact @NIHClinicalCntr Office of Patient Recruitment,1
@NatureComms https://t.co/c06n37zP83,1
the sessions &amp,1
Christoph Bock’s Group,2
Y,1
al placer de ganar,1
Older Patients,1
https://t.co/7qw3yrWbP7,1
Center for Lifelong Learning,1
BCL-W,1
shape &amp,1
Entrenando,1
response &amp,3
Non-Hodgkin's Lymphoma,13
Treatment-Naive CLL,1
Autoimmune Complications,1
DuoBody-CD3xCD20,1
EEF,1
🌹,1
OncoAlert Survival,1
Endstra S,2
Genomic and Epigenomic Alterations,1
Sensing Tissue Damage,1
Myeloid C-Type Lectin Receptors,1
CRISPR/Cas9,1
Flowers to Inhibit Proliferation of Acute,1
Adipocyte Differentiation,1
Silico Analysis of Interactions,1
Genomic,2
The amazing language &amp,1
https://t.co/HcdMzcVjW0,1
@bitafakhri,1
Janice Rees,1
Royal Gwent Hospital,1
"the Surveillance, Epidemiology",1
SEER,6
https://t.co/W9tHKUJ0hh,1
@Amgen @EisaiUS @Roche,1
#leukemia #,1
NGEN,1
LWA,1
@LornaWarwick  @LymphomaAction @CLLSupport @CLLAdvocates #Leukaemia,1
https://t.co/lN7ZOoS8V9,1
the U.S. Radon,1
Safety of Duvelisib Following Disease Progression,1
Stage 0/1 Chronic Lymphocytic Leukemia,1
GOG,1
SPO #TERN,1
CRH #,1
@WHOOP_NSFT,1
https://t.co/QawSwLrET3,1
@carsten_niemann,1
https://t.co/9FAgxRNKFi,1
5hmc,1
Please RT to #CLL SLL,1
@UkCll @CllIreland @CllSociety @CLLSupport @knowyournodes @lymphomahub,1
BBC News,7
@ZPWLC,4
Christoph Bock’s,1
CeMM,1
Stratification &,1
Multiple,1
@PeterMacCC &amp,3
Royal Melbourne Hospital,1
colds &amp,1
Ongoing Research With BTK Inhibitors,1
The Newest Treatments,2
Reserve,2
NDH,1
Immunohistochemical Expression,1
Transformation of Chronic Lymphocytic Leukemia,2
OGT,4
https://t.co/JVkTfVZsHB,1
Genentech Partner,8
Measure Minimal Residual Disease,7
ATH,2
RNWH,1
RUNX3,1
Tues,2
21/01/20,1
Value Considerations - Cancer,1
Minimal Residual Disease Assessment,1
OnkoLogisch,3
IMMUNOTHERAPY,1
⁦@ImmunologyUoB⁩,1
@i_ringshausen,3
https://t.co/pscqEYFrOZ,1
@OxfordGeneTech,1
"BTK阻害薬 
https://t.co/q81PzS4OkO",1
MN,4
@MNAcadPA,1
Appreciative ⁦@sloan_kettering⁩,1
https://t.co/NYdsn3bkfv,1
THR,2
TEK,1
ECR,2
BH3,3
Signal,3
Health,3
The Lymphoma Coalition 2020 Global Patient Survey,1
CLL Signal,1
@ASCO @SIOGorg @YoungSIOG @siognah @EHA_Hematology https://t.co/fTivLKpXXc,1
@GEPAC,4
@AEAL,1
stroma,2
ChadRobbins,1
#JPMHC20 #JPMorgan2020,1
SureSeq CLL + CNV Panel,1
https://t.co/2dlmWzbEQv,1
myeloma &amp,2
#BayArea,2
The Health Nexus,1
SEATTLE,1
GLOBE NEWSWIRE Adaptive Biotechnologies Corporation,1
Blitzima,2
Adaptive Biotechnologies Receives Expanded Medicare Coverage,3
Patients With Chronic Lymphocytic Leukemia,3
Cardiac,1
Philadelphia Lymphoma Rounds,1
D3,1
Teils des Chromosom 17,1
Tumorwachstum,1
https://t.co/dB7wwrnUd2,1
@Jeopardy,1
New Treatments for Chronic Lymphocytic Leukemia - Mayo Clinic,1
Super,2
@ksondermann @doctorpemm,1
https://t.co/XpqOjlguL8,1
COMPLEMENT1,1
Review @CellCellPress,1
@AbdelWahablab @sloan_kettering #,1
Mayo Clinic Hematologist,1
PAN,1
https://t.co/3qSYH9anvQ #,1
https://t.co/c1rfrHAqLN,1
https://t.co/udP8E9JVSV,1
Blutzellen,1
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia,2
MPAC,2
ISA,1
Cowen,1
Medicare Beneficiaries,1
Geriatrics,1
JAMA Oncology,2
Attention Mining,2
@idibaps &amp,1
TEG,3
Woyach Highlights Progress,1
Cello Health #CLL,1
Outlook 'Board,1
Safety of Ublituximab,3
FirstHill,1
https://t.co/SVbZRY9zUU,1
Restores Immune Cell Function,3
EQA #,1
Autoimmune Hemolytic Anemia After Relapse of Chronic Myeloid Leukemia,1
ARC,1
ATYM,1
@AtriumHealth,1
https://t.co/ECHT2Zxhgm,1
SUBMIT YOUR ABSTRACT NOW,2
ANP-BC,4
Promising CLL Research and Updates Offers Hope,2
"al
Post",1
"CR

Nice",1
@LLSNJ @LLSusa,1
@TheLancetHaem International Advisory Board,1
"ImmunoOnc #PROM #HRQoL #eHealth

",1
TAM,2
Predictive Factors,1
NLRP3,1
IL-1β,1
YONDELIS®,1
mantle cell lymphoma &amp,1
@cancerhealthmag,1
the Alliance A041702 Trial in Chronic Lymphocytic Leukemia,1
The Ohio State University Comprehensive Cancer Center,1
Combination With Other Therapeutic Agents,1
https://t.co/HmUN344Dof,1
Ibrutinib/Rituximab Combo Retains PFS Advantage Over FCR,3
Expert,4
BTK Inhibition,4
NewYear,1
Samoan,2
the CLL Global Research Foundation,1
BGS,3
Original,1
@TargetedOnc,1
Ibrutinib/Venetoclax,1
👉 https://t.co/Opi2SP2ZL6,1
@leliaduley,1
the MURANO Trial,2
Watch Astrid Pavlovsky,1
https://t.co/d4y6v37HLo #CLL #,1
the MCC Spain Study,1
CPG,2
https://t.co/90GnEWG4kK,1
αIIbβ3,2
https://t.co/wfbRZOFthA,1
U2,1
https://t.co/tQmBXxNnsJ,1
https://t.co/DyvyKJd6Eo #cll,1
Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic,1
Non Hodgkins,1
Leukemia/Small Lymphocytic Lymphoma https://t.co/TVPa8Er7jG,1
Medical Care for Chronic,1
the Hidden Forces,1
Time-Limited Therapy With Venetoclax/Obinutuzumab,1
Thoracic,2
al Blood Cancer Journal,1
https://t.co/IS5RhURIOW,1
https://t.co/CUnobgUJ3Z #,1
"CLL、、、イブルチニブ長期間使用していいものか。止めれば白血球上昇間違いないし、、、ジレンマ
＃イブルチニブ",1
clin trials &amp,1
BMT,16
NuView Academy,1
ahí,1
Vivan,1
non-Hodgkin Lymphoma,18
Triangle,1
140p,1
Health Marketing,1
https://t.co/0NQ4AYvTw9,1
Raman,2
Safety of Tenalisib,3
the pan-Canadian Pharmaceutical Alliance,2
Dr. Isabel Cunningham,1
https://t.co/AURrYL6HNO,1
LeukaemiaResearch,1
https://t.co/EMnhe7nBto,1
https://t.co/Kz6xC8GMjl,1
MedlinePlus,1
@NASA,1
SIM,1
Anderson Cancer Center,3
detrás de mi ventana,1
Plano Presby,1
the Center for Lifelong Learning's,1
the Initial Manifestation of Progressive Multifocal Leukoencephalopathy,1
CERTHellas,2
https://t.co/pUeLBCGYzZ,1
D2 des Faucons du Cégep de Lévis-Lauzon,1
https://t.co/cTZzaSW9Th,1
SCT,9
Antituberculous Therapy Associated Drug Induced Liver Injury,1
Leukemia &amp,1
the Fixed Duration Trial for Ibrutinib/Venetoclax,1
https://t.co/baaZ9A0ofB,1
Outlook to 2025 Report,4
Concursa,1
estarás participando,1
https://t.co/aPGOPY3oUg,1
Time-Limited Venetoclax-Rituximab,3
https://t.co/4DSKfpcKlY,1
SHIP1,1
adv/ref #CLL,1
Mayo Clinic https://t.co/qgBpEptb1y,1
@RTIHS,1
lymphoma subtypes &amp,1
@Jessica_Okosun,1
PHOENIX,1
TRANSCEND NHL,1
UANC,1
MRL #SSPG #MERI #,1
XTR,1
BOO,1
APSHO,1
https://t.co/DAPAj7EfUb,1
Total-Body Irradiation for the Treatment of Hematological Malignancies https://t.co/RWOLFTjm7y,1
FANCA,2
+ users &amp,1
The Centre for Lifelong Learning,1
consagran campeonas también,1
Researchers Develop A Novel Comorbidity Score for Chronic Lymphocytic Leukemia : Oncology Times,1
the CTCA Department of Medical Oncology,1
Communiqué Intersyndical National des Organisations Syndicales,1
SNU,4
FSU,1
CGT,7
CFTC,4
@OhioState &amp,1
@nationwidekids,1
COP,1
CLL/,1
Join us &,1
Dana-Farber’s,1
Gene Promoter Methylation Impacts Chronic Lymphocytic Leukemia,1
https://t.co/bGkZqno51P,1
🧐Hypertension,1
Health Monitor,1
FIF,1
UKCM,1
EBOX,1
DMA,3
OVB,2
BVC,1
JLP,1
OBD #ARK,1
DOTD,2
MRW,1
Kongress,1
Myelom #CARTCells,1
the Phase 2,2
@gretnhe,1
Expand,1
Monoclonal B-Cell Lymphocytosis,1
lyle_dk @BlodcancerDk,1
https://t.co/KZLjZKxUoa,1
Blanca Espinet,3
Bionano #,2
The Aurora Research Institute,1
the Wilson Grant,1
@YNHH,1
CLL Prognosis,1
MRK,1
Relapsed/Refractory CLL/,1
https://t.co/22lqUWNEYr  #,1
New Long-Term Data Continues,10
Demonstrate Progression-Free Survival,11
Safety of IMBRUVICA®,9
ASH Annual Meeting,2
Tanja &amp,1
@unibirmingham @UoB_MDSRKTO,1
VenR &amp,3
https://t.co/vUYp8Wv21j,1
Johnsons Imbruvica Sales Beat Roches Rituxan In Chronic Lymphocytic Leukemia Market,1
RHHBY NEW ARTICLE,1
Imbruvica Sales Beat Roche’s Rituxan In Chronic Lymphocytic Leukemia Market,1
Sequioa,1
Duvelisib,5
Pan-BTK Inhibitor,2
Korea Biomedical Review,1
#TGTherapeutics Announces,1
Safety of #IMBRUVICA®,1
Provide Expert Access,1
the Nordic #CLL,1
@Seth_E_Karol,1
https://t.co/JKsnsXjLtv,1
TorneoClausura,140
SolDeAmerica VS,39
FINAAAL,2
UNIDASPORELOBJETIVO,244
BTK Resistance,1
BTK Intolerance,1
Ibrutinib-Venetoclax Combo,1
⁦@anthonymatomd⁩ ⁦@sloan_kettering⁩,1
No Grade 3-4,1
BeiGene Announces Clinical Data,2
Stockmarketnews,1
CLL14 &,1
PNA and HTN,1
Dr C,1
New Long-Term #Data Continues,1
PRNewswire https://t.co/L55ktkosW4,1
https://t.co/zGIeVri7K7,1
https://t.co/pXlVYCVYUw,1
🖥Live,1
https://t.co/XXA4XWhTHI,1
https://t.co/k5Vc4CaYn1,1
Mechanisms of Response &,1
https://t.co/5Fh8RQzTf4,1
@UniCologne GCLLSG #Leusm @LeukemiaMDA,1
New Data Demonstrate,4
Chemotherapy-free,7
Treatments in Chronic Lymphocytic,2
@CyteirInfo,1
Alexa,1
RHHBY New Data Demonstrate,1
https://t.co/HvhPu4tx1J,1
Treatments in Chronic Lymphocytic Leukemia,3
Treatments in Chronic Lymphocytic Leukemia https://t.co/t7LIYmA8Lh #,1
PRNewswire,2
Chemotherapy-Free Treatment Combo Achieves High Rates,1
MRD Negativity,2
Cellular Therapies,1
#,2
Patient Power’s Facebook,1
anti-BTK,1
#ASH19 #,1
CD4 w,1
NCTN,2
Tait,1
https://t.co/WdVtKI5PzC @OncLive,1
https://t.co/qlsiRiJPo7,1
Novel/Novel,1
https://t.co/vz5bJ9yQNd #CLL #,1
B.,1
RT CancerFrontline,1
Development (Partial,2
Therapy Approved &,1
@LeukemiaMDA &,28
Blood Cancer Journal,6
btk inhibitors,2
FOXO3a,1
https://t.co/oxdpUKNPat,1
Monoclonal,1
Venetoclax Added,2
NitinJainMD,2
Accuracy for Disease Progression Prediction,1
Phenotype-Based Patient Similarity Learning,1
First-Line Treatment of IGHV-Mutated CLL,1
https://t.co/IiImswbiyh &lt;&lt,1
Ibrutnib,1
Allergy and Clinical Immunology,2
Journal of the National Comprehensive Cancer Network,1
TPT #LOOK #,1
SPR #,1
CHUAC,1
APTO &,1
#AML,1
https://t.co/q53ZxNoRpC,1
Randomized Controlled Trials,2
CLive James,1
EM,2
Discover Verastem Oncology’s,2
https://t.co/tc47cJaGYm https://t.co/5fkVA6V3fO,1
Buddy Reading,1
Steering Committee Members,1
ClinicalEpigenetics,2
https://t.co/0ZpbKId49a,1
https://t.co/2LJKNpchIZ,1
ASH LIVE REVIEW,1
Treat Relapsed or,1
The Silent Killer Treatable,3
Cannabis,1
Leukemia CLL Clinical Trials Guide Companies Drugs Phases Subjects Current Status,2
Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve,2
https://t.co/7AiebQxWpE,1
Taliban,2
Navy,2
MedThread,1
the CLL Society on Giving,1
GivingTuesday,2
https://t.co/8d3MZLx1UJ,1
Adjuvanted Herpes,3
Waldenström Macroglobulinemia Treated,3
First-Line BTK Inhibitors,2
DvoCapiata VS,33
🔄 Ángeles Portillo,1
Fabiola Sandoval ⚽,1
INICIÓ EL PARTIDO,2
https://t.co/XT07AgF4GN,1
Unmutated IGHV &,1
KLHL6,1
New Exchange Listing🚨,1
VZV) Vaccine,1
CLL Treated With,1
Bruton's Tyrosine Kinase Inhibitor,1
S4,1
@Velindre Cancer Centre,1
SLAM,2
Teva Pharmaceuticals,9
Gilead Sciences,4
https://t.co/iZ77LzNrII,1
🇱 @ Rootstock &,1
Vine,1
Foà of @SapienzaRoma,3
Paraguay,1
New Options,1
https://t.co/qtue5X1eiQ,1
https://t.co/ns0sSqIn7M,1
https://t.co/A6Ca3ER3Aq,1
BloodCancer @CLLSupport @CLLAdvocates,1
Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL,1
Speaking &,2
Listening Resources 🗣,2
https://t.co/FHjiQ59xVf,1
EMPIEZA,3
friends &amp,2
Participants With Refractory,1
HealthResearch,1
Routine Clinical Practice,5
Evolving Strategies,1
Pn4CL3,1
CoA,1
https://t.co/VpZJ2z97LV,1
CTR,1
A GOOD Thing,1
Ublituximab &,1
Nice,1
https://t.co/dWeogwiuSq,1
SCIG,2
Second Malignancy Risk Higher,1
CLL International Statistical Classification,2
Artificial Neural Network,1
https://t.co/rxyYLy1Ncm #ash2019,1
FINAAAAAAAAAAAAL,1
Chemotherapy Foundation Symposium,1
the Spanish Club of #CLL @UniStrathclyde,1
https://t.co/USm9xPHmbh,1
Second Action Under International Collaboration,1
MAB #monoclonal #,1
FDA Approved New Treatment Option for Patients with Chronic Lymphocytic Leukemia - https://t.co/zbCWWmbxk1,1
Richter’s Syndrome,1
Richter’s Transformation,1
https://t.co/5SbwlwaD6k,1
FDAapproves,2
https://t.co/VI9nWiuZQ3,1
https://t.co/vyh7yXLojp,1
PML,5
advancement &gt;&gt,1
@CACHEORG EYE,1
EYtwittertagteam,1
@harlowcollegeEY,1
https://t.co/1yxjd5lN3G,1
@TGAgovau,2
FREE @RCGP,1
#Lymphoma &,1
Treat Refractory/Relapsed Lymphoma,2
Quality Assurance of Secondary Immunodeficiencies,1
SID,1
PHEDRA,1
https://t.co/UzFdewRC7K,1
Systematic Synthetic Phonics,1
BiomedChrom,1
MassSpec,1
UCSanDiego Discovered,1
@UCSD,2
SUR,2
PIN #FIF #,1
APGN,1
SCIN,1
GENIUNE,1
Halfway,1
SLL @,1
Meu,1
https://t.co/GacDBGGeij,1
Molica,2
The Metabolic Profiles,1
ON - Molica - - Hematological Oncology - Wiley Online Library,1
https://t.co/Pp1tP3fZq1,1
WordPress,1
Dr Goede,1
Translational Research Conference on Chronic #Lymphocytic,1
FINAAAAAL,2
JUEGA,1
Cancrr Care West,1
CCW,1
Galway University Hospital,2
treatment.#American Journal of Hematology,1
the Center for Lifelong Learning’s,1
the Association of Corporate Counsel,1
Roll Club,1
CLE,1
BITTEREND,1
CCO,2
BetaThalassemia,2
PI3Kγ,1
First-Line Treatment of Chronic Lymphocytic Leukemia,3
Rituximab for Chronic Lymphocytic Leukemia,4
the Federal Bar Council’s Intellectual Property Committee,1
Intellectual Property Counsel,1
Dollar Tree,1
#Venetoclax &,1
EGCG,2
GreenTea,2
tx &amp,1
Nordic Educational Meeting,1
@wordpressdotcom,2
this #Advertisement,1
KGH,1
CREI,1
ITV,3
#Advertising,1
Ad Space,2
Polish Lymphoma Research Group Real-Life Analysis,2
https://t.co/LdzfMZwJKy  #,1
Janssen Announces Health Canada Approval,1
#lymphome #aml https://t.co/ugCL3hFhOT,1
Mantle-Cell,3
⁦@MayoClinic⁩ #CLLTreatment #IGHV #FISH #ChronicLymphocyticLeukemi,1
https://t.co/Q9quYZ58wN,1
@PNAS,1
@MindyHermannRD  &amp,1
"w 
@nevillesanjana",1
Relapse/Refractory Chronic Lymphocytic Leukemia,2
Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System,1
@IUOPA #EntreChem,1
New Options for First-Line Treatment,1
PIN #,4
ARR,1
Supplemental New Drug Application for Ibrutinib,1
https://t.co/kQxRKbFOEn  #,1
MDM2,2
Previously Untreated Patients,2
Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated,1
SP VS,4
@JanRynne @annemarieMurphE,1
DEL PRIMER TIEMPO,3
Fabiola Sandoval,30
information &amp,2
https://t.co/ShP2bFqrew https://t.co/pUtPGcEuri https://t.co/1aty45aCn6,1
PET/Computed Tomography,2
Prolymphocytic Leukemia: Case Report and Challenges on a Diagnostic and Therapeutic Forefront,1
Roeker,1
@DrMiguelPerales,1
Genomics England Pilot,1
CLLsm https://t.co/ACos6oxCHc,1
https://t.co/OBUypxZp7b,1
⚪⚫,7
Expert Access,1
Biosimilar,3
HSMN,3
Janssen Announces Submission of Supplemental New Drug Application,1
IMBRUVICA(R,5
Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia,1
Non-Hodgkin’s Lymphoma &,2
https://t.co/jVc3fTmrSx,1
@LornaWarwick,4
SDRY #RR #,1
SQN,1
SVST,1
https://t.co/Ahc8MFmic4,1
POT1 His266,1
MedTweetorial,1
CLL news &,1
FAAAS,3
FASCO,2
Autologous Peripheral Blood Lymphocytes,1
Venetoclax Effective,3
https://t.co/2m4PiQF214,1
Droplet Digital PCR,4
Court,1
Principal Life Insurance Company,1
https://t.co/8B26dShdgI,1
@michaelgrandner @eatrightFNCE,1
@tarek_turkk,1
PET/Scan,1
@anthonymatomd Great,1
@philtalamo @gotoPER #per_cfs,1
@CECAD,1
Cherokee,1
M Mcap &,1
BRNA,1
CYN #APGN,1
BAB,1
PEB,2
BMV,1
ImmuneDisorders,1
leaflet &,1
support &amp,1
Henlius,1
Payer ÁR,1
González-Rodríguez AP,1
Villa-Álvarez,1
MichaelKeating,1
@katiemazzi,1
Health Monitor Magazine,1
@DukeHealth &amp,1
rel/ref,3
the CLL Open House,1
the Independence Cafe,1
Comparison of Time to Next Treatment,2
Front-line,2
Comparison of Time to,1
"n=342
&lt;75",1
"@anthonymatomd 
",1
https://t.co/MF4USmuFX2 @LymphomaCanada,1
UCSC,1
Progressive CLL,1
Davide Rossi‘s,1
Cure Magazine,1
RP VS,21
Angeles Portillo,1
@walls2 @IrishCancerSoc,1
@jangeissler @knowyournodes @nature @BolanosNat @asleuval @EHA_Hematology @ASH_hematology,1
Invasive Genitourinary #Aspergillosis,1
Tausch,2
MACE,1
Leukemia Study Group,3
PALG,3
⁦@NEJM⁩,3
HSD,1
MTR,1
EDR,1
#ovariancancer &amp,1
🤔😳@GVAsanitat,1
https://t.co/yngXoVcns5,1
Practical Dosing Considerations for Venetoclax https://t.co/0c4vlxVVsK,1
@USDA,1
POV,1
CLL Dra Baltasar,1
Everything’s,1
NHANES,1
@MickeyRubin and @MeatVP,1
J Brown,1
P Ghia &,1
ESH Translational Research Conference on Chronic Lymphocytic Leukaemia,1
@FDAfood,1
the Leeds Institute of Medical Research,1
CLL https://t.co/msiXSxtoxl,1
@FDAfood @US_FDA,1
https://t.co/3WRWkTerwJ,1
PS #,1
ESH Scientific Committee,1
Breast Cancer Awareness Month,1
UTC,5
PIM kinase inhibitor,1
@nevillesanjana #FNCE #CLL,1
@nevillesanjana,2
@nevillesanjana  ,1
Microsoft,1
@nevillesanjana #FNCE #CLL https://t.co/0DZEeezTNp,1
Authenticity,1
Industrial Engineering,1
ITSicherheit,1
SoftwareIng,1
the latest drug &amp,1
@INSERM,1
Retrospective Single Institution,1
CLL w/ Stefano Casola,2
JCO,2
Lymphoma #Research https://t.co/R1iXEW7TUI,1
HaemOncology,1
Independent Review Committee,1
https://t.co/cAHmXFrEIi,1
CLL Treatment Moves Toward Combo Approaches,1
Jen Cassels,1
https://t.co/Li8lAzMlI6,1
ROR Ahead Through Constitutive STAT3 Signalling @J_Immunol  |,1
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells,1
Verastem Oncology,16
https://t.co/br86lyZsSX @OncLive,1
The Dispatch / Rock Island Argus,1
The Post-Appeals EQA Summary Report,1
Individual Laboratory Report,1
@leukemiaMDA @MDAndersonNews,1
@CTOAM,2
Alex Rolland,4
https://t.co/QS1TRHvvOv,1
LibertadoresFem,44
LIZ,3
The Roundup Options Legal Center of Minnesota Encourages Users of Roundup Diagnosed,1
The Steinberg Law Group,5
Information and Support Team,1
CLL Horizons,6
non-Hodgkin’s B-cell,1
@UCLA,1
@andrewschorr @columbiacancer @MDAndersonNews,1
Treating Patients With Recurrent or Refractory B-Cell Lymphoma,1
Natalia Peña,4
Finaaaaal,1
ÑAÑ,6
Carina Caicedo,1
GOOOL de #CLL,3
"el punto penal

",1
EMPIEZA EL 2DO TIEMPO,2
atenta,1
el tanto,1
la caída de su arco,1
the Center for Lifelong Learning,1
Open House,1
kwoods@escnj.us,1
"@DarrylLeong
#Cardiology",1
Braley Research Institute Auditorium,1
1st Line,3
Mayo CLL,1
WC,1
@wwierda of @MDAndersonNews,3
Emerging Combinations Shift Treatment Paradigm for Patients With,1
HemOnc Times,4
Reminder &gt,1
London &,1
#Lymphoma #Research #,1
SALT,1
SEND,1
Recherche,1
Phase 2 CLARITY,1
Gilda,1
Club Quad Cities,1
Obinutuzumab + Chlorambucil,1
NCT02612311,1
Outcomes of Novel Targeted Agents,1
#prostatecancer &amp,1
DEL PRIMER TIEMPO|,1
@ASCO Annual Meeting,1
Transcriptional Modulation,1
https://t.co/NKfLdSBx9I,1
IDIAL_NET,1
مستمر,1
CBC,3
MY... #CLL #,1
🤔 @abbvie @JanssenCilag,1
the Annual Meeting of the German Society for Hematology and Oncology,1
https://t.co/0WOhVvp9rW,1
https://t.co/DE34KS5TTJ,1
Pr C.Leblond,1
Congratulations P Hillman,1
S Fox &,1
practice &amp,2
HTG,1
Monsanto,4
TG Therapeutics Announces Data Presentations,6
Nov 1,1
Lenalidomide Restore NK Cell Function,4
Haemtologica Review Article,1
https://t.co/C6eXAuIJ4,1
University of Colorado,2
Padua University,1
CLL https://t.co/XSMWuuk5Z0,1
CHC WEST 2019,1
EZH,1
AMYT,1
Il s’agit,2
COPIKTRA,12
Victims &,1
VSTM Verastem Oncology,2
"Yakult Honsha Co., Ltd.",6
Japanese Bridging Study Evaluating COPIKTRA,5
@unimelb,1
Verastem Oncology Announces Dosing,2
🔔Standard,1
"Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,,https://t.co/O27j6z6599",1
@POG_LRC @GUcancersci,1
Refractory B-cell,3
Blood Journal,26
PrimeView,3
Leukemia #leusm,1
BSL,1
@GeneQuan,1
Relapsed/ Refractory B-cell,1
vid,1
@ovningsskolan kring,1
Neue Studie,1
Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment With Ibrutinib https://t.co/KSabnAofBR,1
#leukemia @ESHaematology,1
MOSAIC,1
PROS,1
life &,1
OBINUTUZUMAB,1
Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment With Ibrutinib: Status,1
Innate,3
Adaptive Immune Cells,1
Non-Hodgkins,4
Update on Chronic Lymphocytic Leukemia,12
https://t.co/bP9Rm8n0mz #lymphoma,1
Manchester &,1
CancerAwareness,1
Wegener Granulomatosis,3
Professional Practice Portfolio 2 #EYtwittertagteam,1
Christina,1
https://t.co/9nJBMsuSwd,1
https://t.co/eX2ZWag0y5 https://t.co/5OzmWYj8oG,1
Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets,4
Mice Based on Their T Cell Dependency,4
WatchfulWaiting #,1
otra liga provincial,1
TCS,1
GRI #,1
Aptevo Therapeutics,1
UCL,2
w/ @KristianJack &amp,1
StemCells,3
Broad,1
#Cancer Program,1
Departing College Station,1
#texas #,1
Transforming Leukemia Research,3
Lymphoma - Lymphoma Research Foundation,1
Medically Fit CLL,1
@chooseSJC,1
AdvancedPractitioner,1
Potential Upside Indicated,14
Liberum Capital - https://t.co/hBmyROfHx5 -,1
U-MRD,1
Trooper Daniel Jenkins,1
Manta Cell Lymphoma,1
Réussite,1
DvoSantani,4
idelalisib w/Toby Eyre,1
https://t.co/UsqXimboxi,1
New Research: New Recurrent Structural Aberrations,1
BladderCancer,5
@TGTherapeutics https://t.co/2BO3FAOnCx,1
#CLLHZ19 #,1
w @HarmonynetEU EU Research Initiative,1
GSF,3
Francesca Vittoria Sbrana,1
the San Raffaele Scientific Institute,1
the Pro-Active CLL Patient Toolkit,1
3D systems w/Francesca Vittoria Sbrana,1
Ffrangeg,2
Corff,2
Oncology/Hematology &gt,1
HTN+AF,1
SEA SQUIRT,1
@Roche ⁦@HUNIMED⁩ ⁦@SanRaffaeleMI⁩,1
The Importance of Minimal Residual Disease Negativity,5
Personalized Management Based on Patient Characteristics and Cytogenetics,1
Chronic Lymphocytic Leukemia 🙌,1
@UKCLL,2
Dr Montillo,1
Newbie,1
Frontline,1
Mitochondrial Reprogramming Underlies Resistance,1
TGTherapeutics Announces Data Presentations,1
https://t.co/si8zcVR3mz,1
al (N Engl,7
post &,6
https://t.co/yaGGi4ncKP,1
Oludola Omoyiola,1
#CLLHZ19,4
OvarianCancer,4
Venetoclax A Review,1
Venetoclax Venclyxto,1
lymphoma2,1
Oppenheimer,1
NK,2
CLL Forum Clinical Sciences Meeting,1
@LornaWarwick @leliaduley @BolanosNat,3
VPA Research Prices,3
LYA,1
WTF,2
Florian Schönharting,1
DARZALEX Genmab,1
Watch📹,1
Ig,1
Secondary Malignancies,2
https://t.co/VvGl3ZlRsU,1
@DKFZ Heidelberg,1
VSTM Verastem,2
Judith,2
@AMarshallMD,1
Verastem Inc.,1
NasdaqVSTM Verastem Oncology,1
CLL Navigator,1
@Ericllorg shares news,1
ESMO,3
University of Oxford,1
TP53 &amp,2
HDAC6,3
Amazing,1
My Chronic Lymphocytic Leukemia,1
https://t.co/IPOLK45jHt,1
https://t.co/H5ObDr2m8V. https://t.co/S7uaESDdy1,1
Chronic Myeloid,1
Precision’s Investigational New Drug,1
Social Media,1
TDC,1
https://t.co/i4JjobbX9C,1
Progress https://t.co/Lv6hyTh01e,1
Secondary Cancer Risk Remains,1
https://t.co/Kd1uH9D0Ei,1
PPC,1
Monsanto &,1
Bayer,1
CLL Causes &,1
Symptoms,1
Engagement-Innovation/Field Medical Team,1
Nurse Educator &,1
Customer Engagement,1
https://t.co/XkzR6GQej2,1
the MDACC Board Review,1
https://t.co/gKizQd3Cf7,1
@CLLAN #CLLHZ19,1
CLL Advocates Network Horizons,1
Edinburgh,1
Internal Controls,3
Low Positive Control for Minimal Residual Disease,3
el mecanismo de acción,1
https://t.co/Map1I9C34v,1
#JITC Research,6
ARZERRA,2
Novartis Pharmaceuticals Corporation,1
ALES,1
"https://t.co/GWeHSSn1kv
",1
DHHS,1
WLAD2019 NU,1
Frankly Speaking About Chronic Lymphocytic Leukemia,1
the @BoweryMission &amp,1
@UniCologne &,1
REGISTER👉https://t.co,3
#nurses &amp,1
@rcgp &,1
https://t.co/jRwX22P14,2
@LymphomaCanada  @LLSCanada @knowyournodes,1
dag,1
del budskabet #sundpol #,1
SAT,4
"CancerMedMDA 
PhysRelations",3
SignLanguage,1
SOHO2019 @MDAndersonNews @wwierda,1
@LeukemiaMDA @MDAndersonNews https://t.co/ErCTSvgekI,1
lymsm @lymphomahub https://t.co/89Qiis9nyt,1
SAT 9/14 Session XIII,2
Bavaria: Lukas Frenzel,1
https://t.co/SI2Frjd9iL,1
🔬Video,1
Weill Cornell Medicine,5
J Clinical Oncology,1
@KMirza,1
the Medimix LiveTracker,1
ASH Annual Meeting https://t.co/ZdTEeJSaoV,1
https://t.co/tffGDzCzkd,1
NGS #,1
Stephan Stilgenbauer,2
OncoAlert Phase 1,1
The Steinberg Law Group https://t.co/4P9P2l6tpC,1
https://t.co/D6kGpklvWj,1
nonhodgkinslymphoma #,1
Medimix,1
LiveTracker CLL,1
HCPS,1
#haematology #,1
OncoAlert Distinct,1
Oslo University Hospital,1
Houston @Oslounivsykehus @Kreftforeningen,1
@DunleavyKieron,1
the Feinstein Institute for Medical Research,12
Lymphoma #OverallSurvival #Prognosis,5
CancerTherapy,2
GoGold,5
Birmingham researchers &gt,1
pati...,1
Register free &gt,1
@statnews,3
Hackensack University Medical Center,1
MSSO,1
"clinicians @qehbham
Register",1
Postdoc,4
https://t.co/Hh1QFBGMHm https://t.co/oT5ESbkrIc,1
RoundUp,1
@unibirmingham @paulmos63832199 @Paneeshas,1
https://t.co/1HDE415x4x,1
Oncology Newswatch #oncology #Research #Cancer,1
PubMed,8
CCP VS,13
https://t.co/sRWFoSsMAk,1
https://t.co/r0dNrbmVSn,1
Oncology Times,2
@UTSWNews &,1
the Locus Coeruleus,1
The Mount Sinai Hospital Icahn School of Medicine,1
Blastic NK-Cell Lymphoma,2
"@FondazioneTLS
https://t.co/ZtMta7ptsY",1
Anti-Vaccine Movement,1
Higher Melanoma Risk,1
Increased Risk of Hypoglycemia,1
https://t.co/6TAQjm0ngY,1
MSL,1
Books &gt,1
https://t.co/zEl9xl5Dvn,1
CRG,29
@60sfolks #,1
NACIONAL VS,18
https://t.co/0p9udHOw2w,4
Sat Sept 28th CLL,1
@SIOGorg,2
Older Patients',1
Chemoimmunotherapy for Chronic Lymphocytic Leukemia,1
The Binet Staging System,1
https://t.co/285lfW4PyG,1
RIC,2
Personalized Management Based on #Patient Characteristics,3
#Cytogenetics,2
CLL - Five Years,1
the Pro-Active #CLL Patient,2
https://t.co/1qK7aZedHA,1
Leukemia Research https://t.co/WmDfrEKvWU,1
@WeillCornell &amp,3
CLTV,1
KMK,1
Leukemia Research,2
@ZuckerSoM &amp,1
the Society of Hematologic Oncology 2019,1
Leukemia Awareness Month,1
Elephants and Tea Magazine,1
https://t.co/KJbILQ0N15,2
https://t.co/4ORpORcPAU,1
https://t.co/bDNH7T7O7,1
Lymphoma #,3
https://t.co/GCaBLmg9BJ,1
SanLorenzo,2
Stephenie Lacoste,8
Paola Genes,5
Healthcare Resource Utilization,1
Front-Line Ibrutinib,1
https://t.co/Tk9ek1NLAh,1
Opinion,1
"https://t.co/s6Vh7TheRO
@WilmotCancer",1
Baby Shower,1
VENETOCLAX,1
@DrAdamBurns,1
O’Brien S. Evolution,1
2018;15:510–27.2.Hallek M,1
IL,2
Gazyvaro,7
#Medical #Publishers #Conference #Hematology,1
Hallek M,2
BCell Chronic Lymphocytic Leukemia Pipeline Review,1
Global Markets Direct] Prices,1
https://t.co/9NYwj1Q1FC,1
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy,1
EHA24 @EHA_Hematology #,1
BloodCancer #Leukemia #Lymphoma #,1
Pts With Chronic Lymphocytic Leukemia,1
non-CK,1
を含む）」を効能・効果とする新有効成分含有医薬品,1
」,1
GralCaballero,20
Ángeles Portillo,3
GOOL,7
this Mayo Clinic PathWays Case Study: https://t.co/Ep0EEDkwCN,1
Intense Uptake of Liposomal Curcumin,3
Multiple Myeloma Cell Lines,3
Red Blood Cells,3
MYC,2
https://t.co/G9tuXpO9T9,1
BIFF,2
GKP,1
BKG,2
Plasma Cell Dyscrasias,1
Non-Hodgkin Lymphomas,15
Access to Innovation!,1
Leukemia Lymphocytic Chronic BCell Date,2
EPAR Venclyxto,1
"https://t.co/LPdxSkpJ9M

",1
Your CLL Navigator',1
SLL - Hematological Oncology - #,1
#CLL= Committee for Lifelong Learning,1
F-U,1
@bcmhouston,1
finnCap - https://t.co/DQaVG0inzc -,1
Childhood,1
Binet C,1
WT CLL,1
Model https://t.co/a0guvE6MH0,1
https://t.co/P6x0Bmnv2f,1
cme,2
el punto penal,1
FINAL DE LA PRIMERA ETAPA,1
老人家体重下降、反覆发烧恐慢性淋巴性白血病https://t.co/TMjTDw3EDa慢性淋巴性白血病（Chronic Lymphocytic,1
OncoAlert Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia,1
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood,6
Marrow Transplant Research Report,5
Combo Treatments for Chronic Lymphocytic Leukemia,1
ISS,2
QRT,3
SOLG,1
🙏👍,1
@Wiley_Health,1
FMLA,1
EQLS,1
AbbVie’s,5
Tecentriq,1
Innovative Science Solutions,1
Regulatory,1
Quantium Cast Episode,2
TeamCanada,1
@FILO,1
https://t.co/54AA3ss2l2,1
ATS #,1
CPC,1
VOD,1
SMRT,1
FILO,1
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia,2
O-Chl,1
0.072,1
Mutated CLL,1
https://t.co/0Q4QBumLL6,1
#Startups #Venturecapital #,1
PharmaFile - #,1
Cirmtuzumab Blocks Wnt5a/ROR1-Stimulation Of NF-κB To Repress Autocrine STAT3-Activation,1
https://t.co/f7yMuicnB7,1
Scotland Acceptance,1
https://t.co/GUe9czEdfK,2
Combination Ibrutinib/Venetoclax Shows Encouraging Overall Survival Rates,1
Relapsed/Refractory CLL:,1
PrecisionMedicine,3
https://t.co/4R1G78HvHc,1
Covaris M-series,1
OncoAlert Chemo,1
"HemaSphere
https://t.co/EgvCF8Y9eI",1
statin,2
Via @NatureComms,1
https://t.co/KOUNtJkes9,2
Giant,2
Hodgkin,2
Lymphoma &,12
Myeloma 2018,6
Expert Access Program,1
Pada,2
😔 Amin,1
"Jo, &amp",1
@idibaps @hospitalclinic,1
https://t.co/ZjO2hPvLOI,1
HLA-B27 Positivity Did Not Influence CLL,1
SLL Outcomes,1
Leukemia Development,1
Lymphoma Hub Satellite Symposium,2
Chronic #Lymphocytic Leukemia,2
@Harvard Harvard Medical School https://t.co/7SaSN2sDQ4,1
@NEJM: Drug,1
Icahn School of Medicine,3
The Mount Sinai Hospital,2
CCR,3
2023 - Reuters,1
the Management of Lymphoma,2
Video Programs,1
the Institutional Review Board,1
Stage 4 Metastatic Chronic Lymphocytic Leukemia,1
Weymann,1
TWIMH,3
https://t.co/IPCUiVIS26,1
https://t.co/UbtmPLecRl V Nice Work,1
@unibirmingham @SygnatureDiscov @ApconiXLtd,1
從花壇進入醫壇？路邊野花「小白菊」可提取抗癌化合物 https://t.co/h0QaOoPmVf https://t.co/hRV5EMJkCa,1
https://t.co/tZaU2XWO8Y,1
NFkB,2
UVA,1
BIRC,1
LymphocyticLeukemia,3
https://t.co/s647qupPe4,1
Predictive Effect of IGHV Mutational Status and Load,1
World,1
Cancer News,1
USG #TGP #,1
SCS,1
MERC,2
EHG,2
the University of Birmingham,1
https://t.co/XEnBLyqMjl,1
ERK,2
LY3214996,1
https://t.co/3U3MBXAXs1,1
ALLIANCE,4
OS 0.17,1
@NEJM #,2
CLL14+E1912,1
Immunochemo,1
The Logistical Process of Using Oral Oncolytics https://t.co/A2g1zNrDlz,1
https://t.co/zj0IyNYFsy,1
Stanford Medical Center Report,1
#Press,4
Chemoimmunotherapy in Chronic Lymphocytic Leukemia,1
ICGS @eps_unibham @chembham @LES_UniBham,1
@LJMU @SygnatureDiscov @ApconiXLtd @winterbournehg &amp,1
https://t.co/qLAJQ2d9eb,1
#Pharmaceuticalmedicine,3
Rodrigue Mintsa Nguema,1
New Treatments for Chronic Lymphocytic Leukemia,1
the Mayo Clinic,2
COTD,1
https://t.co/WJ97bGww5c https://t.co/L4tVNiPg8C,1
https://t.co/LYSrcdhvCl,1
the Federal Register,1
Nicola,1
JAK Inhibitor Therapy,2
Trial Outcomes,1
Hackensack University Medical Center Hackensack University Medical Center,1
AB Science SA,3
Celgene Corporation,3
Dynavax Technologies Corporation,3
y’a,1
MDR,1
@pfizer,1
https://t.co/r8fMr8MLX9,1
@Sanofi,1
CIS,1
BeiGene’s,1
@joshuabrodyMD,2
Mantel Cell Lymphoma,1
Young Investigator,1
Ansatz,1
https://t.co/cjd9sPRsgd,1
PML Progressive,1
Piersanti K,1
Oyler-Yaniv A,1
Brink MRM,1
Palomba ML,1
Altan-Bonnet N,1
the ECOGAcrin Cancer Research Group,1
de la década del 2000,2
los primeros regímenes de #,2
de la,6
@proactive_uk @CelloHealthplc,7
https://t.co/BWPyVZ6aw1,1
@Daily_Experts,1
CD200 Expression Improves Differential Diagnosis Between Chronic Lymphocytic Leukemia,1
RandomisedTrial,1
Rituximab #Biosimilar 👍Ruxience,1
Pentostatin,1
Ruxience,2
breastcancerawareness  ,1
Non Hodgkin #Lymphoma,1
CellTherapy,4
SaveLives,1
PFE https://t.co/GMqVxW4r3s,1
https://t.co/WJ97bGww5c,2
Evaluate Clinical Activity,1
Summer Graduation Ceremony,1
MGH @MGHImaging @mghradchiefs @PatientPower @CLLAdvocates @iwCLL @CllSociety,1
https://t.co/ui2FYHUYyu @USNewsHealth,1
Global Industry Analysis &,1
Regional Outlook,1
🏡🏪🏥🏘️🏢,1
NOSCM,1
HLA-B27,1
4th State of the Nation Address,1
US News,1
BWNG,1
CTP,2
TTA,1
SAA,2
ITM,1
ZTF,1
KnowyourSubtype,1
BloodCancer https://t.co/mTmDPdM1Ew,1
@SunderlandFDN,1
Preclinical Research Suggests Role for ITK Inhibition,1
Tenemos,1
Aptose Biosciences Inc.,1
pan-BT,1
Therapy For Select Chronic Lymphocytic Leukemia Patients https://t.co/ROZy8OTpsQ https://t.co/SJh2cNGRFN,1
https://t.co/6LFFKt1EjO,1
BriefedUp - UK Stock Market News,4
PHTM,1
SRT,1
OPTI,2
The Untold Story of the Longest Persisting CAR T Cells,1
PhosphoFlow,2
The Untold Story of the Longest Persisting CAR-T Cells,5
Cirugía Oral e Implantología,1
Feliz,1
CienciaEnTuSonrisa,1
Mindanao Real Estate Market Research,1
TeamDavao,1
Dr Mansour Alfayez,1
BTK-Hemmer,1
1st 2,1
PK &,1
evaluate &amp,1
https://t.co/2G0wtY1FL2,2
https://t.co/M0QBLuYKUH,3
https://t.co/GxjuNPwEzt,1
BTK Inhibitors Show Continued Promise,1
LymphomaManagement,2
George Follows &,1
Prof Richard Rosenquist Brandell,2
Eisai,3
"the 11/12 District Championship, Intermediate Provincial Championship and Junior Provincial Championship",1
CC @TriCityNews,1
@cityofcoquitlam,1
@UniklinikUlm @UKKoeln @DKFZ,1
B-Ven-Obi in,1
⁦@wwierda⁩ ⁦@NitinJainMD⁩ ⁦@anthonymatomd⁩ cochair,1
https://t.co/sj04dMOjBX @EHA_Hematology,1
@STATnews,1
CNE/CME,1
the Quality of Life,2
Patients With Chronic Lymphocytic Leukemia https://t.co/DD8rfzigNc,1
Blood Journal Patients,1
"Quinquenel et al

Non-trial",1
Ematoinfo,1
al trattamento della,1
@ospniguarda,1
#FunctionalPrecisionMedicine,1
AbbVie/Roche) Drug Report,2
Aggressive Non-Hodgkin Lymphoma,1
Dr Francesc Bosch @Sidnavigare,1
USG #EBOX #JEL #,1
BSE,1
DOM,1
https://t.co/3T02iS4rWM,1
Regional Overview,1
Moon Shots Program,1
The Kansas Society of Clinical Oncology,2
Tuxella,1
https://t.co/kiZV21UpzD @BloodJournal #leusm,1
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction,1
GameChanger,1
Refractory BCell Lymphoma,1
KWG,2
https://t.co/IKmGFQpGM8,1
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients,1
Internal Medicine @UKKoeln,1
ALB,1
GEO,1
SFE,1
han brindado,1
médicos,1
nuevas alternativas terapéuticas,1
Die Chronische Lymphatische #Leukämie,1
https://t.co/hA9AP9uZfw,1
DUO,7
the Multidisciplinary Acute Lymphocytic,1
Leukemia Care,1
https://t.co/0zbOhV7Jzo,1
FANC,1
Global Industry Report,1
Chemotherapy #Drug,2
https://t.co/8y1b1PeEVl,1
अब इम्यूनोथेरेपी से,1
Cancer #Chronic #Lymphocytic,1
DTG,1
IMB,1
Kuwait Cancer Control Center,1
https://t.co/7T96qoRimA,1
Summer Reading Challenge,1
"https://t.co/SVrUiS9gbt - 40,000+ Visits",1
Registered Users,2
CLL Points Awarded,1
CLL Points,2
CLL Tokens,1
Mason 45040,1
the CLL Society Tribune,2
PMA,2
ExerciseOncology,1
N,1
Scouts,1
TTFT,1
MVA,3
Signale,4
Center for International Blood,1
Marrow Transplant Research,1
Pagel 2 Update on New Chronic Lymphocytic Leukemia Drugs,1
ChemoFree,2
@tomhenryrx,1
the VIsion/HO141,1
Speech,1
Language Difficulties,1
BYG,1
https://t.co/6PTOP9LFl8 https://t.co/4QJnmPs6SV,1
JMIR - Mobile,1
Journal of Medical Internet Research #,1
clonal dynamics &amp,1
Estrogen Receptors,1
@rightrelevance,1
The Nordic #CLL Study Group,1
https://t.co/UlaZvgJkhx,1
StimulusReport,1
observation &amp,1
Bittersweet...Little League,1
⚾,1
Santa Fe,1
https://t.co/Nvy1i5tTMD,1
Patients With Chronic Lymphocytic Leukemia - https://t.co/2wKtGRf4QH https://t.co/tXdsM3dbXU,1
️On-Demand #CME Webinar Series,1
the potential &amp,1
@HallekMichael of University of Cologne,1
Gm Talk,1
https://t.co/bCIwidQdvQ,1
@ALLIANCE_org,2
PI3K delta,3
CancerCare,6
AbbVie Receives Positive Recommendation,2
Institut,1
the @lymphomahub Satellite Symposium,1
National Information Day,1
CLL Society Alert,1
Videos,2
signalling &amp,1
progression &amp,4
MEIP Reveals,1
https://t.co/PSn26BYTQN,1
@AndrewSchorr @PatientPower https://t.co/mKs4CobtDn https://t.co/A88yIVrNmG,1
Technology Supported,1
Digital Health,1
OurHealth,1
OnlineFirst,1
Lymsm #Lymphoma #CLL #,1
lovastatin,1
@Research_MB https://t.co/F1TR1Q7qgK,1
Condoluci,1
session &,1
FTC,1
NICL,1
CKT,1
KOL,3
BeiGene Announces Phase,1
umbralisib @TGTherapeutics,1
KI,5
BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib,1
Relapsed/Refractory Chronic Lymph,1
KML,1
Samstag,1
Ergebnisse,2
the Dept: Dissection of Subclonal Evolution by Temporal Mutation Profiling,1
SC,4
Jos Melenhorst's Research,1
Lugano,1
Science - Henrik Bendiksen!,1
the Pharmacokinetics of Venetoclax,1
Combination with Rituximab,1
NICR,1
first line &amp,1
GenericImbruvica,1
PIN #WEN #CCPG #CLIG #,1
RMM,1
VGAS,1
CLLSA,42
212Pb-NNV003,3
non-Hodgkin #lymphoma,1
@Haematologica #,1
https://t.co/IB9nhktnKO,1
Vit D insuff &amp,13
SuppOnc,1
Venetoclax Approved,5
Veneclexta,1
@NewstalkFM Futureproof Extra Podcast ',1
@SunesisPharma,1
#Pharmaceutical,1
Petra Langerbeins,1
EFS &amp,1
Nationally-Recognized #Expert,1
#clinicaldata &amp,1
@DanaFarber &amp,4
REGISTER👉https://t.co/8OBkOHexjP,1
NUM,1
"al 
#",1
Presse Detail Die,1
Gute News,1
BPI,1
MDM4,4
VENCLEXTA,9
https://t.co/RhzA16Asjz,1
FCR - Study Design - w/ Dr. @wwierda,1
🙂,1
AES,1
fib &amp,1
el primero de muchos,1
LasGumarelas,1
FINAL DE LA PRIMERA,2
FathersDay,1
@IKNL,3
NKRdata,3
R-Venetoclax,1
New Directions,2
Francesca Mauro,1
https://t.co/fbrOAoGbhZ,1
Topps Cactus League,1
MLB,1
@eBay,1
I’m alive &amp,1
YoungEHA,1
@NewstalkFM,1
Chronic Lymphocytic Leukemia &,1
FIRE,1
ARQ531,1
@JanssenEMEA,1
EPA,1
Sequencing #Monotherapy vs.,1
Northwell Health,1
Investigator's Perspective,2
the Chronic Lymphocytic Leukemia Research Front,1
@AndrewSchorr @PatientPower https://t.co/mKs4CobtDn,1
the Chronic Lymphocytic Leukemia Research Front  https://t.co/1DwXTCa2ak,1
The Shifting Therapeutic Spectrum for Chronic Lymphocytic Leukemia,1
Success of Venetoclax,1
Clemens-Martin Wendtner,1
https://t.co/eM0cdv1s9q,1
TCell,1
New Study Identifies Patterns of Growth,3
Leukemia - Science &,2
Technology Research News,2
ARQL,1
C481Sm,1
MEDACorp,1
Vision HO141,1
RR CLL,1
Kings College,1
VenG,1
PF360,1
@eskazanae,1
@TaylorJ_MD @mjcascio https://t.co/0ym9bJsuDO,1
@CllIreland &amp,1
US Army,1
Interested,1
de la consagración,1
🚗,1
Epstein,1
https://t.co/9JFtSxQ0G4,1
Tolero Pharmaceuticals,1
Phase 1/2 Study,1
Previously Treated Chronic Lymphocytic Leukemia,6
@wwierda of @MDAndersonNews &,1
Save,1
Research Projects,1
@EFPIA @EU_H2020 #,1
CONIMAB,2
https://t.co/4xaHAhBkEX,1
https://t.co/SmxuJ6nvAD,1
Tenessee Oncology,1
ImmunoOnc #hemeonc #,1
The Association of Community Cancer Centers,1
el premio de campeón,1
"Semifinal - Vuelta📌

",13
Genetic Research,2
https://t.co/SKkdu6hlw4,1
Nordic CLL group &amp,1
Floyd Hasenrück @Floydiiii,1
Dept I of Internal Medicine @UKKoeln,1
ASCO19,1
https://t.co/y4w252AR8M #,1
Venclexta to Gazyva,1
"STAT3
KAT",1
https://t.co/jATQF0DpTI,1
Lymphoma #Prognosis,5
CancerTherapy #,4
Mayo Clinic Labs' Curtis Hanson,1
Offices Services,1
miR-16-1,4
Global Chronic Lymphocytic Leukemia Clinical Trial Pipeline Highlights,1
Pan-Canadian Oncology Drug Review Expert Review Committee For Combo,1
F,2
chlorambucil &,1
Chlorambucil &,1
Goede NEJM 2014,1
BertaBoys,1
"Semifinal - Ida 📌

",13
DEL PT,4
"Semifinal - Ida📌

",1
CNSmasterclass,4
New England Journal of Medicine,1
Lion,1
the New England Journal of Medicine $RO,1
the New England Journal of Medicine,3
https://t.co/OQkXRhWOCP,1
Oncternal Therapeutics',1
Kombinationstherapie,2
CGCLLSG,1
https://t.co/Zo7rWdprP8,1
Novel Treatment Options,1
https://t.co/YqcwdizLKM,1
@ASCO @NEJM,1
AbbVie Presents Data,3
Venetoclax Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic,1
the New England Journal of Medicine https://t.co/FKiNZwSlfj,1
#ASCO19 Davies,1
https://t.co/iUzdy50A3Q,1
Venetoclax Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Ch,1
Venetoclax Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia,2
Venetoclax Chemotherapy-Free,1
@NorthwellHealth @ZuckerSoM,1
E451,1
https://t.co/ZCkal34hEw,1
Two Pivotal Phase 3 Studies,2
rel/ref #,1
https://t.co/R7Mnd2XjGQ,1
CARTtherapy,1
JanssenGlobal #,1
S103,1
ACCC Educational Opportunities: Addressing Disease States,1
Myeloma,5
EHA Demonstrate,1
Natalia Couto-Francisco,1
https://t.co/GPZ7Gtow5,1
"Fabiola Sandoval  

",1
#ASCO19,2
#NCSD2019 #,1
https://t.co/O8OZtEvxmd #Leukemia,2
Die Kombination,1
Flora,1
Upfront,2
Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma,1
@Swedish Cancer Institute,1
Advisory Committee,1
@tomleblancMD,1
New @NEJM,1
the U.S. Ibrutinib,2
#ASCO19 https://t.co/W18epGYYsa,1
Acute Tubular Injury,1
Venetoclax Combo Effective,1
Front-Line Therapy for Select Chronic Lymphocytic Leukemia Patients,1
MRDneg,1
response inc.,1
https://t.co/5IsAEHcmIU,1
"@ascheliga @guiperini @Rodrigosantucc1 @hematologiasbra 
",1
@Nature,3
@DrHKantarjian @LeukemiaMDA @NEJM,1
@gaddyg,1
Broad Institute,1
@MGH_RI &amp,1
Covaris,1
buffer &amp,1
CancerMoonshot,6
https://t.co/OwozsZ15AA,1
Nordic CLL,1
CLL13/GAIA,1
https://t.co/vhivj6Js5z #,1
@kanagalshamanna @doctorpemm,1
@WVCancer @UCSDHealth @CompassOncology,1
@Baumhedlund @GMOFreeUSA @RachelsNews,1
@doctorpemm,3
https://t.co/X4MkibhzUh,1
The University of Texas,1
the Broad Institute of MIT,1
Harvard,2
Massachusetts General Hospital,1
the University of Washington https://t.co/BXielYWgDg,1
"Carmen Benítez  

#",1
"Angeles Portillo  

",1
"Paola Genes  

",1
https://t.co/vVT0E4dtE5 Science daily News,1
CLL VS,1
https://t.co/E9w1GO7PUh,2
B-Cells,1
Epigenetische Signale,1
Latest Research on Leukemia Therapeutics Market Projected,1
Dr Lindsey Roeker,1
https://t.co/lHf3EZxAPl,1
CHL,1
-11,1
SBP,1
OSA (p&gt;0.05,1
SPM 2,1
Quality Hotel Olavsgaard,1
PatientInnen,1
Diagnose CLL,1
Sie,1
aktiv,1
können,1
Upper Bollinger Band Walk,1
Investors Chronicle,1
Cleveland Clinic Journal of Medicine,1
Vitale/Ferrajoli et al ⁦@LeukemiaMDA⁩,1
de  #Hematondag,1
Bekijk,1
OSUCCC,1
Solove Research Institute,1
i3 Health,1
Market Size,3
SWOT Analysis,3
ATLL,1
Interim Review,1
https://t.co/Ylzkt16bcq,1
the @CllSociety Patient and Caregiver Education Forum,1
@nyphospital https://t.co/Nk518UI9DQ,1
Wacker,1
education &amp,2
families &amp,1
the Food and Drug Administration’s,1
UPENN,1
https://t.co/cp8GF16Ope &lt;--READ,1
Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia,3
International Trademark Association,1
el Dr.,1
FORMACIONDELPROFESIONALSANITARIO,1
Improved Interpretability of Machine Learning Model Using Unsupervised Clustering: Predicting Time,1
Equipo de #XNL,1
UC Irvine) &,1
Dose Modification,1
Related Articles Wnt5a,2
Venetoclax https://t.co/eREHhWWVii,1
Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients,3
https://t.co/AIWDT9tdr0,1
Untreated Chronic Lymphocytic,1
LA Times,1
GralDiaz VS,18
the Patient Power “Making Sense of CLL,1
DavidMaloney @CompassOncology,1
el nido,1
Crowdsourced Stock Ratings,2
Crowdsourced Stock Ratings #BioTechnology #,1
Vetr =&gt,1
https://t.co/n1J6TkNQIk #Biotechnology #BioTech #Stock #CYCC,1
@SSundaramMD @RoswellPark,1
|⁩ Prognostic,1
New CME Event - FDA Approves Venetoclax,1
@drugscom,3
https://t.co/GRQVTWxzM3,1
Venclexta-Gazyva,4
-NK &,1
@NEBiolabs,1
Genentech Inc.,3
CaptainMarvel,1
Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials,1
highlighting &amp,1
https://t.co/yn4k8bhCKc,1
Venclexta plus,17
@abbvie's,1
@Roche's,1
Oncology Priority Review Program,1
Real-Time Oncology Review,2
Sharp Awardee,1
https://t.co/xyI5GRsBgR,1
Bavencio,1
RCC,5
Merck KGaA,1
https://t.co/Xpo2MG4jy7,1
Venclexta + Gazyva,1
AbbVie’s Venclexta,1
@Roche @abbvie,1
LatestComments,1
CAR)-T,1
https://t.co/oohMPulgzs,1
Oral Oncolytic Access,2
CLL14 data,1
Ibr + Gazyva,1
Breaking News,5
the Best Drug Sequence to Treat CLL - Check,1
Myeloma @ZuckerSoM,1
Venclexta plus Gazyva,1
@landau_lab @nature,1
Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients,1
Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients https://t.co/0eNoJetSA7,1
Chemotherapy-Free Combination Regimen for Previous https://t.co/dRgYRkd1K1,1
AbbVie Reports,1
https://t.co/uNlXwX5q1G,1
LMW-PTP,1
Outcomes Of The illUMINTATE Trial,1
UniBarcelona,1
Big Words,1
Continuous Lifecycle London,1
ContinuousLifecycle,1
Lymphocytic Leukemia,4
https://t.co/0qVOBfPtvC,1
I AIN'T HEARD NO BELL,1
https://t.co/BMRhdGq5iv,1
"Belén Benítez  

#",1
Natalia Barros,1
https://t.co/jqqkdOJTix,1
https://t.co/K99zLrzLs3,1
Advocate,1
"chromatin, &gt;43k sc transcriptomes

Lead",1
Growth Drivers and Business Opportunities,1
BSH,3
Previously Untreated Symptomatic Chronic Lymphocytic Leukemia,1
Clinical and Laboratory Prognostic Indicators,1
Markers,1
"Damia Cortaza 

",1
Health Consulting,1
KEYS &amp,1
APP,1
Elena Gitelson Memorial Lectureship,1
https://t.co/yXRE5nWtJG,1
@BioPharmaDive,1
Amazing Hem/Onc Grand Rounds,1
Dean Howes,2
Talha Munir @LeedsHospitals,1
@LLSusa CLL Treatment Updates,1
Drug Sensitivity Screening,1
https://t.co/hTyC0rqmUy,1
Carer Information Day,1
@briankoffman @NYLCandCLL &amp,1
C.L.L.,1
près de,2
"https://t.co/FhaVp0FFhv
",1
Woohoo,1
https://t.co/dGQ0D0vCFy,1
Global Chronic Lymphocytic Leukemia Market,4
CR/MRD neg,1
Akershus University Hospital,1
Blood Journal Less,1
IFTA,1
Stanford University's,1
Autore - - Hematological Oncology - Wiley Online Library,1
🥊,1
Chronic Lymphocytic Leukemia Research Grants,1
Center for Chronic Lymphocytic Leukemia,2
Institute Physician,2
UNMC,2
ÅAS,1
POSTDOC,1
Peripheral Blood Mononuclear Cells,1
Top Profilers Analysis,1
New Technologies,1
MRFR,1
️NEW ONLINE,1
Georgetown Lombardi's,1
@UMGCCC,2
OLIMPIA,4
Leukemia (Blood Cancer,1
BOBADILLA,1
STEPHENIE LACOSTE,1
GALEANO,1
FABIOLA SANDOVAL,1
ANGÉLICA,1
JI,1
comparator+lower,1
CLLSLL,1
OncologyNews,1
Mayo/CLL Society,1
Outcomes Of The illUMINTATE,1
Leukemia and Lymphoma Society,1
Dominic LeBlanc's,1
TNT,2
Without #Idelalisib Followed,1
AKA,1
the Field Heading,2
M.D. @ZuckerSoM,1
lymsm @knowyournodes @BlodcancerDk,1
Christian Poulsen,1
https://t.co/yjsYonpY5d @LeukemiaMDA,2
National Meeting,1
LCE,4
vej,1
LCE @knowyournodes,1
Bone Marrow Crumb,1
M.D. #ChronicLymphocyticLeukemia,1
Cerro,2
◀,1
https://t.co/rU3hSE8C77,1
"Stephenie Lacoste, Carmen Benítez",1
#epigenetics &amp,1
@aimedalliance &amp,2
@anthonymatomd @tobyeyre82 @TheBloodMD @Maryam_Yazdy,1
@AndreGoyMD &amp,1
@NatureComms,1
Key Clinical Trials,1
Alessandro Pastore @AbdelWahablab,1
https://t.co/szj2wfKnrJ https://t.co/IyAwjdT1Cd,1
https://t.co/8Yo4AtlQcb,1
POST-ASH CLL,1
GlobaLLC,1
Leucemia Linfocítica Crónica,1
"Therapy, Development, Growth, Demand and New Technology",2
https://t.co/14iYsk9eLH,1
https://t.co/6jadnpWKcs,1
Myeloma #Lymphoma #,1
‍🔬🔬📺,1
al.,1
Cancer-Free World Podcast,2
group+creatinine,1
https://t.co/DXmtr5nH5a #,1
https://t.co/p4G3GDp99S,1
ThePatient,1
De KH,1
@HOVON,1
sur la protection des données,1
notre solution de gestion de la,1
Health Canada's,1
the Association for Academic Outreach,1
AITP,1
Idela-Ofatumumab,1
CLL14 venetoclax +,1
https://t.co/iLldX6ldJp,1
Idela,1
@LeukemiaMDA https://t.co/0Kgym6A0To,1
UAA,17
empowered &,1
La Carral,2
XSG #SMDS #CWR #JLG #TPOU,1
Skola,1
Lisa &gt,5
PI3K &,1
STAT5,1
Antigen Drive,4
Global Chronic Lymphocytic Leukemia Market Outlook,1
Amy’s Promise,1
Ultmann Chicago Lymphoma Symposium,1
the University of Chicago,1
@UCSDHealth &,2
TEVA Canada Announces,1
CSD Board of School Directors,1
Times Chronicle/Glenside News,1
Cheltenham Little League,1
Non Hodgkin Lymphoma,1
the Power of Patients,1
https://t.co/icImB31ddF  #CLL https://t.co/h1PO1QnTF3,1
PromiseStudy,1
Davids,5
@ASCO @BloodJournal @ASH_Hematology @Daver_Leukemia  @MDAndersonNews    #ASHighlights #CLL #,1
Memorial Sloan Kettering,1
FollicularLymphoma @CLLSupport,1
Teva Canada,1
Teva Canada Announces,1
https://t.co/ja3SVbSbMn,1
DEL PARTIDO,1
https://t.co/M7UlWuvifB,1
Capital Markets Event,1
CLL Society Sponsored Support Group Meetings,2
https://t.co/81UmWfsMR6,1
New Research Article,1
OutspokenOncology,1
@MarkWolfinger &amp,1
@QUBelfast,1
@WeillCornellMed,2
https://t.co/uVHgp5l0kk,1
🐖 @COCHON555,1
@JanRynne @CLLSupport,1
Follicular,1
LivingwithLymphoma,1
https://t.co/QjDcsc3Wyh,1
Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution,1
https://t.co/Q46rYQXnNc,1
the LCE #Lymphoma / #CLL Community Advisory Board,1
the Lymphoma Coalition Europe,1
LCE #Lymphoma,2
@Syopapotilaat,1
@Guytavori @sscowcroft @BolanosNat,1
Lymphoma Coalition Europe,1
Hematol,2
First Non-Chemotherapy Combination Regimen for Treatment-Naive Patients with Chronic Lymphocytic Leukemia,1
PatientCafé,4
f/ @MDAndersonNews #Leukemia Executive Medical,1
Leukemia - Pipeline Review,3
Pharma #Pharmaceuticals #Therapeutics,1
https://t.co/EetnExKPfL,5
Combinations with New Agents Evolve Chronic Lymphocytic Leukemia Landscape - https://t.co/FxuroLalcF,1
https://t.co/Aja2vAYv0h,1
Co-Existing Medical Conditions,4
CLL Society/NIH Patient,1
https://t.co/dYJb9OZZ3m,2
@MoffittNews @LeukemiaMDA @UCIrvineHealth,1
lyle_dk https://t.co/mA1cCuKFS3,1
First LCE Lymphoma/CLL Community Advisory Board,1
the European #lymphoma,2
Lymphoma Coalition Europe’s,1
Advisory Board,1
https://t.co/Ti0mJbEl8U,1
SingleCell,1
DNAseq,1
LibertadLimpeño,1
Estaremos,1
la temporada,1
@zpwlf &,1
Lymphoma/CLL Community Advisory Board,1
https://t.co/VkUtcZerop,1
New Open Access!,1
rituximab &amp,1
HBV,3
the Florida Blood Cancer Conference @LLSusa,1
anxiety &amp,1
@LLSusa #,7
SWEET,1
Baseline PET-CT,1
LSC,1
@UCSDHealth @jeff_sharman @WVCancer @CompassOncology,1
Sells - #,1
NOG,1
Buys - #,1
DYOR,1
#leukemia https://t.co/A2YKMgp0bQ,1
the CLL Society Patient,1
Text World Theory,1
https://t.co/YQ2yImNOPT,1
https://t.co/gvKVzM7QE8 &lt;&lt,1
Lin28b #B1development #CLL #,1
@CelloHealthplc,1
Growth Drivers,2
NCTN #,1
Rezvani @MDAndersonNews,1
NCCN #Guidelines,1
2.2019,1
Supporting Emergent Literacy #,1
https://t.co/hhGs49bhSU,1
Genomic Profiling,1
Controller,1
PBC,2
Radio Pakistan,1
New Advances,1
the Treatment Options for Blood Cancer Patients Conference,1
deteriora la función de la médula,1
mejorar la función de la médula ósea,1
disrupted)+R/R #CLL,1
G3-4,2
@MoffittNews @LeukemiaMDA @UCIrvineHealth https://t.co/Y8Kn3HjWG8,1
best &,1
RGL,1
Czech CLL Study Group,1
@ASBschool,1
Call of the Wild,1
Foundation,2
@Unitemps 🙂,1
Health Plc,2
ResearchHighlight,1
finnCap,1
@Sopheon,1
Ongoing Trials For CLL Patients https://t.co/i28VybE76,1
NSF,1
SBIZ,1
AGL,1
KRAS,1
Dr George Follows,6
@ACTcharity &amp,2
TriKE,1
PatientReporter,3
BloodTests https://t.co/L8vM2h4Pcx,1
Real-World Data Study Focused on Chronic Lymphocytic Leukemia,2
United,2
American Airlines,1
O’Brien &,1
@wwierda @NitinJainMD,1
PST,2
3PM,1
LiveStream,2
@LLSusa @LeukemiaRF,14
YIM,1
https://t.co/TlXMzelD0d,1
Two Distinct Pathways for the Development of Plasmablastic Lymphoma,1
Potential Surrogate Marker,6
Clonal Relatedness,4
‍🔬 https://t.co/X1at7Zy0Xv,1
IBB,4
JDG,1
SPO,2
F 22-Mar-19,1
@MDAndersonNews https://t.co/W1eoI2st8Q,1
NFAT2,1
VDJ,1
https://t.co/ViYyUurHfz,1
RNA Sequencing,3
NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia,2
"Hadadi L, Hafezi M",1
molecule3 Tim3,1
Maball,1
AEWU,1
MTO,2
https://t.co/tyU8vDeUH3,1
Blood Journal High,1
https://t.co/65rkCoKyFo,1
https://t.co/D9tdVBpFvE,1
@AACR @AACRFoundation,1
Dr Anil Awesti,1
Patients with,3
IsleofWight,1
CLLSAIOW@gmail.com,1
YOU CAN BEAT CANCER &,1
@JanRynne @CllIreland @CllSociety,1
STAT-3,1
The Importance of Early Comprehensive Testing,1
"https://t.co/BqzOi0TE1d 
https://t.co/xvCLDQQYuQ #",1
KEEP,1
IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format',1
Dr Rosenblatt ⁦@OncLiveSOSS⁩,1
JKX,1
BUR,2
SSE,1
#NationalBroadcast Grand Rounds,1
https://t.co/wTyx9tzwEw #Leusm @LeukemiaMDA,1
Chronische,8
https://t.co/GHS39LkTtq,1
@Roche #Leukemia,1
Best Drug Sequence to Treat CLL,1
@ZuckerSoM @CllSociety,3
Kinase Inhibitors Autoimmune Toxicity,1
Copanlisib https://t.co/7cmnCX5i0M,1
https://t.co/x29GDShVJa,1
Abbvie / Roche,1
https://t.co/Dphi19weJv,1
Previously-Untreated,1
Pharma #Update,1
enthusiastic discussions &,1
Technology Test,1
Society Alerts,1
https://t.co/R8FYex1xgj,1
survival &amp,1
@warwickuni @WarwickEY,1
the Psycho-Oncology Service,1
Dr George Follows @CUH_NHS &,1
Veclexta,2
https://t.co/DuVYv03lky https://t.co/5GciKMsgaR,1
Blood Journal https://t.co/WfWfCP7esO,1
AttentionMine,3
#ERC20 #,2
UtilityToken,2
FreeCrypto,3
Attention Mine,1
Roche  Holding Ltd,1
CLL @genentech,1
https://t.co/5DyXbIDSVV,1
AbbVie Announces,13
Previously-Untreated Chronic Lymphocytic Leukemia Patients,3
AbbVie News,1
Co-Existing Medical Conditions https://t.co/PRSIKSvs3K,1
Alex Trebek &,1
the Roche Group,1
OTCQX,1
the U.S. Food,1
ABBV - AbbVie,1
Previously-Untreated Chronic Lymphocytic Leukemia Patients https://t.co/l06dmkOR1s,1
Gly101Val,2
Shanmugapriya Thangavadivel,1
Previously-Untreated Chronic Lymphocytic Leukemia Patients https://t.co/fovHQgZdVW,1
Previously-Untreated Chronic Lymphocytic Leukemia Patients - https://t.co/ADjzaWvrQe,1
Breakthrough Therapy Designation and Real-Time Oncology Review,1
https://t.co/8He7SGvQN9,1
Announces Multiple Milestones for Phase,1
"Previously-Untreated Chronic Lymphocytic Leukemia Patients
https://t.co/YHQK2SGLEO",1
CosimaBaldari @unisiena,1
ULE,1
DRX,3
Ibrutinib Bests Chemo Drug Combo,1
Older CLL Patients,1
the Leukemia &,1
The CLL Society,1
SmartPatients,1
https://t.co/bZ0O1JaI0V,1
#Agents Leading,1
#Reduced Toxicity,1
New Agents,8
WM https://t.co/yBDY7po0ow,1
NCCL,1
TLY,1
EKT,3
"Application, Production",1
Upfront Management &,1
https://t.co/OKJbEu1JO2,1
Airdrop CLL,1
BAT Holders,1
BCJ Blood Cancer Journal,1
Next Level Benchmark,1
https://t.co/1ngg5WT5gj &gt;&gt;&gt,1
Affiliate Program,1
🔬 Chronic,3
value meeting &amp,1
NCCN Updates Clinical Practice Guideline,1
Barrientos,2
Cork,1
Fiona Moriarty,1
the University of Kiel,1
https://t.co/Ix0Yq7DC4B,1
Roller Coasters,1
Gestion Agricole,1
Stage B #CLL,1
DiagnosisDay,1
#Patients Voice,1
RareDisease #,1
rs11614913,1
Reach USD 9.1 Billion,2
Leukemia/Small Lymphocytic Lymphoma https://t.co/Ap1gsO2xgP  ,1
The Roll Of Chemotherapy,1
Cancer Research Wales,1
@Laura_em4,1
International Cancer,1
#GeNoMe Consortium,1
Chlorambucil-Kombinationen,1
"Invited Reviews

 Free Access
Advances",1
the Healthcare System,1
@motherboard @sacjai,1
CLL Society Patient,1
https://t.co/RLmGqR9GZ4,1
https://t.co/J6fGQJDIdU,1
https://t.co/wTyx9tzwEw #Leusm @LeukemiaMDA https://t.co/airkm0r53r,1
CME/CNE EXPIRING SOON!,1
MB-CART19.1,1
Acute Lymphoblastic Leukemia Recurrent,1
Lymphoma Recurrent,1
Lymphoma Refractory,1
Chronic Lymphocytic Leukemia Recurrent,1
#CLLPatient,1
PatientReporter https://t.co/YSycoXN09z,1
Columbia,3
post-ASH2018 CLL Society Educational Forum,1
the Swedish Medical Center,1
https://t.co/BD8ZX85mue,1
the CLL Society Patient Playbook,1
Leukemia/Small Lymphocytic Lymphoma https://t.co/Ap1gsO2xgP,1
@JanRynne &,1
Clinical Research,1
clinicians &amp,1
oxford https://t.co/5ILZEeDpqC,1
CAI,1
CancerSurvivor,1
Managing &,1
🌳,2
ASC Distinguished,1
Johnson &amp;a,1
Heilungschancen,1
Neue Forschungserfolge,1
Taiwo,1
Progression #,1
Athina Manakas,1
the Scripps Research Institute,1
The CLL Society Tribune,1
https://t.co/KYaqV1PpFQ,1
IciCLLe &,1
The CLL Society Patient Playbook,1
PIK3,1
@chadinabhan &,1
PatientReporter #CLLReports @CLLAdvocates @CLLSupport @LLSusa,1
Current Research &,9
@ABG_Asso,1
congress,3
CARTable,1
https://t.co/kgQB2nOYfz,1
myelogenous[myeloid,1
急性リンパ性白血病 acute,1
EndCancer PhysRelations,1
Medical Oncology &,2
Lydia Scarfò,1
TV Ada with Drug,1
@LLSusa,5
CLL - Whitaker,19
the Technology for Learning Conference!,1
PowerfulPatient,32
Ibrutinib for Chronic Lymphocytic Leukemia,2
CancerDrugs,3
Central Nervous System Lymphoma,1
https://t.co/Khrpyi2Yae,1
Update zu Chronisch,1
Uniklinik Ulm,1
Saludos @FrancoDeVita hermano seria de gran,1
Saludos,2
seria de gran,3
Saludos @fpetrocelli hermano seria de gran,1
MPM,2
CRU,1
KGP,1
PDQ,7
https://t.co/Jgcg7PfA3b,1
Burger - - British Journal of Haematology,1
"MISE À JOUR TEMPÊTE
Le Cégep est",1
HOS,1
Viktigt,1
PLAYR,1
@warwickuni @WarwickEquality,1
Curcumin,2
EMF,1
the Hardell Group,1
PGDE,2
@EFPIA,3
pueden ayudar,1
https://t.co/IjSJisXTEI,1
LVCG,1
CRU #,1
First Chemotherapy-Free,3
CLL/SLL --https://t.co/HH4fza0dET,1
Chronic Lymphocytic Leukemia－Case Report and Review,2
L-Selectin Expression,2
#Genpact,1
STVG,1
BEZ #KYGA #ISAT,1
FightClub,1
GlovesOff,1
@kkmaggon,1
MSK,6
CLLpatients,2
https://t.co/HeW5WeTY67,1
#lipidomics comparative,1
healthy &amp,1
https://t.co/2DQ0cEsGAL,1
EACCME,1
Personalisation of Chronic Lymphocytic Leukaemia,1
@WarwickEquality @WarwickSocWork @mcgreevy1993,1
https://t.co/pJbh4zfcFf,1
Imbruvica-Gazyva,2
https://t.co/qakYeAkvik,1
Cohort-Expansion,1
@NICE,1
ATRIO,1
12.00H.,1
NCCN Guidelines Insights,3
Imbruvica With Gazyva for FirstLine,1
MMSM #AML,1
The Ohio State University Medical Center,2
Hanasaari Cultural Centre,1
@CancerCareMBFdn @v_banerji,1
Market Share,1
Manufacturer,1
@ImperialMed 😀 @BloodJournal 'MHC,1
d’estar,1
the Peter MacCallum Cancer Center,1
https://t.co/eTI6Xziq7U,1
Sf3b1 Mutation,1
"#Oncologists, &amp",2
https://t.co/TbhycerU8o,1
Journal of Clinical Oncology https://t.co/yMm626Db20,1
Cancer News Chronic Lymphocytic,1
Responders,1
https://t.co/pgKbhiKSSN #,1
Cork Clayton Hotel Silver Springs inc,1
Haematology,1
@CorkARCcancer &amp,1
First FDA,1
CLL Combination Therapy,1
https://t.co/Kqni04vCY1,1
marrow &amp,3
CancerChat,1
Novel Bcl2,1
https://t.co/65rSjgqp9M,1
the Center for Leukemia at Massachusetts General Hospital,4
https://t.co/jZfozofjLw,1
Leukemia @MDAndersonNews https://t.co/ayUdEjydq5,1
https://t.co/IwT8tHj0OS,1
Chronic Lymphocytic Leukaemia,3
@taylorstoronto,1
Nursery,1
TalesToolkit,1
ERIC Consortium Conference,1
SOS,1
SET,3
https://t.co/JKa19WzHFH,1
Ibrutinib/Obinutuzumab for Treatment-Naive Patients with Chronic Lymphocytic Leukemia,1
@raredr,2
@UniofOxford hospitals,1
First Non-Chemotherapy Combination Regimen for Treatment-Naïve,5
the Role of Venetoclax,1
Enhanced NF-κB Nuclear Translocation,1
https://t.co/sKkQSbarXm,1
Dennis,1
First Non-Chemo Combination Therapy,2
Wissenschaftler am Wiener,1
chemotherapy https://t.co/zHOkJfyCOd,1
@GENbio,1
Imbruvica + Gazyva,2
@unibirmingham @LJMU @SygnatureDiscov @ApconiXLtd &,1
Gazyva,5
FDA Gives Greenlight to,1
@Roche #,2
Previously Untreated Patients https://t.co/ZUJVnFTODQ,1
RaspberryPi #ADSB #dump1090,1
The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory,1
@genentech @Pharmacyclics https://t.co/44aXDUvuE9,1
https://t.co/KjdSwhlkG9,1
Lucha Libre,1
@cuh_nhs,1
Non-Chemo Combo Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia,1
the Asics #,1
el ambiente veraniego de SummerFest de @chileluchalibre,1
SummerFest,10
Ibrutinib-Opdivo Combination Shows Promise,1
the Lymphoma Coalition Europe's,1
Lymphoma Community Advisory Board,1
the Alliance North American Intergroup Study,1
Félicitations à Anne-Sophie Paquet,1
Concours,1
https://t.co/AadWOdqR7n,1
Annals of Diagnostic,1
AXL,1
CLL Rewards,1
MDedge Hematology &,1
Oncology,1
info,1
https://t.co/fU5oSWFAXL,2
Leukemia Child,1
#immunesystem,1
NCIC,1
DIS #,1
BHP,1
Relapsed/Refractory Chronic Lymphocytic Leukemia - Full Text View,1
nos,1
FAT,1
Propellants,1
Yayyyy,1
https://t.co/ubR8A4gtlr,1
@MorleyRobbins,1
@DrButtar Advanced Medicine,1
#ImmuneSystem #,1
NCC,2
@JNCCN on Richter's,1
FNA,1
SUVmax &gt;10,1
Postdoc Position,1
Masaryk University,1
Donor,1
KIR,2
ClinicalGuidelines,1
Cello Health Plc,1
Osso Bucco,2
Editorial Board,1
D.C. Area CLL Patient Support Group,2
el grupo alemán,1
https://t.co/gkUlbqaeOa,1
the ⁦@TheEBMT⁩ Chronic Malignancies,2
Lymphoma Working Parties,3
@HopitalAvicenne: https://t.co/VP5IeAaNdm @ASH_hematology,1
Loyola #,1
https://t.co/5vpN8YR4Ob @CllSociety https://t.co/XPtX5i7KQb,1
CCTG,1
Journal of Clinical Pathways,1
MK2206,1
ASO,1
@iofinaplc,1
@Synairgenplc,1
SNG,1
@Taptica,1
Europe Health,1
CYCC,2
PRV,1
Younger Chronic Lymphocytic,2
Primary Healthcare,1
Ibrutinib &amp,3
Other Options for CLL,1
"@TargetedOnc
 ",1
https://t.co/iDA38vBwj4,1
LymphomaConf - so,1
Lyme,1
Finding New Treatment Combinations for Chronic Lymphocytic Leukemia,1
Deadline for Expressions of Interest,1
New Copay Assistance Program for Individuals Living with Chronic Lymphocytic Leukemia Established,1
The Assistance Fund,2
INTERESTING &,1
Loyola Medicine,1
BOTH blood &amp,1
the New England Journal of Medicine @NEJM,1
Nordic CLL Study Group,1
SAKK,1
Israel CLL Study Group,1
Time-Limited Therapy With Drug Cessation Feasible,2
Safety of Ublituximab Plus Umbralisib,1
Aristotle,2
Without Venetoclax,4
@DrRaulCordoba &amp,1
🇪,4
the CLL Research Center,2
Ask The Expert,2
@BiologySexDiff,1
https://t.co/z6xi8OnRVF,1
Tcellrx #,1
anti-PD-1 &,1
The Practical Implications of the Rise of Targeted Therapies for Chronic Lymphocytic Leukemia,1
https://t.co/aisO90DndQ,1
Villa-Álvarez M,1
Sordo-Bahamonde C,1
Gonzalez-Rodriguez AP,1
Villa-Álvarez MC,1
#Prognosis,1
https://t.co/pr7OO179o9,3
activités de perfectionnement de la,1
Epigenetics &,1
"https://t.co/AP6K4vtRn7
Open",1
NEW TRIAL - For,1
@MDAndersonNews @LeukemiaMDA:,1
ALLIANCE &,1
https://t.co/KE0v8M2ZvG @ASH_hematology #ASH18 #Immunotherapy #,1
Catch Optum #,1
Geriatric Assessment in Hematology,1
GeriOnc,1
CLL - OncLive,1
OncLive Panelists,1
IgL,1
Fixed-Duration,1
the EBMT Chronic Malignancies,3
@Roche https://t.co/UwlRsSsYTT,1
@LBCNZ,1
Chemotherapy-Free Regimens,1
https://t.co/yf2w9qvxrv Burgeoning,1
https://t.co/JZrst71iag,1
R-Chl-Len,1
ERIC International Meeting,3
https://t.co/1ixSllNB6O,1
State,2
Plasma Cell Disorders,1
AML/,1
@harvardmed @MDAndersonNews,1
FixedDuration Venetoclax Triplet Active,1
Analysis of &gt;100,6
CLL Reference EpiGenome,4
https://t.co/lWhfBxEWKX,1
Marsh SGE,1
Cer,1
https://t.co/1t3DRAFi7N,1
Future Implications,2
https://t.co/0RP6IzlnMv,1
Response and Resistance,5
Transcriptional Profiles,3
@LeukemiaMDA experts &amp,2
https://t.co/GpRjqMAUKG,2
https://t.co/zdhE7bIWZ9,1
Illness Perceptions,1
MALAT1 lncRNA,1
Cancer Network,2
SN,1
OPG #,1
MMH,1
DrBurger @MDAndersonNews,1
https://t.co/pN4zrOKozC,1
Identify Novel NFAT2 Target Genes,1
"@NEJM #ECM 

",1
Minimal Residual Disease,6
MRD Neg https://t.co/2nuz2mNK6u,1
https://t.co/9vrDW3w7T8 Accounting,1
Payroll,1
FREE Resources,1
Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer,1
BQE,1
NAK,1
https://t.co/w6LidcfnLG #CLL #DrBurger @MDAndersonNews,1
https://t.co/0LPV6lYMrI,1
https://t.co/mqdrx6QpPs,1
@LeukaemiaAus @lymphomaOz &amp,1
pour notre,1
jours de ton,1
xplosionoficial presenta desastre,1
TargetedDrugs,1
https://t.co/wJBfiDl1gO #,1
Lamanna &amp,3
data &amp,5
FX,1
https://t.co/cF3kf7RovQ,1
@PharmaReview @VascularNews,1
AcademicTwitter @UofGMVLS https://t.co/CpWjHXnLEP,1
@LeukemiaMDA @MoffittNews &,2
NCTN @ALLIANCE_org,1
PostDoc &,1
ClinicalTrend,1
Clinical Trend,4
the Broad Institute,1
All Personal Health - https://t.co/C9YiYYf9GQ,1
https://t.co/QtlMO9vQX0,2
US Government,1
Medscape,1
Block Listing Update,1
Wait,3
BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia: Journal of Clinical Oncology,2
https://t.co/Unk2QUYUtw,1
Ibrutinib/Obinutuzumab,1
Younger CLL Patients:,1
nie,1
tylko kontroluję,1
https://t.co/WvhiKvcPxP,1
Attention Mining - #,1
guides&gt,1
medical advisers &,1
https://t.co/wjf0snFsoe,1
https://t.co/vb3NlSNRfN,1
https://t.co/9tMIOWoAUs #ibrutinib,1
Standard of Care in,1
Venetoclax/Rituximab,1
https://t.co/wfWL4FSeR2,1
https://t.co/WvhiKvcPxP - #,1
https://t.co/SxVdRTYLjH,1
https://t.co/9R5qENgIVy @ASH_hematology #HemOnc,1
@sparker @HansBishop1 @chadinabhan,1
The Data Presented In,1
https://t.co/qcj1kn3EX7,1
ASH18 Insights &gt;&gt;&gt,19
Feature,1
"Ott, Brown, Bradner",1
@MGHCancerCenter &amp; co.,1
https://t.co/jE3dbOGC3e,1
das Ergebnis,1
the Novel Treatment Era,3
@Nninitaa,1
https://t.co/PmUyQ86KKm,1
@KarolinskaUnsju,2
https://t.co/G6QcY3bLvz,1
https://t.co/uXY7Saub79 @Ericllorg #ERIC18 #Leusm #,1
Front,3
SickleCell,3
Complete Coverage,1
MURANO #,1
https://t.co/ySSqExib1e @Ericllorg #ERIC18 #Leusm #Leukemia #CancerTreatment #CancerPrognosis #CaMoldx,1
MRDFocus,3
CLL - BioPharma Dive https://t.co/Q9ieW950aD,1
PhysRelations,1
Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic,1
PTCL - ⁦@VJHemOnc⁩  https://t.co/jSGm0ga0WG,1
Medscape Oncology,1
Myeloma #SickleCell #Thrombosis #Hematology,1
FCR PFS,1
TargetedOnc,1
PhysRelat,1
@MDAndersonNews @LeukemiaMDA https://t.co/4AJavx0maT,1
LeukemiaMDA,1
https://t.co/FBudFjAGWT,1
Haematologica Review,1
@APHP,6
https://t.co/PMEZ0uk8NY @Ericllorg #ERIC18 #Leusm #CancerPrognosis #CaMoldx,1
F.. https://t.co/1NPZRlP38v,1
SUPERSTAR,1
BMD,1
EA,1
@DrHKantarjian @LeukemiaMDA https://t.co/tr7x1LelpQ,1
meet new &,1
Previously Untreated Patients Aged,1
Previously Untreated,9
Younger Chronic Lymphocytic Leukemia,2
https://t.co/x0hvBuc0cL,1
TheJames,2
BCL2,1
Stanford U,1
Relapsed/Refractory Leukemia,1
FHCRC,1
Liso-Cel Highly Active,2
WorldHematology2019,1
@Patients_Videos @CRGHaem,1
Phase 3 Combination Data,1
TrialWatch,1
IMBRUVICA® Data,2
@anthonymatomd @UjjaniC &amp,1
Venetoclax Improves Quality of Life for Patients with Relapsed/Refractory,1
JCAR017,1
the CLL Center of the Division of Hematologic Malignancies,1
Harvard Medical School,2
JanssenOncology Medical Affairs,2
Progression-Free Survival Compared to,3
Leukemia/Small Lymphocytic ,2
CRE,3
van #,1
https://t.co/2gc1gQdLDZ,1
https://t.co/UpphK5lyck,1
Cancer Drug Sensitivity Screening,1
myeloma @TaskenLab,1
HRU,1
Therapy,1
#CLLHeroes,1
@Celgene,3
the Triple Combination,1
@OSUMedCenter &amp,2
@paulmos63832199,1
@FWANDROO,1
#Paris #,7
Identified as Drug Target for Chronic #Lymphocytic,1
Essential Core Regulatory Circuitry of Chronic Lymphocytic,1
AbbVie/Roche,5
MabThera®,2
dans la,2
https://t.co/7TaG9tZo0E,1
AbbVie Presents New Data,7
CRTI,1
Combination with Rituximab Compared,2
Plenary #6:,1
Trending Terms,1
the Alliance North American Intergroup,1
https://t.co/m7yUHiK2Cj,1
RCT Alliance,1
the American Society Hematology,1
@UNIMORE,2
the Rai Staging System,2
Combination of Lenalidomide &,4
ibrutinib &amp,3
tolerated &amp,1
Bruton’s Tyrosine Kinase Inhibitor,2
Oral Pres,10
A Phase II Trial of Nivolumab Combined w/ Ibrutinib for Pts w/ Richter Transformation,2
MarriottMarina Pacific BR 20,2
https://t.co/rVwcZ2BZZ8,1
LBA-7 - Acquisition,2
MarriottMarina Pacific BR 2,1
Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia,3
Drs.,2
Published,1
@VJHemOnc &amp,1
CellularTherapy,1
#Lymphoma trials &,1
BloodCancer @CLLSupport,1
Combination with Rituximab in Patients,5
Relapsed/Refractory Chronic Lymphocytic Leukemia Who Completed the Fixed Treatment Course,2
Ami Solutions News,3
TCR,2
https://t.co/6RZeYVXnGN,1
Relapsed/Refractory Chronic Lymphocytic Leukemia Who Completed the Fixed Treatment ,2
Relapsed/Refractory Chronic Lymphocytic Leukemia Who Completed the Fixed Treatment,1
lymphoma https://t.co/2Jh1QQZChI,1
CLL Ham-Wasserman,1
Ham-Wasserman,1
Ham-Wasserman Lecture - On the Architecture of Translational Research Designed,10
Control Chronic Lymphocytic Leukemia,13
Ven &,1
Dr Micheal Hallek #ASH18 @ASH_hematology https://t.co/QanaLHAX3P,1
Hall AB,1
https://t.co/GxquAJlBg6,1
COST,1
CLL Center,1
clinical &amp,2
The Future of Chronic Lymphocytic Leukemia,4
♡,2
North American Intergroup Study,1
Clin Trials Vs the Real World: Treatment Duration &amp,1
Associated w/Pretreatment Modified Charlson Score,1
https://t.co/dG4T5aZdji,1
"🤔
BTK Inhibitor",1
Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia:,1
https://t.co/pXA6X2zTgt,2
Hematology &,1
Oncology Program,1
Lymphocytic,1
@wwierda @DrAnasYounes,1
https://t.co/EnazbEFluZ https://t.co/Q6WX1Rlp9B,1
CFDT,1
CE #Pôle,1
https://t.co/gKIcPCv2In,1
See Chlorambucil,1
here&gt,1
https://t.co/0UQ6KQaLyG,1
CaMoldx,2
Instagram,1
Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review,3
Celltrion,1
TEVA,1
Truxima,1
Combination Therapies A Patient Perspective,1
WednesdayWisdom,3
LivingwithLymphoma #LymphomaStory,1
https://t.co/tn4FWILSpt @Ericllorg #ERIC18,1
⚽️,2
Slide,2
GlobalData,1
DG &,1
PI3K p110δ Inactivation Antagonizes Chronic Lymphocytic Leukemia &,2
Health Central,1
National Institute for Health and Care Excellence,1
https://t.co/hFcaF6EoP1 @Ericllorg #ERIC18 #Leusm #CaGenome #CancerGenetics #CancerResearch #Epigenetics #Leukemia,1
Chris Dwyer &,1
R.I.P.,1
Willamette Valley #Cancer Institute and Research Center,1
wel de #,1
Willamette Valley Cancer Institute and Research Center,2
https://t.co/uNBaFIOM3l @Ericllorg #ERIC18 #Leusm #Remission,1
DrugTherapies,1
Fwd p,1
Healthcare Marketing,3
RIT,1
the Sapienza University of Rome,1
#MRDFocus #Leukemia #Leusm #,1
https://t.co/233Jui2Qwq,1
"the University of California, Irvine Health",1
https://t.co/DlfAUNOD9M,1
https://t.co/xZa1E80dEQ,1
MRD #Remission,1
bright &amp,1
Rainham,1
Complete #Epigenome,1
https://t.co/qRH7IL1N03 @Ericllorg #ERIC18 #Leusm #Epigenetics #Genome #Genetics #Camoldx,1
#Hosting,1
https://t.co/KGc9vIBBu3,1
Beatrice,2
https://t.co/3S9bxwNXiZ,1
the Center of President,1
Blood Journal - https://t.co/gJdqQJ5aud,1
Blood Journal - https://t.co/2GRoIYi0u2,1
CaxTx,1
Wallenberg Clinical Scholar,2
@Ericllorg #ERIC2018 #Immunotherapy #,1
MTPH,1
UK NICE,1
@GVAsanitat,2
wait &amp,1
CLLr @cannabis,1
CBD,1
THC,3
Ibrutinib/Rituximab,1
Pratice,2
Ibr/Gazyva &gt,1
"Clb/Gazyva
Ven/Gazyva &gt",1
Ibrutinib + Rituxumab,1
NCCN #Pharmacy Updates,1
@SapienzaRoma,1
https://t.co/4JaBvlBIy3 @Ericllorg #ERIC18 #Leusm #CancerManagement,1
GlobOnc #Survivorship,1
HealthEconomics,1
DrugCosts,1
"@TDTCML
 #Cancer",1
TuesdayMotivation,1
STUDENTS &,1
ベネトクラクス併用療法、CLL対象のP3試験で無増悪生存期間を達成－米アッヴィ - QLifePro,1
CAP CT,1
BeiGene Initiates Global Head-to-Head Phase III Clinical Trial of Zanubrutinib,1
@houstonchron,1
the University of Texas,4
the B Sharps,1
Project to Improve Communication About Serious Illness - Pilot Study: Status: Recruiting,1
Malignant Neoplasm,1
Lung Disease Chronic,1
Congestive Heart Failure,1
DrugResistance,2
CancerBiology,1
Próximas,1
de su #campeonAbsoluto de #cll,1
https://t.co/d6eneaWmOS,1
Geroge Follows,1
Please RT @HealthierNWL @QMBCI,1
Campo,1
Marc Auckland #Trustee,1
Charity,1
CLL Champions,1
ThankYou,2
everything!,1
Frank Mercer #Trustee,1
Nephrotic Syndrome,1
planning &amp,1
Chair,1
Texas U.,1
World Nursery Rhyme Week,1
https://t.co/OSh0zgle9O,1
https://t.co/l7rJKk6VUy @Ericllorg #ERIC18 #Leusm,1
CaMetab,1
The Palms Country Club,2
https://t.co/UG6XY2ZJu6,1
CURE Media Group,4
👴🏻 #,1
ParentHub,1
SENP2,1
lymsm https://t.co/EEVPUpDrDl,1
#CaGenome #Camoldx,1
CEO &amp,1
Founder,1
the National Chronic Lymphoblastic #Leukemia,1
https://t.co/EQfR9bF0WH,1
https://t.co/CceZMO2fxM @Ericllorg,1
GlobOnc #,1
Xenograft,1
SIA,1
SOU,1
Photomorphogenic 1 Reduces,1
the Sensitivity of Chronic Lymphocytic Leukemia Cells,1
Fludarabine Through Promotion of UbiquitinMediated P53 Degradation,1
@IrishCancerSoc #,1
ScienceWeek,1
https://t.co/4sUDYmm9CH,1
#NovartisInternational AG,1
CD20 &amp,1
Nikolaos,1
Prof Tatjana Stankovic,1
Evolving Paradigms,1
CAMOLDX,1
MIA,1
https://t.co/gc6ZRET7cX,1
https://t.co/cPX3ftAhGL,1
https://t.co/sRLNouUa5f https://t.co/JDqPh7w4kG,1
https://t.co/RREsz4EYjH,1
https://t.co/0rrAUBWGEY https://t.co/h9tiay3Aen,1
Segunda Semifinal,3
IWC,4
Guard &,1
Frankincense for Gnocchi's,1
https://t.co/cbwVxf6etM @Ericllorg,1
Zagreb Patriots,1
@EuropeLacrosse,1
@BigLotteryFund &amp,1
https://t.co/LgQ4k3bUug @Ericllorg,1
@CllSociety @CLLSupport @NYLCandCLL,1
f/,1
H2H,1
https://t.co/KOlr2ocJbJ,1
Consultatant/Haematologist,1
CLL Global Research Foundation,1
https://t.co/0GjvnaOnXx @Ericllorg,1
#BMTSM #HemOnc,1
Symposiumin #Madrid,1
de @pole_emploi #Occitanie,1
the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With,2
CFS,1
#ClinicalTrials,3
BeiGene Initiates Global Head-to-Head Phase 3 Clinical Trial of Zanubrutinib,1
Relapsed/Refractor,1
Adrian Wiestner,2
#lymphoma health &amp,1
TargetedTherapy #CancerTreatment #,1
https://t.co/XJ0hllWFjp,1
LIH,1
BRY #,1
FJET #,1
TCN,1
VCP,1
GMAA,1
Alkoxy,1
Bad,1
Foxo3A,1
https://t.co/hUqLjdgUpU,1
Lymsm #Epigenetics #Genome #Genetics #Camoldx,1
DrugTargets #CancerTargets,1
@Biodonostia @ISGLOBALorg @UPFBarcelona @CIBERONC,1
Flair,2
Roche /,1
@Roche @abbvie #,1
https://t.co/AAZfJ8dQcv,1
First-Line CLL Treatment,2
the Abramson Cancer Center of,1
the University of Pennsylvania,1
CLL Genetics,1
AbbVie/Roche Upbeat,1
First-Line Venetoclax Combo,1
@Roche for,3
MRD4,1
&gt;65y,1
Safety of Chronic Lymphocytic Leukemia Combination Therapy - Fair Number of Hematologic &,9
Non-Hematologic Adverse Effects,5
Roche/AbbVie,1
JPJ,1
Kahl Highlights Frontline Considerations,2
https://t.co/Zmwq9w4fea,1
https://t.co/SDlq6hq4l3,1
https://t.co/wVBG0aawlq,1
@Genentech,4
a Fixed Duration of Treatment,2
CMScript,1
Haematological,1
VENCLYXTOÂ,1
a Phase 3 Trial Evaluating a Venetoclax Combination,2
"Phase III Data Showed That Venclexta Plus Gazyva Reduced The Risk Of Disease Worsening Or Death In People With Previously Untreated Chronic Lymphocytic Leukemia With Co-Morbidities
https://t.co/6AbK4xHmiY",1
HNR,1
Non-Hematologic Adverse,3
Investigación,1
@sehh_es @Hematocat @Hematored @lymphomahub,1
Mark &amp,2
Mayo Clinic CLL,1
Moffitt,2
Leukemia Fundraiser https://t.co/W7SjaNHi8,1
https://t.co/D9MLvfspck,1
NovelDrugs,3
BoneMarrow #HemeOnc #,1
#mentor,1
@Invectys,1
@MDAndersonNews à Houston (USA,1
Anderson Cancer Center  https://t.co/vWQnxarGp9,1
https://t.co/2CFL8WAnuy,1
ALWAYS,1
Via @SkinIncMagazine,1
@cancertrials_ie,4
"@MediaplanetIE

",1
🙏 Blanca Espinet @imimat,1
Alessandra Tedeschi @nig_onco &,1
@Ericllorg,3
Adrian Wiestner @NIH,1
Peter Hillmen @LeedsHospitals &,1
MonoclonalAntibodies,1
guaranteed!@Hemato_Vhebron,1
MedGenome,5
Genetic Test for Chronic Lymphocytic Leukemia,5
Elias Campo &,1
− Data,1
AML &,1
IvoGut,2
#EliasCampo &,3
Investigadors del @cnag_eu,1
eloquent &amp,1
QOL,4
https://t.co/2ctrpWaOGm,1
BeiGene Announces Acceptance,1
Top-Line Pivotal Data,3
BGNE Announces Acceptance of NDA,1
@CRGenomica,2
https://t.co/086NNhx3W1,1
@cnag_eu of @CRGenomica,1
Ultimate,1
Combination Trials Signal Next Wave of Treatment,2
@hoheyn &amp,1
The @cnag_eu of #,1
AMAZING WILL POWER OF WORLD CHAMP ROMAN REIGN,1
https://t.co/TrB3WMchGA,1
Mayo Clinic's,1
@IISLaFe @knowyournodes @AEAL,1
@AspanionVLC @_pethema @sehh_es @_SEOM,1
BCell Chronic Lymphocytic Leukemia Pipeline Review H2 2018 Report,1
BCell Chronic Lymphocytic Leukemia Pipeline Review H2,1
https://t.co/aup0GAqJwd,1
hematologia @HUInfantaElena,1
https://t.co/8ijORrDdiB,1
Microbiomes #ITOC6,1
research &amp,2
Tickets &,1
Hafez,1
accredited &amp,1
LymphomaMyeloma2018 @LMCongress,1
LiveBroadcast,2
https://t.co/SdkkRFK7Cm,1
Eagle Pharmaceuticals,2
GPOR,1
la demande d'autorisation de l'#ibrutinib,1
https://t.co/04GBZOsOab,1
Parikh SA,1
NYSE,3
Announces Supplemental New Drug Application,2
U.S. FDA,12
pathogenesis &amp,1
AbbVie Announces Supplemental New Drug Application,4
Previously Untreated Chronic Lymphocytic Leukemia,2
Combination GAZYVA®,1
Previously Untreated #CLL https://t.co/8Ba5BSNrcr,1
ibrutin https://t.co/AXZoOm1efM,1
New  Genetic Test for Chronic Lymphocytic Leukemia: MedGenome,1
https://t.co/KqsnmR3vj6,1
nie daj,1
BiałejSuce,1
prawa zróbmy,1
Epocrates,1
AnneMarie,1
Novel Agents and Approaches Continue,1
BM Hematopoietic Dysfunction,1
Sameer A Parikh,1
Kanga Exchange,1
Review of @KangaExchange,1
Airdrop,2
Trading Competition - #Airdrop #Tradingcompetition #,1
https://t.co/8yDd0qq1l0 https://t.co/WcpSqU7nve,1
Captain Fantastic,1
Facebook https://t.co/rVfUxNlgfu,1
https://t.co/ccPAmBg4H1,1
National Comprehensive Cancer Network,2
Verastem Oncology’s,3
Clinical Practice Guidelines,1
NCCN @NCCNnews,1
Aggressive Course and Resistance,3
Celltrion's Rituxan,1
Roche’s Rituxan,1
🏹  Saving Lives,1
Congress of the European Hematology Association,1
https://t.co/nlaUsoxMya,1
National Comprehensive Cancer Network®,2
Token,3
https://t.co/ntPbcpbmhE,1
FIERCE,4
Penn Hall,1
KTBFFH,4
CC @MDEdgeTweets,1
HCL,2
Copiktra for Refractory Chronic Lymphocytic,1
Small Lymphocytic #Lymphoma,2
https://t.co/Ubbapfpn5K https://t.co/YbA1beHXSh,1
Cyclacel Pharmaceuticals,2
https://t.co/KxIPoehWRE https://t.co/c5YFOnLI5d,1
COO,1
Tokenfest,1
IRC,1
RemissionMan,1
@KangaExchange for CLL Token Listing + Airdrop +,1
https://t.co/lk0hq906XA,1
Immunotherapy research &amp,1
https://t.co/Rf9qcTbY2e,1
Control of Chronic Lymphocytic Leukemia Development,1
Undergo Functional Exhaustion,1
a New Cancer Drug Called,1
Tettenhall Wood Special School,1
the Pre-Congress Conference,1
#Myelomysplastic Syndromes,1
@MoffittNews https://t.co/HIDgXOqDaM,1
Real-World Treatment,1
The Novel Agents Era,1
Becomes Small Lymphocytic Leukemia,1
IgVH,5
@ksticcoMD,1
CLL Forum Clinical Sciences Day,1
diagnostics &amp,1
@renalmyeloma @kdjhaveri,1
Hodgkin/Non-Hodgkin,1
#Outcomes,1
#World #Hematology,2
the Management of Chronic Lymphocytic Leukemia - ScienceDirect https://t.co/Gokd9N0lsP,1
Boston 2018 - Introduction,1
us &amp,3
peak.#TinCanIslandPort #IbadanDelivery,1
Clinical Nurse Specialist,1
CD8s,1
CLL development &amp,1
https://t.co/pimSjyTc81,1
Skärgårdshavets,1
Novartis Pharmaceuticals,1
Earn Free #,1
INFI,5
the US Food and Drug Administration,1
Opportunity Analysis,1
InstaFloor NA,1
Duracryl,1
Medicine #nobelprize2018,1
https://t.co/jalxkAqEXi,2
JohnTerry,1
@RocheCanada,1
The Changing Treatment Landscape,2
BLOX,1
Martin ⁦@OncLiveSOSS⁩,1
#SanFrancisco &gt,1
#Follicular #Lymphoma,3
Distinguished University,1
GPH,1
@scoopit https://t.co/CFLN8DE33,1
ChronicMyeloidLeukemia #,1
https://t.co/rU64XmdcdF,1
@AACR @CancerResearch #3000researchers,1
CLL Forum,4
Richters Syndrome,2
Prof Francesc Bosch,1
Prof Chris Fox,1
Physicians Earn CPD Credits,1
@stjamesdublin,1
Information Sheets,1
Harley Hudson,1
@UTAustin,1
https://t.co/76EKbhyq1f,1
Health Canada for The Combination of  VENCLEXTA,1
CLL Support Association,1
Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia,1
Krohem B-Cll 2017,1
@KFSHRC #Riyadh,2
https://t.co/2HULkQPLf5,1
cll@patientpower.info,9
https://t.co/0oWf5Xg5S3 &amp,4
WAIHA,1
Notice of Compliance for VENCLEXTA,1
https://t.co/DwYeKGdkgS,2
Imbruvica @Pharmacyclics https://t.co/x6TpmHShGt,1
AbbVie Receives Approval,1
Health Canada for The Combination of VENCLEXTA,1
https://t.co/QhNbarb6Ae,1
Verastem Oncology's,1
Copiktra,1
Affiliate Program Open - #,1
Food and Drug Administration,1
@VerastemOncolog’s,1
Lymphocytic Lymphoma,3
https://t.co/IwSb8csLIr,1
https://t.co/Woh0cZC03q,1
@VerastemOncolog,1
SLL - https://t.co/9yCA1DiJNz,1
SLL - https://t.co/BVqALdRlnl,1
Imagen de,1
Global Clinical Trials Review,14
Zytux,1
https://t.co/jalxkAqEXi #,1
Scotland #RT @JanssenUK,1
EU Panel Backs,1
Be Refined,1
DCLLSG,2
IL-16 &,1
@HENZOKENYA,1
https://t.co/UV7oeOTJBY,2
@LeukaemiaCareFR,1
the Power of Both #Alemtuzumab,1
Bispecific Antibody,1
Individualized Lenalidomide Plus Chlorambucil,2
https://t.co/uLm93Vrvvx,1
RT #,1
Chemotherapy-free Combination of VENCLYXTO,4
a Fixed Duration for Patients with Chronic Lymphocytic Leukemia Who Have Received,2
https://t.co/U3JAzORiAq,1
Rituximab to Treat Chronic Lymphocytic Leukemia,1
MCI,1
https://t.co/8yDd0qq1l0,1
Non Hodgking #,1
Dr Radich,1
Tokenfest Interview Video @TotleCrypto - #,1
https://t.co/FNZwJjes3d,1
ECK,2
the Manitoba Chronic Lymphocytic Leukemia,1
MB Chronic Lymphocytic Leukemia Research: University of Manitoba,1
Targeting Nuclear Export,1
Pharmacy Times Continuing Education,3
Burger &,1
the Outcome of Patients with Chronic Lymphocytic Leukemia - A Single Center,1
MT2018-06,1
Biphenotypic/Undifferentiated Leukemia,1
G #,2
the Pan Pacific Lymphoma Conference,1
https://t.co/TcHNBmhMom #BloodCancerAwareness #Leukaemia,1
"RT MedlyPharmacy ""Medical News Today",1
Medical News Today,11
https://t.co/ljxMgef5OE @BritSocHaem,1
Biomarkers #Genetics #Genomics,1
WLAD,1
https://t.co/bvRV36gkIK,1
FDNY,1
MD of University of Oxford presents,1
Michael &amp,1
CMWP,1
🙏 https://t.co/vsxPJRVNUr,1
"@MDAndersonNews @LeukemiaMDA 
DEBATE: CIT",1
QLQ-C30,2
EORTC,5
QLQ-NHL,2
QLQ-NHL-LG20,2
💖,1
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia,3
https://t.co/ANvIqLfs8d,1
CAR NK #,1
Easy MINE,1
-info &amp,1
LymphomaMatters,1
https://t.co/g1crIkkLly,1
Director of Operations,1
MabThera #,4
https://t.co/KIhC5p6SuF,1
LiveTracker,1
Cancer Bio &,1
Individualized Treatment of Chronic Lymphocytic Leukemia,1
https://t.co/zS2ODsHdiW,1
BELSPO - Belgium,1
Mabtas N,1
the Centre for Cancer Biology,1
TLR2 Expression on Leukemic B Cells,2
CELLO GROUP PLC,1
Target,1
https://t.co/20YX4B80vf,1
VI LEVER MED DET,1
@BlodcancerDk @cancer_dk,1
Spot Leukaemia,1
De la belle visite hier en fin d’après-midi,1
@cegeplevislauzon sont venus minutieusement,1
National Blood Cancer Awareness Month,1
PRIVILEGE,1
https://t.co/1ppj7y3L3n https://t.co/zkQ8r2FA59,1
Cancer Support Community,1
lymsm https://t.co/T9IDIpJpPF,1
Real-World Outcomes And Management Strategies For Venetoclax-Treated Chronic Lymphocytic Leukemia Patients,1
New mRNA #Cancer Drivers Revealed,1
https://t.co/c2yh68Fu1l,1
https://t.co/9XmHi5pTR0 #bioRxiv,1
https://t.co/zZI02OOvsu,1
Individualized Lenalidomide + Chlorambucil &amp,1
Frankly Speaking About Cancer,1
LivingWell #,2
https://t.co/0I20JwlyTN #WednesdayWisdom #,1
@TGTherapeutics Btk,1
Clinical Trials - Cancer Network https://t.co/LouvxzmsTU,1
UAI #,1
#Harrogate,1
the Dept,1
BioInvent Int,1
@MyelomaIreland  &amp,1
@EFPIA @EU_H2020,1
Dear Haematologists,1
CLL Horizons 2018,1
Lymphoma Australia,1
https://t.co/MzHqicfIFv @EHA_Hematology,1
Chose Life,1
https://t.co/Vx72JYhJwC @EHA_Hematology,1
https://t.co/RPRtiz8y3q,1
BloodCancers,1
HOUSE,1
Comparison of Tumor Staging Systems for Cutaneous Squamous Cell Carcinoma in Patients with Chronic Lymphocytic Leukemia,3
Practical,2
the Center for #CLL,1
Cancer Institute,1
https://t.co/fmylGMho2,1
@CllSociety &,1
CLL ARC,1
https://t.co/ytCpdvpuwR,1
the Paul O'Gorman Leukaemia Research Centre,1
https://t.co/7TWYlRwJ2,1
Colonic Involvement,2
https://t.co/Lr0iaERky5 @BritSocHaem,1
#BSH2018 #Leusm,1
Expo,1
Virtual Tumor Board,2
@warwickarts,1
Myelodysplastic Syndromes,1
Non-#Hodgkins Lymphoma,1
Imbruvica @Pharmacyclics,1
#Wilmslow @Sainsbury 's,1
Pls RT @wilmslowcouk @WilmslowRT @NewsWilmslow,1
HSM,1
hepatosplenomegaly,1
Widespread Intronic PolyAdenylation,3
TSG,3
KnowledgeIsPower https://t.co/vWDH1L0eKD,1
Purva Lad &amp,2
U18,1
the FLAIR Trial,1
Pericardial Involvement,2
combinations &amp,2
"@anthonymatomd,",1
@wwierda &,1
Pipeline Insight,2
CheckOrphan https://t.co/drDOGq36ok @leukemia,1
Center for Chronic Lymphocytic,1
@LymphomaAction Glasgow,1
The Fans Real Soon,1
Affecting NF-κB,3
https://t.co/6ZaDaaRVi7,1
https://t.co/PtxdLSMWsV Watch,1
England’s National Health Service,1
ICER,1
https://t.co/LPV5qiOa4J #leukemia #oncology,1
Coventry City Centre,1
Leukemia Clonal Expansion,1
our Office of Patient Recruitment,1
@TimesONeill &amp,1
Obinutuzumab Plus #Venetoclax in Treatment-Naive,1
Disruption,1
SAS,1
@warwickuni,3
First-Line Approach for Chronic Lymphocytic Leukemia,3
New Therapeutic Strategies for Chronic Lymphocytic Leukemia,1
https://t.co/egxVNqkKT3,1
Fluorescence in Situ Hybridization,1
Coventry City Centre Library,1
@Covhour,1
https://t.co/6tFlGjAhbg,1
Life Expectancy &,1
Survival Rates,1
Catalina Channel,1
the Chronic Lymphocytic Leukemia Society,14
Board Changes,1
New Patient Cafe,2
Sat 8/9/18,1
@NHSGGC,1
NCRI CLL trials,1
https://t.co/KK1w3wtbhh,1
NASA,1
EGL,1
BEZ #UEN #CSH #,1
HealthGuru,1
New Social Media Platform,1
the Introductory Video Here,1
Newsocialmedia #,1
Getpaid #,1
FFWD,1
GDL,1
CheckOrphan,2
@LeukemiaRF,2
Group,2
LivingWell,23
NCT03624036,1
KTE-C19,3
Free/Registration,1
https://t.co/peNGE240Iy #EHA23 @EHA_Hematology,1
#ImmuneSystem #Prevention #HemOnc,1
CombinationTherapy #ClinicalTrials #,1
FGG,1
Audio Video Connector - $,1
https://t.co/Z9CF2UxeEM,1
VEC,1
the ups &amp,2
Videos &,1
Bristol,3
https://t.co/YCIzQy3lj5 - https://t.co/SmGmIw0DMQ,1
Obinutuzumab/Chlorambucil,1
https://t.co/KKrrQpsUig,1
melanoma - Hindustan Times,1
@NHSEngland,1
https://t.co/kBpyHWD6c0,1
Sandra overcome #CLL,2
https://t.co/62dAlfv9Av,1
"the University of California, Irvine",1
Die #StiftungLebenmitKrebs,1
Leukämie #CLL,3
the Hematologic Malignancies,2
"the Lyme Disease Connection
Lyme",1
https://t.co/V8aYViYQae,1
Identify,1
https://t.co/2pyzfZsqM5,1
General Aviation Terminal for @AstinAviation,1
@proactive_au  ,1
G  #,1
Giants,1
"@BloodJournal
https://t.co/HVUku3CfcA",1
"Monoclonal Antibody RITUXAN  ,",1
Application for Approval of Additional Indication of CD20-Positive Chronic Lymphocytic Leukemia,1
CLLEF2018,1
Chicago School Of Nursing Oncology,1
https://t.co/Z29SbXmXT0 https://t.co/CViytll0jW,1
NCCN Grand Rounds,1
The Ohio State University Comprehensive,1
三重県の写真（風景や食べ物）を,1
参加してくださいね！！,1
ups &amp,1
Benzene,6
"the Western, Prudent",2
French Innovative Leukemia Organization,2
https://t.co/5VDWV6Yvjj,1
#Leukemia &,1
#Lymphoma Patient #Research Registry Project,1
جاية من عند الاستشاري ب,1
Septicemia Vs,1
Keating of @LeukemiaMDA,3
OncoLink https://t.co/f0a1TSZnqE,1
Keating &,8
@ColumbiaMed &,6
Marek Mráz,1
@CEITEC_Brno @muni_cz,1
"@LeedsHospitals , Stephan Stilgenbauer",3
https://t.co/MxqtEucx6,1
cll@patientpower.info &amp,1
Ge H,1
Dear Church Family,1
https://t.co/OFlcfQctQA,1
Callout Ceremony,1
Anderson Cancer Center’s,1
Review of Anti-CD20 Antibody,1
https://t.co/Cp1bFxo7jB,1
MYI,1
diagnosis &amp,1
https://t.co/fvudiZYlah,1
https://t.co/lcRCZPeXjB,1
Florence Cymbalista @APHP,1
Health Care Costs of,1
Previously Treated Chronic Lymphocytic Leukemia More @ https://t.co/87627pdTqv,1
Kitchkinet,2
The Prognostic Significance,2
Clone Size,1
CaGenome,1
https://t.co/UH17Vo1mQk https://t.co/F0nqezvb9w,1
Gail &,1
https://t.co/NYCols2pzv  @ASH_hematology,1
PatientSupport,1
Prognostic Genetic Testing Underutilized,2
CLL Token,3
EasyTrade,1
Land's End,2
El Fantasma,1
Asembia Live Webinar,1
CLL Symposium,1
Teaneck NJ,1
peripheral blood &amp,2
FCR Chemotherapy,1
#BSH2018,1
CTO,1
INSE,1
A. Acute,1
Appointments,1
Cancer Immunology Research,1
Bored.,1
ClinicalData,2
The Derriford Chronic Lymphocytic Leukaemia,2
https://t.co/sbL8MJSnIA,1
@EU_H2020,1
https://t.co/gMjtw7tIof @ASH_hematology,1
Trustee,2
Thomas &amp,1
"Benedict, &amp",1
Linda &amp,1
the Management of Chronic Lymphocytic Leukemia,3
ChanchoFelipe,1
ZG,1
Resolution of Eosinophilia,1
https://t.co/plrBV3iILb,1
https://t.co/PiazOdtOXy,1
Lymphoma #Leukemia,2
Couch,1
#Hematology #Oncology #Chronic #Lymphocytic,1
University of Texas,2
Nick Rawlings,1
Venetoclax–Rituximab,18
https://t.co/1cAaLDzibm,1
Ohio &gt;&gt,1
Mauro,1
Leukemia Resource Center,1
NOTCH1 Aberrations,2
FCN,1
GothiaCup,1
#BSH2018 #BCL2,1
https://t.co/FNU2MAbIyg,1
FollicularLymphoma,3
https://t.co/fiskDZlLqz,1
@anthonymatomd @Penn,1
@DrGinaEagle,1
Mutational,2
@Patients_Videos @PatientPower @TargetedOnc,1
YoungPatient,1
Rituximab New Chemotherapy-Free Option,1
Office of Patient Recruitment,1
PE,1
@sandraimr &,1
MarlenMurillo,1
CLL https://t.co/xGwJpuaAYT,1
Man Alleges Chronic Lymphocytic,1
https://t.co/c7tJdOpHep,1
Value-Based Care for Patients,1
IgLV3,4
#BEST_CLUB,1
RMLL https://t.co/1UcYhtKnbe,1
regimen &,2
PI3,1
PIM,1
https://t.co/XeSLbylv59,1
Value-Based Care for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia - View,1
member &amp,1
Teammates,1
al described PD-1,1
Clonal Relatedness https://t.co/0FzfdxKCqX,1
Olaparib,1
health &amp,3
@EastLancsCCG,1
WednesdayWisdom #,1
https://t.co/Idhz0Amw1,1
RT TargetedOnc,1
PPS,1
KIBO #,1
https://t.co/ygv8jmWazP,2
HairyCell,1
@IUOPA,1
dig med,1
https://t.co/B0AJSXzOid #,1
• Click,1
Descansa,1
#Huaraz,1
PredictiveMarker,1
Plasma Cell Malignancies Regional Summit - Minneapolis,1
#BSH2018 #Leusm #,1
OurNHS70,1
the Global Industry,1
Expected Growth,1
Dana-Farber,1
lymphoma health &amp,2
#NovelTherapies #,1
CD-20,2
Mercatox Cryptocurrency Exchange - https://t.co/WkBFCoLz1M -,1
WorldCare Consortium,3
https://t.co/51pncHVfgM,1
Methode,1
Wissenschaftler des #,1
@Hemato_Vhebron,1
Venetoclax: Management and Care for Patients With Relapsed or,1
"Refractory Chronic Lymphocytic Leukemia
 https://t.co/TGYCcor1eC https://t.co/uXPjzAQdrG",1
🙏🏾,1
Clinical Hematology,1
Non-hodgkin's,1
"Lymphoma
Chronic Lymphoma/ Lymphocytic Leukemia",1
https://t.co/xTark13SD8,1
https://t.co/5AKCkmESvd @ASH_hematology,1
BRUTAL,1
CancerSucks,5
UC Irvine,1
Abbvie/Genentech's,1
Al Día,1
https://t.co/rlV8jFFWgQ,1
CLL Attention Mining - #Attentionmining,1
AbbVie Announces New Undetectable Minimal Residual Disease Data,1
ETH #,1
Value and Innovation to News,7
Media Consumption,7
RT EHA_Hematology,11
https://t.co/J88BEUmQvO EHA_Hematology #EHA23 #PressBriefing #,1
https://t.co/PFbmZ4a9dV EHA_Hematology #EHA23 #PressBriefing #,1
Colorectal Cancer Charity - https://t.co/48xCOOiRv8,1
T20,1
@blueprint_eu,2
BreastCancer,1
https://t.co/XDBRSgauX8,1
Semmelweis University,1
LuchaLibrechilena #LuchaLibre #,1
Cualquier consulta con él,1
Token Store,1
the Spanish Group of CLL,1
@UIMP,1
https://t.co/YpsTcIt8rp,1
IκBζ,1
Hematology Hub,2
Biomarkers 4 #CLL Response,1
the IL-6/STAT3,1
the advent &amp,1
new novel &amp,1
pts &gt;65 years w,1
New Treatment Option for Previously Treated Chronic Lymphocytic Leukemia,1
https://t.co/76f8rEyyfz,1
https://t.co/icZYDzlLjv,1
the CO-PAY,1
@cardinalhealth &amp,2
Daniel in,1
w/ Venetoclax &,1
MS/MS &amp,1
the CHPP Manuel Fuentes,1
AZA,1
All Personal Health - https://t.co/jZrCwIN9cA,1
Chancen,1
Lymphatischer #Leukämie #,1
https://t.co/ujdDHLUuDu,2
phase1 #,1
https://t.co/zndJ1tj4wy,1
Ella,1
La Dott.ssa Lydia Scarfò,1
al #EHA2018,1
https://t.co/oVnZARqdzf,1
science &amp,2
ARN-LHR-SFO-PHX,2
https://t.co/WtGO20VTkr,1
Bloodwise,2
WMsm,1
LA Sutton,3
summer18 #EHA23 #EHA2018 Ericllorg,2
summer18 #EHA23 #EHA2018 @Ericllorg,1
JanssenGlobal First,2
ClinicalExperts,1
KI Intolerance,1
WT,1
@Csac_Algerie &,1
The Journal of Immunology,1
MorphoSys Presents Clinical Data,7
Blood Cancer Candidate,1
obinutuzumab+ritux,1
@anthonymatomd during,1
https://t.co/UJ2IfrQ4St,1
@lyle_foreningen,1
https://t.co/Tvp8g1GgSb,1
SYNERGISE,1
the @IrishCancerSoc  Decoding #,1
Related Articles Circular,1
Hallek M. #EHA23 #EHA2018,3
@sehh_es https://t.co/Xq2l1ZLFDI,1
@cnag_eu in @NatureMedicine https://t.co/7H3FvxS9nJ,1
Rosenquist R. #EHA2018,1
Rosenquist R. #EHA23 #EHA2018,1
+ Updated Clinical Data for Anti-CD38 Antibody,1
https://t.co/72SATg85yi,1
EHA 2018 Conference,1
RHHBY https://t.co/KDltBOLsd3,1
European Hematology Association Annual Congress,1
#Australia #,1
Featuring @MDAndersonNews #Leukemia Medical Director &amp,1
Leukemia Medical Director &,1
Neue Updates,1
Behandlung von #,1
MSK CLL,1
ECEL,1
The First Test Transaction,1
FUN,1
mpnsm #,1
https://t.co/L4GpfFaWDt,1
https://t.co/2GlPGo7qtg,1
Wierda of @MDAndersonNews Stilgenbauer,1
Hillmen of @LeedsHospitals,2
https://t.co/35Ea33ROAq https://t.co/AHRvFFfqKr,1
Venclexta-Rituxan Combo Approved For Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma,1
Genentech #,1
Venclexta/Rituxan,2
Venclexta and Rituxan,1
@PharmaTimes @abbvie @Roche @biogen #leukaemia #lymphoma,1
Roche Announces,1
University Hospital Cologne,2
Pharmaceutical Business Review - #,1
Cirmtuzumab Inhibits ROR1 Signaling &,3
Stemness Signatures,3
https://t.co/kGjtyPwnV7,1
Der Entwurf,1
Konsultation,2
ÄZQ,2
Kommentare,1
https://t.co/FVFdCEwg0P,1
Approves Venetoclax,2
FDA Approves Venetoclax,1
Second-Line,1
Genentech Venclexta,1
Phase 1 Trial Finds Experimental Drug Safe,1
FDA Grants Venetoclax Full Approval,2
https://t.co/KIFgHoduOe,1
Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy,1
Small Lymphocytic Lymphoma Patients Who Have Received One,1
https://t.co/mCqH0j5NoA,1
BreakingNews,1
#Campaigns,2
@NHSE,1
Chipinge,1
Harare,1
Outcomes &,2
the House of Lords,1
https://t.co/prxXAE7wkQ,1
Non Hopkins Lymphoma 06/16/2016,1
@cnag_eu,1
@icgc_news,1
https://t.co/IYpCv6F6D3 @mamartirenom,1
"Wierda of @MDAndersonNews,",1
🧡🧡,1
GoodVibes,1
Participation,1
#Ethereum,1
https://t.co/hziIxtAFVm,1
FBLive,2
WF 6,1
@warwickuni @warwickinsite @WarwickEY @WarwickSocWork,1
info contact cindy@patientpower.info,5
WLJN,1
Sends TG Therapeutics Stock Soaring,1
PI3K delta inhibitor,3
the Appellate Division's,1
the New Jersey Construction,1
Jos Melenhorst,1
https://t.co/jiEKDSzLiT,1
Children’s Oncology Group,2
Genomics,2
Patients Met Primary Endpoint,5
Ongoing Research,1
Previously-Untreated Chronic Lymphocytic Leukemia,8
https://t.co/9ClxMNKJUO Automotive,1
https://t.co/rX1g49MPcM,1
NORTH CHICAGO,2
the British Journal of #Haematology,1
🤣,1
https://t.co/uct9eoGH2u,1
コミュニカティブアプローチ、#サイレントウェイ、#CLL,1
@debugliesnews,1
GLP,1
@NuneatonNews,1
https://t.co/O2VOFCj4A3,1
@Sunnybrook with @LLSCanada,1
@CIRMnews,1
COG,1
University of California San ... https://t.co/UPmuuPOHm2,1
StayTuned,1
#Research #CLL #,1
#Awareness #,3
CEIGHE,1
ImmunoOnc #CTSM #,1
‍🔬🤝👨,1
Melenhorst,2
@anthonymatomd @NitinJainMD &amp,1
the University of Pennsylvania's,1
Penn #CLL,1
Ibrutinib/Obinutuzumab Combo Improves PFS,1
Outcomes of #CLL,2
"@BloodJournal 
Higher",1
https://t.co/ZXmTgatbEB @OncNursingNews #,1
Genomics #Genetics #Cancer,1
Evolution of #CLL,3
CLL-IPI,28
@MajumderCan,1
https://t.co/H21TjHyS7F,1
https://t.co/wjc1lJG8sQ,1
World Blood Cancer Day,2
ligne de traitement de la,1
TreatmentBarriers,1
"@MDAndersonNews
https://t.co/8Qa1oNMO2e",1
Leeds,4
the @ASCO Annual Meeting,1
👁👁🎥,1
Aberrant CD8 Expression and Atypical #Morphology,1
OCN,2
AVVX,1
BIIB https://t.co/SKJm529KGj,1
https://t.co/q6CZdhL53M,1
Depth &,1
Imatinib,1
@TDTCML #Cancer,2
CLL https://t.co/cuiFGmunyt,1
#Genomic #Research,1
https://t.co/vs0dpgpJZ5,1
https://t.co/lGOni4GF4C,1
the Expert Perspective Tumor Board,1
@blueprint,1
Nadeem-Baker,1
leukemia https://t.co/VYms4b28eb https://t.co/vd6Y3bYgHS,1
https://t.co/XVouuVlxA4,1
@UniBarcelona,9
https://t.co/mqCiHsvXSM,1
#lymphoma Research,1
CNAG-CRG,1
https://t.co/fyR7xtMn8O,1
NewDrugs,1
#hematology,3
Farrukh T. Awan,1
Creative,1
@ciberonc,1
deuce‼️#CLL,1
https://t.co/kkMkEqcnBe https://t.co/0KO3MV3z2Z,1
Expert Assesses Available,1
Haimatus Latam,1
https://t.co/rIluhrfxQa,1
https://t.co/ycbWAsBU4v,1
Columbus Oncology and,1
Hematology Associates,1
Nursing Management #ONSCongress https://t.co/SahDro6urS,1
Patientenleitlinie,2
Ärztliche,1
IL-6/STAT3,2
TGTX safety &amp,1
https://t.co/wJPvn2n9mo,1
TBT,1
BajoCero,1
Campeón Nacional de @chileluchalibre,1
Campeón Absoluto de,1
DevOperation,1
OFA,1
Raleigh,1
SnowcappedMtns,1
IsThisReallyFranceOrSwitz #,1
BestWestern,1
@NICEcomms &amp,1
https://t.co/n2q8Q3pC0i,1
✌,2
University,2
MondayMotivaton,1
ZYDELIGTablet,1
https://t.co/egEr1BpVvL,1
#littleleague,2
https://t.co/t5PPkIcOZP,1
Justin Morneau Field,1
NewWork,2
🏽#BOLO,1
Fraietta JA,1
https://t.co/75FcLNDlRE,1
https://t.co/UoNKVJPJ5s,1
USES,8
https://t.co/193IDMaflA,1
https://t.co/uSfH7psh1Q,1
PSA,1
the Loganberry Trust,1
PLEASE,1
🙏🙏🙏🙏🙏,1
holisticcare @HHFTnhs,1
Biomarker,1
MRD Flow Panel,1
RSP https://t.co/ttLfqqudAb,1
superfoods &amp,1
Haematology &,1
conference2018 #,1
IGIV,1
Composite Lymphoma,1
Advanced Chronic Lymphocytic  ,1
Leukemia/Small Lymphocytic Lymphoma Carrying,1
EvenOdds,1
This Ohio State University,1
Follicular Lymphoma Opportunity,4
wNunn,1
mkl,1
@TheEBMT Chronic Malignancies,1
@warwickuni https://t.co/EJ7DheK7rz,1
Outcomes in Patients with Chronic Lymphocytic Leukemia Treated,1
B-Chronic Lymphocytic Leukemia,1
BSH2018,1
Nanay,1
Response &,2
@LymphomaAction national patient &amp,1
Free @LymphomaAction health &amp,1
Intrinsic Potency,1
#Chicago #Lymphoma,1
SuttonJobs,1
VSTM Verastem Oncology Reports,2
Global Oncology Partnering,1
PR Newswire,1
Pre-Commercial Initiatives,1
Inv...,1
Verastem Oncology Reports,1
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma,2
Follicular Lymphoma Opportunity Landscape and Advancements in PreCommercial Initiatives,1
.@andrewschorr &amp,1
Adult Leukemia Group,1
@ASCO Educational Book,1
army,1
A Named Patient Program,1
Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia,1
New Blog Post,2
"@BloodJournal
https://t.co/3VstSOqFCb",1
National,1
SkinLymphoma #,1
RSP https://t.co/3e7L12TcqF,1
Nursery at Saint Stephens Primary School,1
#edtech #,1
The Cytogenetic Quality of Chronic Lymphocytic Leukemia,1
Mitogen Cocktail of Pokeweed,1
https://t.co/MukQLugfIs,2
https://t.co/CyE2ym5HIj,1
https://t.co/84CcOr7m1P,1
Watch @TargetedOnc,1
"Waldenstroms, Chronic Lymphocyctic Leukemia",1
lymphomas  #,1
Alison Duffy &,1
RAC &,1
Kipps Group,1
"@dailymailonline 
NHS Health",1
Directions in Oncology Pharmacy,1
Toxicities,1
https://t.co/8zASwhup0b,1
Incidence And Management Of Toxicity Associated With,1
Practical Approach,1
"Hawkes
",1
G https://t.co/lg5Mixjn9Z,1
PX,1
https://t.co/W1zhr98mwd,1
@THilalMD,1
Annals of Oncology,2
Oxford Academic https://t.co/CXGEgZzlj7,1
Jacobs @OncLiveSOSS,1
P13K,2
AssistRx,2
Pony Gets Treated for Rare Blood Cancer,1
BRIC,1
@WMIWMF,1
https://t.co/X3T9Z0FSsu,1
@BarbaraEAWilson,1
Dr Eileen Parry + #CLL,1
the InterLymph Consortium,1
Geffen Kleinstern,1
PRS,1
Association of polygenic risk,1
https://t.co/VEc6JrXxxf,1
@CIBERONC @IUOPA,1
@renalmyeloma @CKJsocial,2
SundayMotivation,1
The Leukemia &amp,1
Ann &,1
Notes &amp,3
Acute Myleoid &,1
Patrizia Aureli,1
@EstherSchorr1 &amp,1
watch &,1
True Blue,1
https://t.co/MgnAsOuFC8,1
@TheChristieNHS &,1
@radissonbluMAN 12,1
meet others &,1
https://t.co/WIdTxs4OgO,1
RT,1
@LymphomaAction &,1
non-Hodgkin #FL,1
CLL Giveaway - $,1
eos,1
PD Dr,1
Cyclacel,8
CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia,4
w/Chronic Lymphocytic Leukemia,1
Medical Laboratory Scientist,1
Weill-Cornell NY,1
https://t.co/kgLqn7oXEC,1
CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic,3
https://t.co/bmAT85Yfkx,1
CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia,1
#BSH2018 @CRGHaem @Patients_Videos @CLLSupport @CllIreland @CllSociety,1
APC,1
#SpanishLanguage,2
@LeukaemiaCareUK &amp,1
BBC @CLLSupport  @CllIreland  @cll_news @CllSociety,1
@NYLCandCLL &amp,1
CD-37,1
NANO,1
IMHO Watch &,1
- Active Management,1
Login https://t.co/NKr0ZE2kTa &amp,2
IRAK4,1
https://t.co/6t1wx5q4PM,1
https://t.co/88039xjepT,1
Global Chronic Lymphocytic Leukemia Therapeutics Market,21
Regional,1
"Latest Trend, Share Analysis",1
Initial CLL Treatment,1
@LeukemiaMDA &amp;@ColumbiaMed,1
TCGA &,1
CLLSA/Leukaemia Care,1
https://t.co/0L1hc8CtHk,1
Niche,1
Hematogenix Laboratory Services,5
Launches Minimal Residual Disease,4
the X International Meeting,3
Das Leitlinienprogramm Onkologie,1
CXCR4 Imaging of Chronic Lymphocytic Leukemia,1
https://t.co/Ked99Fh9s2 #,1
https://t.co/R8ITonHSUy,1
https://t.co/JLo1h6PK4v &amp,1
Kirman,1
@CllIreland @CLLSupport,1
the Possibilities Fund Golf Tournament,1
Chronic Lymphatic #Leukemia,1
#lymphoma drug,1
https://t.co/laP8tTUNgo,1
para mejorar,1
#Leukaemia,1
Oxford Academic https://t.co/0hxS0zPaFW @kdjhaveri,1
@CKJsocial,1
https://t.co/c9AwHiJM7o,1
@nicoladandridge highlighting,1
https://t.co/A1a2vAp0KO,1
Instanebel,1
https://t.co/Pwmx814WsC,1
LymphomaConf,1
Company,1
sessioner,1
Leukemia Treated,1
@Trump_ton &,1
LYMSM Selected Trials of PI3K Inhibitors,1
Therapy Related,1
#Wrestlemania #WWE #,5
Brock Lesnar,1
AJ,1
SHIT,1
AJ STYLES,1
Wrestlemania #WWE #,2
Undertaker,1
Bludgeon Brothers,1
NAOMI,1
NUEVO campeon de Estados Unidos Jinder Mahal,1
el titulo,1
MABLE,1
"why, inc.",1
https://t.co/qO63pahX66,1
Anas Younes,2
https://t.co/2qmeTCZwa7,1
Priceline,1
BCS,1
IAH,1
Venetoclax/Rituxan,1
#RareDiseases #,1
@roche’s,1
HALO,2
@abcnews,1
Biotech Daily,1
Venclexta-Rituxan Combo Reduced Disease Progression,1
QT,1
Prognostic Factors,5
#ASH17 https://t.co/ZChb8ktxJP,2
https://t.co/7Uxx8krUBL,1
El Dr.,3
de la leucemia linfática crónica,1
l'elaboració de la nova,1
al @BloodJournal https://t.co/I9Hx766hqr,1
NOS,1
Consequence,1
VitalikButerin,1
AMHH,1
Madrid Association of Hematology,1
Hemotherapy) Congress,1
PI3Ks,1
"Jain, Bagg",1
Widespread,2
RT #CLL,1
@Curing_CLL @cll_news @CLL_Fighters,1
@Patients_Videos @patient print,1
Initial Bounty Offering,1
"U2”

Even",1
ECE,1
Speakers of Other Languages,1
Acute Myeloid,3
#Pediatric,1
USMLE,2
All Personal Health - https://t.co/cmwiYk8XN0,1
AAS #SDRY #,1
Venclexta-Rituxan Combo Delays Disease Progression,1
Neon Therapeutics #,1
International CLL Group,1
Gilead,12
the CARE #,1
Colorectal Cancer Charity - https://t.co/djKXQ3z784,1
BCL2阻害剤が再発または治療抵抗性慢性リンパ性白血病で怒涛の非再発生存率を達成。濾胞性リンパ腫の治療もガラッと変わるだろうねぇ〜,1
Fellows Program,1
All Personal Health - https://t.co/gvpwLBafTF,1
N Engl,1
NYC,7
CLL - #CLL #,1
International CLL Group Updates Trials Guidelines - Cancer Network:,1
International CLL Group Updates Trials Guidelines Cancer Network Prospective,1
HealthCanada,2
Dr @elcheikhjean,1
LSMO,1
Professor Hillmen &,1
Extreme Morning Challenge,1
Casajús-Navasal A,1
Daroca-Fernandez I,1
Refractory Chronic #Lymphocytic,1
VR,2
EurekaBlog,1
ASH-Kongress,1
Leukemia - Canada NewsWire,1
Murano Study,1
Stilgenbauer,2
Health Canada Approves RITUXAN Subcutaneous Formulation for Canadians with Chronic Lymphocytic Leukemia,1
CLLGlobal https://t.co/btsScV7zNG,1
https://t.co/bozT7Tj6pr,1
Experimental #Haematology &,1
Cello Group plc - Final Results,1
RFS,1
https://t.co/qwU5AnSQaU,1
social &amp,1
https://t.co/xKW4536ujv,2
physical &,2
Blanca Espinet et al,1
Chromosome Banding Analysis,1
RSP https://t.co/rwLq4suoyf,1
https://t.co/XUrkAtjWAu  #,1
Wait',1
"https://t.co/NKzyYTM0Gk
 ",1
Colonial Systems,1
the Oncology Nursing Society’s Clinical Journal of Oncology Nursing,1
KITE &,1
CR &,1
the Era of Novel Agents,6
@YorkSportsClub https://t.co/WHZ8shd26o @yorkshirepost @BBCYork,1
ForkDelta,2
ForkDelta Exchange,1
meeting &amp,1
Kinder Camp,1
https://t.co/44gvaKPrkd &amp,1
https://t.co/zBNVK0RiMX,1
@LLSTXG,1
https://t.co/XUrkAtjWAu @MDAndersonNews #CLLGlobal,1
Elevated Levels of Follicular T Helper Cells &,1
Their Association w/ Therapeutic Effects,1
XNW-1011,1
BTK-C481S,1
Acute Promyelocytic Leukemia,1
the Lymphoma Service,1
https://t.co/KMa1o5gPJU,1
Collaboration w @anthonymatomd &amp,1
https://t.co/vDZm1vUJWM,1
BCell Chronic Lymphocytic Leukemia Epidemiology Forecast,1
BCell Chronic Lymphocytic Leukemia Epidemiology,1
the LifeSciences PA Scientific Achievement Award,1
AnnualDinner,1
#Clinicaltrials,1
the World Rankings,1
de la @UniBarcelona,1
La última vez,1
Estimate prognosis &amp,1
https://t.co/9TCB0wz5lD,1
@ascp_chicago Patient Champions,1
Deedee,2
Familial,1
UCSF,3
https://t.co/txwF6OYhap,1
the UK,1
@unibirmingham @uhbcomms,1
@WYHpartnership @lymphomanews,1
Davids Discusses,1
lolofromparis2018 #,1
BCMA,1
Social Policy,2
the Potential Utility of Biosimilars,3
Chicago Lymphoma Workshop,1
TPECS,2
https://t.co/64axgRRDJ6,1
Лечение,14
ЛечениевИзраиле,4
Dr CM Wendtner,1
Schwabing Hospital,1
Expert Forum,1
ανάθεσης,2
https://t.co/0dRnMffT9H,1
Social Studies,4
NiagaraFalls,1
Specialty Registries,1
https://t.co/rn4msKABln,1
Customs Clearing Activity,1
Abat la violence fait à la Femme,1
IFI,1
"MOVIE &lt;3
",1
https://t.co/XkxEhyu2dY @ASH_hematology,1
https://t.co/XUrkAtjWAu #CLLGlobal,1
The UK CLL Forum,1
needs &amp,1
@Patients_Videos #,1
Saint Stephens Primary School,1
New Video Review,1
Token + Airdrop Statistics Review,1
CLLGlobal https://t.co/D7HrQBeqZi,1
pan-Canadian Oncology Drug Review Expert Review Committee,1
@CADTH_ACMTS,1
Activity and Safety of Front-line,1
Pan-Canadian Oncology Drug Review,1
CLL Token Review,1
Farmers,2
DimetSeminars,1
@UNIMIB,1
Quand,1
genre de comportement,1
https://t.co/246WkLbWA6 @ASH_hematology,1
CTSM #,3
https://t.co/dbONKizYw8 @ASH_hematology,1
"ya khouya :p &lt;3

",1
"@AndrewSchorr 
https://t.co/oQyC7a5Ifr",2
Flinn Highlights,1
#Emerging #Combinations,1
CLL Airdrop,2
#technology #,1
#idelalisib https://t.co/wS3Tx6O4Le,1
Marketed,27
ASM,1
https://t.co/FWp16UP376,1
Mission 5,1
Astronaut Rescue,1
La regulación microambiental,1
1st line &amp,2
Mechanism of Action,1
- Healthcare Journal,1
#Family Participation,2
Prof M Hallek &,1
#Combinations Continue,1
@MDAnderson,1
First Line Treatment Correlates,2
"Asslaber D,",1
Reinthaler P,1
Hofbauer,1
CLL @GenAllianceSA,1
Mantle Cell Lymphoma Misdiagnosed,5
Survey  #lymphoma #CLL @HealthZA @DMinistryHealth,1
@CCNSA,1
Hematology Meeting,1
HemeUpdate,1
ImmunoOnc #antibodies,1
Spanish Group of CLL,1
Combinations Continue,1
the Spanish Group,1
Global Pipeline Review,1
Loïc Ysebaert,1
"HUUUUUUGE &lt;3
FREE",1
Science Translational Medicine,1
REDOX,1
XEME Clinical Trials,1
MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel,1
https://t.co/lUNhkmBjHA,1
Updates/Advances,3
Sursik,1
NordicNanovector,1
#boost4charity https://t.co/omAurmIfkr,1
Refractory Chronic Lymphocytic Leukemia/Small Ly...,1
Annals of Behavioral Medicine,1
GG mights &amp,1
TICKETS WILL BE AVAILABLE 20h00,1
@Roche @NovartisScience,1
Biogen,1
Chemotherapy Bob Azopardi,1
抗体の抗腫瘍効果を確認：IRCCS‐AOU,1
Veratsem,1
@antonymato,1
https://t.co/DtmwLihiEV,1
the Gateway Information Session,1
EurekaMag,9
Genomics in Chronic Lymphocytic Leukemia: Current Research &,1
the Immunoregulatory Function of Chronic Lymphocytic Leukemia,1
O'Brien Covers Evolution,1
Psychological Intervention,1
https://t.co/G775okcT80,1
Help Alleviate,2
@TheUSONetwork &amp,6
https://t.co/aYSDqhe97q,1
Camp Talent Shows,1
Factors Affecting Prognosis and Treatment,2
Verastem Submits,7
Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma &,2
@OHSUKnight @WVCancer,2
https://t.co/hJWlxEEkZs,1
https://t.co/lACuuEHgon,1
O'Brien Covers Evolution of Long-Term Data With Ibrutinib,1
CLL Landscape,1
Life-Flight  Dave,1
Texas Hospital,1
Non Curable  Chronic Lymphocytic Leukemia Cll,1
Ectopic ILT3,3
"@unisiena
  ",1
実は今月の12日に『みえまちキャンパスin皇学館』へ遊びに行ったよ！！,1
O'Brien Covers Evolution of Ibrutinib,1
PALG - CLL4,2
Munneke,1
JM,1
KEY &,1
https://t.co/BvbvZpdCtb,1
https://t.co/JBvMYkCozz,1
UBLITUXIMAB,3
UMBRALISIB,2
sup1,1
Social Workers,1
EBV,1
https://t.co/7kfgCPGJsb,1
https://t.co/OOYfeHwLt5,1
BBC,2
Radio 4,2
Digital Radio,1
Differences in Expansion Potential of Naive,2
Personalize Lymphoma Management,1
#Follicular #Lymphoma https://t.co/saZZsGwPXb,1
@Xconomy @VSTMOncology #,1
Ctm,1
Lymphoma Unit,1
Fundacion Jimenez Diaz University Hospital,1
LYMSM,2
@Patients_Videos,2
@mgapatrick,1
Mouse Models,2
https://t.co/CtJifkLhD6,1
Mantlecell Lymphoma,1
CJ Chris- Gratefully Calling,2
https://t.co/SI3mtuyaOg,1
Fundraising Dinner,1
BRIEF,3
Hillmen,1
@Penn:,1
JamGrove 😊,1
: acute,1
acutezorg,1
AEGLE's Webinar,1
St James's Hospital,1
CTRU,1
CLL-Doppelstartern,1
S.C. Finch,1
Future Implications - LWW Journals,2
Future Implications - LWW Journals https://t.co/7E7Jz76sl7,1
"BBC Radio 4) Mon, Feb 12",1
Leukemia  Acute myeloid,1
AndrewSchorr,1
https://t.co/9YEfRijwTn #WeCanICan,1
Google,1
UKGov,5
Domain Capture,1
Method,1
SundayMorning,1
PubMed - NCBI #CLL,1
#charity #WeCanICan Inspire Action,1
NWF,1
https://t.co/BaZ8FuSn1X,1
#charity #WeCanICan Inspire &,1
Take Action,1
FF,1
Earn CE,1
the Role of Targets and Pathways,1
Non-Hematologic Adverse Effects https://t.co/evWKLkDgli,1
#charity #WeCanICan https://t.co/taE2s6uyUk,1
Abraham Lincoln Institute Book Prize,1
Diet,7
outcomes &amp,1
"@haematologica 
@anthonymatomd",1
Leukemia Drug,2
CCS,1
C.J.,3
Clinical Practice Recommendations,2
the Guidelines Committee,1
NSCI #MYI,1
CLL https://t.co/rSQBBBSDEj @UCIrvineHealth,1
Please RT @BBCLeicester,1
@HealthwatchLeic https://t.co/6VlgGPuCs5,1
"BBC Radio 4) Tue, Feb 6",1
CD49b,1
news &,1
A Phase II Study of Venetoclax,2
idelalisib https://t.co/brksVIlMtK,1
https://t.co/uUlGkceyIz,1
front line &amp,1
💔,2
https://t.co/WWgFNB3D9o @ASH_hematology,1
the Front Line,1
https://t.co/IpZzln932M,1
@BloodJournal  https://t.co/BbrurnvaYU,1
https://t.co/jlW6KRj3Z0,1
@proactive_uk @CelloGroup,2
BCR-ABL1,1
https://t.co/J8dvMqcR8M,1
CNS Blast Crisis,1
the department of haematology,1
ACRF,1
non-US,1
PhD &gt,1
@UofCalifornia,2
Helfen Sie,1
ein besseres,1
zu erlangen &amp,1
#genetic &,1
"https://t.co/6iPXhvBDqh
 ",1
こんばんは(^O^)SBCスタッフです,1
the Transplant Renaissance,1
CML Acceleration,1
Relapsed/Refractory CLL - Cancer Network https://t.co/UCIQnVxgHR,1
here&gt;&gt;https://t.co/eUT6yAJ7pE https://t.co/BhQ0jkn739,1
SmallMolecules,1
https://t.co/zMYxfm8OIM,1
Visible Human Journal of Endosco,1
https://t.co/xqyJtshM3B,5
https://t.co/dLv5CRUGKe,1
@OHSUKnight &amp,4
https://t.co/raOkG2z1F0,1
CLLestoeslucha #summerfest2018,1
venetoclax &amp,1
https://t.co/NKr0ZE2kTa,1
https://t.co/CUC6souRtW,1
ImmunoOnc #immunotherapy,1
al show #,1
https://t.co/ykLLyfSCzT,1
@APPGBloodCancer report inc,1
#Cancer #Genomics Recurrent Cytogenetic Abnormalities,1
https://t.co/76ZviEhQxV,1
WestminsterHall,5
Echo Project Management Group,1
FirstTimer,1
EatRight #,1
https://t.co/xby870EcZw,1
CharityTuesday,1
Campaigns,1
Watch and Wait &gt,1
https://t.co/pwXbkgb2CK #,1
Wexham,1
"Kathryn, Kate &",1
NowPlaying,2
GIO,1
@ageukbucks @AgeUKBerks @HWSlough https://t.co/nP7BErYoGf,1
Nätverkar,1
morgon,1
Campbell,1
Stem Cell Transplants,1
MRD Testing &,1
@onclive #leukemia #,1
Matthews &,2
PDF Download Available,1
Avec la #dreamteam #,1
paris https://t.co/9YDmmrV6jp,1
MSCA,1
Venetoclax-Rituximab Outshines Bendamustine Rituximab for Relapsed/Refractory,1
administration of ibrutinib &amp,1
https://t.co/nP7BEsfZxN @FrimleyHealth @ExpressSeries @HWSlough @SouthBucksDC https://t.co/zEqJnnB7wd,1
Dzimkova M,1
https://t.co/7DybSYLaFp,1
https://t.co/p1a1YnZpLD,1
@jackandraka,1
the approach &amp,1
https://t.co/6xByC13gmX,1
JUNO,1
Global Chronic Lymphocytic Leukemia Therapeutics Market By TOP Manufacturers,1
"Regions, Type And Application",1
Global Chronic Lymphocytic Leukemia Therapeutics Market Research Report,2
https://t.co/49wgHdTDTj,1
https://t.co/MFiJwRyUga @LeukemiaMDA https://t.co/JY2NOB1kXI,1
Casi,1
https://t.co/Z86dpP7X1z,1
@hemedoc https://t.co/FjiEf6EQh8,1
the Hartmann Lab Contribute,1
Loophole,1
Global Chronic Lymphocytic Leukemia Therapeutics Market Size,1
https://t.co/x53nJz0mku #Leukemia,1
CLLestoeslucha,1
https://t.co/yJRo5bdlt4,1
https://t.co/uBaLn0tkRm #,1
Ecology]-Loophole,1
https://t.co/aPrpdaLRjI,1
EurekAlert,2
Science News,2
ScienceNews,2
EOG,1
ADM,1
PFD,1
https://t.co/nP7BErYoGf @BucksHealthcare @FrimleyHealth,1
Connected Learning Live #,1
the Extreme Morning Challenge,1
Revolutionary Southampton,1
"Wang L, Fan L",1
Aberrant CD8 Expression and Atypical Morphology,1
#Dental,1
w @anthonymatomd &amp,1
Rockefeller University Press,2
"https://t.co/p86VWRHcrE
",1
Steiner M,1
Pleyer L,1
Egle A,1
Hartmann TN,1
DUO Trial,1
https://t.co/z3HEeMMRvk,1
https://t.co/QH9gUT1QUL,1
Gribben of @QMBCI,2
Lymphoma Daily,12
@FrimleyHealth @PboroCityHosp @CV_UHB @UHBristolNHS,1
Leukemia Daily,11
https://t.co/Za9kXNBWAl,1
@VUMChealth,2
https://t.co/iSSSggpRB1,1
#Optimists,1
LAA,2
https://t.co/JbK45rXoZ3,1
w @anthonymatomd @cardinalhealth,1
CardioOnc CC,1
Strategies for Dealing,2
https://t.co/iOwxtVYZoO @LeukemiaMDA @Power4Patients https://t.co/1OAjNHa7IH,1
https://t.co/U54RUpz5uq,1
Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia,1
dabigatran &amp,2
https://t.co/v5qxdcyDaS https://t.co/1Z0XZxPTe3,1
Wells Fargo,1
@mtmdphd of @Aurora_Cancer &amp,2
https://t.co/2SKkVyH0Pn,1
Q3,1
@wwierda (@MDAndersonNews &amp,2
Early Disease Progression,3
CLL - Cancer Network https://t.co/2Iq8JJAIUr,1
CLL - Cancer Network,1
SA,2
Quality of Life -,1
Venetoclax Active,4
Ibrutinib-Refractory CLL,2
Ibrutinib-Refractory CLL - Cancer Network,1
Ibrutinib-Refractory CLL Cancer Network,1
@hemedoc #,1
North &,1
East #London &,1
Cuando,1
banda de,1
Bonarda” #CLL #,1
Charitable Trust &,1
Off 2 Boston,1
Mayo Clinic Connect,1
Onyx,1
EpiCast Report Chronic Lymphocytic Leukemia Epidemiology Forecast,1
"Detect,",2
Treat Subtypes,2
Intro Camp,1
https://t.co/53l9b34Ses,1
Vale University Health Board,1
C6-ceramide,3
@Nature Communications,1
https://t.co/z2vIvBdUaw,1
Combination With,1
Venteoclax,1
@FrimleyHealth,1
@BrandcastHealth @BrownNhsdeb @BolanosNat @abbvieuk @JanssenUK,1
@CLLCANADA @BrandcastHealth @LLSCanada,1
@wwierda (@MDAndersonNews,1
@nygenome &amp,1
@DominiKemp 🙏🏻,1
https://t.co/7LiO63ZAu6,1
ASHsm,2
The Oncology Journal,2
Dana-Farber Cancer Institute: Study Shows Combining Chemotherapy,2
"Guide, Stahl",1
https://t.co/y4DGtjO4Mw,1
Thrombocytopenia,1
Endongoso,1
Targeted Therapies Improve Outcomes for People With Chronic Lymphocytic Leukemia,3
SoundCloud,5
Pipeline Review,21
https://t.co/SeLTNiEwvO,1
Belated #OHSUscholarship,1
Ibrutinib-Resistant Chronic Lymphocytic Leukemia,1
https://t.co/Llxh87G5OG,1
"@WVCancer
https://t.co/m7DkcBGHZE https://t.co/21T3lYCWuu",1
https://t.co/SBu9aTB1Ho,1
https://t.co/ioYGfwUNQB,1
GMD,1
DNL #,1
CLLSA Chair,1
@OncologyWatch: New Combination Therapy Significantly,1
@PatientPower 's,1
https://t.co/iOwxtVYZoO @LeukemiaMDA @Power4Patients,1
The Role of Rituximab,2
Spoon,1
AMC,1
The Metabolic Approach,1
Venclexta/Venclyxto,1
Venclexta + Rituxan,1
ISO 13485,1
HR 0.17,1
https://t.co/z1kkeFf0KR,1
Leukemia CLL Pipeline Review H2 2017 Report Updated 28112017 Prices,3
the Potential Utility,1
https://t.co/ZNjKuP88uN,1
the State Fire Marshal,1
GWCC,2
C202,2
@drsarahruth,1
"Molecular Pharmacology, Drug Resistance",1
CONGRATULATIONS,1
GURU,1
Daily Wrap,1
"#ASH2017 @OncLive
https://t.co/uCvbzYH0XU",1
Cruciferous Vegetables Associated,1
Fewer Common Side,1
VSTM Verastem Announces Clinical Data,2
the Basics of #,2
Continental News,1
Education Program,2
Pharma Cos News IMBRUVICA,1
Verastem Announces Clinical Data,2
Long-Lasting Responses,2
https://t.co/XAcQjoURTv,1
Health Verastem Announces Clinical Data,1
Sivina/Burger,2
Mutated IGHV &,2
https://t.co/HasF1DE4QD,1
Unsere Rangers,2
Thrombotic Thrombocytopenic Purpura,2
TTP,2
@NitinJainMD - 429 'Combined Venetoclax,2
Noon - Burger - 427 ',2
Dr Adrian Wiestner,1
OBR,2
Patient-Reported,17
Quality of Life Experience,8
Abstract#1750 @ASH_hematology,1
"Lymphoma 
https://t.co/LZY2fzbDP9",1
world w @anthonymatomd @cardinalhealth &amp,1
IMBRUVICA Patient-Reported,1
QOL Experience,1
https://t.co/t0GiCPbPMz @iwCLL #iwCLL2017 #,1
Family &,1
@OHSUKnight &amp; @CompassOncology,1
Hem News,2
Mayo Clinic Health Sciences,1
Genetic Risk Factors,1
Families,1
Georgia World Congress Center,1
DUOTM,1
Justin,1
Dominic LeBlanc,1
Valuebasedcare,1
CURE Media Group Partners,15
Alliance Partnership Program,10
challenges &amp,8
@Zoomer,1
N.B. MP Dominic LeBlanc,6
"https://t.co/y7bEOTu9s1 
#Canada #",1
https://t.co/i0F47Y5p3M,1
Lymphoma Relapsing,1
ITGB2,2
leukemia - LeBlanc,1
https://t.co/HAx7RF0aCy,1
Federal N.B.,1
CDNpoli,1
Cabinet,1
Fisheries &,2
Oceans Dominic LeBlanc,1
https://t.co/WtcrElEIyZ,1
the Chronic Lymphocytic Leukemia Society: CRANBURY,1
Media Group Partners,1
the Chronic Lymphocytic Leukemia Society https://t.co/u15vZOk9SP https://t.co/flnvnfVevD,1
the Chronic Lymphocytic Leukemia Society https://t.co/bxzFUQWdC8,1
w/ @MDAndersonNews @LeukemiaMDA @WVCancer,2
the Chronic Lymphocytic Leukemia Society https://t.co/q8goUP4nkH,1
115k,1
de la relation de,1
https://t.co/z8M4wimabV,1
VSTM - Verastem,1
Druggable Target,1
P13,1
Interferon Regulatory,1
Diary &,1
Bristol - Prof.,1
@PERSIMUNE #MISPCamp https://t.co/fkDVNmQVgk,1
Cello Group's,1
FinnCap,16
GBX,33
PT,8
NICE,1
Venetoclax https://t.co/nl0W6afHj0,1
@Oncotarget on AKT,1
CD154,1
Debbie,1
Hemmol,1
Decoding Monoclonal Antibodies,2
RT PatientPower,2
@OHSUNews,1
https://t.co/R54gAq9wsj,1
Przewlekła #,18
FAKTY,13
=&gt;&gt,14
Dental and Oral Complications,1
@LLSusa #PatientExperience @BloodAdvances,1
@jonasasouza &amp,1
https://t.co/tLUJydiDJC,1
@LeukemiaMDA @CompassOncology @WVCancer,1
VJHemonc,1
CLL Madrid Group,1
@QualityHealthUK,1
https://t.co/m2GfJt7EET #diet #wellness #,1
https://t.co/c2ZCSYlvNP,1
GEPAC,2
GVAsanitat EFPIA,2
Non-Hodgkin #Lymphoma,3
@GVAsanitat @EFPIA,1
CLL https://t.co/GHIYNVsiNu #leukemia #,1
FISH &,1
https://t.co/j4bJ5f7n5j,1
Mutated/Unmutated,1
https://t.co/Gda08eeG4X,1
private &,1
BIG DATA,1
Sistematic Review,1
IGHV-M #,1
Firsthand,1
Living with #ChronicLymphocyticLeukemia,1
https://t.co/VVtrg2oRZM,1
Macitentan,1
the CLL Molecular Oncology Tumor Board,1
Molecular Oncology,1
https://t.co/mhzeGaRTj4,3
Pre-Planned Interim Analysis,1
https://t.co/mzsabJdKIC,1
Liga Provincial de Entre Ríos,1
M13-982,2
@OncoTherapyNet  https://t.co/xR2WaRY5hR,1
@NNUH,1
el HT  #,1
Epa wl,1
Jajajaja #NPDRock,1
@MichuDano,1
Molecular Oncology Tumor Board,2
AMP,1
w/ @ASCO &,1
@MedUni_Vienna,1
Data 2 b presented @ASH_hematology,1
@USDOL,1
DOL,1
MUY,1
ASCOU,5
nursesconf,1
Dr A Cuneo,1
Hematologist - Chronic Lymphocytic,1
Job - Mayo Clinic - Rochester,1
MN https://t.co/Rl1dYZk2le -,1
NowHiring,1
https://t.co/7qGvHeqxEN @MDAndersonNews https://t.co/p8D3mennZW,1
🙀,2
https://t.co/knjRV7i05b @MDAndersonNews @LeukemiaMDA,1
the Virtual Journal Club,1
w/ @AMPath &amp,1
CaseManagers,1
Novel Targeted Agents,2
Acredito,1
Real World,1
SnapShot,1
the Molecular Oncology Tumor Board,1
https://t.co/t0DXVbsobZ,1
Hubs #LymphomaHub,1
Hepatocyte Growth Factor,1
Italia,2
Ponto de,1
Coisa,1
Research Matters,1
#Profiling,1
COBLL1,1
https://t.co/6KpMz7qdFl,1
the #Stress of #CLL Treatment,1
Leukaemia CARE’s,1
https://t.co/uN8pj0rVfD,1
Furman &,1
QualityImprovement,1
Bendamustine + Rituximab,1
Myeloma https://t.co/EF5cq0UvAk,1
@Curing_CLL,1
Chronic #Lymphocytic #Leukemia,1
Bagacean C,1
@sparker,1
🏔,2
https://t.co/1TP61GPtwC,1
IgVH-mutated,1
https://t.co/j1INkl86cp,1
protein &amp,1
WEBINAR - #,1
https://t.co/1vQPFBzXAD,1
Kinder,1
Longest,1
ASH17 @ASH_hematology w @DrMatasar &amp,1
@SakharoffP,1
FLAIR &gt,1
Mantle Cell Lymphoma+,1
Ibrutix,2
Collision Metastasis of Chronic Lymphocytic Leukemia,3
Glioblastoma ACase Report,2
https://t.co/DxAjhiAWGh #iwCLL17 @iwCLL,1
CLL Register,1
Webinar] Defining,1
#Secondary #Malignancies,1
Esanex Announces First Patient Dosed,6
the Future of Value-Based Cancer Care,1
AlbertoMontero,1
dioxin &amp,1
Webcast-Defining,1
Value-Based Care for Patients with Relapsed/Refractory,1
https://t.co/hsYMA711y0,1
the #Stress of #CLL Treatment https://t.co/xCls7C4Dgu https://t.co/wh8ZrC8A2M,1
Tanya,1
DCI Annual Retreat,1
https://t.co/ezDhF6lrcP,1
Dr Furman,4
Ireland Analysis Of Outcomes,2
https://t.co/fNlR2tY6MP,1
#lymphoma &amp,1
VPHAwards,1
@QMBCI https://t.co/9LJyWlZO6S #,1
@UNCSON Register,1
therapeutics &amp,1
Symp Mgmnt,1
https://t.co/mJlJ2zWtPD,1
CLL - Oncology Care Model,1
#Cancer #Genomics Functional,1
SML,1
https://t.co/qSEN8OdQQ0 Chronic,3
Quick Review - Few Pointers,1
Club des Logiciels Libres,1
OSSEC,1
el manar,1
https://t.co/8b8sIV07qM,1
Non-Hodgkin’s Lymphoma(NHL,3
#epigenetics Genetic,1
HARMONYAlliance,1
#Hematolog,1
@lymphomahub @MyelomaUK @MDS_UK @WmukInfo @BrownNhsdeb,1
Esanex,1
CCL Feeling,1
MRD-Adapted Therapy Approach Yields Good Results,1
Current and Future Goals,1
NY Genome Center,1
Bernal por recibirnos,1
Buenos Aires,1
Clipstone,1
1.111,1
iOnco Analytics - Newsletter,1
Blwyddyn,1
Gwaelod/ Year 3Ll,1
https://t.co/s0abaRWK3y,1
CLL - https://t.co/VnBROKC5Vy,1
CLL - https://t.co/srHbDClbGV,1
#Lymphoma #Leukaemia #Oncology #Cancer,1
cold &amp,1
Hairy Cell Leukemia &,1
"Kreuzer, &amp",1
@RCGP Annual Conf,1
CLL - https://t.co/jqVuxNHESn,1
cll metabolism &amp,1
https://t.co/whddmPFAeh,2
HOA,1
the Australian Government’s,1
https://t.co/iRYqx1DllE,1
Aus Government,1
Ibrutinib - @PharmaDispatch #Aushealth,1
the mechanisms &amp,1
CURE Magazine,1
aspartame &amp,1
CllFighters,4
RT❤,1
AL #,1
https://t.co/xqyJtshM3B https://t.co/Z0jvaaftnh,1
"SpotLeukaemia 
Welcome",1
NewVisuals,1
PatientSurvey,1
Legendary Hockey Player’s Game-Changing Diagnosis - https://t.co/A4XgbZCuqX,1
BINGO,1
@J_Immunol #Bcells,2
Legendary Hockey Player’s Game-Changing Diagnosis https://t.co/KX5JDZI1MX,1
Tx w @anthonymatomd,1
https://t.co/T1UAQCa9UK,1
https://t.co/1eT3EMUfwj,1
Los Gimnastas Rusos,1
GAV,8
MAG,1
@BlodcancerDk,1
PLL,3
https://t.co/XRUowaK5gi,1
Coop,1
Via @SickChicOrg,1
BBC Radio,1
10-10:30am,1
Multilatérale,1
Hey @Pharmacyclics @JanssenUS &,1
GMD #,1
Prodigiosin,1
the experiences &amp,1
CancerLett Chronic,1
https://t.co/G9cJOStejl,1
@dogrschools,1
BloodCounts Project,1
https://t.co/fdkKPKCLN1,1
CLL https://t.co/OsoeyzJSoh,1
@cancertrials_ie @IrishCancerSoc,1
Cello Group plc's,40
w/knowledge &amp,1
VOCÊ TEM CARA DE QUE NÃO CONHECE,1
https://t.co/PcDPH3KUtW,1
Ectopic Expression,1
Akt Activation,1
Bcells @BloodJournal https://t.co/4kRf3fEPzK,1
🙀#,1
Stunts,1
Pathological Findings,1
https://t.co/A9IyMJZJVK,1
Yours,1
DanLandau,1
w/ @LeukemiaMDA @CompassOncology @OHSUKnight,1
@JADPRO @APSHOorg @KurtinSandra https://t.co/gINbkX76Wq,1
Colonia Las Liebres,1
https://t.co/vwCDuWA2Tn,1
CLL - https://t.co/YOJ0L6gMQc #Oncology #Lymphoma #Leukaemia,1
Uzi Vert,1
High-Risk,1
https://t.co/NT0IIwSLCI,1
https://t.co/rS8hb2pT0B,1
https://t.co/QNJN8T02lj,1
https://t.co/7yWPl3u4DE,1
https://t.co/TZaecuRfAI,1
Cello Group,8
@kingfisherplc,1
KGF,1
DGE,1
SIXH,1
AbbVie/Roche’s,1
https://t.co/3OEA9xMHht,1
rpcGcbcgKL,1
BCL2 &,1
genetics,1
https://t.co/OAQMbgctxE,1
P3 Trial Evaluating Venetoclax Tablets,1
Combo with Rituxan,1
the Treatment of Pats,1
Leukaemia News,1
https://t.co/qAAGZ0ZC8Y,1
https://t.co/cfEMJUaMsM,1
@CCCNHS,2
L3/BR2-4,8
930A #CLL Session,2
Abst CLL-102 Venetoclax,2
CLL Session,2
the Art Update,2
Breakfast w/,2
L3/P1,2
https://t.co/okrhEgWSyJ,1
Adicionando Ublituximab,1
https://t.co/ew4bsaNdr0,1
https://t.co/1Yd54lRduY,1
The #Microenvironment,1
TSUNAGUfilm,1
Leukemia Treatment Options,1
Prognosis https://t.co/YjOizgk4Ep,1
@scoopit https://t.co/YYY9LYRk17,1
@Patient Power - a Cancer Community,1
Stephan Stilgenbauer #,1
☝,1
UHD,1
Maintenance #Lenalidomide,1
VOTE,1
L3/Chevy,2
Common Problem,2
PE HCS UGM,1
Helpful,1
Qs &,1
ESMO17,1
Elias Campo @hospitalclinic,1
Burger @MDAndersonNews https://t.co/9ytjisgRWl,1
Salmonella,1
BCell Chronic Lymphocytic Leukemia Global API Manufacturers Marketed,2
Arvind Arumainathan &,1
Sabe,1
https://t.co/OjrO0vW4hO,1
Dr Brown #,1
https://t.co/m65F9b0zMV,1
LymphoTrack NGS,1
RJ,1
Duvelisib (@Roche,2
https://t.co/k1dyBPsSil,1
https://t.co/6HLk0izg7k,1
Society of Geriatric Oncology Task Force,1
Completes Target Enrollment,1
Dr LeClair &,1
e-pathology.flv,1
CLL)-Mayo Clinic,2
TerryHamblin,1
Blog Mutated / Unmutated,1
ile başetmenin,1
yolu,1
https://t.co/kjweLogXih,1
#MakeBloodCancerVisible,1
CLLexperts,1
BCell Chronic Lymphocytic Leukemia Pipeline Review H2 2017 Report Updated 22082017 Prices,3
https://t.co/T9mWhyaI0C,1
CureCancer,2
the Cell of Origin,1
https://t.co/6lNLRhMuGe,1
https://t.co/pFdV8scXMx,1
#BloodCancerAwareness Month,1
Altered N-Linked Glycosylation,3
"Израиле

Читать",6
Health Engineer @redgroove1,1
https://t.co/fyRTvLetpm,1
@IrishCancerSoc @LeukaemiaCAREuk #SpotLeukaemia,1
Mutated IGHV4-34,3
Shared and Distinct Immunogenetic Features and Clinic,1
Shared and Distinct Immunogenetic Features,2
https://t.co/QpRN40tZNR,1
@Futurism,1
https://t.co/TJZWSUXKS5,1
CCR #Cancer Drug Updates: Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia,1
https://t.co/8WrGMWo5q1,1
Journal of Onco-Nephrology,1
HittaMiz,7
The Biologics of,1
"Acute Lymphocytic Leukemia 
Acute Myelogenous Leukemia",1
@IrishCancerSoc https://t.co/2QY4GikpWL https://t.co/tLQgx8LAv7,1
approvals &amp,1
PD-L1 Immune Checkpoints Molecules,3
🚀🙊,1
https://t.co/AUrpaoagTX,1
Emili Monsterrat @hospitalclinic,1
#Buteyko &,1
U13,1
https://t.co/PD9brZNgxN,1
https://t.co/44RL1Rj7ys,1
@HealthUnlocked https://t.co/gsAV9aJFei #CLL #,1
de la #UniversiadaMundial,1
GAF #Cll #Clll,1
Global Clinical Trials Review H1,3
The American Cancer Society,1
the Era of Novel Agents https://t.co/5vio4hSZS4,1
#Leukemia,1
RT❤ https://t.co/8etE2Dmydw,1
#posse #,1
CarePartner,2
BloodCancer awareness &amp,1
Dr Power's,1
S3-LL #,1
Ublituximab / Ibrutinib,1
LWI,1
LymphomaExpert,3
S100-A9,1
@UCSDNews &,2
deletion &,1
University Hospital Cologne:,1
CLLOrigenes,2
https://t.co/1OulND8JR5,1
#ICAHO2017 @btfoundation https://t.co/lWwOLsGscK,1
the Portland Marathon,1
Wendtner C-M,1
Global Chronic Lymphocytic Leukemia Therapeutics Report - Market Size,1
Quantitative &,1
Qualitative Analysis of Tregs,1
sequencing &lt;2%,1
https://t.co/DiLcKY2x6c,1
Fatigue,1
https://t.co/rKrPcUlegz,2
https://t.co/Jlzb98l2LK,1
@Jasoncology,3
https://t.co/ULOloxZeor,1
Pharmacy Forum,2
@NortheasternCOS  ,1
https://t.co/Q5GcL1Gwat,1
Momento,1
LuchaLibreChilena #LuchaLibre,1
RT AJKD,1
CLL Outcomes,1
safe &,3
https://t.co/EJn9BvnYtt,1
SUPER,1
w/ LeClair &,1
Alex &amp,1
Christoph,1
CLL13,3
#Liverpool #CLL &,2
AEGLE,2
FCR https://t.co/7CPkCZOr8a,1
HodgkinLymphoma,2
ABVD,2
https://t.co/7G5xtUD1Tj,2
Leukemia Emerge,1
CLL RockFighter,2
@NortheasternCOS #CLL #,1
Kipps &,1
Improve With Novel Therapies,1
@BSH_ASM,1
https://t.co/MjVUNAFDrI,1
https://t.co/PhkmM4478V,1
RockFighter,8
CLL Esto,14
Siguiendo,4
TargetTherapy,1
Ublituximab/Ibrutinib Beneficial in Patients With Chronic Lymphocytic Leukemia,3
the Era of Novel Agents https://t.co/UiBNMCwmDK https://t.co/gsYrMpmEXn,1
The Mike Paetzold Daily,8
SPMS,1
Sophie Laird,1
@wessexGMC Genetics Lab,1
https://t.co/Imk1MT014v,1
Join him &,1
https://t.co/sNqM3Nd0eH,1
S3-LL,1
Info/Dokumente https://t.co/yn98i21gfM,1
RT EJShpallMD,1
https://t.co/M3AteLdLHu,1
NPDROCK,1
Chlorinated,1
AMPK,1
Woman Files New,1
MYD88 &,1
Mutations Cooperate,1
#LuchaLibreFemenina #Wrestling,1
CancerResoures,1
BL https://t.co/UgHcecZu0V,1
Idealisib,2
CBC-Diff,1
BCell Chronic Lymphocytic Leukemia Pipeline Insight,2
Richter Transformation https://t.co/RdbWETx9FX,1
BCell Chronic Lymphocytic Leukemia Pipeline Insight 2017,1
TCRM,1
Living Club Level Life,1
#Lymphocyte &,2
@UTSC,2
Sunesis Announces,1
BCell Chronic Lymphocytic Leukemia Epidemiology Insights,1
Wichtig Nephrology,1
Celtic,1
Webinar Replay,3
Cello Group plc,12
RPC,1
Sunesis Pharmaceuticals Announces,2
New Rituximab Formulation Approved,1
Bl3LlD yn,1
BR #,1
Burke,1
Israel - #,1
https://t.co/KtKhwlztMO,1
https://t.co/KrbBAwM9ZV,1
@WFInsurance,1
DNAdamage #CD180 #TLR4 https://t.co/USUCF0bWLL,1
https://t.co/nYD7Aofhw1,1
WNT,2
https://t.co/1tkjETBMpv,1
Umbilical &,1
ALL &,1
effort &amp,1
Combination Induced High Rate of Bone Marrow MRD Negativity,1
IgG Levels,3
Forefront #Clinical Timeline,1
#Pharmaceutical #Sciences,1
@cancer_dk #CLL #,1
Eosinophilic,2
https://t.co/ejfYtpNJ0E,1
Lymphocyte &,2
@PatientPower @MDAndersonNews #Leukemia #Cancer #Oncology https://t.co/NjgeHD2D44,1
@TNONCOLOGY,2
LuchalibreChilena #LuchaLibre,1
https://t.co/xqyJtshM3B https://t.co/nMfxWUdVbN,1
https://t.co/zU8l472k6F https://t.co/jxgbWrIOLM,1
A Christmas Toast,1
https://t.co/GYNDZaZdUk,1
Patients &,1
بيفضل,1
@ChristallaJ @Eastfield_EN3,1
Aberrant RNA Splicing,1
@cancertrials_ie &,1
https://t.co/ZJckvGTENZ Feinstein Institute Scientist Recognized for Innovative Chronic Lymphocytic Leukemia Research,1
Chromosomal Abnormalities &,1
#Nktcells,1
Invariant NKT,3
"Non-Hodgkin’s Lymphoma
Chronic Lymphocytic Leukemia",1
Safety of BGB-3111,1
Refractory Chronic Lymphocytic Leukemia/Small Lympho,1
EHA https://t.co/BLyvcMq0JF,1
Fludarabine,1
Genentech #ENHANZE #,1
FollicularLymphoma #,1
.@PatientPower - #ClinicalTrials,1
Absolute Lymphocyte Counts Predictive of Survival With CLL Post-FCR - Cancer Therapy Advisor https://t.co/fh39BCOWT8,1
Venclexta/Venclyxto Effective,2
post-FCR https://t.co/KaUefm5OnS,1
Immunoglobulin Genes In Chronic Lymphocytic Leukemia:,1
BGB-3111 &amp,1
https://t.co/OjrD2KpUiM,1
Pr Stilgenbauer,1
https://t.co/hpxASKuDPi,1
GFM france,3
Dr P,1
Subcutaneous Rituxan,1
genentech,2
follicular &,1
C Moreno @hematosantpau,1
https://t.co/3lss5KZJm9,1
Primer,1
DSSG Digest,1
Chornobyl Cleanup Workers,3
DRG,2
@gnubila_fr,2
Edelmann &,1
Gribben @JOP_ASCO https://t.co/cAYZZ5rF4i,1
Atrial fibrillation &amp,1
NEW PhII Study,3
New Cancer Drug Defeats Multiple Tumors https://t.co/OY8DLo7znq,1
Newsmax via @Newsmax_Media,1
Therapeutic and Drug Pipeline Review,1
Feinstein Institute Scientist Recognized for Innovative Chronic Lymphocytic,1
Jefferies of $23,1
RRMS,1
NIHRJL,1
Leukemia-Pipeline Review,1
AcuteMyeloid,1
Tourney,1
https://t.co/iCQqGeYuSv,1
MBDseq Method,1
Commandments for Managers,3
EGIA,2
Initial Therapy - Cancer Therapy Advisor,1
Emerging Targeted Therapies and Immunotherapies,1
Continued #Progress,1
BAY,1
IBRUTNIB,1
CLL #,2
PI3Kd,1
PO QD,1
NHL #Lymphoma and,1
Feinstein Institute Scientist Recognized for Innovative Chronic Lymphocytic Leukemia Research,2
Deutsche Sutidiengruppe CLL,1
Abstracts &,1
the EHA Learning Center,1
Restores Fludarabine Sensitivity,2
Die CLL Cheerleader,1
https://t.co/JKC2oQMLee,1
Therapeutic Outlooks,1
BCell Chronic Lymphocytic Leukemia Global Clinical Trials Review,6
Dr Cramer,1
CLL-BAG2 Trial,1
BeiGene Presents Updated Phase 1 Data,1
BTK Inhibitor BGB-3111,7
https://t.co/4X7iYhsSUK,1
AbbVie Symposium,1
btk,2
https://t.co/Zy6qwlNA0Y,1
BGNE Presents Updated Phase 1 Data,1
#Patients,1
Data Presentations Covering New Approaches to Cancer Specialties,1
MiR-16-1,2
@unimelb &amp,4
SaturdayMorning,1
Pharmacy Forum:,1
PowerPoint Slides - https://t.co/Hd3ypNweNh  ,1
P3 Study of Ibrutinib in Combination,1
Fiebre #WomensWrestling,1
ไรไม่รู้,1
Roundup &,4
Therapeutics Development of Chronic Lymphocytic Leukemia,1
Leukemia CLL Pipeline Review,6
mgmt &amp,1
PennCancer,1
the Highlights on CLL,1
@ASCO https://t.co/zDbnfBziK8,1
New Data Presented,4
P3,2
PennMedicine,4
TG Therapeutics Announces Positive Data,5
TGTX Presents,1
the Janssen Disease Lens,2
https://t.co/qwEjiZt5db,1
CarlJune,1
@rafefurst @Saispas75 @MicheleDeane  @ourgreennation,1
Hall A. #,1
Hall A. #ASCO17,1
OncologyTube  https://t.co/uCg2Ij7tvK,1
CLLU1,4
Lawsuit https://t.co/iKIFs5cD38  1.713.535.7176,1
Response Rates,1
https://t.co/B6WfZCiPzJ,1
NNECOS,1
@TheBloodMD,1
@CancerDartmouth,1
Inherited &,1
https://t.co/2yQcviGUsm,1
IHI,1
Lazarex,1
al on inherited &amp,1
NOVN,1
CTL119 &,1
York Live Your Life Conference,1
Sat 3,1
Clinical and Molecular Evidence of Atovaquone,1
https://t.co/XyJmREmieI,1
MEI Pharma Announces Pre-Specified Response Rate Exceeded,3
Dose-Escalation Study,2
RT!,1
Dose-Escalation Study of ME,1
CD8 Expression In B Chronic Lymphocytic Leukemia,1
"residential radon levels @CllSociety
https://t.co/zBqEp2TPrV",1
https://t.co/sgYLTr58UU,1
https://t.co/nNLYRt93A7,1
Glioblastoma ACase Report https://t.co/zLWck07DXb,1
https://t.co/PJSR7lzF7k,1
Sunesis,1
el insta de @chileluchalibre,1
Cairo-2015,1
this World Blood Cancer Day,1
https://t.co/QQHZ9YpeWE,1
CLL Subtype Report,1
#iwCLL2017,3
@pubmed @NCBI,1
E-Newsletter,1
Multiple Sclerosis,1
Toby,1
https://t.co/7eexAvuHz5,1
the Diagnosis and Initial Treatment,1
chemotherapy &amp,1
ONO,3
PI3K isoform,1
Guide - Adverse Events,1
IGHV4-34,1
SHARED,1
CLINICA,1
@OncLiveSOSS @MoffittNews #,1
@Ramikomrokji,1
Assembly,1
Unique Selling Point,1
Ffwrdd,1
🙏🙏🙏🙏🙏🙏🙏🙏💔,1
the @Copa90 vid!,1
#Denver &,1
Sat.,1
the Origin,1
Diagnosis &,1
Initial Treatment,1
#Ventoclax,1
2MGH,1
An Unusual Pattern of Pulmonary Involvement of Chronic Lymphocytic Leukemia,1
CHESUN,1
Wierda &amp,2
Leptomeningeal Involvement,1
PI3K isoform Inhibitors,1
https://t.co/6JJ93f9ka8 &,1
Prof Brown,1
CLL - Cancer Therapy Advisor,1
https://t.co/OHF8gztJLS,5
#Lymphoma #SupportiveCare,1
Ubiquitin-Specific Protease,1
USP7,1
Comparison of NGS &,1
https://t.co/a4jsK8d7j6 https://t.co/iVpQluHfXb,1
UTX,1
IB,1
Monocytes &,1
immunosuppressive &,1
"Keating of @LeukemiaMDA 
https://t.co/NvGxo5HeyA @MDAndersonNews #CLL",2
CXCR4,1
function &amp,1
Via @BloodJournal,1
LeuSM https://t.co/6bP0BhFA6,1
https://t.co/dsgQMM3itW,1
The Largest International Assembly on Chronic Lymphocytic Leukemia,4
Donor Affects Outcomes Among Patients With CLL Undergoing,1
InyeAhn,1
WCM,1
Prof Hallek,1
https://t.co/uCXb24G1dV Been,1
IMBRUVICA Pooled Outcomes Data,1
https://t.co/51YWgH6K8K,1
Uppsala Univ,1
Pooled Outcomes Data,1
MRD &,1
detection &,1
RT &,1
Hallek #CLL #,2
CIT &,1
Marriott Marquis,1
Dr Jumaa,1
Via @BloodJournal  https://t.co/KJwT6q0bGn,1
i#brutinib,2
NR,3
Neutrophils &,1
Enhance Migration of Chronic Lymphocytic,1
Leukemia Cells,1
Biomarker for Future Relapse,1
The Largest International Assembly on Chronic Lymphocytic Leukemia CLL Kicks Off,1
BloodReviews,1
https://t.co/W4AWrZtfS4,1
immune genes &amp,1
Chicago - Chronic Lymphocytic Leukemia/Small Lymphocytic,1
Bicycle Infrastructure,1
the Rubber Meets the Road #CLL webcast 06/15,1
https://t.co/KVM2GjvrCS,1
Personalized Drug Analysis,1
N+1 Singer,9
mantle cell,2
Ireland &,1
https://t.co/xKTyExNmMh,1
Pan troglodytes,2
CL,3
"FanArt  de #DLN -Saga  #CLL
 María",1
FRS - Huge Congrats Max,1
@UniCologne @UKKoeln,1
https://t.co/C96xN77F2N,1
the Real World https://t.co/1VyFKCwUDu,1
MedlinePlus Medical Encyclopedia,1
Oxford Academic https://t.co/A7SsIYCFaD,1
https://t.co/Ubo7TxGgEh #,1
#Healthcare,1
Investigate Tumor,1
ONO/GS-4059,2
Hofstra Northwell School of Medicine,1
Investigational BTK Inhibitor ONO/,1
@DrMDavids &amp,4
High-Risk Chronic Lymphocytic Leukemia,2
Cardiac Considerations,1
Register &,1
The Multiple Myeloma Daily,2
the PW World -,1
coming &amp,1
@CNNI,1
#APWA #,1
Constructing and Maintaining New Athletic Fields,1
Muchísimos,1
RendirseJamas,1
Maipu,1
"👽✌
💀",1
un show de #LuchaLibre,1
BCell Chronic Lymphocytic Leukemia  Pipeline Review,3
LA OLA,1
Avslutningsmiddag,1
ON https://t.co/G61FcnL9Yw,2
Nivolumab-NSCLC &,2
https://t.co/mnXv5drH5i,1
MYCrelated,1
Staging CT,3
Early Stage Chronic Lymphocytic Leukemia,3
https://t.co/RS84eZH1gt,1
"myeloma, &amp",1
Checkpoint Inhibitors,5
Customs Clearing,1
Forging New Frontiers,1
The Long &,1
"FDA Adverse Event Reporting System -
 ",1
PLCG2 C2 &amp,1
NHS Scotland,1
https://t.co/58MIiTx0FA,1
@oncologytube,1
ONO/GS-4059 https://t.co/A2DUdJL0N9,1
NY,5
Leukemia Defeated With PH Balance and Nutritional,1
@TuftsCancerCtr,1
https://t.co/GoR0l3fp29,1
CLLの勉強会,1
Medical Sciences] https://t.co/ZOj0SoWViO,1
Kinase Inhibitor for Chronic Lymphocytic Leukemia,1
RockyMtn Cancer Centers &,1
BCR &,1
DLBCL &amp,1
RESEARCH STUDY AVAILABLE],1
RockyMtnCancer &amp,1
TGR-1202,2
Clin Path Research,1
#clinicaltrials &amp,1
The Association of Dyslipidemia With Chronic Lymphocytic Leukemia,5
ODAC,1
แสงตะวันล่วงลับดับจากฟ้า,1
CJ,3
@IrishCancerSoc &,1
Constructing and Maintaining New Athletic Fields - #CLL 04/27/17,1
https://t.co/1EcEdUKDlw,1
@umanitoba &,1
ARCTIC,1
lymphoid malignancies &amp,1
Global Chronic Lymphocytic Leukemia Market Will Grow,1
https://t.co/hccIwqetzC,1
NOTCH1 Mutated Chronic Lymphocytic,1
Idelalisib &,1
First-Line Options,1
ResearchMoz,2
UTR,1
https://t.co/7XmOkKgxMe #,1
Bonus Resources Included,2
https://t.co/5FRfnhSPL7,1
@vmwarensx &amp,1
Chill,1
hall meeting &amp,1
Once-Daily Oral Ibrutinib,1
https://t.co/SONawnSfr1,3
USA - @CelloGroup,1
FCRL6,1
https://t.co/kWvcldgC2k,1
RDW,2
Best Practice &,1
Research Clinical Haematology,1
@andrewschorr @MDAndersonNews,5
PubChase Epigenetic,1
LAS 16:00HRS Evento Reborn de @chileluchalibre,1
https://t.co/t0tCxcEojT,1
https://t.co/67pW7IHVOt,1
Physician's Choice &,4
https://t.co/AIBPb6nV7m,1
Optimal Approaches for Management of Patients with Deletion,1
https://t.co/IFqBTJCx6l,1
Lymphoma Canada,1
Global Chronic Lymphocytic Leukemia Market Review,1
Trends &amp,1
https://t.co/F9HnDSWBlm,1
BCell,2
https://t.co/g3vIi8XBXA,1
SHM,2
https://t.co/wWdi2MYiPw,1
Leukemia #ChemoProtocols,1
decisions &amp,1
Hampers Leukemia,1
TrumpCare,1
Stamatopoulos et.,1
https://t.co/3jFaXczvKx,1
Society of Geriatric Oncology,1
SIOG,2
Thoracic Complications,2
RT https://t.co/0ErERA72RY,1
#bloodcancerconf #lymphoma,1
The Hill Resource,2
#Ublituximab/#Ibrutinib #Combo Succeeds,1
duvelisib &amp,1
Oxford U Hospitals,1
NGS #LymphoTrack IGHV SHM Assay,1
The Future of Chronic Lymphocytic,11
Safety &,8
BCR Signaling Pathway,1
Congratulations @Verniaiev_GyM #,1
TG Therapeutics ublituximab Effective,1
TG Therapeutics Announces Positive Topline Data,3
RTX,1
Clonal,2
#MultipleMyeloma &amp;follicular,1
The Association of #Dyslipidemia With Chronic Lymphocytic,1
https://t.co/hdDGM7ZCJs,1
https://t.co/WVlzOczLwh,1
TOLL,1
Cholesterol Levels,1
TomKipps @UCSDHealth @DiseasePrimers,1
Kapadia2017 https://t.co/bgFOazx9It,1
OpeningDay,1
TomKipps @UCSDHealth @DiseasePrimers https://t.co/mnOXsweKdi,1
SME,1
the Public Works World,1
https://t.co/vaSGomqB1w,1
e.g. BTK &,1
Attn #CLL,1
Patient &,1
🏀 #hornets #cll #McDonalds https://t.co/wth5EzRTgM,1
Effective Utility Management,1
Leukämie – Vollständige #Infografik,1
Therapy of Chronic Lymphocytic,1
https://t.co/q3hRV9WSqP,1
DanaFarber,3
https://t.co/gVZs59ToJh,1
https://t.co/ICz4JSxoPQ,1
https://t.co/0ERmsAJJQB,1
@ONAcom Read,1
CalgaryMarathon,2
Progressive Multifocal Leukoencephalopathy,1
https://t.co/ILDg62QwfP,1
Immune System Genes Linked,1
https://t.co/dKxeEGjW8o,3
https://t.co/8Bj7Do9qmp https://t.co/g4wrEO527r,6
Intervention Radio,2
BTK C481S-Mediated Resistance,1
Radiotherapy &,1
https://t.co/qBzlCzcPO7,1
BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia,1
w/ @LeukemiaMDADrs Keating &,1
Lamanna https://t.co/xXIVc4d16i &,1
https://t.co/0eVcVoe5wY &,1
the Global Chronic Lymphocytic Leukemia Market,7
https://t.co/Nr3Z6qKNBW,1
Genotype,1
@mjmauroMD,1
d'informations sur notre,1
Promoter Hypomethylation and Expression Is Conserved,2
"GG guys &lt;3
",1
ABT-199/GDC-0199,4
https://t.co/m4JW4TcAj8,1
Bgb-3111,7
https://t.co/yDyMPiBOeq #CLL,1
@vallhebron,1
pts &amp,1
New &,1
My Perspective,3
#HaemOnc &,1
Idelalisib Increases Progression-Free Survival,1
Apapa,1
Chronic Lymphocytic Leukemia Cells,2
@Naturecomms,1
CCR1,1
Future CLL Relapse - Cancer Therapy Advisor,1
https://t.co/kGDuWfzJFG,1
https://t.co/71TNDIBQtn,1
efficacy &amp,1
#Study Identifies,1
Antidote https://t.co/GtIjntMBJN #CLL #,6
VETMEDICS - About Chronic Lymphocytic LeukemiaAbout Chronic Lymphocytic Leukemia,1
malignancies?Dr,1
Drs Keating &,1
VLL VS,1
Shynron,2
MX Cll &,1
https://t.co/zC5HLYu87l #CLL,1
#BioAsia2017,4
SurbhanaJurong,4
CLL @PatientPower Live Meeting,1
https://t.co/zsXeO6a3R4  #iwCLL2017 #Hematology #Oncology https://t.co/EuXDBdpNG7,1
"New Study, Overview, Global Clinical",1
B. Chronic,1
Nghanolfan Ddwr Cilfynydd/ 3LlD,1
Cilfynydd Water Centre,1
Powerpoint Presentations - https://t.co/Hd3ypNweNh  ,1
https://t.co/1YkgVMVLsm,1
@UCSDHealth Met,1
Santa Barb on Gazyva/Imbruvica,1
https://t.co/hCc7yRwfHt,1
Strategies,1
NYP,2
https://t.co/fYCg2yR0wp,1
New Study,1
Current Research of Drug Treatments,1
Tumour,1
ANGPT2,1
https://t.co/sgJ5dovpGh #WorldCancerDay,1
@ImedexCME,1
Megan,1
CLL Landscape to Change Dramatically,1
Novel Targeted Agents For,1
CLL-Therapie,1
Hagen,1
CLL)-Mayo Clinic #,1
Idag,1
Antigen,3
null https://t.co/jwiFKPfSj2,1
@andrewschorr @CUH_NHS @MDAndersonNews,1
https://t.co/Y6mQU8LclI,2
Restoring Innate NK,1
HaemOnc,2
https://t.co/X6DETWVb2P,1
https://t.co/8looNciZyM,1
New Pharmacotherapies,2
w/ @USOResearch &amp,1
LymSM #,1
CPD,1
SIOG:,3
more &gt;&gt,6
JANSSEN,1
Lepaf,1
https://t.co/RHyvzJYJUJ,1
GrandRounds Highlights,1
GrandRounds @Lankenau,1
the Era of Oral Targeted Therapies,4
Consortium,1
MICROSCOPE,1
detect &,1
ET/10,1
Jiménez Díaz University Hospital #Hematology,1
Challenges,1
ICGEBSeminars Today,1
Tumor Host,1
el tratamiento de la,1
#ASH16,13
PTS w/ #CLL,1
https://t.co/1PLrAMgTpG,1
SIOG Task Force,2
Venetoclax + Rituximab Studied,1
Primer https://t.co/EgtpZSGwOa,1
Society of Geriatric Oncology Task Force https://t.co/Spj5gPhyi2,1
Ruxolitinib May Improve Symptom Control,1
INFI Duvelisib,1
https://t.co/mY81GxbMUI,1
https://t.co/66vCRgGOTJ,1
#OrphanDrug Designation,2
TGR-1202 for Chronic Lymphocytic Leukemia,1
Value Chain Analysis,1
Gribben #ASH16,1
https://t.co/NhGL9Yzw0X,1
Front-Line Therapy,2
Why Rapid Development of New Drugs Poses New Challenges,2
https://t.co/Sgqzd6wd77,1
OS &,1
https://t.co/Y2A1LRmHll https://t.co/rFP9WIQIsq,1
SYK/JAK,1
https://t.co/A2sQgM1XIg,1
The Expression of Toll-Like Receptors in Patients,1
Relapsed/Refractory CLL https://t.co/X52YxJQMKI,1
tnt,1
https://t.co/smIULquK3a,1
Safety Analysis of BCL-2 Inhibitor #Venetoclax https://t.co/URt4yJwPao,1
https://t.co/ph3DemyiHf,1
HDAC,1
Clinical Pathways,1
https://t.co/SkNJ3QwVPw,2
Methylprednisolone,1
PPAR-Delta Promotes Survival of Chronic Lymphocytic,1
Dating https://t.co/JA5Tw4gEfE @PatientPower #,1
Participants Share Their Dating Advice,3
Global Chronic Lymphocytic Leukemia Market to Grow,1
2020- Key Vendors,1
https://t.co/b0D7fwiEHK,1
TG Therapeutics Reports,1
#OrphanDrug Designation for the Combination of #,1
Gizmodo Australia,1
@ABCNews,1
Indirect Comparisons,1
MRD Eradication With Alemtuzumab Consolidation Improves OS,1
WATN,1
TG Therapeutics Announces Orphan Drug Designation,5
https://t.co/BeisxcGouB,1
TGR-1202 for Treatment of C,1
TG Therapeutics Inc Announces Orphan Drug Designation,1
TGR-1202 for Treatment of Chronic Lymphocytic Leukemia,2
TGR-1202 for Treatment of Chronic Lymphocytic Leukemia https://t.co/7oT6Puycsk,1
TGR-1202 for Treatment of... https://t.co/hskvAO4Qld,1
TGTX Orphan Drug Designation,2
BeiGene Presents Updated Clinical Data,5
Signal Transduction Pathway,4
Cruzando,1
mtg &amp,1
ovarian+bladder cancer &amp,1
3rd International Conference on New Concepts,1
Market Opportunities,1
Skyrocket - https://t.co/Qb5eH31JmI,1
sarcoma &,2
@LeukemiaMDA Register,1
https://t.co/mYctmok9ge,1
Rac1,2
@LeukemiaMDA w/ @ColumbiaMed Sign,1
Clue,1
RT https://t.co/IAnhVHbXci Chronic Lymphocytic Leukemia Defeated With PH Balance and Nutritional Th,1
RT https://t.co/kNsC25e9y3 Chronic Lymphocytic,1
@UniofOxford,1
Drug Holidays,2
LAP,1
National Cancer Institute,2
Ochsner Medical Center,1
HemaCare,1
#Leukemia #Cancer,1
The CognoNews Journal,1
Med-IQ CE: Review benefits &amp,1
Brace yourselves &lt;3,1
https://t.co/FCOFfKA2Fi https://t.co/WXP4VvEZq4,1
Interrupt Chronic Lymphocytic Leukemia Cell,1
Older,2
UPenn,2
https://t.co/C9r4pHwIVG https://t.co/g4wrEO527r,1
@USOResearch &amp,1
Relapsed/ Refractory,1
https://t.co/WIzepZtkJa,1
the Elderly A Position Paper,2
International Society Geriatric,1
Management of Chronic Lymphocytic Leukemia,6
International Society Geriatric Oncology @SIOGorg,1
#ASH16 Daily Wrap w/ @andrewschorr,2
ASBMT https://t.co/4y0Cl94B8m,1
Tumor-Microenvironment Interactions,2
the Current and Future Economic Burden,1
https://t.co/QKPnD18HlP #,1
Genomic changes &amp,1
https://t.co/MRU5hoXmZ3,1
https://t.co/UnhLTH9ICZ #,1
Data Suggests #CheckpointInhibitors May Be Active,2
Big News,7
"Genomics
Evolution",1
Phase Ib/II,1
https://t.co/g2dyWU45OW,1
Single Patient,1
w/ S Stilgenbauer,1
Participants Share Dating Advice https://t.co/mW07mPwCLI @PatientPower,1
RBC,2
IDH,3
HCT,1
Complete Remission,1
Recurrent Cytogenetic Abnormalities,1
NHL &,1
Pipeline Review H2,2
Transformation https://t.co/ozk42ZWFTr @CleClinicMD,1
prostate &amp,4
https://t.co/4FjfZDYiIz,1
MRD-negativity &amp,1
Colony-Stimulating,3
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms,2
ford,1
the Future Next Line,1
@HealthCanada,1
Market Insight Report,1
https://t.co/1ZeGRoS5nN #lymsm,1
Legion,1
Congrats @Roche $RHBBY &,1
https://t.co/of9gSwpJWA,1
Leukemia Drug Approved for Conditional Marketing,1
@andrewschorr @CUH_NHS @MDAndersonNews @WVCancer,1
#Combo #Feasible,1
https://t.co/MunGK5CosL via @onclive,1
Cirmtuzumab Inhibits,1
Induced Rac1-Activation,1
CombinationTherapy #NovelDrugs #Cancer,1
@abbvie,1
https://t.co/lHBi4gZuh0,1
UAB,2
Conditional Marketing Approval,1
Single-Agent,1
Lymphoma Society https://t.co/epKyrUCRp7 https://t.co/8KxpPSqQX7,1
.@OhioState &amp,1
European Commission Conditional Marketing Approval,1
@Roche conditional,1
Turtle,1
CarePartner #CancerResources #Oncology,1
#ASH16 #,2
a Treatment-Naive Patient With Chronic Lymphocytic Leukemia,1
BUPA Home,1
Beşiktaşımızın,1
Juno Therapeutics Announces Complete Response,1
Dr Kadri &,1
GEN Genetic Engineering,1
https://t.co/SpUrUpX7d2,1
BM CLL,1
Murine B1 Cells Exhibit Potential To Develop Into ',1
Leukemia/Small Lymphocytic L,1
PI=@CLLdoc,1
AbbVie Release,1
https://t.co/2jxBXsNscy,1
mAb + idelalisib,1
Importance of Considering New &,1
Traditional Treatment Options,1
Steele #ASH16,1
https://t.co/a9cF5ue3ZF,1
CD8+ #CTL019,2
SanDiego,1
No3199,1
CLL)-Mayo Clinic https://t.co/W8LbCOBYQU,1
CLL)-Mayo Clinic,1
Chlorambucil #ASH16 #cll #gerionc,1
#ASH16 #CLL,1
"#ASH16, @Pharmacyclics &",1
Lymphoma 5Year Analysis,1
Nivolumab/Ibrutinib Combo Shows Promise for Richter Transformation #ASH16 #immunotherapy #cll #,1
#ASH16 Oral,1
MRD-Neg,1
FL Treatment,1
CD8+ CDL019 #,1
OS #ASH16,1
@cardinalhealth @anthonymatomd &,1
#ASH16 for @Pharmacyclics &,1
• Spleen,1
• Infection,4
https://t.co/qRf9SLg3Fb,1
https://t.co/NW4W2Q5Cv0,1
@DrDJPeace,1
DHL,1
https://t.co/7Ys5Jta8tV,1
CLL Guide,1
Potential Concerns,1
https://t.co/NL3iI5NPmU,1
Mechanism of Action &,2
Combination,2
CD8+:CD4+ #CART,1
Delta One,6
Clinical-Grade Expansion/Differentiation,2
Identify Cells,1
Transformation &,2
AcuteLeukemia https://t.co/n7PXWZnBOs,1
Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review,5
High-Risk #CLL,2
U.S. Customs,1
Ibrutinib-Refractory Chronic Lymphocytic Leukemia,1
Clinical Outcomes,1
ROR1 &amp,2
Follows,1
@HOPARX,1
At-Large @HeidiDiann,1
https://t.co/qGMtnOSkqQ,1
MPLN,4
#IgVH SHM,1
DHL @lymphoma &amp,1
GenomicData,1
skyrocket https://t.co/xWUukOfCWM,1
P Langerbeins,1
Elias Campo #,1
Elias Campo #CLL,1
time evolution &gt,1
antigen &amp,1
https://t.co/Z8AIorKXEm,1
w/ P Langerbeins,1
@tdhlf @lymphomahub @lymphoma,1
Global Chronic Lymphocytic Leukemia Therapeutics Market 20152019 Prices,1
https://t.co/1znyp2MWyQ,2
Translocation,1
Slows Down Progression,1
Corner Cafe,1
CDF,1
https://t.co/Thg8geshXX,1
https://t.co/jE1cw2w2fw https://t.co/WSniBPIbe8,1
Refractory Chronic Lymphocytic Leukemia CLL Pipeline Review H2 2016 Prices,1
Refractory Chronic Lymphocytic Leukemia CLL  ,2
#Inhibitors #Oncology #,1
Recommendation for Diet During Watch,1
Honokiol,3
https://t.co/kXh4PFXCAb,1
Jamieson,1
"charreftouna &lt;3
",1
https://t.co/jscV9sq8tP,1
S Stilgenbauer,1
https://t.co/ydgjtqXH73 Includes,7
SLC,1
SFO,1
TSA,1
DFW,1
The Power of Virtual Connection,2
Drugs May Confer Survival Benefit,1
Global Chronic Lymphocytic Leukemia Treatment Options,3
@myESMO,1
Tolerable &,1
Refractory Chronic Lymphocytic Leukemia CLL Global Clinical Trials Review H2 2016 Prices,1
Understanding Biology,1
Treatment Options,1
Relapsed/Refractory Setting https://t.co/zeQPM0gWmt,1
A Study Venetoclax,1
Current &,1
https://t.co/t84OM9YsbU,1
The Next Generation of Targeted Molecules,1
CLLI,1
LymHub,2
PubPDF - Full Text Article,1
Precision Medicine &,1
Mutation Detection Advances,1
https://t.co/ZLzLBY4apD,1
WAF1/CIP1,1
SocialMedia,1
the Lymphoma Coalition @knowyournodes,1
lobbying &amp,1
MPN Horizons,1
SMP,1
estudio de sensibilización,1
de los,2
Watch &amp;/or Wait,1
https://t.co/VbD5mdJ1d6,1
NL,1
mpncll16  #,1
IOS Android,1
Windows #,1
https://t.co/MVQkgxXBAW,1
Ireland CLL Support Group,1
mpn,2
https://t.co/5bJwcYCi7A,1
Evolution of #CLL Therapy,1
Clinical,1
Focus on PFS Endpoint,1
Antigen Receptor Stereotypy,1
https://t.co/msCGWoO9Gw #LymSM #,1
FRET,1
H50,1
https://t.co/uNjgwq8e08,1
Leukemia - Life Expectancy,1
Non-Hodgkin&amp;#039;s Lymphoma,1
LeukemiaAwareness,2
Sin,1
NADA,1
TargetedTherapies,1
#Health #Professional #Version - PubMed - NCBI,1
https://t.co/ZBuwdmnrWC Includes,1
Leukemia https://t.co/LImcR8MvKf,1
hope &amp,1
SupportiveCare,1
https://t.co/S6v2DRcERi,1
@BloodJournal reg,1
https://t.co/2StErbtzdE https://t.co/fIgwRXxYC3,1
Posttranscriptional Upregulation,1
Reactive Oxygen Species,1
@BloodJournal w @anthonymatomd &amp,1
Acute Leukemia,1
Standard of Care &,1
Importance of Clonal Evolution https://t.co/yHVDDdbTzw @UniCologne,1
ChemoImmunotherapy,1
CLL-IPI https://t.co/MHAaPA3PkC @VJHemOnc,1
Transcriptomic Characterization of Mutation Reveals Its Pleiotropic Effects,1
Verastem Licenses,1
#InfinityPharmaceuticals,1
@GENbio #oncology #,1
Management of Chronic Lymphocytic,1
Patient Cafe®,1
#CancerResources #Oncology,1
Blood https://t.co/RI4qjby9xI #LymSM,1
ada,1
banyak jenis,1
Improve Therapies,1
Student's &amp,1
https://t.co/UqkyG7pskt,1
Prague &,1
Thx Prof Trněný &,1
https://t.co/DrMfiOHROp,1
https://t.co/DfKSw4jNjg,1
Western Canada,1
1D,1
https://t.co/IryrdLlfqx,1
Include #Novel #,1
juga,1
https://t.co/F8E50kAkNr  #,1
Importance of Considering,1
Tumor Lysis Risk Status,1
Medische #,1
"to~
Acute Myeloid Leukemia",1
SAVE,1
https://t.co/TM0sDD0kXS,1
Second-Generation #,1
@andrewschorr @MDAndersonNews @ColumbiaMed,1
A2,1
Global Relapsed Chronic Lymphocytic Leukemia,5
Clinical Trials Review,1
CureClick,4
CLB,1
@andrewschorr @wwierda @MDAndersonNews #Leukemia,1
https://t.co/XZCTWjSTsl,1
@LeukemiaMDA @ColumbiaMed &,1
https://t.co/YPFEMhSS3K,1
Minimal Residual Disease Predicts Survival,1
Market Analysis Research Report,1
https://t.co/NVO9KEYmVM,1
#Regulatory,2
Pharma @abbvie @Roche,2
Best Practice Research Clinical Haematology,1
https://t.co/lxTcHNfYQQ,1
ABBVIE,1
CMP,1
https://t.co/QrvR0JgpM9,1
mutations &amp,1
Oral Agents,1
https://t.co/VBOIZ8Xs19,1
#Leukemia #Epigenetics #Genetics #Oncology https://t.co/axgQhYCX5l,1
Research to Overcome Problem of Resistance to New #CLL Drugs,1
LittleLeague,4
@ArenaHayward #MuchDeserved https://t.co/erKssxrajz,1
Indole-3-Carbinol Synergizes,1
LIH’s Department of Oncology's,1
https://t.co/4ssvSIv23d,1
https://t.co/3JBTGAK7MS,1
Auf,1
@AKAarsalan,2
LYN Kinase,2
https://t.co/jUPvxUUMkl,1
JNJ,2
Flying Cows,1
https://t.co/9HULPjShkv,1
https://t.co/CCvuqiIRaU https://t.co/mnD3j2cjsA,1
Worldwide Relapsed Chronic Lymphocytic Leukemia,4
Ke... https://t.co/md2IB1b10,1
Pos Metro Batam,4
https://t.co/S1XlPY6L3B,1
https://t.co/ACusUcgn0b,1
the Value of Treatments,1
Experiencia,1
St olav Waterway https://t.co/HMt7KmmX13,1
Rainbow,1
Influence of Treatment Modality on Outcomes,1
Global #DNAmethylation,1
Importance of Educating Patients,1
Hallek @UniCologne &amp,1
LYN,1
@ColumbiaMed @LeukemiaMDA &,1
https://t.co/Jr1xPG6Cim,1
IL-1,1
https://t.co/17o3F9DdNG,1
https://t.co/oPEjWMBY7m https://t.co/P5fqrCN3sy,2
IL-17A,1
IL-22,1
https://t.co/RBjKw7Qhoi,2
xD &,1
https://t.co/QU8aydQMxr,1
@power4patients &,2
@Intakeme https://t.co/HlWQBVlOUb,1
#Compartir #,1
eUpdate,2
https://t.co/dPafR9uCVi,1
unturned!#Cost-Effective Service,1
https://t.co/xOhkBgZQVG,1
@McMasterU #,1
CME/CE Webinar,1
JLL &,2
FST,2
The Evolving Role of Chemoimmunotherapy,1
https://t.co/wXgZT0XgTn @nyphospital,1
PML #,1
PPT Slides - https://t.co/IFv21xwAa1,1
https://t.co/u6XQV7EyH1,1
https://t.co/7BXjcIM0s2,1
MD Discusses Risk Assessment,1
Combining Evolutionary Perspective,1
#Genomic Methods,1
GCLLSG) #Hematology,2
CHC2016,1
@ASBMT,1
C5 Building Mae,1
PrimaryRocks,1
Hypoechoic Nodular Spleen and Liver… https://t.co/s0kdM8F4Zj #,1
ASBMT,1
Katyal/Johnston,1
@CancerCareMBFdn,1
https://t.co/xHuSnzLRAV,1
Peter MacCallum Cancer Center,1
Refractory Chronic Lymphocytic Leukaemia With 17p Deletion,1
CLL Meeting,1
https://t.co/GCDgMDaSsI @EMJReviews,1
"Obinutuzumab, Ibrutinib &",3
1L &,3
Rel Chronic Lymphocytic Leukemia,3
PatientCafe,2
#Oncotarget Cross,1
MayoClinic,2
HodgkinsLymphoma,1
CLL - $,3
Customs,1
the Evolution of #CLL Therapeutics https://t.co/vUTmwxoaV5,1
https://t.co/XCyjRcuZ9I New Report Available,1
Combination with Fludarabine &,1
@NIH Dr Wiestner,1
MedicBoard https://t.co/1lHepjuelZ,1
ThemaDerWoche,4
Global Refractory Chronic Lymphocytic Leukemia Market,5
@WeillCornell &amp;@nygenome,1
evolutionary &amp,1
https://t.co/TTG7JI6ow8,1
#Leukemia Awareness Month,6
️#baba👑,1
https://t.co/X7II4Pj5li,1
BLCTT,1
Prospect &,1
https://t.co/wLM6u7VXId,1
osoba,1
https://t.co/xBuDernylx,1
Safety and Efficacy Considerations,1
Safety of CLL Treatment and Reimbursement,1
ELP,1
Live Webinar,1
New ESMO Guidelines eUpdate Chronic,1
ConstructionLien,1
@SUMedicine,1
https://t.co/WSo37bNlsm,1
AmericanCancer,1
https://t.co/bdwlmMBKjs #,1
Ibrutinib Active,1
DYK Chronic,1
https://t.co/97Usb0aBRo,1
Queretarock,1
https://t.co/2JQwb15MA6,1
@dukemargolis  conference- Impatient Patients Part,1
@WinnipegRHA Wave,1
First-Line Therapy for Chronic Lymphocytic Leukemia,4
CLL Study Group,1
https://t.co/LgpmXuOh2q,1
100k,1
Infografik,1
JPM,1
ClL,2
Venetoclax Produces High Response Rate,1
survivorship &amp,1
Cenkos Securities Ltd.,1
Cello Group - https://t.co/8qhwbBJgGe - #,1
PowerfulIn2016,7
PoliceUnited,1
OFFER - TODE20150318001/GERMANYScientists,1
Thompson et al #Atrialfibrillation,1
OT,1
Donnerstag,1
de las leucemias linfáticas crónicas,3
NCCN Guidelines for Patients,1
Overcoming #Immunodeficiency,1
https://t.co/Ip409D9VKB,1
NOD,1
New Data,6
Uruguayan,1
@Sidnavigare https://t.co/03EUA9pjTB,1
Medical Insurance Billing &,2
Doctor Office,2
HELIOS,3
Novartis/Genmab’s,1
Young/Fit #,1
The Usual Suspects',1
https://t.co/vK0Mvu50LH,1
Cheson Highlights Choices,1
CancerRes,1
@VJHemOnc @UniofOxford #Leukemia,1
@BloodJournal w @anthonymatomd,1
PatientPower,1
Autoerotische Abenteuer,1
Global Chronic Lymphocytic Leukemia,3
Resource,1
CLL Canada,1
1st Review,1
Imbruvica/Chronic Lymphocytic Leukemia(CLL)/Small Cell Lymphocytic Lymphoma(SLL,1
Expanding Options,1
https://t.co/k5rizUTDs9,1
#idelalisib,2
Ohio State University,1
El día de hoy,2
Patient Selection for Treatment With Ibrutinib,2
Mutational Landscape and Underlying Mutational Processes,1
BatamPort,1
Inherited Genetic Variant Increases Risk of Chronic Lymphocytic Leukemia,1
Global Chronic Lymphocytic Leukemia Market Research,1
CPH,1
Ideal,1
BRIEF-Genmab:,17
@NovartisPharma,1
BMF Super-Enhancer Polymorphism,3
"Beckwith, Kyle; Novel Immunotherapeutic Strategies for Chronic",1
@conlinmccabe &amp,1
Flow Cytometry,1
Minimal Residual Disease Assessment Improves Prediction of Outcome,1
New Upfront Treatment Algorithm Emerges,1
Symptomatic Hypercalcemia,1
Initial Therapy for Patients with Chronic Lymphocytic Leukemia,33
New Upfront Treatment Algorithm Emerges for Chronic Lymphocytic Leukemia https://t.co/ny3LWrylQJ #,1
Additional Indication of #ChronicLymphocyticLeukemia #,1
Distinguished Professor,1
TG Therapeutics Announces Orphan Drug Designation For TGR-1202,2
Functional Differences,1
IgM &amp,1
https://t.co/zexBNeekh7,1
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated,2
Fludarabine-Refractory Chronic Lymphocytic Leukemia,1
TG Therapeutics Announces Orphan Drug Designation for TGR-1202 for Treatment of Chronic Lymphocytic,2
TG Therapeutics Announces Orphan Drug Designation for TGR-1202 for Treatment of Chronic Lymphocytic Leukemia,4
Fabio Kerbauy - SP,1
Orphan Drug Designation,1
BRIEF-TG Therapeutics,3
CLL-IPI Validated,1
Newly Diagnosed Patients https://t.co/n79zIdUnBn,1
TG Therapeutics Announces Orphan Drug Designation for TGR-1202 for Treatment of Chronic,1
TG Therapeutics Announces Orphan Drug Designation for TGR-1202 for Treatment of Chronic Lymphocytic Leukemia https://t.co/5sdpS5UxLm,1
https://t.co/BQjd2ZPhQL,1
OncologyTube,1
Your HealthCare Team,2
CLL - Target TOSO,1
XPO1,1
CCNNA,1
PROVINCIADESANTODOMINGO,1
NNA,1
Patient Cafe,1
Vax,1
https://t.co/ZrprX0fucv,1
CLL Patients Responded,2
https://t.co/FWt41tElmz,1
https://t.co/ez1ZGK0edX #,1
Priority Review for @Novartis,1
national &amp,1
https://t.co/3iBw1FCBzj,1
BMF Super-Enhancer Polymorphism https://t.co/CwtMPAA9W4,1
#BloodCellsMolDis Cryoglobulinemia,1
#Genetic,1
SLims https://t.co/DCzBbnpVvj,1
https://t.co/1PNfLPAglt,1
@PS4CoDFAs,2
CHC,2
NewEvidence,2
the Cod Local League,1
VIDE0,1
@Swedish https://t.co/M0t1TDId2A,1
MOV,1
Leukemia - Peripheral Blood,1
CLL https://t.co/7139nQlniR,1
"CLL 
 ",1
https://t.co/IgdsdUbkCq,1
Atypical Pneumocystis,1
💥🏐💚,1
Baby Come Back,1
CUB,1
Maravilloso el Gimnasta,1
JuegosOlimpicos,1
PLATA,1
BRONCE Individual,1
GBR,2
COL,1
JPN,2
Roche MabThera SC,1
el Título Olímpico Individual,1
#AliBshow #PokemonGo,1
@timfenske  &amp,1
PowerfulPatient Video Blog,1
PatientCafe Participants,1
💥🏐,1
agents &amp,1
Hilar Nodes,2
The Changing Therapeutic Landscape of Chronic #LymphocyticLeukemia|https://t.co/7PH0xK9nel,1
The Changing Treatment Landscape of Chronic Lymphocytic,1
GeorgeDuke,1
The Hematologist #CLL,1
#Inhibitors Be Combined,2
Potential Risks that Influence Treatment,1
ATTACK,1
ENVIRONMENT,1
Consolidation Appears Effective,3
https://t.co/aCm8t5suS8,2
https://t.co/E0Jglkjnkj,1
@ICGEB,1
Second IWCCLL Compilat,1
Onclive,3
The Changing Treatment Landscape of Chronic Lymphocytic Leukemia,1
CureClcik,1
New Health Hashtag 👉 #,1
Cello Group Plc,1
B-NHL &,1
Onclive https://t.co/nMA7ou3cv2,1
https://t.co/iubCBHf5AP,1
QOL Essential,1
Ibrut https://t.co/pq80D9RkC2,1
#LYMPHOMA &,1
"Patience 
https://t.co/gQe9fTHnFt",1
NYGC Publication-Clonal,1
HELIOS Trials,1
BRIEF-Janssen,14
https://t.co/O7571plOa0,1
https://t.co/aY7sFc51j7,1
H1,1
Classic Loveline,1
Dr Kahl,1
PeerView https://t.co/BjpePtm9Nq,1
Dr Armitage,1
White Dinner,1
Eliot,2
NOUS,1
ASH2014 https://t.co/6xxz3z9XeF,1
Global Chronic Lymphocytic Leukemia Treatment Industry Report,1
https://t.co/2DATlR683o,1
mantle cell lymphoma &amp;chronic,1
Minimal Residual Disease Negativity,1
https://t.co/2KWuK6ARs6 #,1
Varied,2
Imbruvica® Effective,2
Recurrent Chronic Lymphocytic Leukemia,2
Global Chronic Lymphocytic Leukemia Market Size,1
CLL Study Group's,1
https://t.co/08uikESZeQ #,1
hRRM2,1
PBR,1
Second-Line Treatment for Chronic Lymphocytic Leukemia,2
DogLeukemia,1
Non-Hodgkin #,1
Unique NGS Panel,3
https://t.co/JEyzxPBZpr https://t.co/K4P6x0HvFv,1
J Jones,1
Barr @UR_Med &amp,3
CJ Chris-,2
2016 - Research and Markets,1
2016 - Research and Markets https://t.co/sW04zkriWy,1
https://t.co/bOS4zzGOw6,1
HRQOL,1
@MaurerStats  https://t.co/gs3GehB0Nw,1
"Cancer Genetics, Inc.",4
Unique NGS Panel for Chronic Lymphocytic,3
Unique NGS Panel for Chronic Lymphoc,1
Hematology Practice Implications From ASCO,1
SPIT,1
auspol New,1
Libs,1
@MDAndersonNews @Daver_Leukemia,1
DIA2016,1
màs màquinas,1
@MDAndersonNews @LeukemiaMDA #,1
https://t.co/4iYSJ3v20k,1
Campeón de Madrid,1
#Receptor #Inhibition Paints,1
#European #Approval,1
"Breast, &amp;Lung Cancer",1
https://t.co/6kddKPyBKG - Chronic Lymphocytic Leukemia,1
Auston Matthews #,1
NHLDraft,1
Technavio Announces,5
MRD-Negative Status,2
PR Newswi,1
@Novartis,5
https://t.co/0UoBfy5Q2s,1
https://t.co/fsgJyOOqif,1
@jenniferzarou &amp,1
The structure &amp,1
ScrewCancer,1
"Израиле

Читать:",1
#Oncotarget Deregulation of SOCS5,1
Unanswered Questions - https://t.co/OwCWrmOVH5,1
B12,1
Non-Hodgkin’s Lymphoma Patients,1
French FILO Group,1
🎶,3
Global Refractory Chronic Lymphocytic Leukemia,5
2016 - Research,1
2016 - Research and Markets -  ,1
ATE,2
https://t.co/LTmNGdP9S7,1
#Blood Integration,1
The International Prognostic,1
Global Chronic Lymphocytic Leukemia Market Growth,3
2020 - Analysis,3
Technologies &,4
@EHA_Hematology https://t.co/8bzlMGZzCQ,1
Ibrutinib Highly #Effective,1
Cancer Data &,1
Outcomes Conference,1
Rabbitte,1
Govt,1
PRT,3
Android,1
https://t.co/LCmIn7HI1C,1
Dr Jones,1
Calculate,1
Leukemia Awareness,1
https://t.co/qI6bOkNS7w,1
Potential for Chronic Lymphocytic Leukemia,3
Efficacy Data,1
Clinical Predictors,1
Non-Hodgkin’s,1
Davide Rossi,1
https://t.co/MP1MEZafMq,1
FCR Regimen Confirmed,2
Central,2
Stilgenbauer &,1
Download Lyft,1
Überblick,1
cisplatin,1
Phenotype &,1
Global Chronic Lymphocytic Leukemia Market Trends,1
Special Regulatory Designations to Create Opportunities,1
"https://t.co/PaYCiOeMcc
Link",1
ORR &,1
J. Soumerai @MSKCC_OncoNotes,1
N. Lamana @Columbia,1
https://t.co/ErNpYsdUCD,1
.@abbvie &amp,3
FDA Grants Venclexta,1
Bendamustine &amp,5
LLC - https://t.co/Y2gycK2qnd  #CLL,2
First-Line Treatment of Patients with Chronic Lymphocytic Leukemia,1
New Ibrutinib Combination Regimen Shows Substantial Benefits,3
https://t.co/Knw1uDzNoW,1
New Drug for Chronic Lymphocytic Leukemia,22
Info for Patients with Chronic Lymphocytic Leukemia,1
https://t.co/HNGhhc2uY9,1
@roche #CLL RT,1
https://t.co/Cwr7g6c7Gy @roche,4
RT https://t.co/0kUlH1fhUc,1
CMLL,1
TherapeuticExploitation,1
CLL RT,1
KRAS &,1
First-Line Treatment of Patients w/ Chronic Lymphocytic,1
MabTherea,132
CDF https://t.co/kkdnpzs9ke,1
https://t.co/zaZcsxgavF,1
https://t.co/DO9NlMhu2y,1
Roche's,1
Lampson,1
https://t.co/0nhtYgzh48,1
Cancer Drugs Fund,1
First-Line Treatment of Patients with Chronic Lymphocytic,2
https://t.co/dvm0fU8ZNA,1
@Roche #CLL,1
https://t.co/8Va8s0hemn https://t.co/HcESBVYEZG,1
First-Line Treatment of Patients with Chronic Lymphocytic Le,1
Approval For IMBRUVICA For Chronic Lymphocytic Leukemia Treatment,1
https://t.co/aDocP2ZQev @BloodJournal,1
Approval For IMBRUVICA For Chronic Lymphocytic,1
https://t.co/2IgGbW129C,1
Doublet,1
https://t.co/YV2SXpA89q,1
First-Line Treatment of Patients with Chronic Lymphocyt,1
Approval For IMBRUVICA For Chronic Lymphocytic Leukemia,1
First-Line Treatment of Patients with Chronic Lymphoc,1
EU Commission,1
ABBV European Commission,1
First-Line AbbVie Newsroom,1
First-Line Treatment of Patients,1
Channel News Asia,1
European Commission for Patients with,1
SETD2,1
https://t.co/Xy9fFvnCxt,1
HealthNews,6
https://t.co/aYO2p6CLsQ,1
ZURICH,2
https://t.co/7HyoEY8cdM,1
Article Roche's,1
https://t.co/LYzfFjqEav,1
https://t.co/wSNiSkfJfN,1
https://t.co/2xoJIiGquT,1
https://t.co/2P5VNtu3DR,1
https://t.co/pESRGf4BQM,1
https://t.co/siz9pcBX57,1
FDA Approved New Drug For Chronic Lymphocytic Leukemia In Patients With A Specific Chromosomal Abnor,1
the council of Islamic Ideology #Cll,1
@QMUL @MDAndersonNews @LeukemiaMDA,1
Kwok M,1
Davies N,1
advt,1
@KlasraRauf @AmirMateen2,1
IslamicState,1
OACR,1
@LLSNYC @MDAndersonNews @CllSociety,1
https://t.co/o1c07WcZSW,1
Lymphoma #PHASEII_INT,1
Sags,1
https://t.co/iKEJ9PGM95,1
@LLSusa @LLSNYC,1
Approves New Drug for Chronic Lymphocytic Leukemia,1
https://t.co/PlyNpiSCZ5,1
https://t.co/thXPn6TzSe,1
Patient Power's,4
https://t.co/cOQlnhZ0I1,2
MicroRNA Expression,5
@Genmab's,1
Vitamin D insufficiency &amp,5
AbbVie/Roche's,2
https://t.co/0aQaOgFniY #,1
CD-20 Antibodies,2
SPRY2,1
Habitat for Humanity,1
VAT,6
https://t.co/EVO3YXJz3l,1
ClinCancerRes,1
https://t.co/D30uRfyOf5,1
CD126,4
Previously Untreated Chronic Lymphocytic,1
IGF/mTOR,1
Larry &,1
https://t.co/08NLvP9wHu,1
@LLSusa @LLSNYC @ImermanAngels,1
"A Town Meeting for Patients, Families &",6
Care Partners,6
https://t.co/Qs4f0YFBtY https://t.co/5sZQ4e6XXO,1
https://t.co/rgaUy46vjm,1
@MDAndersonNews @ColumbiaMed @columbiacancer,1
cll https://t.co/6e6de8EtYk,1
SMPs &amp,1
#Combo,1
w/ @MDAndersonNews &,1
https://t.co/NQlkarZTei https://t.co/GceD3OjC9v,1
Relapsed/Refractory Del(17p,1
https://t.co/jUF4ImN64I,1
https://t.co/m38G8aBDgb,1
https://t.co/NQlkarZTei https://t.co/MdxXLzPrYH,1
SHU,1
TELT Menu,1
Ian Pollard,1
@gear_4_music,1
Include Overall Survival Data,3
Weill Cornell,1
Optimizing Treatment for,1
Include OS Data,1
HDL,1
clonal &amp,1
NOTCH1 &,1
C91.11 Chronic,4
https://t.co/0fYkMy8vKv,1
LuchaLibre #Wrestling,1
@CllSociety &amp,1
the Food and Drug Adm,1
CIENCIASMEDICASNEWS,1
https://t.co/HxRW4UIDUT,1
https://t.co/YtQsOskAsq,1
https://t.co/R9GPP7rQe1,1
https://t.co/4Vm6AAnySX &gt;integrin,1
Global Chronic Lymphocytic Leukemia Market Analysis,1
Bendamustine + Rituximab Effective,1
https://t.co/SzZaYNyqPq Join,1
https://t.co/HNKKBWWuXJ,2
-15,1
@MDAndersonNews @QMUL,1
Solid Malignancies,1
Janice,2
the Use of Venetoclax,1
CLL Treatment,1
ABT,1
European Medicines Agency,2
ScienceDaily,1
nonhodgkinlymphoma @BloodJournal  https://t.co/OdvavUFOjS,1
WeillCornell,2
Extra-Adrenal Myelolipoma Containing Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case… https://t.co/9ZuDN2Xq9J #leukemia,1
@Intakeme https://t.co/IFt9fQBmjX,1
"@MDAndersonNews @ColumbiaMed 
&amp",1
TAMBIÉNESHABLARDELHOMBREYSUSDERECHOS,1
EV,2
PowerfulPatient https://t.co/bwfg93Fn3Z,1
https://t.co/Rz5gFgwk32,1
https://t.co/gHfjuYYU9Z,1
w/ @MDAndersonNews 's,1
ON THE PHONE/WEB: Want,1
NEW RESEARCH SHOWS WHY IT IS DIFFICULT TO CREATE CHRONIC,1
Patients w Chronic Lymphocytic,1
GANAR,19
https://t.co/680mTpIUsR https://t.co/4gIDdBOMWW,1
Leukemia - New Drug Approvals,1
https://t.co/aDH7fMXkx6,1
https://t.co/Qqp7XhSC7,1
https://t.co/g8jh7BlDIk #,1
Treat Chronic Lymphocytic,1
https://t.co/OZ7aGwz9v6,1
BioSpace] Venetoclax Approved,1
https://t.co/gSzBVEz0Pq,1
@columbiacancer@WeillCornell  &amp,1
@MDAndersonNews https://t.co/UPU2iGYcw9,1
https://t.co/fYCg2yzp7P https://t.co/uL1je4kIWd,1
Dr Stephan Stilgenbauer on Chronic Lymphocytic Leukemia,1
https://t.co/tAb2cwV0Ty,1
w/ @SeattleCCA 's,1
https://t.co/lIx0YRsfsu,1
The Coachella Valley Takeover,1
Diamond or Nothing Else,1
https://t.co/swovFgik8,2
@WeillCornell@MDAndersonNews &,1
101 Chronic,4
https://t.co/cX908BslvD #,1
NCCNac2016,2
DPLO - Diplomat,1
MABTHERA,1
Eastern Little League,1
Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia,1
the U... https://t.co/zQE7tvEciQ #,1
New Drug for Chronic Lymphocytic #Leukemia,1
@MDAndersonNews @UCSDHealth @CancerTodayMag,1
breakthrough designation &amp,1
LABline,1
https://t.co/XlGRdTrNtw,1
@AlaricD_BPI,1
@Roche Venclexta,1
@psich_en,1
Biomarker Proteins,1
@patientpowereu &,1
@abbvie @genentech #,1
the First BCL-2 Inhibitor,4
Colomer D,1
LLS Welcomes FDA Approval,2
FISHprobe,1
Caspase3,1
STAT3 &,1
a Type of Chronic Lymphocytic Leukemia,5
The US Food and Drug Administr,2
https://t.co/g22h9spvkd,1
@Drugscom @abbvie @genentech,1
@HECTORYEMMI,1
https://t.co/cbgINuNhns,1
Pharmafile https://t.co/5p5bLbEl2L,1
https://t.co/8aQ3Ew5hHz,1
AbbVie Receives,2
FDA Accelerated Approval of Venclexta,8
Venclex... https://t.co/ixcbMITbHS #CML #,1
"Global Chronic Lymphocytic Leukemia Market Insights, Epidemiology",1
https://t.co/N0qnmggpKH,1
New Treatment Option for Hard-To-Treat Type of Chronic Lymphocytic,1
Venetoclax Approved for Patients With CLL,1
The US Foo,1
Lymphoma Society Applauds Approval,1
https://t.co/Nb3lRk7jzN,1
Venetoclax Gets Accelerated,1
the First BCL-2 Inhibi,1
el venetoclax para el,2
https://t.co/qETDPBvvUe #lymsm,1
https://t.co/NutxL2mmRT,1
Accelerated Approval,1
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients,7
Accelerated Approval for People With a H,1
#AbbVies,1
FDA Green Lights #AbbVie,2
"New Chronic Lymphocytic Leukemia Drug Venclexta

  ",1
w/A #,1
https://t.co/7sZcJ7P9qO #,1
https://t.co/nUNLo70nC5,1
FDA Approves Drug for Chronic Lymphocytic,1
CONSTELLATION,1
New Chronic Lymphocytic Leukemia Drug Venclexta,4
Hooray,1
AbbVie &amp,1
#Vencexta @genentech @Roche @abbvie,1
Abbvie's Caancer,1
https://t.co/twWJKwB1Ox,1
https://t.co/HOLmm5Ss9M,1
https://t.co/5DA5gtIFFB,1
Small-Molecule Inhibitors: Ibrutinib,2
a... https://t.co/AD2novCVdc #,1
https://t.co/SsL7cxx3gV,1
https://t.co/sRhNBSfVa9,1
Bejaia for Champions League,1
Zamalek #CAF #,1
First-Line Ibrutinib Improves PFS,1
Maintenance Lenalidomide Has Limited Feasibility,2
JCI,1
https://t.co/akw3SpjVys,1
STELA,1
the Feinstein Institute,1
Tarli,1
https://t.co/MGn04YPjEI,1
Journal of Clinical Investigation,1
https://t.co/TQvBvyn5k1,1
w @UCCancerCenter @UChicagoMed &amp,1
@HematologyNews1  ,1
the Hospital Experience of,1
CLL  ,1
#Supplements @MDAndersonNews,2
Keating of @MDAndersonNews,1
@UCSanDiego @MDAndersonNews @Bannermdandersn,1
NCCN Recommendations for Relapsed Patients With,1
https://t.co/wSKYomo704,1
Tweetchat &,1
First-Line Ibrutinib Improves Progression-Free,1
el unico,1
IGHV1-69,2
HIV-1,2
LdnOnt @habitat4home,1
https://t.co/L4deLz7IHb,1
@UCCancerCenter &amp,2
Dr Allan,1
FDA Denies,1
https://t.co/kL1KOvCoZN,1
https://t.co/yJBc0qxI0,1
#Idelalisib):,1
@straightgrain &amp,1
@MDAndersonNews https://t.co/h7EjilJbPW,1
https://t.co/icc1Hiv1kL,1
Relapsed Chronic Lymphocytic,12
@MDAndersonNews @QMBCI @PetermacCC,2
Incidence &,1
https://t.co/s1Gglc0hO6,1
Merrill https://t.co/NxOu4yo1sX,1
Citation Classic,1
Strategies for Maintaining Response,3
CNBC,1
Österborg,2
https://t.co/K8wBhzNkuN,1
Nike+,13
Geriatric,1
Hodgkin’s Lymphoma,3
CXCR3/CXCR4,1
PI3K Signaling,2
Normal B Cells,7
NCCN - Lymphoma News,1
@MDAndersonNews @LeukemiaMDA  ,1
https://t.co/RSVcu54cFN,1
LLL,1
PowerPoint Slides - https://t.co/IFv21xwAa1,1
el próximo,1
EspañaItalia,1
OncoTherapy Network https://t.co/QuTw130vHE,1
DLL,1
depression &amp,1
130p,1
group &amp,1
PCODR,1
#AskTheDoctor,4
Mayo Clinic - https://t.co/JDcfNfeYcF,1
the Cancer Network https://t.co/nkp9XIVnnb,1
Hair &,1
Lymphoma Overview,1
SAWYER,1
NH,1
Torneo Nacional de ayer,1
Next-Generation Small Molecules #CLL #,1
Leukemia Suggest Potential New Uses of Existing Canc,2
@MDAndersonNews @QMBCI @PetermacCC and,1
NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic Leukemia,14
https://t.co/BLnDEmcWlN,1
the ePatient Health Academy,1
@intakeme @power4patients,1
@prairielakes,1
GS,1
@anthonymatomd and @ASH_hematology &amp,1
https://t.co/neJoFieJcW,1
Leukämie - Welche Maßnahmen,1
First-Line Therapy for Chronic Lymp,1
gat,1
News Network,1
FDA Halts Six Idelalisib Combination Studies,1
https://t.co/SgqJ2myZ4B,1
Recommendation,1
Missed Endpoint,1
Bendamustine/Rituximab Improves Outcome,1
#Imbruvica Indication,1
https://t.co/gPyVudpDnP @Pharmacyclics,1
standard &amp,1
Hematology Treatment Center,1
Mayo CLL Group,1
Adverse Outcomes,2
@MDAndersonNews @QMBCI @PetermacCC &amp,1
https://t.co/RK5L0x3W3b,1
Transposon,2
AbbVie Inc. &,1
https://t.co/njNoXmwIwk,1
ROR1 inhibitor https://t.co/j5Vzw3heAz &gt,1
GreatNews,1
the First-Line Treatment of Chronic Lymphocytic Leukemia,2
https://t.co/UnqzDgx1Sv #,1
@TheUSONetwork @MDAndersonNews @UFMedicine,1
https://t.co/UbHlTS0oRK,1
NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic #Leukemia &amp,1
Hodgkin #Lymphoma,1
PATHOGENESIS,1
the First-Line Treatment of Chronic Lymphocytic,1
J&amp;J/AbbVie's,1
Shari,2
RT PatientPower #,3
https://t.co/3ZkhrVlRmZ,1
the First-Line Treatment of Chronic Lymphocytic Leukemia https://t.co/rnccbDHbql,1
First-Line Treatment of Chronic #Lymphocytic,1
@drugscom @AbbVie,1
RareDisease @wwierda,1
The US Food and Drug Administ,3
The US Food,1
the First-Line Treatment of Chronic Lymphocytic Leukemia https://t.co/jzsFB37kBH,1
the First-Line Treatment of Chronic Lymphocytic Leukemia - https://t.co/vaXplU4qqT,1
the First-Line Treatment of Chronic Lymphocytic Leukemia - https://t.co/9Y0QTEHrt1,1
Stallone,1
First-Line Treatment for Chronic Lymphocytic Leukemia,12
Pharma Cos News,1
https://t.co/L6o064PmtY,1
@Mesarg,1
https://t.co/7m16Q0gmAk,1
https://t.co/Q5MhOJvOmZ #oncology #,1
https://t.co/NvB7EniuoY,1
Leukemia Patient-Friendly Guides Put,2
NCCN Patient Education Resources for Patients with Chronic Lymphocytic Leukemia,1
FDA Grants Chronic Lymphocytic,2
Leukemia Drug Priority Review,2
MM https://t.co/zpRYa3oG7P,1
C91.1 Chronic,2
NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic,1
NCCN Publishes New Patient Education Resources for Patients with Chronic,1
Curab,1
https://t.co/iG3ESuYxVj,1
https://t.co/WY2KqN8NIb,1
WVCI,2
Imbruvica For,1
The Relationship Between Genetic Testing,2
BMT Journal,1
Higher Risk for Other Cancers,1
https://t.co/GPPeG4kl5H,1
WES,1
Higher Risk for Other Cancers https://t.co/7ThAT5qy1j,1
"Higher Risk for Other Cancers 
 #",1
RR-CLL Correlation,1
Immune Characteristics,1
Leukemia - Cancer Therapy Advisor https://t.co/0143EDsnCy,1
@MoffittNews #watchandwait #CLL,1
@sloan_kettering &,1
@LeukemiaMDA @Bannermdandersn,1
Anglo-Norman England,1
ILK,1
TNFalpha,1
@MDAndersonNews #,1
https://t.co/WX5wmx8seo,1
@ColumbiaMed @MDAndersonNews &,1
P2 Team,1
Front-Line Chemoimmunotherapy,3
READING &amp,1
Cisplatin-Based Immunochemotherapy,1
TeamDiabetes,13
Ottawa Hospital - General Campus,2
https://t.co/I71t0Fk4Ku,1
The Value of CT Scans,2
https://t.co/IvgJZxsoch,1
@TrialX,1
https://t.co/5b7lEtFnNp,1
OncologyPRO,1
Valor,1
https://t.co/7a3Qj1vcac,1
PowerfulIn2016 https://t.co/ApFZ5ohb3A,1
Azerra Delays Cancer Progression,1
FCR Immunochemotherapy?,1
"Management of Chronic Lymphocytic Leukemia
Stephan Stilgenbauer et al",1
PowerfulIn2016 https://t.co/OM8xbZRXdi,1
Patient Power Team,2
RT ClinicalProfess Researchers,1
https://t.co/jwCXpqgp5P #Healthcare #Cancer,1
#Healthcare #Cancer,1
https://t.co/Ol9faIMMQ9,1
ada Chronic Lymphocytic Leukemia,1
https://t.co/QLIkd7HgyG #,1
the Inflammatory Drive,2
yaitu Chronic,1
Burger,1
Front-Line Chemo-#immunotherapy,1
https://t.co/yjFqFcTvMc,1
Chal #CLL #,1
https://t.co/SYVzspnP4I,1
FCR Immunochemotherapy,1
Combination w/ Rituximab,1
LSD,1
The Oncology Newsletter,1
@UCCancerCenter &,1
@MDAndersonNews -Combining New and Emerging,2
Popular Science,1
+ @genentech @Roche,1
Anti-TOSO #CAR #,1
"Venetoclax Safe, Active",2
SLL With Poor Prognostic Features,2
Leukemia - #Pipeline #Review,10
Novel Molecules,1
Supportive Treatment,1
Pathogenesis of Chronic Lymphocytic Leukemia: Cytogenetics,1
@DrJitsu,1
Venetoclax/Rituximab Combo Gains FDA Breakthrough Designation,2
Retweeted Blood Journal,1
Leukemia: https://t.co/OQn7g3B2mF,1
MD @UCIrvineHealth Update on Chronic Lymphocytic Leukemia,1
Venetoclax Granted New Drug Application,1
Eagle Pharm Announce Commercial Availability,1
https://t.co/B3spkUxvPk,1
Basquet,6
Combination w/ Rituximab for Leukemia,1
ISAC,1
https://t.co/gibLp7w4d6,1
@curemagazine-,1
https://t.co/AkzLc3iPcg,1
Front-Line Idelalisib,1
Idelalisib Improves Progression-Free Survival,1
Markierungen,1
https://t.co/AxF6cF40nk,1
MedHuérfanos,1
Venetoclax - BCL2,1
🏹B-cell,1
@marrow,1
https://t.co/IQEhIoUyI1,1
https://t.co/6j6wsry1B7,1
A @MDAndersonNews Expert's Review,1
ASH15 News,1
Hemoglobin News Clinical,1
@Roche RT,1
Lacrosse,1
@PODuff,2
Extended Treatment,2
https://t.co/OW0R2Zt4bI,1
https://t.co/E4PscaNt8W,1
https://t.co/BjxPKk0rZ5,1
Complete or Partial Response,1
https://t.co/bxOwAe3CxR,1
@Roche PRT,1
https://t.co/zyeQwpNrYL,1
CFM &,1
IMAGE,1
Complete or Partial Response https://t.co/4sU67cK2Lz,1
Leeds University  https://t.co/ZjkTFwF81S,1
https://t.co/8H8gp7KKnx,1
Combination with Rituximab for the Tre,1
Response Rate,1
https://t.co/X9diVApVvC,1
Complete or Partial Response https://t.co/nahlI65YnN,1
#RichtersSyndrome @MDAndersonNews  https://t.co/PUpBbTkqzH,1
@LeukemiaMDA #,1
@SeattleCCA,1
Bruton Kinase Inhibitor,1
the Management of Chronic Lymphocytic,1
#Canada #,1
https://t.co/5Ja6qnbK9C,1
Venetoclax Priority Review,1
Second-Line Treatment,1
700th appearance &amp,1
@Roche @AbbVie,3
@ColumbiaMed @MDAndersonNews @LeukemiaMDA @UCSDHealth,1
https://t.co/r6hP3LnTz9,1
U.S. &,1
Estov  @LeukemiaMDA &amp;Dr,1
Combination #Clinicaltrials,1
@LeukemiaMDA  https://t.co/AX6YB0zsC6,1
MDA,1
CLL Study,1
#Venetoclax New Drug Application,1
Zumba w,1
Gribben &,1
European Regulators Accept Applications,3
the First Potential BCL-2 Inhibitor,1
@LeukemiaMDA  https://t.co/i9oLY8KP8W,1
@UFMedicine,1
CLLMDA,5
los logros de,1
https://t.co/IYUfiRLQ8k,1
TweetDeck,1
#CLL news,2
Dr. Follows #CLL #,1
monotherapy &amp,5
The Plan Works,1
https://t.co/T8b3R4bhTW #,1
Centro - Peruíbe https://t.co/ikNZgmLdQX,1
MDACLL,1
para pacientes de #,1
linfática crónica &gt,1
Industry - Pipeline Review,1
Novel Treatments of Special Cases,9
Liga Provincial,1
@UCSDHealth,2
Wierda @LeukemiaMDA @wweirda,2
Ibrutinib Bests Chlorambucil,3
CLL Society Newsletter,1
@QMBCI @PeterMacCC &amp,1
https://t.co/S47LmIeOdW,1
https://t.co/htw0h9qhcD,1
Treanda &,1
Bruton’s Tyrosine Kinase Inhibitor Safe and Effective for Chronic Lymphocytic Leukemia,1
Ibrutinib-Treated,1
New Drug Approvals Bring Hope,4
@ItsBayleyWWE,1
Rituximab for Previously Treated CLL,2
Small Lymphocytic #Lymphoma https://t.co/ud0M0gc4vb @TheLancetOncol,1
#Obinutuzumab/#Venetoclax,1
@LeukemiaMDA @TheUSONetwork,1
https://t.co/854SswrFIA,5
La banda,1
Alemtuzumab Active,2
Large Granular Lymphocytic Leukemia - https://t.co/0CB1Zo9t1J,1
Fellow #CLL,1
Large Granular Lymphocytic Leukemia,1
https://t.co/zcOFtIGBzj,1
Italiana,1
de Tarrasa,1
Patient-Powered Research Networks,1
Therapeutic Combinations,2
@MDAndersonNews @LeukemiaMDA https://t.co/vleExyfUbw,1
B-Lymphoblastic Leukemia,1
LSS,1
New Drug Combination Improves Outcomes,2
FMNI Student,1
Santa,1
/via,1
KFSHRC,1
w/ BTK,1
Collaborators Present New Data,1
Refractory Chronic Lymphocytic Leukemia Patients,9
Veux,1
Leukemia Suggest Potential New Uses of Existing Cancer Drugs,7
Leukemia Suggest Potential New Uses of Existing,3
Next-Generation Drug Challenging Imbruvica,1
Initial Therapy for Patients with Chronic Lymphocytic,1
nonHodgkinlymphoma #Bendeka,1
https://t.co/os4JDzdVzm RT https://t.co/91spRfao1z,1
TOO,1
Leukemia Mutations Uncovered New Uses of Existing #Cancer Drugs,1
ADV,1
TLS 3/56,1
w/Venetoclax,1
Banner,1
New Cancer Drug Effective,1
@Elaine Schattner,1
https://t.co/8fUrz0mihQ #,1
The Q3 Chronic Lymphocytic,1
Cyclin-Dependent,1
JNK,1
Novel Agents Increasingly Individualize,1
@ONAcom,1
GM,1
https://t.co/aBHaQ0TuBh #,1
RT https://t.co/s1DUAVPJwm,1
Tashify.com,1
https://t.co/Lfh9cQdJKO,1
Forbes] Venetoclax,1
Buy Lops,1
https://t.co/HXi89JQoQH,1
@ForbesTech,1
https://t.co/R0cAvjJ6vX #,1
#News Venetoclax,1
https://t.co/y3tH7ozYnM,1
TNN,1
https://t.co/wFhkQ4XSWr,1
New England Journal,1
No Safety Concerns in Trial,1
CIT-Treated #CLL https://t.co/4sWFM1UtG7,1
@BusinessWire,1
Leukemia Suggest Potential New Uses of Existing Cancer Drugs https://t.co/6SdaYOUUPr,1
Roche;Non-Hodgkins Lymphoma,1
https://t.co/RIR8t98w8Q,1
https://t.co/6RmH0ImcXw,1
CLL - Nodes,1
https://t.co/GScolfpvsm,1
https://t.co/P4iBny6Tdd,1
https://t.co/AfHB3jtUpi,1
RES,2
https://t.co/xW3OJTG1bY,1
Phase 2 RESONATE-17 Data Show Robust Clinical Activity,1
Helena,2
Leukemia Suggest Potential New Uses,1
https://t.co/MZlLiEz5uO,1
Chemotherapy for Treating Cancer,1
https://t.co/fDljSw13AI,1
Phase 1 Venetoclax,1
https://t.co/Eru2kg4WDf,1
standard chemo https://t.co/UDlu3A5qxS,1
https://t.co/HLy0fOT0p7,1
AbbVie Announces New England Journal,1
https://t.co/JGeINso0PX,1
MedicalXpress,1
https://t.co/t3ATVYm6kj,1
Ibrutinib Improves Survival in Treatment,2
AbbVie Announces New England Journal of Medicine Online Publication of Venetoclax Phase 1 Data,5
ABBVIE ANNOUNCES NEW ENGLAND JOURNAL OF MEDICINE ONLINE,1
RELAPSED/REFRACTOR,1
https://t.co/zF22Wqo4Hk,1
RT ChpHealthcare Mutations,1
AbbVie Announces New England Journal of Medicine Online Publication,3
The Kind of Cancer,1
Early Outcomes for Patients w/Rai 0/1 #CLL,1
the Connect #CLL Cohort Study,1
LIVE Webcast #AmericanSocietyofHematology,1
https://t.co/GQRer68aBq,1
2nd Generation BTK,1
Gazyvaro NOWY,19
PBL,19
https://t.co/T14X5Kp6US,1
AbbVie Announces New England Journal of Medicine Online Publication of Venetoclax Phase 1,2
Ibrutinib VS Chlorambucil,1
TreatmentNaive Chronic Lymphocytic Leukemia Patients,1
Relapsed/Refractory Chronic Lymphocytic Le,1
Practice-Changing Trials,1
Roche ASH,1
Orlando: Data on Chronic Lymphocytic Leukemia,1
https://t.co/Jl5h3dMlOC,1
United States Chronic Lymphocytic Leukemia Therapeutics Industry,1
https://t.co/UbTuHZbjhO,1
@Mariet_Martinez de #UnacancionparaNovalie y de #CLL,1
https://t.co/zyrd5DXxOo,1
https://t.co/cq2V1wqyoa https://t.co/bJt1FaP9uT,1
CLL News,2
Drs Jeff Sharman &,2
Kanti Rai &,2
Quality Improvement Approach,1
the Evolution of #CLL Therapeutics,2
https://t.co/5S9OFbC0NS #EmergingDrugs,1
Favorable Safety Profile,1
https://t.co/aQTOjJrbOz,1
CLLSA Meeting,1
IMPPC,1
queremos la,1
#sergio #petsitting,1
ScienceSwitzerland,2
Powerpoint Templates - https://t.co/IFv21xwAa1,1
The International Cancer Genome Consor... https://t.co/YNxlokT8Gq,1
CacyBP/SIP,1
#Patient,3
Farhana,3
United States Chronic Lymphocytic Leukemia Therapeutics Industry Review,1
EFL,1
https://t.co/YxrQT0Q1nS,1
https://t.co/PnBuFHbhlb,1
Sept Patient Cafe,1
CXCR3,1
CAL-101,4
Tolero,1
Gilead’s Zydelig® Combined,2
https://t.co/DnTns9WT2W,1
UGH,1
DH Cancer Drug Fund,1
Neupogen Shot for Stem Cell Donation https://t.co/5zzI0M1jMj,1
Bespoke Human Immune Cell Assays - Blog https://t.co/hpj1mhh237 #,1
Infinity Announces Completion Of Target Enrollment,4
A Phase 3 Study,3
https://t.co/5sCpF9X2Kc,1
Gilead’s Zydelig,1
#Novel,1
#Challenges #Remain,1
RT https://t.co/zO1EJl8JPn Gilead,1
A Phase 3 Study https://t.co/RQyrnKDHDF,1
https://t.co/GSjQWyjCNC,3
SLL RT,1
https://t.co/d7DJ9Fa22D,1
Phase 3 #,1
Their Own Words,1
BAX/BCL-2 RATIO,1
LPL &,1
Afternoon Session Replay,2
@NTUdigital #,1
USOncology,1
Modern Art,1
Bauhaus,1
@wearecare,1
Glad,1
@KathyCollins15 &amp,1
Analysis for Chronic #Lymphocytic,1
@haematologica https://t.co/UZdKAh8pFj,1
Download - https://t.co/n4gSXBeRiV,1
TravelAlberta #,1
https://t.co/X5YjxDIIyL,1
ACPMA,2
https://t.co/QQzL5FNcb2  @ACPMAChapter,1
Request,1
Positive &,2
Large-Scale Genomic Analysis Gives New Insights Into the Chronology,1
Evolution of CLL,1
Multiple Recurrent Mutations Linked,1
Haematological Illnesses,1
https://t.co/euMeItTe2F,1
Leukemia - Cancer Therapy Advisor,1
RT https://t.co/Lg1JUF4HI9,1
Tokio,1
The Q2 Chronic Lymphocytic,1
gimnastas,1
el Título Absoluto Individual,1
TDN,1
ASU Alumni Artists Club,3
ASU,3
The Institute of Applied Bi... https://t.co/6E7L4xXxQe,1
non-Hodgkin #lymphoma &,1
Heinz,2
TESL Canada,2
Focus on Chronic Lymphocytic Leukemia,1
TheCommission,1
Register for Breakthrough Developments,1
AML @ColumbiaMed @Columbia,1
#Potential,1
https://t.co/EnrkpoMhIa,1
FCR Achieves Long,1
ReseachBib,2
CER,1
Anderson Hospital,1
Idelalisib Plus Rituximab Highly Active,2
CLL Powerpoint Presentations - https://t.co/DzzjXouUWD  ,1
https://t.co/0kE9xJlzkO,1
SCANDAT,1
CSTCPD,1
provocan el,1
MYC Translation - Potential New Therapies,1
Paris Nov,2
@WCMNYPJCTO,1
#OneGoal #FasterTogether,1
PLL #,1
Bryan/College Station,1
Lancashire Lge/Nth Lg,1
SQ Veltuzumab,1
https://t.co/ZEFMeGFP83,1
https://t.co/flpMhCtvae #Leukemia,1
International Hematology Club https://t.co/8XvdjzYdjH,1
the Cure - Tired,1
copa de gchu,1
Empowerment and Learni #CentralHouston #,1
Initial Findings Show Acceptable Safety With Ibrutinib for Asymptomatic,1
New Clinical Trial for Patients with Relapsed or,1
http://t.co/5tQmQh2u8w,1
http://t.co/TbF5XYGTSf,1
http://t.co/qabuPfFcuO,1
ThursdayRecap,1
IPH2201,1
Empowerment and Learning,1
JustPosted,1
the Genetic Background of Chronic Lymphocytic Leukemia,1
Previously Treated Subjects,1
KnowledgeIsBestRx @MDAndersonNews,4
BMS,1
InnatePharma,1
http://t.co/j3F8sVqxSX,1
omega3,1
MCHC,1
MCV,1
http://t.co/Sw8x9vTuTQ,1
Success,2
#wait #,1
NHL Star,1
Paradigm @MDAndersonNews #,1
"Penn, Memorial Sloan Kettering &",1
AMI,1
Research and Markets: Global B-Cell Chronic Lymphocytic Leukemia Pipeline Review,1
http://t.co/tgAVk7B8Zc #,1
Innate Pharma Opens,1
http://t.co/eiJvInvb4V,1
Hematology News Absence,1
Austerite,1
First Personalized,2
"Trial, Long-Term Remissions",2
Myeloma 2015 http://t.co/IjY2ElY6AH,1
http://t.co/kEzsqIp6xZ,1
Advocacy Group,1
@Datamonitor_HC,1
Barts,1
Cultural Heritage #Conservation,1
#CLL Meeting,1
@Bannermdandersn @MDAndersonNews,3
ONS Meeting - Gazyva®,2
Blood Bank Study: No Evidence of Leukemia Transmission Risk,1
Relapsed/ Refractory Chronic Lymphocytic Leukemia,2
"CLL
 Entradas",1
Gilead #Sciences,1
the Treatment of Untreated and Relapsed/Refractory,1
@TippinAaron n @SammyKershaw,1
Aggressive NH,1
Int J Dermatol,1
@Gilead,1
England &,1
Wales,1
Ph.1b/2a,1
IPH2201 &amp,1
@IDIBAPS,1
AbbVie Announces Submission of a Supplemental New Drug Application,3
a Proactive Patient,4
@dwodarz,1
mAb,1
CardiacGenomics Tumor,1
FDA Grants #Priority #Review,2
Myeloid Malignancies,1
Supplemental New Drug Application for Treatment-naive,3
CLL Submitted,1
Cholecalciferol,1
Vitamin D Deficiency,1
http://t.co/6lhFqQEriK,1
#Options,1
Powerpoint Presentations - http://t.co/IFv21xwAa1  #,1
Unique,1
Prof Ghia,1
Supplemental New Drug Application,3
BS of @LeukemiaMDA #,1
Transplant,1
@wwierda  'Cellular Therapies,1
Global Chronic Lymphocytic Leukemia Therapeutics Market 2015–2019 Report,1
Disease Biology',1
TG Therapeutics Announces Special Protocol Assessment,1
CLL @LLSusa,1
the First Phase 3 Clinical Trial for Patients Chronic Lymphocytic,1
the Management of Patients,1
#biotechnology Research and Markets,1
CELLO GROUP,1
Medical Sciences,1
Supplemental New Drug Application for Treatment-naïve,1
+6% &amp,1
AIM @VOXmarkets,1
A2:,1
WORLD LYMPHOMA AWARENESS DAY,1
Point,1
Supplemental New Drug Application for Treatment-naïve Chronic,1
http://t.co/7pPZavUuhm,1
EMJblog,10
a Chronic Lymphocytic Leukemia,1
Single-Cell Analysis,1
Supplemental New Drug Application for Treatmentnaive Chronic Lymphocytic,1
Haemato,1
Haemato-Onc Relaunch http://t.co/wabDqGv0hB,1
Colonie Little League https://t.co/Vbag6ncEbx,1
vamos lucho,1
MTL,1
1st Group of Patients to Receive Personalized Cellular,1
Stanford,1
Ritz,2
http://t.co/Tbd699Odlz,1
http://t.co/Dyc82XyNwp,1
BMB,1
http://t.co/6dMtSAJPac Pew Research Center,1
Research and Markets: Global Chronic Lymphocytic Leukemia Therapeutics Market,4
#biotechnology Research and Markets: Global Chronic Lymphocytic Leukemia Therapeutics Market,1
SYD,1
CIRS,1
Global Chronic Lymphocytic Leukemia Therapeutics,1
CLLlive,1
Journal Geriatric Oncology #,1
DTES,1
http://t.co/gdRozi1SR2,1
VoteJKT48ID,1
REOLYSIN,1
Targeting Peripheral &,1
Krise,1
getting @Penn &amp,1
Participants With Chronic Lymphocytic Leukemia Story,1
First Group of Patients to Receive,1
North American Education Forum,1
lymphoma &amp,1
Participants With Chronic Lymphocytic Leukemia,2
PAL's Trial Talk,1
림프구성 백혈병(Chronic,1
Follicular #Lymphoma http://t.co/vaj5A9JnpO,1
GOOD NEWS @genentech &,1
@abbvie &,1
workouts &amp,1
Center for Learning and Leadership,1
Dyer,1
Antigen Expression,1
BoneMarrow - The Spongy Tissue Inside Bones Where Blood Cells Are Made,1
the Newest Regional Executive,1
NBC,1
darmian &amp,1
poin penuh,1
NORD,1
Safety and Pharmacokinetic Study of BTCT4465A,1
GM-CSF,1
"Lymphoma
Exosomes",1
Real Madrid,1
http://t.co/81ct0leKZI,1
AML&gt;MYELOCYTIC LEUKEMIA(jd,1
LYMPHOBLASTIC,1
PET/CT,3
Patients with Lymphocytic #Leukemia,1
#Immunophenotyping,1
http://t.co/Xoot6vLnta,1
The Ottawa Hospital,1
@CLLdoc &amp;Dr,1
the Future Hold,1
NCCN Guide,1
Reference Guide,1
parabens teamo,1
el regalo baaammmmmm,1
cll-122#18,1
El Último Lonco International Trailer,1
chilena,1
Recognition,1
Lymphoma Society Applauds Encouraging Data,1
Route of Administration,2
41612 - Sandler Research,1
http://t.co/yyWPvCDcrJ,1
KnowledgeIsBestRx @Bannermdandersn,15
http://t.co/kyO4q4RnrV,1
American #,1
BestFreinds,1
LCSM,4
Ibrutinin,1
http://t.co/Byy5t8cC5,1
あれからとても考えているくらい、あたしの中で点になったイベントだった！,1
Venetoclax Met Primary Endpoint,1
• Large,1
• Chronic,1
ODER,3
GeriatricMed,1
http://t.co/zUcSWxP7Pk,1
CRAZY LIFE LAB面白かった！,1
Reaaaaal,1
Con Tam,7
Con Tam #MOGA15,1
the New Business Partners Joining,1
Hetero,1
University of Texas Discuss Findings,1
New Cell Line Model,1
VirtualMeetups,1
"Leukemia
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia",1
Perturbation of the normal,1
"Hai :X

",1
Research and Markets: Global Refractory Chronic Lymphocytic Leukemia,2
Companies &,5
Drug Profiles,4
GenArray,3
RT conkers3,1
global insight &amp,1
New Approvals Shift CLL Treatment,1
Review of Novel Therapeutics,1
Older Patients http://t.co/BxhOoRnlba,1
IDELALISIB,1
http://t.co/OOU5uFFv3R,1
Identify Proteins Relevant,1
Global Medical Discovery,1
Leukemia - A Medical Dictionary,2
Annotated Research Guide,2
The New Movement,1
IWU,1
PLC,1
http://t.co/tGYbu5emL5,1
GNMSF $,1
Outcomes of Patients With Chronic Lymphocytic Leukemia,5
Transformation After Transplantation Failure,7
http://t.co/eMLzXTIjdY,1
News @CelloGroup,1
AUG @ScienceinSport,1
GBO,1
Newest,1
ChristineLeeTIC,3
MDACC Hematologic Malignancies Retreat,1
Anderson Hematologic Malignancies Retreat,2
FAB,1
TACI,1
KnowledgeIsBestRx,1
the Contemporary Era,1
Untreated Chronic Lymphocytic Leukemia,2
CRC,1
http://t.co/VpSFAHNHHH,1
http://t.co/O2M7WxVZl3,1
PracticeUpdate,3
Benda,1
The ASCO Post Ibrutinib + Bendamustine-Rituximab Called New Standard,1
Patients With Previously Treated,1
Chronic Lymphatic #Leukaemia,1
http://t.co/S3NwakQ2Df,1
http://t.co/Gf7rswA7HG  ,1
u &amp,1
neva argue &amp,1
Poitou-Charentes,3
MeenaSurieWilson - Author,1
Multiplicom,6
New Health Hashtag,1
Clinical Research Coordinator,1
NewVia,1
@cityofhope Drug,1
http://t.co/XbhSWckiTG,1
Protein Profiling Suggests Venetoclax,1
Optimal Partner,1
"Cancer Genetics, Inc. Awarded Largest Clinical Trial in Company",1
KnowledgeIsBestRx @MDAndersonNews @power4patients http://t.co/LAXXer6ggN,1
KnowledgeIsBestRx @MDAndersonNews @power4patients,2
PPT Slides - http://t.co/IFv21xwAa1  ,1
FelizLunes https://t.co/AszwY1KSkh,1
PiezaÚnica,1
Roche &,1
Biogen MabThera,1
Follicular B-Cell,4
RT CancerWallonia,1
LIRILUMAB,1
Przewlekła białaczka limfocytowa,1
http://t.co/OqFGv0u0Eq,1
alberteinstein board review,1
Horizon After Positive #Phase #III #Combo #Trial With,1
https://t.co/zhusLBvYdP,1
tengo mi mochila,1
#Baxtter #Bariloche1Mes #Cll #CSM,1
the Rock&amp;Roll Review,1
the Pennine League,1
el corazón de cualquier,1
Leukemia@kkmaggon,1
miR-181b,1
Cancer/sNews: Proteins,1
сша,2
PowerPoint Slides - http://t.co/Hd3ypNweNh  ,1
BFR,1
Dr Khouri @MDAndersonNews,1
fpv,1
http://t.co/xetbGNlm2y,1
Advantages of #Monoclones,1
Reports Outline Chronic Lymphocytic Leukemia Study Findings,1
Pharmacyclics Inc.,1
Outcomes of Patients with Chronic Lymphocytic Leukemia,2
Leukemia / Small Lymphocytic #Lymphoma,1
ASCOU Tumor Board,1
Tucci P,1
miR106b,1
PP2A - http://t.co/gXPcpng8jo,1
EHA20,1
CT019,1
Reunión,1
EHA #Hematology,1
First Press Conference,1
GNW-News,1
.@Novartis &amp,1
@Bayer,1
BCL,2
#German Team Develops,1
Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage,1
@Moshcam,1
Comprehensive Analysis of Disease-Related Genes,1
Adapt,1
John-mother &amp,1
SurvivorSelfie,1
https://t.co/d30I5NTYH2,1
http://t.co/CSiZS7OWMh,1
http://t.co/lLyPDsLxdl,1
http://t.co/v2CCUOiKtG,1
RT http://t.co/s8LvP9mr2B,1
Cancer News Ibrutinib,1
http://t.co/NwabKYld9j,1
LCB,1
3rd Team,1
RT http://t.co/SmQLlPwA9L,1
Improved Survival for Treatment-Naive Chronic Lymphocytic Leukemia,1
Improved Survival for Treatment-Naive Chronic Lymphocytic Leukemia Patients in Phase III,1
Improved Survival for Treatment-Naive Chronic Lymphocytic Leukemia Patients,1
http://t.co/kLjcZgqgTH💎,1
Tuveson &,1
NfKB,1
type &,1
Nfkb,1
IFN,3
米国臨床腫瘍学会の生涯教育サイト「慢性リンパ性白血病の治療」：Management of Chronic Lymphocytic Leukemia,1
CLL http://t.co/CF4sScrw8,1
the US FDA,1
evaluating &amp,1
Combination With Ofatumumab Improves Progression-Free Survival,3
Previously-Treated Patients With CLL,1
HELIOS Interim Analysis Study Data Show Significant Reductions in Risk of Progression,11
New Ibrutinib Combination Regimen Shows Substantial Benefits in,3
Wally Yocum,1
Meet Wally Yocum,1
Previously-Treated Patients w/ Chronic Lymphocytic Leukemia,1
CLL Progress,1
Previously-Treated Patients With CLL - http://t.co/FCRUVpQEmj,1
U15,1
duvelisib,1
EntrepreneurMindset,4
Dose of IMBRUVICA,4
Previously-Treated Patients With Chronic Lymphocytic,1
Long-Term Safety,1
ANDA,1
Previously-Treated Patients With Chronic Lymphocytic Leukemia,1
DrPatel,1
GML,4
JWL Wood Cup,1
CLL HELIOS,1
I+BR,1
Wendy Stock,1
Relapsed Chronic Lymphocytic Leukemia http://t.co/TjNiAguKeh,1
HELIOS Interim Analysis Study Data Show Significant Reductions,1
De... http://t.co/09aGIWi8UX,1
LYMPH NODES SHOW FREQUENT,1
http://t.co/1hHuDWbjA3,1
Dr Jones Explains Relapsed Chronic Lymphocytic,1
The CARE #Hematology Session,2
http://t.co/NCcQrwHN9M,1
Great League,1
SUV &amp,1
Update on Treatment &,1
Evaluating &,1
Managing Options,1
https://t.co/kOqwQ87NOh,1
Randy,1
PEN Board,1
Dorwal P,1
http://t.co/gZ2YlPEG6a,1
The Cancer Experience Registry,1
Heywood CC,1
http://t.co/agFfVsOvXp Ask,1
Relapsed/Refractory #Lymphoma,1
@dailytelegraph,1
747,1
RT patient,3
Inspired &,1
CSC,1
the Chronic Lymphocytic Leukemia Center,1
Dana-Farber Cancer,1
Safety and Cost,2
The 6 Ethics of Life,1
zarejestrowane w Europie,1
IκBε,1
IL-21 http://t.co/V2ERiMVOjo,1
InstaHorse,1
Drawing First Blood http://t.co/DPNZqPliYz,1
Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia  Evidence,1
JEM,1
Inhibits Proliferation and Induces Apoptosis,1
https://t.co/sNA2yJIFZD,1
Kinase Inhibitor,1
Clinical Review,2
#College Station,1
CD-47,1
https://t.co/W3f0G9E9TD,1
Team,1
http://t.co/WZwfey64Ci New #CLL #Patient Stories-How,1
wi... http://t.co/FsOcGSLrzu,1
😏,1
http://t.co/QMP3fnhioF,1
Moertel Lecture @ALLIANCE_org,1
http://t.co/ixzGJtl7ud New,1
RR B-non-Hodgkin #,1
Investigational Medicine Venetoclax Receives Breakthrough Therapy Designation,6
allogenic SCT,2
http://t.co/44Ly5YwhvL,1
TG Therapeutics Announces Clinical Data,1
http://t.co/phrx1UKCE4 New,1
http://t.co/MCoqOWdg2B New,1
http://t.co/Go9dkr2L1h New #CLL #Patient Stories-How,1
Volver Volver,1
MT @mtmdphd,1
Weill Cornell Clinical Trials,1
http://t.co/256Do46MxZ,1
ITP - Chronic Lymphocytic Leukemia,1
the #Pathophysiology of #CLL http://t.co/q8Yy1PdU3c,1
Guy #Horion,1
Liverpool,1
New_shit_Dans_Les_Bacs,1
ToundraBoy,1
Health - Google News Chronic Lymphocytic Leukemia Breakthrough Drug Gets Approval,1
Leukemia Breakthrough Drug Gets,9
FDA - WallStreet,9
MT @JAMAOnc Predicting Prognosis,1
WallStreet OTCChronic Lymphocytic Leukemia Breakthrough Drug Gets,1
WallStreet OTCChronic Lymphocytic,1
AbbVie Receives Breakthrough Designation for Cancer Drug,1
http://t.co/ooHAniAfnA,1
Breakthrough Therapy Designation @US_FDA,1
CLL http://t.co/o2XNVjSUqi #CancerNews,1
Venetoclax For Chronic Lymphocytic Leukemia With 17p Deletion,1
CLL - Communication &,1
Support https://t.co/hLdhDkMBat #lymphoma,1
cor,1
el más guapo,1
el amor,1
cll) http://t.co/RphXhL2PDq,1
The Hematologist,2
@ULHS #Renting,1
ALW,1
j'y pensais,1
Combo Delays #Progression,1
Canada Empowers #CancerPatients #CLLLive,11
Nicht,1
http://t.co/2IFZ21rBrC A,1
P,1
CLL Molecular Onc Tumor Board,1
Ivanhoe Newswire,1
http://t.co/PwAWBN72FM,1
http://t.co/dBEBYOm8YZ,1
Phase III #,1
Up-Regulates,1
the MiRNAs Hosted,3
Parana #U15,1
Upstate NY,1
http://t.co/XtViLD85K8 A,1
@LeukaemiaAus #FDA,1
http://t.co/JhrhHZdzyT,1
Health Beat - Home,1
Symptoms of #CLL - Chronic Lymphatic Luekemia,1
Ekata,1
http://t.co/dk2kpl0Ad7,1
UCSD Moores #Cancer Center,2
EVER,1
the Central Lancashire League,1
Longer-Term #Data Demonstrate Durable Responses,1
RIP140/NRIP1,2
Incl Complete Responses,1
CLL Molecular Oncology Tumor Board,1
Lymphoma Program,1
the Pathophysiology of Chronic Lymphocytic Leukemia,1
Molecular Oncology Tumor Boards,2
Longer-Term Follow-Up Data Demonstrate Durable Responses,2
AACR15 Followup,1
http://t.co/UMZxREpf8I,1
JE,2
@HeysideCC,1
LLC - http://t.co/KDeqZTqxpT,1
Altas,1
Outcomes of Patients With Chronic Lymphocytic,1
Sanlam Securities,4
Tumor Board,1
Virtual,1
http://t.co/rzG6uGWEbs Virtual,1
ImpactPaques,1
dx'd CLL,3
Small-Molecule Inh,1
Monoclonal Antibodies,1
Geoff &,1
pathologist &amp,1
Clb,1
Outcomes of Patients With,2
http://t.co/uXmQ1lZ4k0 Virtual,1
OpportunityAnalyzer,1
http://t.co/QeLtp6diaZ Virtual,1
Genetic &,1
Outcomes of Pts With Chronic Lymphocytic,1
http://t.co/N7TGzAuYrm http://t.co/nKCVsvC5hk,1
TMJ,7
Knees,7
AJH,1
http://t.co/Fv2fDvbSrB,1
Nodality Unveils PathPro Chronic Lymphocytic Leukemia,1
the Ataxia,1
Atypical Chronic Lymphocytic Leukemia,1
conhecendo galera nova,1
Little League Opening Day 2015,1
SAR245408/XL147,2
"Lymphoma
Pharmacological",1
PathPro,1
#SingleCell #Nodality,1
Practica,2
ROS Modulation,1
http://t.co/Ou1nTYlpcl For,1
@jonasasouza,1
#Hematology #Health,1
de Santiago,1
@LLSAZ,1
Leukemia Development / #CLL #,1
#Blood Journal,1
Patients with Recurrent or Persistent Chronic Lymphocytic Leukemia,1
Leukemia / Small Lymphocytic Lymphoma,1
enn fortjent,1
#Costly,1
Deutsche,1
TEL,2
EfficientUnis,1
@8am &,1
https://t.co/h1B42Pzr69,1
Hematología RECURRENT MUTATIONS REFINE,1
SNPmicroarrays,1
USCAP2015,1
GGC,1
SNParray,1
the City Living London,1
Newcar #,1
NRBCs @,1
University of the Sunshine Coast https://t.co/zZKcuwQ5C2,1
el salón #,1
de tu #CLL,1
Bcell Lymphoma,1
las niñas viendo,1
Patients With Previously Treated High-Risk #,1
http://t.co/r9BxCZxPRB,1
Las chicas del Lucho,1
CANAM CLL,1
Whangarei Hospital #,1
Imbruvica Significantly Delays Disease Progression,1
Treanda/Rituxan/Imbruvica,1
ISI,1
http://t.co/CfrROVve2W,1
NonHodgkin Lymphoma,2
AMAZING,2
https://t.co/cttTqlfWBL,1
General Information About Chronic Lymphocytic,1
Practica #,1
Nenussssss,1
http://t.co/CaYjyOPs2W,1
http://t.co/GOyj0fZ3Wb,1
The Lymphoma Hub Awards,1
Addenbrooke's,1
am &,1
Spoonie,1
@jisc,2
SEDA,1
the Changing the Learner Landscape,1
MD ANDERSON Clinical Trials,1
Shirt,1
#openhouse2015,1
Super Crazy #ECW,1
ECW,1
First-Line Treatment Selection,4
Super Crazy,1
@g_ermaan,1
Upfront Treatment,3
#Chileluchalibre,1
Herkenbaar,1
Haemato-Oncology,1
Monoclonal B Lymphocytosis,1
MT @MDAndersonNews #Innovation,1
WNYPE,1
https://t.co/qxOL7KU1hE,1
Penn Researchers Report,1
con la promo,1
the Wolf Survive,1
@dhoneysett CWU 3,1
RBI,1
MSU,1
the Moon Shots Program,2
Medical News,1
Leben,1
http://t.co/rYyQL5wKeJ #,1
http://t.co/Y5x9CMugVT,1
Researchers Examine Etiology of Ibrutinib Discontinuation,1
BBC News - Leukaemia:,1
Mati ✌,1
#Services,1
New Zealand Conference on Geomechanics,1
http://t.co/pxxDx7CdjW,1
NZTA,1
Completed Cliff Stabilisation,1
Cliff Stabilisation,1
@LLSusa @teamintraining @TNT_EPA,1
CFA,1
civilworks,1
Lisp Like Language인 #,1
C Like Language,1
http://t.co/hqQ3e72b7K #,1
http://t.co/2x7KL4c6nl,1
La conversación con las chicas jajajajaj,1
http://t.co/cNQ0MtpBEJ,1
Autoimmune #Hemolysis Other,1
MT @ASCO,2
🐴,1
Heavily Treated,1
VHIR,1
http://t.co/wVhl6fWtog,1
#Bendamustine Rapid Infusion Product,1
Heavily Treated Chronic Lymphocytic,1
Heavily Treated Chronic Lymphocytic Leukemia Patients Following Allogene,1
Alison Michie &,1
Pharmacyclics Inc,1
Heavily Treated Chronic Lymphocytic Leukemia Patients,1
http://t.co/M5z2sVDNRR,1
Heavily Treated Chronic,1
Heavily Treated Chronic Lymphocytic Leukemia Patients Following Allogenei,1
Heavily Treated Chronic Lymphocytic Leukemia Patients Following Allogen,1
Hoy,1
The Evolving Role of Hematopoietic Cell Transplantation,1
Novel Btk Inhibitor Heads,1
UWI,1
http://t.co/m8SZ9ENZk3 Calling,1
Buy @CelloGroup,1
#Newsletter,1
http://t.co/davHvjXWcX Calling,1
http://t.co/R67g4T2ifw Calling,1
http://t.co/nqCKjidiwV,1
http://t.co/I4FFjTXdou,1
#IGGYA #FD,1
Quien Al #Cll,2
"OT
&gt;Forklift Operator-",1
TechOffer,1
SCG,1
http://t.co/6gxFpaYnfL,1
XmAb5,1
miR-3676,1
Anti-CD44,1
http://t.co/b6JuYORmY5,1
Sutton,1
http://t.co/bD2orF1ZOU,1
Hedgehog/GLI,1
Mantle Cell Lymphoma Treatment,1
http://t.co/OE9wd3EybJ,1
Mutation Analysis,1
Anderson #Leukemia,1
http://t.co/V8758lQnnx,1
CLL - OncLive #,1
#Dentistry,1
Kiss ♡♡♡♡ #Muuaxx,1
@docphin,1
这就是距离 !,1
Mobile Technology,1
the Sensory Learner,1
Names ‘#Cancer Advance,1
Dutch Hematology,1
MTV Awards,1
crazy &amp,1
http://t.co/tGMVWFXNTz,1
Transformation of Treatment for Chronic Lymphocytic Leukemia,1
http://t.co/dPF5egAGOm,1
Research and Markets:,2
Discontinuing Ibrutinib,1
http://t.co/3glIcUQKEv,1
"RT 
#",3
Sold Out,2
DonateloPen,1
City Living London,1
LRS #,1
the Lavender Moon,2
Drug-Free Macromolecular Therapeutics Induce Apoptosis of Patient Chronic Lymphocytic Leukemia Cells,1
Aberrations http://t.co/oDdhyTCBj7,1
the Molecular Landscape,2
OUTCOMES,1
http://t.co/l4SBigfcKM,1
http://t.co/pQf72IvfYU,1
homie &amp,1
Bestfriend,1
Friends,3
Anfield,1
Lymphom,1
https://t.co/WRtTkZ0PiY,1
IMMUNOCHEMOTHERAPY,1
